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Abstract 
In this thesis I explore strategies to building better primary health care systems for 
Indigenous peoples with a focus on management and prevention of vascular diseases. This 
body of research takes a multimethods approach and is conducted in two inter-related 
parts. 
Part A: Effectiveness of primary health care for Indigenous 
peoples 
lbis stream of research examines one important aspect of health care quality- effectiveness 
of clinical care. I initially focus on health system monitoring by reviewing how adequately 
the New South Wales (NSW) Department of Health reports, by Aboriginal status, against 
; 
national performance chronic disease-related indicators. I identify substantial limitations in 
the quality and breadth of indicators reported in NSW and propose several strategies to 
improve monitoring capacity. A key recommendation from this review is the need for 
robust data from the primary care sector. I then provide a response to this recommendation 
through the conduct of a case record audit in Aboriginal Medical Services (AMSs) 
assessing the effectiveness of primary health care for a variety of clinical measures. In 
addition to two other studies I have co-authored, involving mainstream Australian general 
practices (Appendices A and B), I demonstrate widespread under-performance in the 
primary care system. I then outline two studies exploring the role of point of care 
electronic assessment and decision support tools to improve system performance. The first 
describes an electronic cardiovascular disease (CVD) risk assessment program at a Maori 
governed Primary Health Organisation in Auckland, New Zealand. The second study 
describes the development, validation and mixed methods evaluation of an Australian 
Electroni'c Decision Support (EDS) system for CVD risk management which was piloted 
for use in both AMSs and mainstream general practices. Both studies demonstrated that 
electronic risk management programs can be rapidly implemented, achieve high levels of 
practitioner acceptability and are able to provide timely, reliable, and easy to obtain 
estimates of primary care system performance in the management of vascular health. 
lV 
/ 
l:o 
Part B: Access to health care for ln~igenous peoples 
In this part of the thesis I explore broader contextual factors that ought to be considered 
when trying to implement interventions to improve primary care system performance. To 
address this I conducted three studies that are closely linked to those in Part A. First, I 
describe a qualitative systematic review to explore the factors that influence access to 
health care for Indigenous peoples in Australia, New Zealand, Canada and the USA. This 
review was informed by the theoretical construct of 'candidacy' which describes the ways 
in which eligibility for health care is negotiated between individuals and health services 
based on both implicit and explicit criteria. I synthesise a large body of disparate literature 
sources to explore the utility of candidacy theory at the macro system, health service and 
health care encounter levels. ~econd, I describe the methods for a large-scale, Australian 
qualitative study exploring staff and community views on building better systems of care 
for Indigenous peoples. In addition to candidacy theory, the central Australian philosophy 
of kanyini was incorporated into the theoretical framework. Kanyini describes the 
obligation to nurture, hold and respect one another. I use these frameworks to identify key 
health service system features that affect access and quality of care and I discuss these 
findings in the context of the recent Australian governments' Indigenous health reform 
initiatives. Third, I conduct further analyses of the interview data involving GPs in the 
Australian decision support study described above in Part A. Drawing on actor-network-
theory I examine GP perspectives on how the primary care network responds to a 
technological innovation. I assess how GPs used the tool in health care encounters, their 
attitudes to being advised by the tool and I explore the factors that influence their notions 
of best practice. The implications for implementation of EDS tools into primary care 
services are discussed. 
The two inter-related parts of the thesis thus produce a suite of qualitative, quantitative and 
mixed methods studies that sequentially build a greater understanding of what is needed to 
build better primary care systems. By combining a deductive, hypothesis-driven 
component (Part A) with an inductive, exploratory component (Part B) I offer both 
pragmatic and complex insights to this field of inquiry. The former informs us about how 
well the primary care system is performing for Indigenous peoples and explores innovative 
interventions to improve performance. The latter recognises the contribution of broader 
contextual factors, occurring at multiple levels that need to be considered when 
implementing those interventions. 
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Chapter 1: Introduction to a multi methods thesis 
This thesis has grassroots origins. For the past twelve years I have worked as a General 
Practitioner (GP) in IndigenousMgovemed health services in Australia and New Zealand. 
Despite the allMconswning demands of everyday work I have witnessed a tireless energy 
within these services to provide care for both Indigenous and non-Indigenous peoples. As a 
result of working in this health care environment two questions have recurred in my 
professional life and consequently they constitute the research questions for this thesis. The 
first is seemingly straightforward but not well described: how effective is the care provided 
in Indigenous primary health care services? The second is broader and more complex: 
what is needed to build better primary care systems for Indigenous peoples? 
My methodological approach to answering these questions is located within the emerging 
' field of mixed methods research. Drawing from both quantitative and qualitative research 
traditions, mixed methods research has been proposed as a distinct 'third methodological 
movement' .1 It is pragmatic in orientation, combining quantitative and qualitative methods 
to produce fmdings that go beyond what would have been obtained if these methods were 
conducted separately. It is a growing field and is increasingly being used in diverse 
disciplines including health science, psychology, sociology and education. Not all research 
that uses qualitative and quantitative methods is appropriate to be labelled as mixed 
methods research. Tashakkori and Teddlie propose that a truly mixed approach 
methodology incorporates multiple research strategies at all stages of the research project 
(i.e.: problem identification, data collection, data analysis, and fmal inference).1 Morse 
distinguishes mixed methods from multimethod designs.2 The former refers to single 
studies with multiple components and the latter to a series of separate studies that are inter-
related and designed to address an overarching_ research problem, as is the case in this 
thesis. She established three principles to multimethod designs? The frrst principle is to 
identify the theoretical drives of the research project. These drives can broadly be 
characterised as inductive, characterised by exploration and discovery or deductive, 
characterised by testing a theory or hypothesis. The second principle is for the researcher 
to develop overt awareness for when the quantitative or qualitative aspect of a project is 
the dominant component at any given stage and to know when he or she is working 
1 
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inductively or deductively. The third principle is that when using a multimethod design 
each sub-project must be methodologically independent and not violate any scientific 
principles by drawing on methods from another sub-project. This is particularly pertinent 
when considering issues of sample size, types of data collected and analysis method. 
Morse devised a nomenclature to schematically illustrate mixed and multimethod designs. 3 
Qualitative and quantitative are abbreviated to 'Qual' and 'Quan' respectively. The upper 
case notation is used to indicate the dominant method and lower case represents the 
supplemental component; a plus ( +) sign indicates that the methods are used 
simultaneously; a (--+) sign indicates that the methods are used sequentially. Example 
notations for paired methods include: (1) QUAL+ quan which indicates that the qualitative 
method is the dominant method and a supplementary quantitative component is conducted 
simultaneously to add a different perspective to the inquiry. A common design scenario for 
this occurs when a quantitative survey of a representative sample is added to the conduct of 
in-depth interviews with a purposive sample to triangulate findings; (2) QUAN--+ qual 
indicates a deductively driven project in which a particular hypothesis is quantitatively 
tested and a subsequent qualitative component is added to further understand the 
quantitative findings. This design is common in clinical trials in which a qualitative 
process evaluation is added to make sense of the quantitative findings. 
To address my broader question of what is needed to build better systems of primary care 
for Indigenous peoples, I take a predominantly inductive approach. Nested within this, 
however, are deductively driven research elements primarily directed toward the question 
of how effective is the care provided in Indigenous primary health care services. Using 
Morse's nomenclature3 this thesis is a multimethod research program with a predominantly 
sequential design. Figure 1-1 outlines the overall schema of the thesis research elements. 
2 
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Figure 1-1: Thesis schema using Morse's nomenclature for Mixed Methods Research*3 
Reviews 
Empirical 
descriptive 
research 
Interventions 
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Chapter2 
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'- ~ 
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QUAL+ quant QUAL 
) 
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'--
Quan = quantitative method used; upper case indicates this is the dominant mode of inquiry; lower case indicates this is an 
adjunct to the dominant mode; if both are in upper case this implies equal weighting to both components 
(+) indicates that the methods are conducted simultaneously 
(-) indicates the sequence in which each sub-study component was conducted. It iOustrates how analysis and 
interpretation of one component was used to inform subsequent components 
In Part A, the deductive stream of the thesis, I ask three questions about the effectiveness 
of primary health care for Indigenous peoples: 
( 1) How adequately do health systems monitor the effectiveness of primary health care 
for Indigenous peoples? 
(2) What is the extent and nature of the gaps between best practice recommendations and 
actual care provided in both Indigenous and mainstream primary care services in 
Australia? 
3 
(3) Are electronic tools useful interventions to improve the monitoring and effectiveness 
of care in primary health care systems? 
To provide some, but clearly not all, answers to this component I focus on vascular health 
care. This refers to the management and prevention of tluee inter-related diseases, 
cardiovascular diseases (CVD), chronic kidney disease (CKD) and diabetes. Chapter 2 
reviews health systems monitoring of health outcomes and system performance for the 
vascular health of Aboriginal peoples. I use the New South Wales (NSW) health system as 
a case study to explore this issue. Although this chapter makes extensive use of 
quantitative data, the overriding thrust of this work is exploratory, seeking to understand 
...- the breadth and depth of available data for monitoring the health of Aboriginal people in 
NSW. Chapter 3 builds on this assessment of health systems monitoring and outlines a 
case record audit of the effectiveness of vascular health care in Aboriginal Medical 
Services. In this study I examine 'evi~ence-practice gaps' in vascular risk management for 
routinely attending Aboriginal and Torres Strait Islander adults. When combined with two 
other quantitative projects involving mainstream Australian general practices (Appendices 
A and B), these three studies pr~>Vide a comprehensive analysis of vascular risk 
management in Australian primary care settings. 
Chapters 4 and 5 outline a program of work exploring the ability of electronic tools to 
improve primary care system performance in the provision of vascular health care. Whilst 
maintaining a distinct focus on Indigenous health care, I also incorporate mainstream 
general practice perspectives in this section. Chapter 4 describes a 12 month audit 
evaluation of a newly implemented electronic CVD risk assessment program at a Maori-
led Primary Health Organisation in Auckland, New Zealand. In Chapter 5, I explore the 
role of electronic decision support (EDS). I outline the development of an Australian 
primary care EDS tool for vascular risk management and report the findings from a mixed 
methods pilot evaluation conducted in both mainstream and Indigenous health services. In 
this study the quantitative and qualitative components are equally weighted. Together, the 
two studies from these chapters provide important insights on the process of implementing 
electronic interventions in primary care on a large scale. In particular, they shed important 
light on particular design features that might affect their uptake. 
4 
In Part B, the inductive stream of the thesis, I respond to my broader question of what is 
needed to build better systems of primary care for Indigenous peoples. I explore broader 
health sy$tem issues that might influence (1) the effectiveness of care and (2) the success 
of interventions such as those described in Chapters 4 and 5. I build my analysis at three 
inter-related levels: health system factors, local health service organisational issues and 
provider-patient factors occurring at the point of care. 
In Chapter 6, I conduct a qualitative systematic review of factors affecting access to health 
services for Indigenous peoples in Australia, New Zealand, Canada and USA. A key 
feature of this review is the synthesis of disparate literature sources (grey and empirical, 
quantitative and qualitative, descriptive and interventional) to provide multiple 
perspectives. Although there is some quantitative analysis of key themes provided, the 
dominant method in this review invo~ved the use of emerging qualitative synthesis 
techniques. I assess the utility of the theoretical construct of candidacy which is derived 
from a similar qualitative systematic review of access to health care for vulnerable 
populations in the United Kingdom. Candidacy describes the ways in which eligibility for 
health care is jointly negotiated between individuals and health services. 
In Chapter 7, I further develop the insights from the systematic review in an empirical 
study, the Kanyini Qualitative Study (KQS). This large scale study also follows 
sequentially from the findings of the Kanyini Audit (see Figure 1-1). KQS examines 
community and health professional perspectives on the factors necessary to build better 
systems of care for Aboriginal and Torres Strait Islander peoples. There are two 
components to this study, a health systems assessment which combines an organisational 
survey with structured staff focus groups and a semi-structured interview component 
involving health service staff and community participants. I build on candidacy theory by 
locating it alongside the Central Australian concept of kanyini or 'holding' which describes 
the principle and obligations of nurturing and protecting others. I describe in detail the 
methods taken to conduct this study and provide an analysis of the health systems 
assessment component. I locate these fmdings in the context of the recent shifts in 
Australian government policy for Aboriginal and Torres Strait Islander health. 
5 
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In Chapter 8, I return to EDS systems, conducting exploratory analyses of interview data 
collected in the study described in Chapter 5. In this chapter I take a sociological approach 
and use actor-network-theory to understanding the relationships between technological 
tools, their users and the organisational environments in which they are placed. I argue that 
there is an evolving dynamic between these various 'actors' and that understanding their 
relationships is critical to appreciating the impact of technological innovations on the 
primary care workplace. 
When taken together the deductive and inductive components of this thesis provide a 
multidimensional analysis to building better primary care systems for Indigenous peoples. I 
argue the importance of developing pragmatic and well evaluated interventions. I also 
argue that in order to yield maximum benefit, these interventions need to occur in an 
environment that is responsive to the broader socio-political aspects oflndigenous primary 
health care. 
References 
1. Tashakkori A, Teddlie C, editors. Handbook of mixed methods in social and 
behavioural research. Thousand Oaks, California: Sage, 2003. 
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PART A: HEALTH SYSTEMS MONITORING, 
EFFECTIVENESS OF PRIMARY CARE 
AND INTERVENTIONS TO IMPROVE SYSTEM 
PERFORMANCE 
..-
Chapter 2: Robust data to close the gap: How do current 
vascular and maternal/newborn indicators 
perform as measures of progress in 
Aboriginal health in New South Wales? 
Publication details: Peiris D, Mohsin M, Jenkins A, Cass A, Hughes C Robust data to 
close the gap: How do current vascular and maternal/newborn indicators perform as 
measures of progress in Aboriginal health in New South Wales? Australian and New 
Zealand Journal of Public Health 2010: 34 (6), 563-571. 
Author contribution: I conceived of the study, performed the literature search and 
analysis of the findings, wrote the first and subsequent drafts for journal submission and 
was the primary author for responding to reviewer comments. Dr. Mohsin assisted with 
extracting data from New South Wales data collections and all authors reviewed and 
commented on the journal manuscript drafts. 
2.1 Abstract 
Objective: Focussing on maternal/newborn health and vascular diseases, to review NSW 
Health's reporting, by Aboriginal status, against national performance indicators relevant 
to preventable chronic diseases. 
Methods: We reviewed seven indicator documents and the Australian Institute ofHealth 
and Welfare Chronic Disease Indicator Database to identify national indicators. We then 
compared six NSW Health reports with these national indicators to assess whether or not 
they routinely report by Aboriginal status and region. 
Results: NSW Health routinely reports against six maternal/newborn and fourteen 
vascular-related national indicators. Five of the maternal/newborn indicators report 
performance by both Aboriginal status and region. Eight vascular-related indicators report 
by Aboriginal status and one (diabetes hospitalisations) reports by both Aboriginal status 
and region. We found substantial limitations in the quality and breadth of indicators. These 
related to under-enumeration of Aboriginal status, small or potentially unrepresentative 
8 
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samples, inadequate longitudinal or regional data and a lack of indicators relevant to the 
performance of primary health care. Notwithstanding these limitations, we found wide and 
persistent disparities in outcomes for Aboriginal people for all indicators in all regions. 
Conclusions: NSW Health reports adequately, by Aboriginal status, for maternal/newborn 
health monitoring (albeit constrained by under-enumeration), but provides limited 
information about vascular health. There is a need for a minimum national chronic disease 
indicator dataset against which all jurisdictions would report performance by Aboriginal 
status and region. Improved monitoring requires: (a) population-representative data from 
the primary health care sector; (b) greater coordination between hospitals and primary care; 
(c) improved health survey sampling with the incorporation of physical/laboratory 
measures; and (d) sustained efforts (especially data-linkage initiatives) to address under-
enumeration. 
2.2 · Background 
Federal and State governments have pledged to close the life expectancy gap of Aboriginal 
. and Torres Strait Islander people within a generation. Accompanying this pledge has been 
unprecedented fmancial conunitment by the Council of Australian Governments (COAG)1 
and major health reform proposals that could substantially influence health care, both in 
NSW and Australia?·S A key component of these reforms is the imperative to address 
Aboriginal and Torres Strait Islander health inequalities and to better measure the efficacy 
of Australia' s health care systems in achieving such gains. 
A primary criterion by which health care systems are increasingly being judged is their 
success in improving outcomes for vulnerable populations. In establishing a framework for 
success, the United States Commonwealth Fund recommends monitoring by sound metrics 
for assessing whether or not strategic goals are being achieved. 6 Identifying the most 
appropriate metrics and establishing mechanisms for the collection of high quality data are 
crucial for assessing the health care provided to Indigenous peoples. Robust mechanisms 
for measurement of macro-performance, which can be compared across regions and with 
non-Indigenous health care, have been identified as a key priority.7 
9 
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The Aboriginal and Torres Strait Islander Health Performance Framework (A&TSI HPF) 
is the most comprehensive attempt yet to develop such a mechanism. 8 It was established to 
monitor the impact of the National Strategic Framework for Aboriginal and Torres Strait 
Islander Health and to influence policy analyses, planning and program implementation. 
Drawing from the National Health Performance Committee framework,9 three tiers of 
indicators (each with a number of sub-dimensions) are outlined: ( 1) health status and 
outcomes (health conditions, human function, life expectancy and deaths); (2) determinants 
of health (environmental and socio-economic factors, community capacity, health 
behaviours and person-related factors); and (3) health system performance (effective, 
appropriate, efficient, responsive, accessible, safe, continuous, capable and sustainable). 8 
In 2007, the Clinical Excellence Commission in New South Wales (NSW) published its 
first 'Chartbook' on the quality ofhe~th care in NSW.10 Modelled on Commonwealth 
Fund reports, the Chartbook provides performance snapshots on trends in several 
indicators. Intended to complement the NSW Chief Health Officer's Report11 and other 
relevant annual reports, the Chartbook aims to monitor these trends, identify areas for 
further investigation and to act as a resource to facilitate change. The 2008 Chartbook12 
includes a new chapter on selected outcome indicators by Aboriginal status. Review of 
these indicators raise three broad questions. Which national performance indicators are 
routinely reported against by Aboriginal status in NSW? How reliable is this information? 
Given the proposed national health reforms, how well-placed is NSW to monitor the 
effectiveness of these reforms for Aboriginal people? 
We seek here to answer these questions as they relate to one health priority area, namely 
preventable chronic diseases. Given there are currently over 400 indicators in the 
Australian Institute of Health and Welfare (AIHW) Chronic Disease Indicator Database 
(CDID),13 we focussed on two priority areas: (1) maternal/newborn health because of the 
importance of a 'life-course' approach to chronic disease and (2) vascular-related diseases 
(cardiovascular disease (CVD), chronic kidney disease (CKD) and diabetes) and their risk 
factors because these conditions make the greatest contribution to disease burden. 14 
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2.3 Methods 
This review comprised three steps. 
Step 1: A review of Federal government documents that report performance indicators by 
Aboriginal/Torres Strait Islander status in maternal/newborn health and vascular diseases. 
We focussed on 'strategic change indicators' which measure change in the shorter term 
and for which more immediate action can be taken; we therefore excluded 'headline 
indicators' related to mortality.15 We used a purposive sampling strategy to identify 
indicator documents. For inclusion, documents needed to be recent (published after 2007); 
national in focus; relevant to preventable chronic diseases in primary care and/or hospital 
settings; and have explicit indicator definitions. We took four approaches to our search: (1) 
A review of data sources in the A&TSI Health Performance Framework and a 
'snowballing' search for other government and non-government documents which used 
I 
these data sources; (2) consultation with content experts in health care safety and quality to 
identify additional documents; (3) a keyword search for Indigenous-related indicators in 
the AIHW CDID; and (4) a review of the proposed indicators in the discussion 
documents/reports relating to the proposed national health reforms. The final indicator list 
was reviewed by staff from the Office of Aboriginal and Torres Strait Islander Health 
(OATSIH). 
Step 2: A review ofNSW Health documents to identify indicators which matched those 
identified in Step 1. We searched the NSW Health website for routinely published reports 
on health performance monitoring. Staff in the Clinical Excellence Commission and the 
NSW Centre for Epidemiology and Population Health reviewed the retrieved reports and 
advised on the need to include any additional reports. For the indicators identified from 
these documents, we examined the quality of the data collections from which they were 
derived, their duration of reporting and whether or not they reported by Aboriginal status 
and/or any one of the following regional units (Area Health Service, Local Government 
Area or Accessibility/Remoteness Index of Australia (ARIA+)) 
Step 3: For those indicators identified above which do report by Aboriginal status, we 
sought to provide a snapshot of the routinely available types of information. We extracted 
and summarised data from the Health Outcomes Information Statistical Toolkit (HOIST), 
11 
from published reports and from the Australian and New Zealand Dialysis and Transplant 
Registry. For maternal/newborn health indicators,-bi-variate (cross-tabular) analyses 
compared_indicators with the results expressed as percentages by year. Aboriginal status 
and ARIA+. Information on vascular risk factors are expressed as weighted percentages for 
the Aboriginal and total population by urban and rural region. Hospitalisations and dialysis 
data are expressed as directly age standardised rates by year and Aboriginal status. 
2.4 Results 
Performance measures described within four Federal government, 8 15"17 and three national 
.... health reform documents3 1819 were reviewed. These are presented in Table 2-1. No 
additional indicators, not already included in these documents, were identified from the 
AIHWCDIC. 
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Table 2-1: Non-mortality maternal/newborn and vascular health indicators described in 
national documents that recommend reporting by Aboriginal and Torres Strait 
Islander status 
Indicator ~ HPF Reported in Proposed in Data 
Tier current health reform sources 
documents documents 
MaternaUnewborn health 
• Mean, low, premature birth weight prevalence l A&TSIHPF NHHRC NPDC 
by maternal Indigenous status (reported by PCOID 
various maternal & birth characteristics) 
• Mean birth weight, low & high birth weight by 1 HFL CTG OSCAR 
newborn Indigenous status 
• Tobacco use in pregnancy 2 A&TSI HPF NHHRC NPDC 
PCOID 
_.. • Smoking, alcohol consumption & illicit drug use 2 HFL OSCAR 
at < 13 weeks pregnancy and in third trimester 
• Breast feeding practices 2 A&TSI HPF NPHS NHS 
NATSll-IS 
• Timing of first antenatal visit 3 A&TSIHPF CTG NPDC : PCOID HFL NHHRC OSCAR 
Vascular health I 
• Circulatory diseases/ diabetes hospitalisations 1 A&TSI HPF NHS 
and self-reported prevalence, general practice PCOID NATSll-IS 
encounters NHMD 
• Blood Pressure (BP) hospitalisations, self- BEACH 
reported prevalence, general practice encounters 
• End-stage renal disease- incidence, 1 A&TSI HPF ANZDATA 
hospitalisation and treatment modality 
• Smoking prevalence 2 A&TSI HPF CTG NHS 
• Overweight and obesity prevalence PCOID NPHS NATSIHS 
• Level of physical activity 2 A&TSJ HPF NPHS NHS 
• Sufficient daily fruit and vegetable intake NATSlliS 
• Hospitalisations due to tobacco 2 PCOID NPHS 
• Hospital separations attributed to obesity/ 
tobacco 
• Glycated haemoglobin recording and control for 3 A&TSIHPF NHHRC OSCAR 
diabetics GPNPI APCC 
• Cholesterol recording and control for diabetics HFL Medicare 
• BP recording and control for coronary heart 
disease! diabetes 
• Provision of chronic care plans (Medicare Items 
721, 723) 
• Services with a documented chronic disease 3 A&TSIHPF GPNPI SAR 
management strategy GPNPI 
• Services with chronic disease registers/ recall 
systems 
• Provision of health assessments 3 GPNPI OSCAR 
(Medicare Items 704, 706, 708, 710) HFL Medicare 
• Access to coronary heart disease hospital 3 A&TSIHPF NHMD 
procedures 
• Ambulatory care sensitive conditions- diabetes 
complications & angina 
13 
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Indicator HPF Reported in Proposed in 
Tier _ current health reform 
documents documents 
• Provision of cardiovascular disease (CVD) risk 3 Not reported CTG 
assessments 
• Access to medicine and non-medicine 
management for people at elevated vascular risk 
and/or with diabetes 
• Risk factor recording & control for CVD, 
chronic kidney disease (CKD) and diabetes 
(includes psychosocial risk) 
• Brief interventions for smokers, people with 3 Not reported NPHS 
overweight/ obesity 
• Diabetes receipt of an annual cycle of care 3 Not reported NllliRC 
• Specialist access for secondary prevention of 3 Not reported CTG 
chronic disease 
• Reduced time to admission and guidelines 
implementation for CVD, diabetes, CKD. 
• Access to cardiac/ stroke rehabilitation, dialysis 
and transplantation 
• Waiting time at 90th percentile for cardia· 3 Not reported NHHRC 
thoracic surgery 
Table Abbreviations 
HPF Health Performance Framework 
Indicator Documents 
Aboriginal and Torres Strait Islander Health Performance Framework8 
Productivity Commission: Overcoming Indigenous Disadvantage Report15 
Data 
sources 
Not stated 
Not stated 
Not stated 
Not stated 
Not stated 
A&TSIHPF 
PCOID 
GPNPI Department of Health and Ageing Divisions of General Practice National Performance Indicators 
Program17 
HFL 
CTG 
NllliRC 
NPHS 
Office of Aboriginal and Torres Strait Islander Health (OATISH): Healthy for Life Essentiallndicators16 
Steering Committee for the Close the Gap campaign for Indigenous Health Equality18 
National Health & Hospitals Reform Commission Interim Report19 
Data sources 
NPDC 
NHMD 
NHS 
NATSlliS 
OSCAR 
SAR 
BEACH 
APCC 
ANZDATA 
National Preventive Health Taskforce National Preventive Health Strategy 
National Perinatal Data Collection 
National Hospital Morbidity Database 
National Health Survey 
National Aboriginal and Torres Strait Islander Health Survey 
OATSlli Services Collection Analysis and Reporting System 
Department of Health and Ageing Service Activity Reporting Database 
Bettering the Evaluation and Care of Health program 
Australian Primary Care Collaboratives program 
Australian & New Zealand Dialysis and Transplant Registry 
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Six NSW Health reports were examined for their reporting against these indicators. 11•20"24 
The data sources are primarily derived from three NSW data collections: the NSW 
Midwiv~s Data Collection (MDC) 1994-2007, NSW Admitted Patient Data Collection 
(APDC) 1993-94 to 2006-07 and NSW Population Health Survey (PHS) 2002-05. Box 1 
summarises the scope and methods used in those data collections and describes issues 
relating to data quality. 
Text Box 2-1: Profile of three NSW data collections relevant to maternal/newborn and 
vascular health monitoring 
The Midwives Data Collection (MDC) 
The MDC is a population-based surveillance system covering births of at least 20 weeks 
gestation or 400 grams birth weight in public and private hospitals, including home births. Data 
are collected on maternal socio-demographic characteristics, reproductive history, pregnancy 
and perinatal outcomes. A validation study found that the majority of MDC data items have 
more than 90% inter-rater agreement and kappa coefficients above 0.70.43 Data on maternal 
Aboriginal status, but not the Aboriginal status of the baby, are routinely collected. MDC data 
are linked to birth registration records from the Registry of Births, Deaths and Marriages to 
assess enumeration of maternal Aboriginal status, In NSW this enumeration rate was estimated 
to be 69.3% in 2005.23 
The Population Health Survey (PHS) 
The PHS is an annual computer-assisted telephone survey which commenced in 2002. It 
collects information about health behaviours, health status, health service use and access, and 
social capital. A stratified two-stage cluster sample design is used by targeting a sample of 1500 
people in each AHS per year. Weighting factors are used to estimate the rates at AHS and state 
level. Eight hundred Aboriginal participants are estimated to be needed to detect a 5% 
difference in prevalence estimates. 20 Between 2002 and 2005, 56,677 adult respondents (aged 
16+) participated in the survey; 930 were Aboriginal. When compared with the 2001 census 
figures, Aboriginal survey respondents were more likely to be female (61 .3%) and to reside in a 
rural area (65.6%).20 One report on Aboriginal adult health has been published based on these 
data20 with the next report expected in 201 0. 
The Admitted Patient Data Collection (APDC) 
The APDC provides data each financial year, covering services provided by public hospitals 
(including psychiatric), public multi-purpose services, private hospitals and private day 
procedure centres for admitted patients. It includes data on interstate hospital admissions of 
NSW residents.11 From 1998, the APDC changed from reporting admissions to reporting 
episodes of care. This might have lead to a small increase in enumeration. A validation study 
found that enumeration of Aboriginal status in the APDC was 88% overall- 81% in urban, 89% 
in inner regional, 95% in outer regional and 100% in remote areas.11 
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Six maternal/newborn indicators and fourteen vascular disease-related indicators identified 
in the national documents are routinely reported against in NSW. Table 2-2 summarises 
these indicators, the duration of reporting and whether or not they report by Aboriginal 
status and/or region. For those indicators routinely reported by Aboriginal status, key 
performance features are described below. 
16 
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Table 2-2: National maternal/newborn and vascular health indicators routinely reported in New South Wales (NSW) 
Pr~ncipal data Data Data routinely reported by: Reports Indicators HPF•tier reporting Aboriginal Aboriginal status collection sources period Region b status &region 
NSW Mothers and Babies Repolf3 Midwives Data Collection Teenage pregnancy 1 1994-2007 Yes Yes Yes 
Report on child health from the NSW (MDC) Tobacco use in pregnancy 2 1994-2007 Yes Yes Yes 
Population Health Survey1 Low birth weight prevalence 1 1994-2007 Yes Yes Yes 
The health of the people ofNSW- Premature birth prevalence I 1994-2007 Yes Yes Yes 
Report of the Chief Health Officer Antenatal visit <20 weeks of pregnancy 3 1994-2007 Yes Yes Yes 
(CH0)11 NSW Population Health Duration of breast feeding up to 24 months 2 2002-2006 No• Yes No 
Two Ways Together• Survey (PHS} 
Report on Adult Hea!th21 /Report on NSWPHS Overweight & obesity prevalence 2 2002-2008d Yes• Yes No 
Adult Aboriginal Health20 from the Current daily & occasional smoking 2 2002-2008 Yes" Yes No 
NSW Population Health Survey· 
Diabetes or high blood glucose prevalence I -· 2002·2008 Yes• Yes No 
The health of the people ofNSW- Fruit and vegetable consumption 2 2002-2008 Yes• Yes No Report of the CHO 
Physical activity in adults 2 2002-2008 Yes• Yes No 
Cardiovascular risk factors by diabetes status 2 2006-2007 No No No 
The health of the people ofNSW- Admitted Patient Data Cardiovascular disease hospitalisations I 1994-2007 Yes Yes No· 
Report of the CHO. Collection (APDC) Stroke hospitalisations 1 1994-2007 No Yes No 
Two Ways Together Diabetes hospitalisations 1 1994-2007 Yes Yes Yes 
Type of ambulatory care sensitive conditions 3 1994-2007 No Yes No 
Cardiovascular disease procedures 3 1990-2007 No " Yes No 
Diabetic amputations 3 1990-2007 No• No No 
Diabetic eye complications 3 2006-2007 No• No No 
ANZDATAr Dialysis treatment prevalence• 3 1997-2006 Yes No No 
a. Health Performance Framework 
b. 'Region' is defined as reporting by any of the following: Local Government Area, Area Health Service, Accessibility/Remoteness Index of Australia 
c. Data not routinely reported by Aboriginal status due to small sample size 
d. Data for overweight/obesity and diabetes from the 2004 National Aboriginal and Torres Strait Islander survey are also reported in Two Ways Together. 
e. Data are reported separately for Aboriginal people based on survey respondents over the 2002-2005 period 
f. Australian and New Zealand Dialysis and Transplant Registry 
g. The population prevalence of maintenance dialysis provided for end-stage kidney disease (both peritoneal and haemodialysis). It includes hospital, satellite and community-based (home) dialysis 
17 
Maternal/newborn indicators 
Figure 2-1 shows the trends in five indicators by Aboriginal status and area of residence. 
During the period 1994-2007, the prevalence of pre-term (less than 37 weeks of gestation) 
and low birth-weight (less than 2500 gram) babies born to Aboriginal mothers remained 
significantly higher than for babies born to non-Aboriginal mothers in all areas (p<0.001). 
Smoking prevalence in pregnancy declined for all mothers, but remained higher for 
Aboriginal mothers (p<0.001). A higher, stable rate of teenage pregnancies was observed 
among Aboriginal mothers (p<0.001). There have been improvements in access to timely 
antenatal care for all mothers and, although a significant difference remains (p<O.OOl), 
there has been a narrowing of the gap between Aboriginal and non-Aboriginal mothers. 
The proportion ofNSW Abo'riginal mothers starting antenatal care before 20 weeks 
gestation has risen from 63.0% in 1994 to 79.5% in 2007, with a notable improvement in 
major cities. 
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Figure 2-1: Maternal and newborn health indicators by Aboriginal status and region in NSW, 1993-94 to 2006-07 
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Data Source: The NSW Midwives data collection (MDC), 1994-2007 (HOIST) Centre for Epidemiology and Research, NSW Department of Health. 
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Vascular disease indicators 
Table 2-3 shows the estimated prevalence of selected vascular risk factors for Aboriginal 
people and for the total NSW population over a similar time period. Owing to the small 
sample size for Aboriginal people in the PHS (n=930), the wide 95% confidence intervals 
around these estimates results in large imprecision. 
Table 2-3: Vascular risk factor prevalence rates for persons aged 16 years and over by 
Aboriginal status and sex in NSW 
Urban Rural 
Risk factor Population 
Males Females Males Females 
%(95% CI) o/o (95% CI) % (95% CI) % (95% CI) 
Current daily or Aboriginal 2002-2005 41.3 (28.3-54.3) 41.1 (32.1-50.2) 46.7 (38.2-55.2) 42.2 (35.3-49.0) 
occasional smoking 
Total NSW 2005 2l.6 (19.4-23 .8) 16.6 (15.0-18.2) 25.1 (22.7-27.6) 19.9 (18.2-2l.6) 
Diabetes or high Aboriginal 2002-2005 5.1 (0.8-9.5} 5.8 (2.0-9.5} 15.3 (9.9-20.8) 12.4 (8.0-16.8) 
blood glucose (as 
notified by a doctor Total NSW 2005 8.3 (7.0-9.5) 6.8 (5.8-7.7) 8.6 (7.4-9 .8) 7.0 (6.0-8.0) 
or hospital -
excludes gestational 
diabetes) 
Overweight and Aboriginal 2002-2005 48.9 (35.5-62.3) 53.2 (43.6-62.8) 62.1 (53.3-70.8) 53.3 (46.0-60.6} 
obesity (Body mass 
index >25kg/m2} Total NSW 2005 55.5 (52.9-58.1) 39.3 (37.2-41.4) 62.0 (59.4-64.6) 49.2 (47.1-51.3) 
Adequate fruit Aboriginal 2002-2005 32.0 (19.8-44.2) 41.7 (32.9-50.6) 34.5 (26.5-42.5) 39.9 (33.3-46.4) 
consumption (at least 
2 serves per day} Total NSW 2005 44.4 (4l.9-47.0) 57.6 (55.5-59.7) 44.9 (42.2-47.5) 57.4 (55.3-59.5} 
Adequate vegetable Aboriginal2002-2005 7.6 (2.0-13.2} 17.0 (9.6-24.3) 4.1 (1.8-6.5) 13.0 (8.4-17.7) 
consumption (at least 
5 serves per day) Total NSW 2005 4.0 (3 .0-4.9) 8.9 (7.8-10.0) 6.4 (5.2-7.6} 12.7 (11.5-14.0} 
Adequate physical Aboriginal 2002-2005 68.7 (56.6-80.9) 44.0 (34.9-53.2) 51.8 (43.3-60.3) 46.7 (39.9-53.6) 
activity (at least 
150mins per week on Total NSW 2005 57.1 (54.4-59.7) 48.2 (46.0-50.3) 55.4 (52.8-58.0) 45.5 (43.4-47.6} 
5 separate occasions) 
Data Sources: 2002-2005 Report on Adult Aboriginal Health and the 2005 Report on Adult Health from the New South 
Wales Population Health Survey (PHS)20 21 • 
Nevertheless, when compared with the total population surveyed in 2005, Aboriginal 
males have approximately double (p <0.01) and Aboriginal females approximately three 
times (p <0.001) the rate of self-reported current smoking. A significantly higher 
20 
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prevalence of overweight and obesity for urban-residing Aboriginal females 
(approximately 1.4 times greater, p<0.05) was also noted. 
Figure 2-2 shows the age-adjusted hospitalisation rates for the period 1993-94 to 2006-07 
for diabetes and CVD-related conditions for the NSW population, by Aboriginal status and 
the age-adjusted rates of dialysis treatments for the Aboriginal and total NSW population. 
These data reflect the increased disease burden experienced by Aboriginal people for these 
three conditions. 
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Figure 2-2: Diabetes and Cardiovascular disease hospitalisations rates, Dialysis treatment prevalence by Aboriginal status and sex 
in NSW, 1993-94 to 2006-07 
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1. Data Sources: NSW Admitted Patient Data Collection 1993-94 to 2006-07 (HOIST), Centre for Epidemiology and Research, NSW Department of Health, Australian and New 
Zealand Dialysis and Transplant Registry. 
2. Data for all three graphs were age adjusted using the estimated resident population for NSW 1993-2006 as the reference population and the Australian population as at 30 
June 2001 as the standard. 
3. Dialysis treatment prevalence refers to the population prevalence of maintenance dialysis provided for end-stage kidney disease (both peritoneal and haemodialysis). It 
includes hospital, satellite and community-based (home) dialysis. 
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Figure 2-2: Diabetes and Cardiovascular disease hospltallsations rates, Dialysis treatment prevalence by Aboriginal status and sex 
in NSW, 1993-94 to 2006..07 
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June 2001 as the standard. 
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includes hospital, satellite and community-based (home) dialysis. 
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Whilst hospitalisations of non-Aboriginal people for CVD have declined by 11% over this 
period, the rate amongst Aboriginal people has increased by 25%. By contrast, the diabetes 
hospitalisation rate has risen for all people, with Aboriginal people experiencing a 3.1 
times greater rate ofhospitalisations than non-Aboriginal people in 2006-07 (p<O.OOl). 
Similarly, while the rates of dialysis treatments have risen for both the Aboriginal and total 
NSW population, Aboriginal people experienced a 1.8 times greater rate of dialysis 
treatments than experienced by the total NSW population in 2007 (p<O.OOl). 
2.5 Discussion 
.- This review of indicators routinely reported by NS W Health has assessed how adequately 
those measures report outcomes by Aboriginal status against national indicators in two 
priority areas -maternal/newborn health and vascular diseases. The major obstacles to 
improved monitoring relate to both th~ quality and breadth of indicators currently reported. 
NSW Health reports on a range of chronic disease-related indicators in other areas (e.g. 
psychosocial, respiratory and environmental health) and augments this reporting with ad 
hoc research and information from national data collections. We do not make any 
assumptions about the quality of reporting by Aboriginal status in these other areas. For the 
indicators examined here, the most persistent problem affecting data quality is enumeration 
of Aboriginal status. For the APDC, the estimated enumeration rate of88% is reasonable 
and does not, therefore, preclude useful data interpretation. The MDC, however, has 
persistently low enumeration rates of around 70%. Data linkage using administrative 
datasets is a promising area, both for quantifying and improving enumeration. Using data 
linkage, the 2006-07 ABS Census Data Enhancement- Indigenous Mortality Quality 
Study estimated NSW enumeration oflndigenous status to be 87% - substantially better 
than previously reported?5 NSW Health has been conducting data linkage research to 
enhance MDC enumeration. It is expected that revised enumeration estimates will be used 
in future reports. 
We found other important limitations in data quality and breadth. The key additional 
problem with both NSW and national perinatal statistics collections is that they report by 
Aboriginal status of the mother and not of the baby. In NSW and nationally, 36% and 28%, 
respectively, of registered Aboriginal births have an Aboriginal father and non-Aboriginal 
23 
, 
mother.26 1bis leads to gaps in our understanding of health outcomes for a large proportion 
of Aboriginal babies. The OATSIH Healthy for Life program and a Northern Territory 
indicator program are now reporting data by Aboriginal status of the baby!627 The next 
NSW Health Mothers and Babies report is expected to follow suit. 
For the APDC data, only two indicators (CVD and diabetes hospitalisations) are routinely 
reported by Aboriginal status. Although known areas of disparity, access to CVD-related 
procedures and rates of diabetes complications are not regularly reported by Aboriginal 
status or region.28 29 Only one CKD-related indicator, dialysis treatment prevalence, was 
identified. Figure 2 demonstrates an apparent divergence between the rapid increase in 
diabetes hospitalisation rates and levelling out of dialysis prevalence, especially amongst 
Aboriginal women. This could be explained by delays between the onset of diabetes and 
the manifestation of end-stage kidney disease (ESKD), or by competing mortality from 
' 
premature CVD, or by poor dialysis .outcomes which might reduce the increase in dialysis 
prevalence despite rising incidence ofESKD. Because of marked regional variation in 
ESKD incidence,30 evidence of poorer access to dialysis in rural and remote areas,31 and 
high rates of CKD risk factors in primary health care,32 more comprehensive monitoring 
with a broader range of indicators is warranted. 
A limitation to the PHS data relates to sampling. Because the 2002-05 report on adult 
Aboriginal health did not have an a priori design, a convenience sample was gathered over 
three years to obtain an adequately powered sample size. There is an over-representation of 
females and rural respondents. Conversely, telephone-assisted data collection might lead to 
a substantial under-representation of Aboriginal people in remote areas, given that only 
43% of Aboriginal households in remote areas and 82% in non-remote areas report having 
a working telephone.33 NSW Health currently uses 'Bayesian smoothing techniques' to get 
better estimates at small geographical levels for the total population. This method has not 
been tested for Aboriginal populations, however, and its limitations are not yet known. It is 
also likely that assessing the prevalence of health conditions based on self-report surveys 
produces under-estimates. 34 Combining health surveys with physical and laboratory 
measures, as is done in the US National Health and Nutrition Examination Survey,35 would 
allow for more comprehensive estimates of health status. Linking data from such surveys 
to primary care, hospitalisations and mortality data would allow for measurement at 
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multiple points in the system. The NSW '45 and up' population-based cohort study of 
260,000 people plans to link self-reported survey data with other datasets; specific sub-
studies will include physical/laboratory measures.36 Although restricted to those aged 45 
and over, 0.8% of the sample (2,149 people) identify as Aboriginal and/or Torres Strait 
Islander. This, one of the largest cohorts ever assembled, should facilitate an understanding 
of health status, resource utilisation and outcomes for this population. 
Another objective of this review was to assess preparedness to monitor progress in the 
proposed national health reforms. When classified using the HPF, most of the indicators 
regularly reported by Aboriginal status come from Tier 1 (health status) and Tier 2 (health 
behaviours). Many of the current Tier 3 (health system performance) indicators are derived 
from the primary health care sector and are traditionally considered a federal 
responsibility. Increased coordination between primary, secondary and acute care services, 
as highlighted in the NSW State Health Plan37 and in the proposed health reforms,2• 4-5 are 
needed to enhance performance monitoring. The 'Close the Gap' Steering Committee 
recommends several new primary-care based Tier 3 health indicators which expand 
considerably on the current diabetes-focussed indicators.18 Current primary care data 
monitoring is poorly equipped to monitor such indicators. Accurate enumeration of 
Aboriginal and Torres Strait Islander status, universal uptake of electronic medical record 
systems, consistent and reliable data entry, electronic management and auditing tools and 
regular reporting mechanisms are needed to effectively monitor primary care. Recent 
initiatives in the Aboriginal Community Controlled Health Services (ACCHS) sector16 27 38 
hold promise, but mechanisms in the non-ACCHS primary care sector are considerably 
under-developed. The new reporting requirements for the Divisions of General Practice17 
and initiatives such as the Australian Primary Care Collaboratives39 are potential avenues 
for addre~sing this problem. 
The problems of insufficient breadth and quality of indicators are not restricted to New 
South Wales. Extensive reviews of health system monitoring for Indigenous peoples in 
Canada 40 and New Zealand41 highlight that the issues identified in this paper are pertinent 
to all three countries. It is essential, therefore that there be an appropriate, minimum 
chronic disease indicator dataset against which all jurisdictions can report by Aboriginal 
status and region. The Aboriginal and Torres Strait Islander HPF, the most advanced 
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national indicator framework, is a suitable reference point for developing this dataset. 
Several inter-related factors ought to be considered in developing such a dataset. First, 
although the focus of this study was vascular and maternal/infant health, there is a need to 
include health systems process indicators which are not condition specific. Attention to 
such indicators, ideally linked to health outcomes, can facilitate an early 'diagnosis' of 
health systems problems and can anticipate reasons for delays in progress on health status 
improvements. Second, any proposed indicator needs to be of sufficient quality to warrant 
inclusion. The AIHW chronic disease indicator project group considered a quality indicator 
to be one that was relevant, applicable across population groups, technically sound (valid, 
reliable, sensitive to change, robust) and feasible to collect. It also needed to be timely, 
marketable and lead to action.42 Third, Indigenous academics and representative bodies 
have long argued for full participation in determining how health system performance is 
measured. This includes the need to erpbrace Indigenous concepts of health into systems 
measurement, building local monitoring systems at the community level to complement 
macro-system monitoring, and making data feedback more accessible to the communities 
and health services whence these data originate.7 The Northern Territory and Queensland 
indicator programs,27 38 developed by the ACCHS sector, are two successful modeis that 
adhere to these principles. 
With the proposed national health reforms gaining momentum and substantial funding 
becoming available for COAG 'Close the Gap' initiatives, there is renewed vigour in 
addressing Aboriginal and Torres Strait Islander health disparities. Despite the challenges 
in ensuring robust data, it is imperative that health systems are not paralysed by waiting for 
perfect data before taking action. The persistent and wide disparities in health outcomes, in 
relation to the indicators reported in this paper, substantially outweigh data quality 
concerns. Nevertheless, reliable measurement of progress in addressing these disparities is 
needed. This requires population-representative data from the primary health care sector, 
improved coordination between hospitals and primary care, improved health survey 
sampling with the incorporation of physical/laboratory measures and sustained efforts to 
address under-enumeration (especially data-linkage initiatives). The NSW Chief Health 
Officer's Report and the Chartbook on the quality and safety of health care in NSW are 
useful tools for facilitating health care improvements. Through future Chartbook iterations, 
the Clinical Excellence Commission will monitor progress on health disparities across 
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individuals' life-courses and engage with key stakeholders to improve health outcomes for 
Aboriginal and Torres Strait Islander people. 
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3.1 Abstract 
Objective: To describe cardiovascular disease (CVD) risk management in Indigenous 
primary health care. 
Design, setting and participants: Review of 1165 randomly selected case records of 
Indigenous Australian adults, aged?: 18 years, regularly attending eight health services in 
diverse settings in New South Wales, Queensland and Central Australia, October 2007-
May 2008. 
Main outcome measure: Adherence to CVD risk screening and management guidelines, 
especially with respect to overall or absolute CVD risk. 
Results: More than half the people in the sample (53%) were not adequately screened for 
CVD risk according to national recommendations. Under-screening was significantly 
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associated with younger age, less frequent attendance, and lower uptake of the Medicare 
Health Assessment. Ofthe sample, 9% had established CVD, and 29% of those aged2:: 30 
years were classified as high risk according to the 2004 National Heart Foundation of 
Australia (NHF A) adjusted Framingham equation. Of those with CVD, 40% (95% CI, 
30o/o-50%) were not prescribed a combination of blood pressure (BP) medicines, statins 
and antiplatelet agents, and 56% (95% CI, 49%-62%) of high-risk individuals without 
CVD were not prescribed BP medicines and statins. For high-risk individuals not 
prescribed BP medicines or statins, 74% (95% CI, 64o/o-84%) and 30% (95% Cl, 23o/o-
39%) respectively, did not meet 2004 NHFA criteria for prescribing of these medications, 
and of those already prescribed BP medicines or statins, 41% (95% Cl, 36o/o-47%) and 
59% (95% CI, 52%-66%) did not meet respective guideline targets. 
Conclusions: These management gaps are similar to those found in non-Indigenous health 
care settings, suggesting deficiencies across the health system. Prescribing guidelines 
which exclude many high-risk individuals contribute to suboptimal management. 
Guideline reform and improved health service capacity could substantially improve 
Indigenous vascular health. 
3.2 Ba~kground 
The lack of progress in improving health outcomes for Aboriginal and Torres Strait 
Islander (Indigenous) Australians has resulted in intensified efforts to close the life 
expectancy gap within a generation.1 Despite having a 2.5-fold greater total disease burden 
than the non-Indigenous population,2 Indigenous Australians substantially under-utilise 
primary health care consultations,3 4 pharmaceutical subsidies3 and specialist care.5 
Important barriers to improved primary health care might include this inadequate access, 
an insufficient capacity in health service systems6 and dysfunctional patient-provider 
interactions. 7 
At least one third of the total Indigenous disease burden is due to vascular-related disease: 
cardiovascular disease (CVD), chronic kidney disease (CKD) and diabetes? Six risk 
factors (tobacco, high body mass, high cholesterol, physical inactivity, high blood pressure, 
low fruit and vegetable intake) explain most of this vascular disease burden. 2 Despite the 
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availability of evidence-based therapies to manage these risk factors, significant evidence-
practice gaps exist in both Indigenous8 and mainstream primary health care. 9 
Vascular disease prevention strategies based on a person's overall or absolute 
cardiovascular risk maximise benefits and outperform the traditional approach which relies 
on management of single risk factors in isolation.10 Risk-based targeting of safe, effective 
drug therapies to those most likely to benefit could substantially reduce the total disease 
burden. 11 There has been little research on the utility of absolute CVD risk -based 
management in Indigenous health care settings. Improved identification and management 
of high·risk individuals, based on adequate risk delineation, could provide a major 
opportunity to reduce the burden of disease in Indigenous people. 
The Kanyini Vascular Collaboration is a national health services research program 
• 
established to improve vascular disease outcomes for Indigenous people. The program's 
first study, the Kanyini Audit, aimed to describe the identification and management of 
CVD risk in primary health care services and to identify opportunities for improvement. 
3.3 Methods 
An audit of a random sample of health care records oflndigenous Australian adults was 
conducted in collaboration with eight health services in New South Wales, Queensland, 
and Central Australia between October 2007 and May 2008. Sites with diverse service 
activity, based on size, location, funding and staffing, were selected. 12 According to the 
Rural Remote Metropolitan Area classification (RRMA), 13 two services were in capital 
cities (RRMA 1), two in major regional centres (RRMA 2-3), two in rural locations 
(RRMA 4-5), and two in remote communities (RRMA 7). Seven are Aboriginal 
Community Controlled Health Services and one is a state government Indigenous health 
service. 
Sampling 
We used electronic patient information systems at each health service to produce a list of 
potential participants. A case record was eligible for inclusion if it identified the patient as 
an Aboriginal and/or Torres Strait Islander aged~ 18 years who had attended the service at 
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least twice in the preceding 2 years. Using a random number generator, 200 records were 
selected in each of the five larger services, while a third of the eligible records were 
sampled in the three smaller services. All services predominantly used electronic health 
records, although supplementary paper records for ancillary information were also 
reviewed. 
The auditors were experienced health professionals familiar with the medical software. The 
web-based data collection form instantaneously queried apparently spurious data entries. 
Prescribed medicines were searched for on a pharmaceuticals database embedded within 
this form (using both generic and trade names). At completion, 1 0% of the records were 
reaudited to assess inter-rater reliability. 
Estimation of CVD risk 
Based on the 1991 Anderson Framin'gham equation, we calculated five-year CVD risk 
estimates for people aged ~ 30 years (people aged < 30 years were excluded because the 
Anderson Framingham equation is not validated for this group). 14 This equation uses age, 
sex, smoking status, blood pressure (BP), total and high-density lipoprotein (HDL) 
cholesterol levels, presence of diabetes, and presence of left ventricular hypertrophy to 
predict the risk of a first cardiovascular event (coronary heart disease, stroke, congestive 
heart failure and peripheral vascular disease). As the presence or absence of left ventricular 
hypertrophy is not reliably documented in primary care records, this was assumed to be 
absent. 
We calculated risk using the most recent results available (including an average of the two 
most recent BP readings), whether or not the subjects were being treated for that risk 
factor. Recognising that the Framingham equation might wtderestimate risk for Indigenous 
populations, 15 and acknowledging the absence of population-specific risk equations, the 
risk estimate was adjusted based on the 2004 National Heart Foundation (NHF) of 
Australia recommendations.16 People with a recorded diagnosis of coronary heart disease, 
cerebrovascular disease or peripheral vascular disease were assigned to the established 
CVD group. People with diabetes, an albumin: creatinine ratio > 3.0 mg/mmol, or an 
estim~ted glomerular filtration rate (eGFR) < 60 mL/min/1.73m2, as well as those aged 
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~ 75 years, were automatically assigned a 5-year CVD risk~ 15%. For all others, a 5% 
upward adjustment to the Framingham risk estimate was applied. 
Risk factor screening and management 
The 'screening gap' was defmed as the proportion of people, recommended for screening 
for a particular risk factor, for whom no result of screening had been recorded at least once 
in the previous 2 years. Screening recommendations for our study were based on the 
National guide to a preventive health assessment in Aboriginal and Torres Strait Islander 
peoples11 and the Guidelines for preventive activities in general practice.18 Generally, 
these recommend screening Indigenous people for all the Framingham equation risk 
factors (except left ventricular hypertrophy) from the age of 18 years. 17 Screening 
recommendations for proteinuria and CKD were based on Kidney Health Australia 
guidelines19 (with screening recommended for people with any one of the following: age 
I 
> 50 years, systolic BP > 140 mmHg, diabetes, current smoker, body mass index 
~ 30 kg/m2). 
Two 'prescribing gaps' were defmed: (i) the proportion of people currently not prescribed 
BP medicines or statins, where the NHFA guidelines, current at the time ofthe audit,1620 
recommended treatment; and (ii) the proportion of people classified as being at high 
cardiovascular risk who were not prescribed BP medicines, statins or antiplatelet 
medicines. We also used Pharmaceutical Benefits Scheme (PBS) criteria for statin 
subsidies to assess prescribing gaps.21 The 'treatment gap' was defmed as the proportion of 
people, already prescribed BP medicines or statins, in whom target levels were not being 
reached. The study design did not allow for an assessment of adherence to medication 
regimens. 
The provision of Medicare Health Assessments for Aboriginal and Torres Strait Islander 
people aged 15-54 years (Item 710) and~ 55 years (Items 704, 706) were recorded. These 
assessments mandate recording of CVD risk-factor information, along with other 
preventive health measures. Medicare-rebated general practice management plans (Item 
721) for people with CVD, CKD or diabetes were also recorded. 
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Statistical analyses 
Frequency distributions were reported as proportions, means or medians. Inter-rater 
agreement was assessed using the t<: statistic for categorical variables, and intra-class 
correlation coefficients for continuous variables. A pooled, overall t<: statistic was 
calculated using inverted variance-weighted averages. Logistic regression models (for 
percentage outcome variables) and linear regression models (for continuous outcome 
variables) were used to assess (i) age-adjusted sex differences in risk-factor characteristics 
and (ii) age- and sex-adjusted associations with completeness of recording of Framingham 
risk-factor variables. Because frequency of health care consultations was not normally 
...- distributed, the association with screening practices was analysed non-parametrically using 
Wilcoxon's rank-sum test. 
Ethics approval 
Our ,l)tudy protocol was developed in collaboration with the participating Indigenous health 
services and approved by four regional ethics committees. A written participation 
agreement was signed between each health service' s governing body and the coordinating 
research institutes. 
3.4 Results 
Sample characteristics 
We reviewed 1165 case records from the participating health centres. The mean age of the 
patients was 41.1 years (95% Cl, 40.3-42.0 years); 59% were female, and 72% were 
~ 30 years. The recorded ethnicity was Aboriginal in 90%, Torres Strait Islander in 9%, 
and both in 1%. We re-audited 111 case records ( 1 0%) at five sites. Inter-rater agreement 
was high. For the categorical variables, the pooled t<: statistic was 0.91 (95% CI, 0.88-
0.93). For continuous variables, the range of the intraclass correlation coefficient range 
was 0.87-1.00. 
Screening gaps and classification of CVD risk 
An overview of management practices and risk-factor screening gaps for each health centre 
is given in Table 3-1. Screening gaps occurred across all sites and were not related to the 
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remoteness of services. Major contributors to incomplete absolute risk assessments were 
under-screening for cholesterol and albumin: creatinine ratio levels. Table 3-2 gives the 
risk-factor characteristics in people with relevant information available. 
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Table 3-1: Care practices and screening gaps at audited health centres, by health c~ntre location (two centres at each location) 
Capital city Major regional centre Rural location Remote community Total 
Patient records and consultations 
No. of records sampled 200 200 200 200 75 39 201 so 1165 
Median (range) consultations per patient in 8(2~9) 8 (2-98) II (2-106) 8(2-84) 9 (2-56) 6 (2-41) 14 (2-78) 12 (2-97) 10 (2-106) 
previous 2 years 
Consultations per patient (average e;.) provided by:• 
General practitioner 66% 86% 47% 62% 79% 65% 37% 12% 60% 
Registered nurse ~~. 13% 26% 11% 21% 35% 60% 87% 31% 
Aboriginal health worker 4% 1% 24% 22% 0 0 0.3% 0 10% 
Other staff 1% 1% 2% 5% 0.2% 0 3% 1% 2% 
Medicare Health Assessment itemt 
Adult health check (18--54 years) 44% 20% 11% 47% 22% 3% 19% 33% 28% 
Older persons check~ 55 years) 59% 35% 30% 44% 44% 0 14% 14% 33% 
GP management plan 49% 4% 27% 17% 61% 0 0 44% 22% 
Risk-factor screening gapt 
Smoking status 44% 13% 20% 18% 24% 15% 46% 48% 29"/o 
Blood pressure 17"/e 16% 1% 3% 21% 8% 6% 10% 10% 
Body mass index 5~/e 39"/o 32% 28% 61% 33% 51% 48% 42% 
Blood sugar level (without diabetes) 37% 4~/o 10% 18% 48% 3~/o 11% 23% 26% 
Total: HDL cholesterol ratio 69% 52% 58% 32% 48% 92% 44% 44% 52% 
eGFR§ 46% 37% 27% 23% 34% 62% 34% 23% 34% 
Albumin: ereatinine ratio§ 80% 78% 66% 44% 84% 100% 47% 45% 65% 
Framingham screening gap, 74•/o 44% 56% 32% 46e;. 93-;. 59% 46% 53% 
Data are percentage of column totals unless otherwise stated. HDL = high-density lipoprotein. eGFR = estimated glomerular filtration rate. 
• Pen:entages may not add to 1 00 because of rounding. t Proportion of patients with a Medicare Health Assessment item in previous 2 years. The denominator for adult health checks and older 
persons checks was the number in the specified age range. The denominator for GP management plan was patients identified as having cardiovascular disease, chronic kidney disease or diabetes. 
:1: The proportion of patients recommended for screening, but a screening result had not been recorded at least once in the previous 2 years. § The denominator for eGFR testing and albumin: 
creatinine ratio included those with any one of the following: age, > 50 years; systolic blood pressure, > 140 mmHg; diabetes; current smoker; body mass index, 2: 30 kglm2. f The proportion of those 
aged 2: 30 years lacking information on screening for one or more Framingham risk variables. Left ventricular hypertrophy was imputed as not present 
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Table 3-2: Vascular risk-factor characteristics of patients obtained from health records 
Women (n = 693) Men (o=47l) 
P(age-
Risk factor No. with No. with adjusted sex 
information No. (
0!.) or information No. ( 0!.) or differences)* 
available mean (SE) available mean(SE) 
Diabetest 693 149 (22%) 472 100 (21%) 0.99 
Family history of coronary heart 693 92 (13%) 472 46 (10%) 0.07 
disease in a first-degree relativet 
Current smoker 483 226 (47%) 349 212 (61%) < 0.001 
Body mass index,~ 30 kg/m2 384 182 (47%) 294 90 (31%) <0.001 
Mean (SE) systolic blood pressure 642 122.4 (0.71) 409 125.4 (0.79) 0.006 
(mmHg) 
Mean (SE) cholesterol level 
(romol!L) 
Total cholesterol 410 4.8 (0.05) 275 4.9 (0.07) 0.71 
LDL cholesterol 323 2.9 (0.05) 203 2.8 (0.06) 0.51 
Triglycerides 410 2.1 (0.11) 276 2.6 (0.14) 0.18t 
HDL cholesterol 334 1.2 (0.02) 222 1.1 (0.02) 0.04 
Total: HDL cholesterol ratio 334 4.5 (0.08) 222 4.7 (0.10) 0.09 
Albuminuria§ 194 88 (45%) 144 73 (51%) 0.26 
eGFR, < 60 mUmin/1. 73 m2 407 45 (11%) 273 22 (8%) 0.20 
LDL = low-density lipoprotein 
HDL = high-density lipoprotein 
eGFR = estimated glomerular filtration rate 
• SignifiCant differences are in bold type 
t If there was no mention In the record of diabetes or family history of heart disease, it was imputed as not present. 
* Trigtyceride values were log transformed for significance testing of sex differences 
§Defined as an albumin: creatinine ratio,> 3.0 mg/mmol 
Fifty~three per cent of those aged~ 30 years lacked information on screening for one or 
more Framingham risk variables. When compared with the over 30 year olds for whom all 
Framingham risk variables had been recorded, those with insufficient recorded risk 
information were significantly younger (mean age, 45.4 years v 50.2 years; sex-adjusted P 
< 0.001), had been seen less frequently at the health service (median number of 
consultations, 8 v 17; P < 0.001), and were less likely to have received a Medicare Health 
Assessment (26% v 68%; age- and sex-adjusted P < 0.001). However, there were no 
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significant sex differences and no association between care-provider category and 
screening for all Framingham risk variables. 
Nine per cent of the total sample had established CVD, and 16%,4% and 29% of those 
aged~ 30 years had a 5-year CVD risk oflow (< 10%), medium (lOo/o-14%) and high 
~ 15%), respectively, according to the 2004 NHFA-adjusted Framingham equation. 
Prescribing and treatment gaps 
Prescribing ofBP-lowering medicines and statin therapy, respectively, as measured against 
NHF A guidelines, are given in Figure 3-1 and Figure 3-2. For individuals currently not 
prescribed statins (Figure 3-2) in whom NHF A guidelines recommend their being 
prescribed (n = 208), only 30% would qualify for subsidised treatment under PBS criteria. 
Figure 3-1: Blood pressure (BP) management measured against 2004 National Heart 
Foundation of Australia guldelines*18 
BP 
Information 
not recorded ) 
n=111 (10%) 
~I lnfonnatlon 
recorded I 
n .. 1o54 (90%) I 
( Treatment ~ot 
Indicated 
n=635 (88%) 
-----
( Not attaln!ng J 
targata 
n=-136 (41%) 
Achieving 
targetl 
n=193 (59%) 
Screening gap 
(n=111) 
+ 
Prescribing gap 
(n=90) 
I + 
I Treatment gap 
., (ns136) 
Except where indicated, the denominator for each percentage is the number in the preceding step. 
• Treatment indication was based on a consistent reading of> 130/80 mmHg for those with diabetes or chronic kidney 
disease, and > 140/90 mmHg for an other patients. Target BP levels were defined as: (i) s 130/80 mmHg for patients with 
established cardiovascular disease, diabetes, chronic kidney disease, or albumin: creatinine ratio> 30 mg/mmol; and (ii) s 
140190 mmHg for all other patients. 
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Figure 3-2: Statln prescribing measured against 2005 National Heart Foundation of 
Australia/Cardiac Society of Australia and New Zealand guidelines*20 
LDL 
lnfonnation 1 
not recorded ) 
n=639{55%} 
LDL Jl 
lnfonnation 
~ recorded J J 
n=526 (45%) 
( T1Htment not 
lndlcated3 
n:o115~ 
( Not attaln!ng J 
targets 
n=120(59%) 
Achieving 
targer4 
n•83 (41%) 
Sc'~;;ing gap 
(na639) 
+ 
Prescribing gap 
(n=208) 
I + 
1 Treatment gap • (n=120) 
Except where indicated, the denominator_for each percentage is the number in the preceding step. 
• Treatment indication was based on a low-<lenslty lipoprotein (LDL) cholesterol level > 2.5 mmoi!L or any level in the 
presence of established cardiovascular disease. Treatment target LDL level was defined as < 2.5 mmoVL 
t Includes 27 patients in whom the serum triglyceride level was > 4.5 mmoVL and LDL level could not be calculated 
Figure 3-3 examines prescribing gaps by CVD risk category. Forty per cent of people with 
established CVD were not prescribed combination therapy (BP medicines, statins, 
antiplatelets), and over half of the high~risk individuals without CVD were not prescribed 
both a BP lowering medicine and a statin. When applying the 2004 NHF A guidelines for 
prescribing ofBP~ and lipid-lowering medications for individuals classified as high risk 
who have not yet experienced a cardiovascular event, treatment would not be 
recommended for 74% (95% CI, 64o/cr84%) and 30% (95% CI, 23o/cr39%), respectively, 
despite their high-risk status. Similarly, when applying PBS subsidy criteria for statin 
prescribing to this high-risk group who have not yet experienced a cardiovascular event, 
30% would not qualify for the subsidy. Receipt of a Medicare preventive health check was 
not significantly associated with improved prescribing of BP medicines or statins for high-
risk individuals. 
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Figure 3-3: Prescribing of major cardiovascular medication groups by absolute 
cardiovascular disease (CVD) risk category* 
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• Five-year cardiovascular disease risk was estimated using the 2004 National Heart Foundation of Australia adjustments to 
the 1991 Anderson Framingham equation 
3.5 Discussion 
This study provides a comprehensive analysis of CVD risk identification and management 
in Indigenous primary health care settings. While case record audits have limitations in the 
accuracy of data captured, we identified several issues with important implications for the 
effective management of cardiovascular risk. 
The first of these was the large screening gaps. Although the absolute risk-based approach 
has theoretical benefits, its utility was limited by under-ascertainment of risk. The 
screening gaps were broadly similar to those found in mainstream general practice 
settings,22 and were especially large for younger, less frequent attendees. They were not 
related to remote location. It was encouraging that Medicare Health Assessments were 
associated with significantly smaller screening gaps. Point-of-care testing could be an 
effective strategy to ameliorate the under-performing of cholesterol and albumin: 
creatinine ratio tests. Although a national point-of-care program exists,23 lipid testing does 
not attract a Medicare rebate for health services participating in this program. 
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Substantial prescribing gaps were encountered for those at highest risk of a CVD event, 
although risk management compares favourably with previous Australian and New 
Zealand studies. 9 22 24 25 Importantly, around a third of high-risk people without CVD were 
classified by both NHF A guidelines and PBS subsidy criteria as not qualifying for statin 
therapy, and almost three-quarters did not qualify for prescribing ofBP medications under 
the 2004 NHFA guidelines; this could be considered a 'guideline gap' . Although the 
changes in the 2008 NHF A guidelines will assist BP management, substantial gaps remain 
in recommendations for lipid-lowering drugs. This supports the findings of Chen et al that 
there is not only a need for improvement in guideline adherence, but for guidelines 
themselves to adequately identify appropriate individuals for treatment. 26 
The barriers highlighted above are not restricted to Indigenous health care. Although the 
large variability in Aboriginal and T~rres Strait Islander health services may mean these 
findings are not representative of all service settings, the similarity in findings with 
mainstream general practice22 suggests these barriers are prevalent across the primary 
health care system. 
Based on our study's findings, we endorse current recommendations that an absolute risk-
based approach to screening be recommended for Indigenous adults, and that this be 
incorporated into a preventive health assessment. 17 This check should include the 
Framingham risk factors (with optional assessment ofleft ventricular hypertrophy)-
albumin: creatinine ratio, eGFR, body mass index and waist circumference, and blood 
glucose level for people without diabetes, and glycated haemoglobin (HbAlc) level for 
those with diabetes. Although it might be reasonable to assume that younger people are 
less likely to have a CVD event (which might partially explain the large screening gaps in 
younger people), the sharp rise in Indigenous CVD mortality after the age of 30 provides a 
strong argument for comprehensive screening from at least this age. Although a national 
absolute risk-based screening guideline has recently been released,27a single risk-
management guideline now needs to be developed to address prescribing gaps. It must 
avoid the assumption that all Indigenous people are at high risk, and be linked to 
appropriate resourcing to support its implementation. Given the evolving and uncertain 
evidence base, regular revision of the guideline would be essential. 
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Addressing guideline-related barriers alone is not sufficient. Future work in the Kanyini 
Vascular Collaboration will enable a better understanding of health system barriers and 
enablers, which can be used to develop well evaluated, novel intervention strategies in 
partnership with providers of Indigenous health services. If we are to close the gaps in 
screening, prescribing and treatment in Indigenous primary care, substantial investment in 
primary health care systems is needed to implement sustainable, risk-based chronic 
vascular disease programs that are responsive to community needs. 
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4.1 Abstract 
Aim: To examine the cardiovascular disease (CVD) risk profile and management for the 
fust 12 months of an electronic risk assessment program at Tamaki Healthcare, Auckland. 
Methods: An audit of risk assessment and medication data supplemented by a manual case 
record review. 
Results: 1522 people were screened representing around 15.5% of the eligible population. 
Of the 1420 people with data available, 248 (17.5%) had a calculated five-year CVD risk~ 
15% and another 177 (12.5%) had previous CVD. Maori were significantly more likely to 
be at high CVD risk than non-Maori (OR 2.07 (1.51-2.84); p<O.OOl). For Pacific peoples 
(mostly of Samoan, Tongan, Niuean, Fijian, or Cook Islands origin) there was no increased 
likelihood of high CVD risk. Medication data were available for 399 (95.5%) people at 
high CVD risk. Prescribing rates for this group were 78.1% for blood pressure lowering, 
71.9% for lipid-lowering, 65.3% for anti-platelet, and 50.3% for all three therapies. Whilst 
this group may represent the better end of the management spectrum, success in achieving 
47 
.... 
treatment targets was modest. For 451 people with either diabetes or established CVD, 
65.9% and 66.1% were not meeting blood pressure and lipid management 
recommendations respectively. There were very few disparities in prescribing rates and 
attainment of target levels by ethnic group. 
Conclusion: This study has shown that a primary care electronic risk assessment program 
can be rapidly implemented within 12 months. Although the sample may not be 
representative due to a small proportion screened so far, major disparities in risk factor 
prevalence rates were found, particularly for Maori. Furthermore, substantial guideline-
practice gaps were encountered in the appropriate prescribing of cardiovascular medicines 
and attainment of recommended targets. Several Tamaki Healthcare initiatives to address 
these findings are discussed. 
4.2 Background 
Cardiovascular disease (CVD) is the leading cause of premature death and disability in 
Aotearoa/New Zealand (NZ)1 and it remains the main reason for the widening gap in life-
expectancy between Maori and non-Maori? It is well established that absolute risk-based 
approaches to CVD event prediction have better discriminating ability3 4 and cost-
effectiveness5"7 than the traditional, single risk factor-oriented paradigm. 
Although Aotearoa/NZ has been a world leader in promoting an absolute risk based 
guideline, 8 its uptake has been variable and significant gaps in evidence based care 
remain.9-11 The recent incorporation of electronic risk assessment tools has been promising 
in improving uptake of the absolute risk paradigm.12- 15 
The PREDIC'fTM decision support system, implemented in ProCare Primary Health 
Organisations (PHOs) in Auckland, is producing valuable information on CVD risk factor 
epidemiology. Such data, along with a unique national health identifier, place the country 
in a good position to generate population specific risk assessment tools. Moreover, with 
PHO funded incentives and future national CVD performance indicators, 16 identification of 
at risk populations is likely to increase over the next few years. 
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Despite these promising initiatives important and yet unanswered questions remain. It is 
not clear whether risk-based screening programs lead to improved management practices. 
In addition to the impact on population health outcomes this has significant implications 
for health planners. 17 Furthermore, given that Maori are disproportionately affected by 
CVD, it is critical that research is undertaken to see whether Maori are equally benefiting 
from absolute risk based care. This study seeks to provide further information in these 
areas. 
4.3 Methods 
In December 2006, Tamaki Healthcare Charitable Trust, a Maori-led PHO, implemented 
an electronic CVD-risk assessment program across twelve of its member general practices. 
In 2007 a further three practices joined and one practice left the PHO leaving a total 
enrolled population of around 42,00P people in the Auckland area. 
Based on the screening recommendations by the New Zealand Guidelines Group (NZGG),8 
practitioners were funded to perform an electronic risk assessment for the following 
groups: 
• Maori/Pacific/Indian subcontinent groups: men 2:: 35 years, women 2:: 45 years. 
• All other ethnic groups: men 2:: 45 years, women 2:: 55 years. 
• People with known risk factors for CVD or diabetes: men 2:: 35 years, women 2:: 45 
years. 
• People with diabetes regardless of age. 
Two electronic risk assessment options were available within existing practice 
management systems: PREDICT and the MedTech 'Edge-CVD management' module. 
Ethnicity was derived from the PHO register through a combination of self-identification 
and retrieval from the National Health Index. Using the NZ coding system18 we grouped 
ethnicity into five categories: NZ European/Others, Maori, Pacific peoples, Indian 
subcontinent, and other Asian. Thirty-six people of mainly Middle Eastern or African 
origin accounted for the 'others • in the NZ European/Others category. 
NZ Deprivation Index quintiles are geographically determined using variables from census 
data and are a measure of socioeconomic status (one= least deprived, five=most 
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deprived).19 These data are supplied by the NZ Ministry of Health and, at the time of 
analysis, calculations were made using the 2001 census (NZDepOI). (As of July 1, 2008 all 
PHO registers were updated using 2006 census data.) 
Data were collected from: 
1. A de-identified version of routinely submitted CVD risk assessment data; 
2. A medication query run at each clinic to obtain the prescription history (from January 
2006 to March 2008) for those who had undergone a CVD risk assessment; and 
3. A manual clinic record review of patients with either a calculated or clinical five-
...- year CVD risk of~ 15% was conducted by a PHO nurse to determine details of non-
pharmacological management practices. 
For part (3) we purposively sample;a all available Maori and Pacific records and took a 
random sample of other ethnicities to obtain equal proportions. 
Five-year risk of a fatal or non-fatal CVD event was calculated using the 1991 Anderson 
Framingham equation. 20 Event endpoints include myocardial infarction, coronary heart 
disease, stroke or transient ischaemic attack, peripheral vascular disease, and congestive 
heart failure. Included in this calculation were the NZGG five percent upward adjustments 
for high-risk groups. These groups are based on ethnicity (Maori, Pacific, Indian 
subcontinent), family history of coronary heart disease, high risk diabetes (diabetes 
duration> 10 years, albuminuria, or HbA1C>8%) or metabolic syndrome (derived from the 
National Cholesterol Education Program ATPIII 2001 definition).8 The adjustment is made 
only once. Recent data suggests that the five percent upward adjustment for ethnicity is a 
more accurate estimate ofrisk.21 
Frequency distributions were reported as proportions or means/medians. Differences in 
individual risk factors and treatment prescribed for ethnic groups and social deprivation 
quintiles were either adjusted or standardised for age and sex. Because the major CVD-risk 
factors are integrated in the Framingham risk equation, we did not adjust for any of these 
in assessing differences in overall CVD risk across ethnic and social groups. Statistical 
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analyses were carried out using SAS v9.1 software (Cary, NC: SAS Institute Inc, 2002-
2003). 
All member practices provided written consent to participate in the study and were given 
the opportunity to review the fmal manuscript. The study was also reviewed by the 
chairperson of the Northern X Regional Ethics Committee and under its Observational 
Studies Guidelines it was detennined that it did not require committee review and 
approval. 
4.4 Results 
CVD risk profile 
In total, 1522 people had an electro~ic CVD risk assessment performed over the screening 
period December 2006-November 2007. Clinical data were available for 1420 people 
(55.7% male, 44.3% female). Only 40 people (2.8%) had more than one risk assessment 
performed reflecting the recent implementation of this program. For these individuals we 
report data from the most recent assessment. Table 4-1 below gives an estimate of the 
proportion of patients screened at each clinic in the target risk groups. 
In calculating the number of patients in the target group we were only able to extract 
demographic information from the PHO service utilisation records. This means that some 
people with the clinical criteria for screening (outlined above) who were outside the age 
criteria range will be excluded from this denominator. Nevertheless a marked variation in 
screening rates was apparent. 
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Table 4-1: Estimate of the proportion of patients in target groups screened between 
December 2006 and November 2007,_ by clinic 
Number of months Number of patients Number of patients Coverage Clinic in theCVD 
screened in target groups % program seen at least once 
A 6 6 1057 0.6 
B 11 11 574 1.9 
c 7 16 623 2.6 
D 8 14 545 2.6 
E 12 29 744 3.9 
F 10 44 792 5.6 
G 8 72 1239 5.8 
H 9 15 191 7.9 
I 7 54 413 13.1 
J 12 169 1139 14.8 
K 9 53 155 34.2 
L 10 277 644 43.0 
M 12 375 853 44.0 
N 12 387 864 44.8 
Total '1522 9833 15.5 
Table 4-2 outlines the demographic and risk factor characteristics of the sample. When 
compared with the population eligible for screening, there was little difference in Maori 
representation (13.0% ofthose screened vs. 14.3% of those eligible). When compared with 
the NZ European/other group, the major disparities by ethnicity in risk factor prevalence 
were due to smoking (high rates amongst Maori and Pacific, and low rates amongst Indian 
subcontinent people) and diabetes/metabolic syndrome (high rates amongst Maori, Pacific, 
and Indian subcontinent groups). 
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Table 4-2: The demographic and risk factor characteristics of 1420 people with a CV:D risk assessment perfonned 
n Mean age Personal Current/rec Mean systolic BP MeanTC:HDL Diabetes High risk Family Metabolic 
(years) CVD ent smoker (mmHg) (95% Cl) ratio (95% CI) (%) diabetes history syndrome 
history(%) (%) (•!.) CVD(%) (%) 
Males 
NZ European/Other 219 58.7 13.4 22.6 130.8 (128.6-133.0) 4.14 (3.97-4.30) 11.8 45.8 23.5 11.2 
Maori 93 54 20.7 35.8. 131.2 (127.9--134.4) 3.95 (3.71-4.19) 31.7*** 47.9 34.2 34.3*** 
Pacific 129 53.3 10 29.6 129.9 (127.1-132.6) 3.81 (3.61-4.02)* 36.7 ... 54.8 22.6 43.5*** 
Indian sub-continent 318 51.1 16.1 9.&••• 125.7 (123.~127.5)••• 3.92 (3.79--4.06) 3o.o••• 40.4 29.5 26.8*** 
Other Asian 32 57 12.4 2.8· 125.7 (120.1-131.2) 4:00 (3.59--4.41) 37.1*** 35.5 8.4 31.5** 
Total 791 54.1 14.8 19.3 128.8 (127.7-129.9) 3.94 (3.86-4.01) 26.6 45.4 26.4 26.2 
Females 
NZ European/Other ISO 59.6 9.2 13.8 131.9 (129.4-134.4) 3.60 (3.45-3.76) 13.3 28.7 23.6 5.4 
Maori 92 57.9 12.2 50.9*** 131.6 (128.4-134.8) 3.67 (3.48-3.97) 21.4 60.0 .. 38.4* 22.8*** 
Pacific 114 56.8 6.1 18.3 128.9 (126.0-131.7) 3.35 (3.17-3.52)* 38.0*** 64.5 ... 28.2 36.4••• 
Indian sub-continent 249 54.6 10.9 1.2*** 126.1 (124.1-128.1)*** 3.34 (3.21-3.46)** 29.2*** 31.7 32.5 23.7* 
Other Asian 24 60.6 0 5.9 132.8 (126.4-139.0) 3.45 (3.06-3.83) 28.6 23.6 18.8 16.8 
Total 629 56.9 9.4*** 14.8" 128.6 (127.4-129.9) 3.50 (3.41-3.56)*** 25.8 44.6 29.9 21.2" 
Total assessed 1420 55.4 11.5 17.1 128.7 (127.9--119.5) 3.74 (3.68-3.80) :Z6.l 45 28.1 23.7 
Notes: 
Ethnic sub-group means are age adjusted and prevalences are age standardised to the total population 
Total prevalence rates are age/sex standardised 
Significance testing between ethnic groups was performed for each sex using NZ European as the referent group and was age adjusted 
Significance testing for sex differences used males as the referent group and was also age adjusted 
--p <O.oo1, ""O.o1 <p>o.oo1. ·o.o5<p<0.01 
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Table 4-3 below shows the NZ adjusted Framingham risk profile stratified by sex. In total 
425 people (30.0%) were identified to be at high CVD risk (either a clinical or calculated 
five-year CVD risk of~ 15%). Maori were significantly more likely to be at high CVD risk 
than non-Maori (OR 2.07 (1.51-2.84); p:S 0.001). For Pacific peoples, despite high 
smoking rates and diabetes, there was not an overall increased likelihood of high CVD 
risk. This can be mainly attributed to younger age and lower past CVD event rates. For 
NZDepO 1 quintiles, the Quintile 5 group was significantly more likely to be at high CVD 
risk than Quintile groups 1-3 (OR 1.54 [1.19-1.99]; p<0.001). 
Table4-3: Sex stratified NZ adjusted Framingham risk profile by ethnlclty 
/ 
% % with NZ adjusted Framingham %with 
Gender and receiving Five year CVD risk CVD n 
etbnicity NZ So/o 
adjustment <10% 10-14% ;::::15% 
Males 
NZ European/Other 219 33.8 45.2 14.2 21.5 19.2 
Maori 93 100 28 18.3 32.3 21.5 
Pacific 129 100 33.3 27.9 27.9 10.9 
Indian subcontinent 318 100 54.4 17.6 15.4 12.6 
Other Asian 32 43.8 56.3 9.4 18.8 15.6 
Total 791 79.4 45.4 18.1 21.2 15.3 
Females 
NZ European/Other 150 26 63.3 12 14.7 10 
Maori 92 100 38 27.2 21.7 13 
Pacific 114 100 53.5 22.8 18.4 5.3 
Indian subcontinent 249 100 71.9 13.3 5.6 9.2 
Other Asian 24 29.2 66.7 20.8 12.5 0 
Total 629 79.7 61.4 17 12.7 8.9 
Total assessed 1420 79.5 52.5 17.6 17.5 12.5 
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Medical management for high-risk individuals 
Prescribing patterns- Medication data were available for 1334 people (93.9%) of the 
sample. Figure 4-1 below shows the prescribing patterns of the three major cardiovascular 
medication groups by CVD risk. 
Figure 4-1: Cardiovascular medication prescribing patterns by CVD risk group (n=1334) 
100% .----------------------------------
90% +----------------------------------
Five-year CVD risk 
• <10% 
. 10-14% 
· ~15% 
80% 
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60% 
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0% 
BP Lipid 
lowering 
Anti platelet BP + Lipid 
Lowering+ 
Antiplatelet 
BP = blood pressure. Five-year cardiovascular disease risk was estimated using the NZGG adjustments to the 
1991 Anderson Framingham equation 
For the vast majority of people, the prescribing patterns for all three therapies remained 
consistent across the 27 months of medication history. There appeared to be little impact 
from the risk assessment itself in stimulating new prescriptions. For high-risk groups 
(either a clinical or calculated 5-year CVD risk 2: 15% ), across all ethnicities, prescribing 
rates were 78.1% for blood pressure lowering, 71.9% for lipid lowering, 65.3% for 
antiplatelet, and 50.3% for all three therapies. 
For patients prescribed lipid lowering therapy, 91.3% were prescribed statins, 4.9% statins 
and fibrates, and 3.8% fibrates alone. Exclusion of patients prescribed fibrates alone did 
not appreciably change the results. For blood pressure lowering therapy, both Maori (OR 
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3.63 [1.64-8.08]; p=0.002) and Pacific peoples (OR 2.67 [1.25-5.70]; p=O.Ol) were 
significantly more likely to be prescribed medication when compared with NZ 
Europeans/others after adjusting for age and sex. No significant differences were found 
between the two Asian ethnic groups and NZ Europeans/others. 
For antiplatelet therapy, lipid lowering therapy, and combination therapy, for all three drug 
groups there were no significant differences in prescribing patterns across ethnic groups. 
Similarly, there were no significant differences in prescribing patterns across all NZDepOl 
quintiles for all three therapy types and combination therapy . 
Adequacy of treatment- Success in achieving target thresholds (as set by the NZGG) for 
people with established CVD or diabetes was examined. In these groups blood pressure 
targets of <130/80 mmHg and lipid :levels of a total cholesterol <4 mmol!L, LDL 
cholesterol <2.5 mmol/L, total cholesterol: HDL cholesterol ratio <4.5 are recommended. 
Practitioner recording of LDL cholesterol results was not mandatory in this program and so 
attainment of lipid targets was largely derived from total cholesterol and total cholesterol: 
HDL ratio results. 
Figures 4-2 and 4-3 below show the gaps in reaching target thresholds for 451 people with 
either diabetes or established CVD. 
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Figure 4-2: Proportions achieving blood pressure targets for people with CVD or diabetes 
according to NZGG guidelines 
1------- Medication data unavailable 
n=20 (4.2%) 
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(30.0% ~thoSe on treatment) 
~~~i'jo/.~7: 
{47.2% a.' .~ not.~.bwalrnentl 
.··;;r"i~;l:;~:. . ·"ij;!!;; 
• Target BP <130/80mmHg 
as defined by the NZ Guidelines Group 
65.9% and 66.1% of people were either not attaining target blood pressure and lipid level 
recommendations respectively or were not prescribed guideline indicated therapies. There 
were no significant ethnicity variations in achieving target blood pressure or lipid levels 
with one exception - Indian subcontinent people were more likely to be achieving target 
lipid levels (OR 3.15 [1.80-5.52]; p<0.001) than NZ Europeans/others after adjusting for 
age and sex. Similarly, there were no significant differences in achieving target blood 
pressure or lipid level recommendations across all NZDepO 1 quintiles. 
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Figure 4-3: Proportions achieving lipid level targets for people with CVO or diabetes 
according to NZGG guidelines 
Attarpr 
n=127 , 
(36. 7% of those on treatment) 
• Target levels 
Total C~erol <4mmoVL or 
Total Cholesteroi:HDL ratio <4.5 or 
LDL-Cholesterol <2 .5mrnoVL 
as defined by NZ Guidelines 
Not at tarpr 
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prescribed 
:treatment) 
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indicated ... 
n=79, ':,"<!!; 
as.2% of !hose: 
not prescribed 
treatment) 
n=20 (4.5%) 
Medication nof!ndlcated 
n=26 ' . (24.8% of those riot prescribed 
treatment) . . 
Other medical management for high risk individuals- Records from 283 (66.6%) of the 
425 high risk patients were manually reviewed. Table 4-llists the key fmdings from this 
fmal component of the audit. 
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Table 4-4: Non-phannacological care practices for people at high CVD risk 
All high risk people n=283 (Maori n=73, Pacific n=70, Indian/other Asian n=72, NZ European/Other 
n=68) 
Median nwnber of consultations in the previous two years 
Mean % of consults for each patient in which the blood pressme was checked 
% with at least two documented lipid checks in the previous two years 
%with documentation of lifestyle assessment or advice at least once in the previous two 
years for: 
(1) smoking 
(2) nutrition 
(3) alcohol 
(4) physical activity 
%with a green prescription recorded* 
% currently enrolled in the Care Plus programme** 
People with diabetes (n=l35) 
% with a documented specialist review in the previous two years 
% with a documented eye review in the previous two years 
%with at least two HbAlc checks in the previous two years 
% with a Diabetes Get Checked review in the previous twelve months 
Notes: 
12 
52.6% 
42.8% 
29.3% 
34.3% 
9.5% 
36.4% 
7.8% 
54.0% 
43.7% 
56.3% 
77.8% 
92.6% 
* Green prescription is a national program in which patients are provided with written advice and a 
support service to adopt healthy lifestyle practices. 
** The Care Plus program is a NZ Ministry of Health program for chronic care management 
4.5 Discussion 
This study has shown that an electronic risk assessment program can be rapidly 
implemented in a primary care environment with 15% of an approximate 10,000 eligible 
population screened in less than 12 months. Aside from the usual drawbacks of clinic 
records based research, the variable uptake by practitioners and inconsistent screening 
amongst its enrolled population is clearly the major limitation to this study. We urge 
caution, therefore, in extrapolating these fmdings to the general population. As with other 
studies14 it is hoped that Tamak.i Healthcare' s electronic risk assessment program can 
increase overall screening rates across all clinics and reach those at highest risk ofCVD. 
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The factors behind the variable uptake are worth exploring via a 'systems' approach 
examining issues such as workforce capacity, infonnation systems, financial incentives, 
leadership, training, and support for the program. Attention to such issues was key to 
improvements in CVD screening rates in two recent NZ studies. !3,22 Systems level audit 
and feedback cycles using the Wagner Chronic Care Modet23 have also been shown to be 
of benefit in Australian Aboriginal health services.24 
Consistent with the literature, we found Maori to be at the greatest risk of CVD. The 
fmdings suggest that some of the biggest gains for Maori in CVD risk reduction lie in 
smoking prevention/cessation and diabetes prevention/management. Lifestyle interventions 
at both the primary care and population level are key components to this. The recording 
rates of lifestyle management practices in this study were low. This is not to say that 
lifestyle management is not being peyformed but the fmdings complement the Rafter et al25 
study highlighting that CVD lifestyle management is not well documented by most 
primary care practitioners. Current electronic CVD risk assessment packages have little 
emphasis on non-pharmacological management. Integration of lifestyle assessments into 
the electronic assessment along with prompts to perform brief interventions, especially 
smoking cessation,26 could improve CVD outcomes. 
For pharmacological management, the prescribing patterns of the three guideline indicated 
therapies (antiplatelet, blood pressure and lipid lowering medicines) for high risk 
individuals were higher than those found by Ridell et alu and markedly better than those 
by Rafter et al. 10 As with the Ridell study, it was encouraging to fmd no evidence of 
ethnicity or NZDepOI quintile disadvantage in prescribing patterns. There was even some 
evidence that blood pressure medication prescribing was better for Maori and Pacific 
peoples. 
The stable prescribing history may mean that these high risk individuals have a better 
management profile than those who have not participated in the programme and so caution 
should again be exercised in extrapolating these findings. Even so, despite better than 
previously published prescribing rates, large gaps remain with only half of individuals at 
high risk prescribed all three indicated therapies. Furthermore, very large gaps were found 
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in attaining NZGG recommended targets for blood pressure and lipid levels. Two out of 
every three people with either diabetes or CVD were not meeting these targets. 
Despite the considerable body of research that informs clinical practice, this study reflects 
a consistent finding that there are substantial gaps in the uptake of evidence into routine 
care.
27 Studies exploring the reasons for sub-optimal implementation of clinical guidelines 
in general practice indicate complex and multiple barriers at the health-system, doctor and 
patient leve1.28 Electronic decision support is a promising initiative to address some, but 
clearly not all, of these barriers. Further research is needed in Aotearoa/NZ on the best 
implementation strategies for well described evidence. This would help broaden our 
knowledge of the critical contextual issues that make the uptake of evidence successful in 
some settings and not in others. 
As a Maori-led PHO the disparities in CVD risk between Maori and non-Maori are of 
prime concern to Tamaki Healthcare. These disparities are not restricted to CVD. In 
response, the PHO is in the process of re-orienting itself toward meeting the fundamental 
goal of improved and equitable health outcomes for its enrolled population. A key strategy, 
therefore, is to effectively engage with the PRO's provider practices in the creation of 
integrated programs that focus on prevention and management of chronic conditions. In an 
environment where limited resources need to be channelled for the greatest effect, Tamaki 
Healthcare considers this to be one of the areas where the greatest health gains for Maori 
can be made. The PHO has commenced work on a Maori model for chronic conditions 
management and is developing strategies to promote the uptake of this model amongst its 
member practices. Such a model needs to complement and go beyond traditional doctor-
patient oriented care. 
Existing services that exemplify this include a diabetes self management and education 
program which is aligned with the Whare Tapa Wha modee9 and additional clinical 
services that have a specific Maori focus (dietician, health psychology, child health and 
smoking cessation services). Several new positions (including a cardiac rehabilitation 
nurse, community support worker, and two lifestyle planners) have been created to support 
these programmes. 
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The PHO will also examine whether additional financial incentives to undertake CVD 
reviews for Maori and other vulnerable groups will result in improved screening and 
management of CVD risk. Whilst increased access to services and population-based 
initiatives are essential, a sustained commitment on the part of government to addressing 
ethnic and socioeconomic inequities in health is equally crucial. 
Coordinated and well resourced strategies could maximise the impact of CVD programs 
and ultimately enhance primary health care's contribution to better health outcomes. 
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Chapter 5: An Electronic Clinical Decision Support Tool 
to Assist Primary Care Providers in 
Cardiovascular Disease Risk Management-
Development and Mixed Methods Evaluation 
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co-authors Joshi, U sherwood and P;8tel. I coordinated ethics submissions, designed the data 
collection forms and the interview guide with Rohina Joshi. I supervised the research 
assistants for data collection, conducted the interview evaluation, performed the statistical 
analyses, coded the interview data and co-interpreted the qualitative findings with Tim 
Usherwood. I wrote the frrst and subsequent drafts for journal submission and was the 
primary author for responding to reviewer comments. Co-authors Webster, Groenestein, 
Usherwood and Patel were responsible for initial development of the decision support tool. 
All co-authors reviewed and commented on the journal manuscript drafts. 
5.1 Abstract 
Background: Challenges remain in translating the well-established evidence for 
management of cardiovascular disease (CVD) risk into clinical practice. Although 
electronic clinical decision support (CDS) systems are known to improve practitioner 
performance, their development in Australian primary health care settings is limited. 
Objectives: Study aims were to (1) develop a valid CDS tool that assists Australian 
general practitioners (GPs) in global CVD risk management, and (2) preliminarily evaluate 
its acceptability to GPs as a point-of-care resource for both general and underserved 
populations. 
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Methods: CVD risk estimation (based on Framingham algorithms) and risk-based 
management advice (using recommendations from six Australian guidelines) were 
programmed into a software package. Tool validation: Data from 137 patients attending a 
physician' s clinic were analysed to compare the tool' s risk scores with those obtained from 
an independently programmed algorithm in a separate statistics package. The tool's 
management advice was compared with a physician's recommendations based on a manual 
review of the guidelines. Field test: The tool was then tested with 21 GPs from eight 
general practices and three Aboriginal Medical Services. Customized CDS-based 
recommendations were generated for 200 routinely attending patients (33% Aboriginal) 
using information extracted from the health record by a research assistant. GPs reviewed 
these recommendations during each consultation. Changes in CVD risk factor 
measurement and management were recorded. In-depth interviews with GPs were 
conducted. 
Results: Validation testing: The tool' s risk assessment algorithm correlated very highly 
with the independently programmed version in the separate statistics package (intraclass 
correlation coefficient 0.999). ·For management advice, there were only two cases of 
disagreement between the tool and the physician. Field test: GPs found 77% (153/200) of 
patient outputs easy to understand and agreed with screening and prescribing 
recommendations in 72% and 64% of outputs, respectively; 26% of patients had their CVD 
risk factor history updated; 73% had at least one CVD risk factor measured or tests 
ordered. For people assessed at high CVD risk (n = 82), 10% and 9%, respectively, had 
lipid-lowering and BP-lowering medications commenced or dose adjustments made, while 
7% newly commenced anti-platelet medications. Three key qualitative fmdings emerged: 
(1) GPs found the tool enabled a systematic approach to care; (2) the tool greatly 
influenced CVD risk communication; (3) successful implementation into routine care 
would require integration with practice software, minimal data entry, regular revision with 
updated guidelines, and a self-auditing feature. There were no substantive differences in 
study fmdings for Aboriginal Medi~al Services GPs, and the tool was generally considered 
appropriate for use with Aboriginal patients. 
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Conclusion: A fully-integrated, self-populating, and potentially Internet-based CDS tool 
could contribute to improved global CVD risk management in Australian primary health 
care. The findings from this study will inform a large-scale trial intervention. 
5.2 Background 
Cardiovascular disease ( CVD) accounts for 18% of the total disease burden and 11.2% of 
health system expenditure in Australia. 1 Australian Aboriginal peoples experience around 
five times greater CVD burden than other Australians.2 Despite recent gains, CVD remains 
Australia' s biggest killer, accounting for 46,134 deaths and disability in around 1.4 million 
' Australians in 2005.1 Although effective preventive therapies are available for people at 
high risk of a first and subsequent CVD event,3"7 substantial challenges remain in 
translating this evidence into clinical practice. Our recent studies of CVD risk management 
in mainstream Australian general practice and indigenous health service settings found 
around half of routinely attending adults did not have sufficient information collected to 
comprehensively screen for CVD risk. For those identified at high CVD risk, only a 
minority (31% in mainstreall;l general practice settings and 40% in indigenous health 
services) were prescribed guideline-indicated medications. 8•9 
The reasons for suboptimal implementation of clinical guidelines include complex and 
multiple barriers at the health system, doctor, and patient level.1° For a time-constrained 
general practitioner (GP), consolidating numerous guidelines to make clinical decisions is 
challenging. This is particularly true for CVD, where overall or absolute risk assessment is 
recommended and simultaneous management of multiple risk factors is required. Despite 
guideline endorsement of the absolute risk-based approach, few Australian GPs use 
cardiovascular risk assessment tools to guide m.anagement.11•12 
Clinical decision support (CDS) - in Australia also commonly called electronic decision 
support (EDS) - is one of the most promising interventions to improve uptake of guideline-
based recommendations in clinical practice. In two systematic reviews on the effectiveness 
of CDS, around two-thirds of studies demonstrated improvement in practitioner 
performance.13•14 Key features of successful interventions included instantaneous output 
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generation for use at the point-of-care, minimal data entry, provision of automatic 
prompting for GPs, and a requirement that GPs actively respond to recommendations. 
A number of controlled evaluations of CDS systems that are integrated with electronic 
medical records (EMRs) have been conducted in the areas of CVD risk and diabetes.15"19 
They have shown variable improvements in risk factor screening/documentation and 
overall processes of care. Beyond trial settings, several countries have successfully 
implemented large-scale CDS systems for CVD risk in primary care settings. In the United 
Kingdom, an electronic CVD risk assessment (but not decision support) package is being 
integrated into one of the most commonly used GP software systems.20 In the United 
States, the ATHENA decision support system is able to be integrated with a variety of 
primary care software platforms to promote guideline-based management of blood pressure 
(BP)?1 In New Zealand (NZ), an In~emet-based CVD risk management system based on 
the New Zealand Guidelines Group·recommendations22 has been fully integrated into the 
cowttry's most popular medical software platform. This system has demonstrated 
improvements in uptake of CVD risk assessments?3 Although there have been attempts in 
Australia to consolidate evidence about CVD management into a point-of-care paper chart 
tool, 24 GPs would prefer decision support in an electronic format. 12 
Here we outline our methods for the development of a CDS tool and present the fmdings of 
a preliminary evaluation of its use in primary care settings. This forms the first stage of a 
broader research and development program that will lead to the implementation and 
controlled evaluation of a tool that is fully integrated into Australian primary care software 
systems. 
5.3 ~ethods 
Development of the CDS tool 
For risk assessment, an algorithm was written based on the 1991 Framingham risk equation 
to predict five-year risk of a frrst CVD event (coronary heart disease, stroke, congestive 
heart failure, peripheral vascular disease)?5 Recognizing that this equation might 
underestimate risk for certain clinical conditions and for specific ethnic groups, 
adjustments were made using recommendations from the New Zealand Guidelines Group 
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and guidelines from the National Heart Foundation (NHF) of Australia.26•27 The risk factor 
variables and adjustments are summarized in Textbox 5-1. 
Text Box 5-1: Framingham risk equation variables and adjustments used for calculation of 
5-year CVD risk in the Clinical Decision Support tool 
Framingham risk factor variables: 
• Age 
• Sex 
• Smoking status 
• Blood pressure (BP) 
• Total and high-density lipoprotein cholesterol levels 
• Presence of diabetes 
... • • Presence of left ventricular hypertrophy 
5% increase to the baseline risk score is made once only if any of the following are 
present: 
• History of premature CVD in a fil1)t-degree relative 
• Body mass index ~ 30 kg/m2 
• Total cholesterol > 8 mmoi/L 
• Systolic BP > 170 mmHg 
• Diastolic BP > 100 mmHg 
• Diabetes duration > 10 years 
• Glycated hemoglobin (Hb~1C) > 8% for the last 12 months 
• High-risk ethnic background (Aboriginal, Torres Strait Islander, Maori, Pacific peoples, 
South Asian) 
Age=:: 75 years and calculated 5-year risk< 15%, then risk is adjusted to 15% 
If the following high-risk conditions are present and calculated 5-year risk is < 20%, then 
risk is adjusted to 20%: 
• Established CVD (coronary artery disease, ischemic cerebrovascular disease, peripheral 
vascular disease) 
• Left ventricular hypertrophy 
• Genetic dyslipidemias 
• Diabetes and chronic kidney disease (estimated glomerular filtration rate [eGFR] < 60 
mUmin/1. 73 m2) 
• Proteinuria (defined as either albumin to creatinine ratio~ 30 mg/mmol or proteinuria> 1 
g/day) 
To defme the risk management outputs of the tool, pharmacological treatment 
recommendations from six Australian CVD-related guidelines current in 2007 were 
consolidated into a single algorithm.26•28"3l The thresholds and treatment targets for BP, 
lipid, and anti-platelet management are summarized in Textbox 5-2. 
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-Text Box S-2: Indications and target levels for CVO medication management programmed 
Into the Clinical Decision Support tool 
1. Anti-platelet medication indications: 
• Established coronary heart disease 
• Diabetes 
• Ischemic cerebrovascular disease 
2. BP medication 
Indications for commencing treatment: 
• BP > 125/75 mmHg for the following: 
o Diabetes and proteinuria (defined as either albumin to creatinine ratio> 30 
mg/mmol or proteinuria > 1 g/day) 
o Diabetes and chronic kidney disease (defined as eGFR < 60 mUmin/1 . 73 m2) 
• BP > 130/80 mmHg for all others with diabetes or isolated proteinuria 
• BP > 140/90 mmHg and any one of the following: 
o Established CVD 
o Chronic kidney disease (eGFR < 60 mUmin/1 . 73 m2) 
o Aboriginal, Torres Strait Islander, Pacific Islander, Maori, South Asian 
background 
o Adjusted 5-year CVO risk> 10% (assuming lifestyle advice given for 3-6 
months) . 
• BP > 150/95 mmHg and adjusted 5-year CVD risk < 10% (assuming lifestyle advice 
given for 3-6 months) 
Target treatment levels: 
• BP < 125/75 mmHg for those with diabetes and proteinuria 
• BP < 130/85 mmHg -for: 
o All others with diabetes 
o Chronic kidney disease 
o Isolated proteinuria 
o Age < 65 years 
• < 140/90 mmHg for all others 
3. Lipid medication 
Indications for commencing treatment: 
• Established CVD at any level 
• Genetic lipid disorders at any level 
• Diabetes and serum triglycerides > 2 mmoi/L 
• Low-density lipoprotein cholesterol > 2.5 mmoi/L and any of the following: 
o Diabetes 
o Aboriginal or Torres Strait Islander 
o Adjusted 5-year CVD risk > 15% 
Target treatment levels: 
• Low-density lipoprotein cholesterol < 2.5 mmoi/L 
The risk assessment and management algorithms were programmed into a stand-alone 
software package (Igor Pro 6, WaveMetrics Inc, Portland, OR, USA) that produced a 
single-page output. If there was complete risk factor information available, a risk score was 
generated and plotted along a colour spectrum bar and treatment recommendations were 
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provided. If information required for absolute risk assessment was absent, the output 
identified the variables missing and the colour bar was changed to greyscale. Because 
many Australian guidelines are not exclusively risk based, some treatment 
recommendations could still be made despite incomplete risk factor information. Examples 
of these two types of output are shown in Figure 5-1 and Figure 5-2. 
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Figure 5-1 : Sample Clinical Decision Support output with complete information and color bar 
Rlilt .Kstltlllll . .... t: 
Ao• 63 
Sex: Female 
Lthen~utar lr1Ptr1rophy No 
Current Ont12 months) 1moMng. y~ 
Totai·ChOitJitrOl 48 
Trig!y(endes 10 
HDL·ChOiesltrOI. 1 3 
LOL·CholeslerOI 30 
SyltoHt liP" U2 
OluiOtkBP 86 
CrnW~ine 1 89 11M 
Ptolllnl.wia No 
ChroniO]dnl'tdtstase Yes (.OrR·47) 
tGfR<eOthllrMl Of ptoteifWrll 
Otabttn. Yes 
Diabetes for moralhan 1 Oy: No (Ox 2005) 
HbA1 c •8'.6 morelhan 1 year No 
,_yolw~...,.(CVD~ No 
Oene1k. dysllpldaemla· No 
FamUynis1oryofCVD No 
HOhet ~sk elllnklt( No 
Bodymauindu: 28.7 kg/m2 
Upld tnerapy No 
Blood ptesaure thetapy Yes 
AnbplaiBiet tnerapy: No 
"' IIPORTAHJ NOTE!r>tSis I PIAL SOflWAAI. 011. Y-0 ISIO;JT N1Bf.6)10 l!fi'UCI' il.HCAI. .l..(>CO(NI f(flfC4\WAl PAlfNTS !"' 
'i!lllll\oiiY •• f\1(1 ~··~ -""lt.llt"ll 
f lb!WIMl.,.., IIU I 
21°-4 (high) 
c ......... u. .............. b t_nl ....... fiOI ..... b tl; 
JIC 1 Ma J CITIZEN 10"an-1946 (63) 
1 Eumplt Sl , Cernperd~Mn, NSW No 12'4~. 
~23M¥dt~ 1~35 AM 
• AbtoiUitri'k aneumtnt IS ; bltiUU i1!1t tH 50, aod tlfllilltd BP, altwlt<l lltoldt, 
tUitiiJ, and ctullk Wu•v dlteast ill prutnl 
· Olabttn monitoring 11 
• l.JCHdt Mluauon Ia 
....,... ... BP 111 preaent 
• BP monliOMO It t 
· SruolllniJ ceuauon or redUe•on Is 
as •Jt ~ ~5. ll.1llelu, Cl(l), 11114>idnv, and 
fot mulllple hull\ ben81tls 
• Upld modlf/lno therapy IS ''' " '~•ll<l_ as di.JI~ttu o~~•l eNville~ lipids, an~ flo!V .. ed 1iik are present 
• BP lowering lllerapy Is as mullple tndlcaUons 11e present 
· Anbplateletllerapy •s .,.. u s diabetes Is present. 
• BlOod preasuratowenng lllerapy IS n!'lr"•tt••ni !}J g•! as ~tabetas Is p11sent and BP • 1 30195mmHg 
~'~; 
. ~· 
.... 
~arllk iSWI 
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Figure 5-2: Sample Clinical Decision Support output w ith incomplete information and greyscale bar 
Rbk ................... &! -~-
AGe 48 
Sax lolale 
lal'f'l'*ltUIIf ~ophr <lilA> 
Cootnl Onlll months) tmoi<IIIQ <N/4> 
--
Tolii-ChoiHIIrol 56 
TotolltloldH 15 
HOL·CheltJllrOI 
I 
08 
LOL·Ctooles1trol 53 
8yAOll(9P 138 
Ooatlolk 91' 80 
Crtllonlnt S1 ,.M 
P!olellltMII No 
Chlonlc kle!ne'(dlsease No (oOrA 78) tOfRtCM:MIVffttft tf .,_l•n••.t 
Ooabtlls No 
Ooabllts for mort Ill an 1 Or No 
H11Ait>8'4morelloan 1 ytlr No 
-.,.,cor-....... (CVO) No 
OtntUt d'f$Hpldtemil No 
F amlly hi$1Diy Of CVO N a 
Higher nst dlnl<1ly No 
BodymassllldU l..S kfim2 
Upid lloarapy No 
Blood PIISSUrt therapy No 
MllplalelellltriPY No 
· 1ntorma110n on ltn ~~e~1o kul.ll IWttll OtJiov It iR!I!iilnor~ 
$<11~•••Y .. Cllfo .~_,,, au• .. u~• 
Mr A CITIZEN 10-Aug.1960 (48) 
12 Enmple Sl. C~mpar~. NSW No 11\.1~­
~. 23 M.llch 200t 10'.U AM 
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Validation testing of the tool 
De-identified data from all consecutive patients with complete risk factor information 
attending a specialist vascular clinic over a 3-month period (May to August 2008, n = 137) 
were entered into the tool by a trained research assistant to generate CDS outputs. The 
validity of these outputs was assessed in two parts. First, a researcher who was not 
involved with the algorithm development programmed the Framingham risk equation and 
adjustments into a second statistical software package, STAT A version 9.2 (Stata 
Corporatio~ College Station, TX, USA). Correlation between risk scores generated from 
the CDS tool and the STAT A program were assessed. Second, an experienced physician, 
.,. blinded to the CDS tool management recommendations, reviewed the risk assessment data 
for each patient. She then performed a manual review of the guidelines and assessed 
whether anti-platelet, BP-lowering, and lipid-lowering medications were indicated or 
whether targets were being met for tliose patients already prescribed BP-lowering and 
lipid-lowering drugs. Agreement between the CDS tool and the physician's 
recommendations was assessed . 
. 
Field testing in primary health care 
The tool was field tested in two different Australian primary health care settings: eight 
teaching general practices in Sydney and three Aboriginal Medical Services (AMSs) in 
New South Wales. Sampling was purposive and sought GPs interested in research and 
training who might critically appraise the tool and provide recommendations for its future 
development. A diversity sample in terms of GP age, gender, and size of practice was 
sought. Consecutive, routinely attending patients (Aboriginal?.::: 35 years, non-Aboriginal?.::: 
45 years) were invited from the waiting room to participate. The patient age range is based 
on Australian guideline recommendations for absolute risk assessment screening. 32 Each 
GP had outputs generated for around 10 patients. This number was considered sufficient to 
allow (1) adequate exposure to a variety of tool outputs, (2) an appreciation of the tool's 
application in a typical working day, and (3) minimal administrative burden to the GP or 
the practice. Figure 5-3 provides a schema for how the study was conducted. Because the 
pilot version of the tool was built using stand-alone software, it lacked the ability to pre-
populate with demographic and clinical data already existing in the EMR. Thus, the key 
role of the research assistant was to act as a proxy for this pre-populating feature by 
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accessing the relevant risk factor information from the patient's EMR. In essence, this 
simulated the situation that might occur if the tool was built into the GP's practice software 
system. The resultant output was given to GPs prior to the consultation for review with 
their patients. 
Figure 5-3: Study schema for evaluation of the Clinical Decision Support tool 
Clinic staff inform potentially eligible participants 
(Aboriginal clients aged >35 years, non-Aboriginal> 45 years) 
irrespective of the reason for their visit 
Step 1 
Research Assistant (RA) obtains informed consent from 
participant to access his/her health record 
Step 2 
RA obtains available data from practice software and paper 
files and enters data into EDS software on own laptop. The 
EDS output is generated by the tool and the RA prints this. 
Step 3 
RA gives doctor the printed EDS output prior to the 
consultation. Doctor completes a brief questionnaire 
evaluating the output at the end of the consultation 
Repeat Steps 1-3 for 1 0 consecutive participants 
End of study 
Doctor completes a separate end of study questionnaire & 
participates in an interview evaluation 
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Evaluation and analyses 
A mixed methods evaluation was conducted following the methods outlined by Tashakkori 
and Teddlie.33 Specifically, the quantitative and qualitative components were equally 
weighted and combined simultaneously to obtain an understanding of the effectiveness 
(quantitative), acceptability (quantitative and qualitative), and feasibility (qualitative) of a 
CDS tool for CVD risk management in primary care settings. 
At the end of each consultation, GPs completed a short survey on their attitudes about the 
tool and management provided. At study completion, GPs completed a second survey on 
their practice characteristics. This survey adapted some questions from a previously 
published instrument.34 GPs then participated in an in-depth interview evaluation. 
Interviews were semi-structured and conducted by a GP researcher who had a practical 
working knowledge of the tool in clihlcal settings. Interviews covered three domains: (1) 
general attitudes about the tool and its impact on the consultation; (2) a review of specific 
tooi outputs; (3) recommendations for future tool development. Full details of the survey 
instruments and interview guide are provided in Attachments 1-3. 
Descriptive statistics and quantitative analyses were conducted using SAS version 9.1 
(SAS Institute Inc, Cary, NC, USA). Management decisions were assessed as to whether 
GPs acted on recommendations from the tool output. Interview recordings were 
professionally transcribed, and thematic content analysis was performed drawing on the 
-methods outlined by Patton.35 Interview transcripts were initially reviewed in their entirety 
to become familiar with the data. They were then open coded to core thematic categories 
and these analyses were conducted contemporaneously with data collection. At the end of 
study, the investigator team met on several occasions to determine how these open-coded 
categories would be relationally grouped to determine the final major themes. NVivo 8 
(QSR International, Melbourne, Victoria, Australia) was used to help organize the data 
through this analysis process. 
The study was approved by both the Sydney South West Area Health Service and 
Aboriginal Health and Medical Research Council ethics committees. Patients and GPs 
gave written informed consent to participate in the study. Signed agreements were obtained 
from the three participating AMSs. 
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5.4 Results 
Validation of the tool 
The tool's risk assessment algorithm showed near perfect correlation with the 
independently programmed algorithm used in STAT A (intraclass correlation coefficient 
0.999). The variation was wholly explained by different rounding methods used in each 
software program. For prescribing recommendations, agreement between the tool and the 
physician's recommendations for initiation of anti-platelet and lipid treatment was 100%. 
Agreement on meeting guideline targets for those already prescribed BP- and lipid-
lowering treatments was also 100%. Agreement on initiation of BP treatment was 97% 
(kappa 0.95). In both cases of disagreement, the BP was< 125/75 mmHg and the physician 
judged that treatment was not indicated, while the tool recommended that treatment could 
not be determined due to missing inf~mnation on proteinuria 
. 
Field testing - Quantitative evaluation 
Twenty-one GPs participated in the study. Practices varied greatly in size, ranging from a 
solo GP practice with minimal administrative support to a large practice with 23 GPs and 
15 nurses. Table 5-1 outlines GP characteristics and their use of electronic practice 
management features. Table S-2 shows the risk factor characteristics of the patient 
population by Aboriginal status and prescribing rates of preventive CVD medications. 
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Table 5-1: Characteristics of the 21 participating GPs in the Clinical Decision Support pilot 
study 
No. % 
Male 12 57 
Age group (years) 
20~29 1 5 
30~39 3 14 
40-49 11 52 
50+ 6 29 
Postgraduate qualifications 
-- Fellowship of the Royal Australian College ofGPs 15 71 
Diploma (e.g. obstetrics, child health) 11 52 
Master (e.g. public health) 4 19 
Participate in research sometimes or oft~n 19 90 
U~ oflnternet at least once daily 19 90 
Electronic practice software features always used 
Medication prescribing 20 95 
Automated pathology results downloaded 19 90 
Online billing 14 67 
Electronic patient recalls 13 62 
Scanning of paper documents 12 57 
Electronic care plans 12 57 
Disease registers 7 33 
Frequency of performing cardiovascular risk assessments for 
Aboriginal 35+ years, non~Aboriginai4S+ years 
Never 3 14 
Less than 500/o of the time 16 76 
Greater than 50% of the time 2 10 
Preferred method of assessing risk 
New Zealand guidelines color charts 15 71 
Calculators within medical software 2 10 
Other methods (e.g. downloaded calculator) 1 5 
Risk assessment never performed 3 14 
78 
---
Table 5-2: Baseline risk assessment characteristics of 200 patients attending their GP• 
Non-Aboriginal Aboriginal Total 
(n = 134) (n =66) (n =200) 
A&e in years (mean :1:: SD) 51.5 ± 29.8 50.1:1:: 10.62 51.1 :1::25.1 
Female 79 (59%) 45 (68%) 124 (62%) 
Rec:orded diabetes 37(28%) 30 (46%) 68 (34%) 
Current smoker" 36 (27%) 33 (50%) 69(35%) 
5-year adjusted CVD risk 
Low risk ( < 1 00/o) 28 (21%) 16 (24%) 44 (22%) 
Moderate risk ( 10-15%) 12 (9%) 9 (14%) 21 (11%) 
High risk(> 15%), excluding 28 (21%) 11 (17%) 39 (20%) 
established CVD 
Established CVD 30 (22%) 13 (20%) 43 (22%) 
Unable to estimate risk due to missing · 36 (27%) 17 (26%) 53 (27%) 
information 
Medication prestribed 
Lipid-lowering 67 (50%) 31 (47%) 98 (49%) 
Anti-platelet 50 (37%) 20 (30%) 70 (35%) 
BP-lowering 85 (63%) 37(56%) 122 (61%) 
• Reported as no. (%) unless otherwise indicated. Percentages may not add to 100% due to rounding. 
b Current smoker or quit within past 12 months. 
For the 200 CDS outputs generated for review, GPs agreed or strongly agreed that the 
output was easy to understand (77% of outputs), that screening and prescribing 
recommendations were appropriate (72% and 64% of outputs, respectively), and that 
recommendations on treatment targets were appropriate (70% of outputs). Fifty-two (26%) 
patient records were updated with CVD-related information, most commonly family 
history, past history ofCVD, and smoking status. Figure 5-4 highlights the changes in risk 
factor screening and management following the consultation. Ninety-five (48%) patients 
received changes to their management, of whom 49 (52%) received lifestyle advice on 
CVD risk factors. For people assessed at high CVD risk (n = 82), 10% and 9%, 
respectively, had lipid-lowering and BP-lowering medications commenced or dose 
adjustments made, while 7% newly commenced anti-platelet therapy. 
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Figure 5-4: CVD management practices before and after a consultation involving the 
Clinical Decision Support tool 
Urinary albumin creatinine ratio 
Blood pressure (BP) 
Cholesterol (including H 
Estimated glomerular filtration rate 
Smoking status 
0% 
S-4-1: Risk factor recording rates 
20% 40% 60% 80% 
% of total sample (n=200) 
• Previously performed & 
not updated 
• Previously performed & 
updated 
• Not previously performed & 
newly checked 
• Not previously performed & 
not checked 
100% 
S-4-2: Prescribing of CVD medicines for those at high CVD risk 
(S year CVD risk >IS% or established CVD) (n=83) 
Anti-platelet + BP + Lipid lowering 
BP + Lipid lowering 
• Already prescribed 
Anti-platelet medicines • Newly prescribed 
• Not prescribed 
Lipid lowering medicines 
BP lowering medicines 
0% 20% 40% 60% 80% 100% 
% of high risk individuals 
S-4-3: Attainment of guideline targets for individuals at high CVD risk already prescribed CVD medicines 
BP lowering treatment (n= 66) 
Lipid lowering treatment (n= 54) 
(Missing information for n=1) 
0% 20% 40% 60% 80% 
• Already reaching target 
• Not reaching target & 
treatment changed 
• Not reaching target & 
no change to treatment 
100% 
% at high risk already prescribed CVD medicines 
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Field Testing- Qualitative Evaluation 
All GPs participated in the interview evaluation, with interviews ranging from 
approximately 30 to 60 minutes duration. One interview was conducted with a pair of 
participants, two interviews were conducted over the telephone, and the remainder were 
individual face-to-face interviews. Three major themes arose from the interview content 
analysis that will be reported here. A fourth substantive theme was identified that related to 
how tools are used in general practice and the role of evidence-based medicine in decision 
making. As this issue extends beyond factors related to the CDS tool and was not a specific 
objective of the study, an in-dep~ analysis of this theme will be conducted separately. 
Theme 1: Systematic provision of care 
' 
Most GPs felt that the tool was effective in providing comprehensive support in CVD risk 
' 
management, both at the point-of-c.are and as an adjunct to reviewing their clinical 
performance. 
Oh well it does help, because it's your data there ... and you look at it and you think 
'Oh gee, that's not there. I haven' t put that in' or 'Well yeah, they are not to target 
there' ... So it's just a reminder that you might think you're doing okay, but there's 
nothing like seeing the actual figures to make you realize that 'Okay, there's room for 
improvement here.' [Interview 7: Male GP over 60 years] 
I think it was quite a good thing because you would finish the consultation about 
whatever that was about and then you'd almost have a separate time set for looking at 
cardiovascular risk ... Otherwise, I would think about doing it through the 
consultation, but you just seem to forget and then you would think 'Oh damn it, I 
should have done that.' So having that piece of paper there gave you that 
conversation: 'Well now we've finished everything, let's look at this.' [Interview 12: 
Male GP 40-49 years] 
I think it's useful to us ... It's basically like a mini audit. So anything that makes you 
look a little bit deeper at the person sitting in front of you is always worthwhile ... 
[Interview 19: Male AMS GP 40-49 years] 
Importantly, howev~r, recommendations based on single risk factor readings, out-of-date, 
or even false readings undermined the full benefit of such a tool. GPs sought clarification 
on the underlying assumptions in how risk was calculated and management 
recommendations were made. For the few GPs who were dissatisfied with the tool's 
recommendations, these issues accounted for much of that dissatisfaction. 
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It gives information which, as it's blandly presented, you go, 'How did you get that?' I 
got a couple of people where I got a 20% number and you go, 'Oh that's madness, 
that's not you,' and often because it's based on single digit information ... like a 
single blood pressure. [Interview 11: Male GP 50-59 years] 
The other issue I have with this data which came up is it uses the last available input 
... I think what would be really good is something that came up and said, 'This is the 
risk, but we've used data that's three years out of date ... You need to be doing it 
again! ... just a reminder to say, 'Ah, I should be thinking about that for everyone.' I 
think that would be really useful. [Interview 17: Female AMS GP 20-29 years] 
GPs further highlighted the need for ongoing revision as guidelines are updated. 
We're used to every month getting a download of the new drug file, the new program 
data ... with therapeutic guidelines ... There's a little button that says, this is emerging 
guidelines or these are the things that have just been incorporated within it ... You 
don't really want to be working on guidelines that are too old. [Interview 11: Male GP 
50-59 years] 
Theme 2: Risk communication 
Despite only brief exposure to the tool, many GPs commented on its role in risk 
communication. The synthesis of multiple risk factor information onto a single page 
appeared to promote a beneficial dialogue with patients. The need for an evaluation from 
the patient perspective was highlighted. 
I think the biggest impact is that it changed the way I talked about what I was doing 
with patients, in that it made it a much more slick, neat package to describe the normal 
screening that you do for risk management. And so I felt it was easier to deliver some 
description of where they're at now. And from their point of view, I mean it's hard to 
know, but they seemed to understand that it was a multifactorial thing, rather than just 
being one of those single disease problems ... The thing that I don't really know, that I 
guess would be useful, is what they think when they walk out the door, what they 
actually understand of what I've said. [Interview 2: Female AMS GP 40-49 years] 
Most noteworthy was the prominence of the color bar (see Figure 5-l) in promoting 
discussions about risk management. 
I like this one [referring to the color bar] ... I mean, everyone knows that red means 
danger, so if they're heading towards this one, it's a lot more visual, the impact ... 
[Interview 15: Female AMS GP 30-39 years] 
I could see the potential for using it to discuss with the patient ... I like the fact that it 
had that nice bar with the color gradations because my other previous use of trying to 
describe risk has been using that one from the New Zealand calculator, and it's very 
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complicated. It's too complicated. And I find it really, you know, very pretty, but 
difficult for the patient to really get much sense out of. So I liked that single bar. I 
thought that was much more useful for people. [Interview 9: Female GP 50-59 years] 
Yeah, and even the colored diagram is really helpful in seeing and being able to say, 
'Look, this is going into orange- this says high in red.' And there's almost an 
emotional response to the colors that come back there that is actually really useful 
compared to me saying, 'Look, people with diabetes have heart attacks and strokes.' 
[Interview 4: Male AMS GP 30-39 years] 
Additionally, some GPs considered that interactively changing the risk factor profile and 
resulting risk score (including color category) would facilitate conversations about the 
relative contributions of individual risk factors to overall risk. 
I could think on the absolute risk bar, if you've got an arrow for where they sit now, 
potentially you could have an arrow for if you were to modify what was modifiable 
and where could you get. 'You [the patient] could ultimately work your way down to 
here,' and it might be a way of saying, 'Well, there is the gap,' and that might be 
helpful as a motivator. [Interview 8: Male GP 30-39 years] 
So that gets me thinking about talking to the patient about the relative merits of 
putting them on drugs compared to smoking, and I think as an interactive thing I could 
bring up this thing and change her smoking or change her BMI ... and say, 'This is a 
much simpler way of dramatically changing your absolute risk.' [Interview 16: Male 
AMS GP 50-59 years] 
Theme 3: Challenges for implementation in routine care 
\Vhile GPs felt that it was appropriate and feasible to incorporate CVD risk management 
into routine care, the time pressures in doing so were highlighted. A major potential 
constraint identified would be the time required for data entry. A common view expressed 
was that a tool integrated with practice software would need to be pre-populated with as 
much risk factor information as possible. 
I think it depends on the patient. The ones where I think it takes most time are those 
where it's not been brought up and it turns out that the risk is high. So where you feel 
the stakes are higher ... and it's not really been on your radar and it's certainly not 
been on the patient's radar. There aren't that many of those. For most of the patients 
where the risk is high, you're already aware that their risk is high ... In that context, it 
isn't that much extra work. [Interview 4: Male AMS GP 30-39 years] 
I'm not sure how you can do it, because some are from pathology reports coming 
back, some things you have to measure, and then some people don't put it in the right 
boxes. They just type in. So if you don't put it in the right place, then the software 
won't be able to pick it up. Ifl have to go enter [data] into this thing, then I'm pretty 
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sure very few people are going to do it ... just like the New Zealand one ... But, ifyou 
could extract it automatically, or maybe I fill in the occasional one ... then that's fme. 
[Interview 10: Male GP 50-59 years] 
One ofmy rules in general practice is 'every 30 seconds counts,' so if it becomes 
something that slows the program down, if it becomes something that blocks your 
progress on doing what you want to do ... they're the things that would make it less 
usable ... rather than becoming distracted by this thing because you are stuck with 
closing boxes and pop-ups and forced to put data in ... What I like about this [the 
CDS tool], it pulls information together for you so you don't have to look through 7, 8 
different places ... [Interview 11: Male GP 50-59 years] 
This was considered particularly germane to GPs who are less comfortable with EMR use 
and where information may not be stored in an extractable format. 
Less-computer-literate doctors will fmd it less useful because they don't have the 
information there ... So, if people put garbage in, you will get garbage out, and I don't 
think that is going to change ... I.can't imagine a paper file doctor wanting to use the 
tool in the first place. So I think your target is only likely to be people who are more 
computer savvy. [Interview 8: Male GP 30-39 years] 
Some GPs advised of the need for a more graphically oriented layout and innovative 
prompting mechanisms that avoid contributing to the already congested number of 'pop-
up' prompts present in their systems. Additionally, some GPs felt that the screening (as 
opposed to management) recommendations offered little additional value and, in their 
time-poor context, may distract from the recommendations about indicated preventive 
therapies. 
I find it all too wordy ... I can't read those words while I'm sitting there with a 
patient. I still have to sit there and think, 'What does that sentence actually mean?' So, 
it needs to be very graphic, where it says the same thing to you graphically. [Interview 
2: Female AMS GP 40-49 years] 
[The tool was] almost too busy ... I've only got a minute to glance at it .. . People 
normally wait about four, six weeks to come and see me, and so they've got a lot of 
stuff they want to see me about ... I don't need to know that lipids evaluation is 
recommended for those aged over 50. What you want is the real necessary stuff ... 
those first four things (the screening recommendations) actually weren't necessary ... 
You've got 15 minutes at most and ... if you don't have that information in the first 
two lines, people won't read it. [Interview 14: Female GP 40-49 years] 
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5.5 Discussion 
This preliminary evaluation demonstrates that a valid decision support tool for CVD risk 
management can be successfully developed and that such a tool was favorably received by 
GPs working in two distinct primary health care settings. The baseline prescribing patterns 
ofCVD medications to high-risk individuals were broadly similar to those reported in our 
previous Australian audit studies. 8•9 The improvements in risk factor screening and the 
intensification of existing therapies were promising signs of the tool's ability to promote 
absolute risk-based care. It was also encouraging that despite, or perhaps because of, the 
high rates of Aboriginal CVD burden, the tool was viewed positively by AMS care 
providers. A large-scale controlled evaluation would clearly be needed to substantiate these 
preliminary study findings . 
The evaluation identified key aspects of both the tool' s scientific design and functionality 
; 
that are likely to be crucial for successful wider implementation. Our findings support the 
systematic review evidence that CDS tool features associated with improved performance 
include factors such as integration with routine workflow, provision of automated decision 
support, and provision of recommendations rather than simply assessments.14 Perhaps the 
most fundamental fmding from this study is that CDS tools need to be effectively 
incorporated into routine care and avoid being viewed as an optional, additional burden to 
the workload. Integration within existing medical software systems and maximal use of 
information contained in other parts of the EMR would reduce data entry and increase the 
tool's use. Although the uptake ofEMRs in the Australian primary care system is 
widespread for prescribing medications and pathology services, their routine use for other 
purposes is more variable.36 This poses both challenges and opportunities for CDS tools. In 
this pilot, the research assistant accessed health information from disparate parts of the 
EMR, including free-text information. The ability to automatically 'push' data into a CDS 
tool and limit burdensome data entry is dependent on the extent to which information 
exists in an extractable format. If the amount of extractable information is scant, this could 
pose a major barrier to use of CDS tools. The tool itself, however, can be utilized as a 
strategy to overcome this problem. If the information that is entered directly into the tool 
can be 'pulled' back into the appropriate parts of the EMR, then there is a dual purpose 
being served- that of performing a clinically relevant task at the point-of-care and a data 
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cleaning process. In practical terms, this would mean that the CDS output would either be 
automatically generated based on existing data or prompt the practitioner for any missing 
data. This missing data could then be entered directly into the tool and written back to the 
appropriate part of the health record, avoiding the need for double data entry. This makes 
future risk assessments easier to perform, affords extraction of more reliable data for 
auditing and quality improvement purposes, and supports the use of shared electronic 
health records across multiple service providers. Full EMR integration is also a key 
consideration in supporting other components of chronic disease management such as 
chronic care plans, well person's health assessments, and audit cycles of care (all of which 
attract Australian government-funded rebates). This could ensure that the tool facilitates 
existing care, rather than competes with it. 
The NZ Web-based decision suppo~ system for CVD risk has been purposefully designed 
to be 'agnostic' to the EMR environment and is capable of pushing and pulling data with a 
variety of commercial products. As a centrally deployed system, there is also a mechanism 
for rapid implementation of updates as subsequent guidelines evolve (already a priority 
issue in Australia given that three new CVD-related guidelines have been released since 
initial programming of this tool). In order to meet these specification requirements in the 
Australian context, adequate resourcing and a close collaboration between researchers and 
EMR vendors are needed. The Medical Software Industry of Australia, which is the peak 
representative body for all EMR providers, the Australian Health Information Council, and 
the Australian government's National E-Health Transition Authority are key stakeholders 
that can assist with establishing industry standards on CDS tools. Furthermore, 
endorsement of these tools by the peak national bodies responsible for generating and 
disseminating guidelines could further increase GP confidence in their validity. 
An important consideration for future development of the tool is to more fully understand 
its impact on communication of CVD risk between care provider and patient. This study 
confirms previous findings that GPs use these tools to facilitate the provider-patient 
interaction.12 Of particular note was the role of the color spectrum bar in communicating 
risk information and the desire to interactively change this based on different risk 
scenarios. While this tool examined decision support for the care provider, further work 
examining how best to provide decision support for the patient is needed. This includes 
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identifying acceptable fonnats for conveying risk infonnation, evaluating the impact of 
decision support on health care interactions, and exploring its potential for use outside the 
clinical consultation (e.g. self-management programs and personal eHealth records). 
Limitations 
A limitation of this preliminary evaluation was that changes in care provider practices were 
based on a single consultation, reducing the ability to assess the potential impact of the 
CDS tool over time. A second potential limitation was the sampling method. Rather than 
seek a representative sample, we sought GPs who might actively contribute to the future 
development of the tool. AMSs were considered important settings to assess whether the 
tool was acceptable for use in a population with high levels of health disadvantage. Despite 
this purposive sampling, the types of medical software used, the electronic features used 
within those software systems, and the rates of performing absolute risk assessments were 
broadly similar to those reported ili. the Australian literature. 12•36 
Future Implications 
The implications of a CDS tool for CVD risk management extend well beyond being a 
point-of -care clinical resource. Data from UK CVD risk programs have allowed for the 
generation of population-specific risk prediction equations that outperfonn Framingham-
based algorithms.20 The NZ decision support system, combined with linkage to mortality 
and hospital databases, is similarly allowing for rapid advances in CVD risk factor 
epidemiology. The combination of a centrally managed Internet-based system with local 
management of program specifics by primary health organizations allows for a 'ground up' 
approach to incorporating population health aspects into such systems. Along with 
epidemiological advances, both the UK and NZ systems allow for the use of large-scale 
primary care data to monitor health system performance. In Australia, such systems will 
play an integral role in the broader eHealth strategies being proposed to reform the health 
care system.37"39 Performance measures in CVD risk management are integral to the UK 
Quality and Outcomes Framework and are allowing for large-scale analyses of regional 
variation and progress in reducing health inequalities.40 In Australia, this is especially 
pertinent to addressing Aboriginal health inequities where specific indicators for the 
measurement and reduction ofCVD risk are proposed.41 Awareness of these broader issues 
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and incorporation of the major study fmdings into the next phase of the project will 
provide a strong foundation to develop, implement, and evaluate an integrated CVD risk 
management system in Australian primary health care. 
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Attachment 1: GP questionnaire completed at the end of each patient 
consultation 
Department 
of General 
Practice, 
Westmead 
Hospital 
Electronic Decision Support 
Feasibility Study 
End of consultation questions 
Patient 10: LI_I_I_I_LI Sex (FIM): 1_1 
~ v 
l'Hl!GEO~ 
INS'Tm1n 
,~ ..... 
We are coledinQ 1hiS lnfonnation to evafuate lila EDS tool and develop 11 furttler. This Is an untested tool: 
plou. use your clinical J!ldgment ID manage y01X patient Your U$1stanee Is appredaled. 
PIMM note that the questions below 1pply tor this pi~Uent only 
PIHa Indicate wlwther you IG1'M. 01 dlugree wtth Strongly OtsagrH Neut>'3l AQlM SIJongly Don't I 
the statement below dlllgrH """ 
know t:/r I 
~ 
L. The EDS printout was easy 1D unclersland 0 0 0 0 0 0 
The SCteen!ng/ monitorlnc! recommendallons ware 0 0 0 0 0 0 appropriate 
The ttftlmtn!. recommendations were ~te 0 0 0 0 0 0 
For patients aha.dY taldng BP 01' chqlesterol medicines, 
the rtcOmmendallons on meeting targets were 0 0 0 0 0 0 
appropllate 
2.. Diet you update your clinical records based on the recommendations of the EDS toot? j'fj No If yes, wflfcll of the following did ywtldd or updlte? D 
0 Family histofy of cardiovascular disease 
0 Past history of cardloVasaJiar diMase 
0 Smoking status 
0 Gon.UC dyslipkfaemlal FamU!al Hypercholest&rolaemla 
0 Diabetes staius 
0 Othec cardlovasculat disease n~(ated Information (please speclly): 
3. Did you Ofder « perfonn IllY of the fDUowlng for your patient In thtis conaultatlcn? I~ No If yes, pJeue tick u many as spply. D 
0 Blood pres$11'8 D Total choleSterol ~ Fasting Blood giU<:olefGTT 0 Height & weight 0 HDL Serum creatinine/ eGFR 
0 Waist circumference 0 LDL 0 Urinary Atlumin Creallnine Ra)io 
0 Urinalysis 0 Trfglycertdes 0 HbA1c 
0 ECG 0 Elecltolytes 
• D Olher'tests (~)lease SQeCIM~ 
4. Did you c:llllnp the treatment plen tot your psUent? I~ No It yes, which of the. following did you change ar ldd? 0 
0 Blood,pressure lowering therapy 
D Blood g~ucose lowemg therapy 
0 Lipid lowering therapy 
0 Anti-plate~ Ulerapy (asplrln; clopldogrel, dlpyrlmaclole etc.) 
0 Ulest)'le modillcaliolllldvfce (either Smokklg, Nutritional, Alcohol or Physic& Activity a¢11ce) 
0 Other treatrnen1s (please 'l)tCify) 
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Attachment 2: GP questionnaire completed at the end of the study 
Department of 
General 
Practice, 
Electronic Decision Support 
Feasibility Study 
End .of study GP questionnaire 
~ v 
~E.Gl!OIIG& 
INSilTIJTI! West mead Hospital "'~-
We are collecting this information to evaluate the Electronic Decision Support tool and develop it further. 
Because this is an untested tool we are interested to know your opinions about its feasibility for use in 
General Practice. Your responses to the questions below will give us important background information 
about you and your practice and will take about 15 minutes to complete. All responses are private and 
confidential. Your assistance is greatly appreciated. 
Section 1: Your Background 
1.1 What is your age? 
D 20-29 
D 30-39 
D 40-49 I 
D 50-59 I 
' 
D 60 or over 
1.2 What is your gender? 
D Male 
0 Female 
1.3 What is the primary lanauaae you speak at home? 
1.4 What country were you born in? 
1.5 From which university did you obtain your medical degree? 
!Year araduated: 
Please list up to four of your post-graduate medical qualifications below: 
1.6 
Qualification Institution Year awarded 
1.7 Are you vocationally registered? 
D Yes 
D No 
1.8 How many sessions per week do you work at this practice? 
1.9 How many sessions per week do you work elsewhere? 
Never Sometimes Often Very often 
1.10 How often do you participate in research? D 0 D D 
1.11 How often do vou conduct your own research? D D D D 
-' 
! 
I 
I 
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Section 2: Practice Characteristics 
12·1 How many of each category of the following staff are 
employed in this practice? (if none then please write Doctors 0 
'0': 
Nurses q 
Aborigin.al H~aJt!'l Wqrkers D 
Practice Man~gers q 
tJ I Other !ldmini~ativ~ ~Wf 
Allied Health professionals D 
2.2 Which of the following best describes access to bulk- ... 
billing at your practice? (please choose one) Exclusively bu!~-~illing 0 
Selective bulk-billing (eg. children, p seniors, concession card holders) 
_.,. 
. · No bul.k-billiog D 
pther billing arrangements (please specify): 
I 
' 
2.3 Is your practice accredited? 
0 Yes 
0 No 
If so what year was the practice first accredited? (please leave blank if you don't know): 
12.4 Please Indicate your agreement or disagreement with the following statements about your practice. 
Strongly Strongly 
Disagree Disagree Neutral Agree ~ree 
. .. 
I con~~el' ~s pr~iCE:l to b~ innpvatiye. D D 0 0 ·o 
We are actively doing things to Improve 
q~ality of care. D 0 p p D 
After we make changes to improve quaiJW! 
D D 0 D 0 we evaluate their effectivene~. 
We h~ve qu11li!Y problems in our pr1'\Ctice. D D D D 0 
Qyr pr99~1:®~ ~nd ~yslt;)ms ar~ Q09cf. ~t 
oreventina errors from occurrino. D D D D ·o 
2 
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Section 3: Use of !nfonnation Technology 
.. . 
~. 1 How often do you use the Internet for personal and/or ~veral .times a day D professional use, including e-mail from home, work, or another 
location? D Daily 
We~kly D 
Monthly 0 
less than monthly or. not at all 0 
~.2 Which practice software system do you currently use at your Medical Director 0 
practice? 
~~~ D 
Best Practice [J 
Practix C1 
Ptfler (please specify): 
: 
; 
~.3 OVerall how satisfied are you with Very Very 
the computer systems at your Unsatisfied Unsatisfied Neutral Satisfied Satisfied 
practice? 
0 D D D D 
~.4 Please indicate which of the following features you use in your practice. 
Not available at Available but I do I use some of f use most or all 
this practice DQ!_USe it the time of the time 
ElectrQniq m~icati(ln pre~crib!ng D D D D 
Electronic pathology ordering q p D D 
. . ~, 
clect!'OI!iC dQWT!I9i¢$ gf pal~IQgy 
result$ · · · 0 D D D 
Electronic c_are plans Q D [J 0 
E!~ctroni~ (li~e~~ ~~ist~rs 
D [j . D (eg. ~~~~t~~) . . D 
Electrooically generated recalls 
(e.g. immunizations, pap smears) D 0 D CJ 
. . 
; 
. • o· D D D .. ~levtroniQ on-lifle billing 
Scanning of paper documents into 
practice software D D D D (eg. speciali~ letters) 
---- -----
3 
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I I r 
.5 I How much of a barrier is each of the following to successful implementation of computer systems at your 
ractice? 
Not a barrier · Minor barrier Major barrier 
.Staff trainii"!Q I 0 0 D 
Privacy! Security concerns 0 D 0 
ifv1edi®f ~~are !im~tions D D 0 
ems has been for each of the areas below. 
Very Somewhat Somewhat 
~ 
ne~ativ~ ne~ativ~ No effect positive Very pol?i~ive 
"ijle pr~ctic~ of !'lvid~nce Q~~~ met;llcin~ D D 0 D 0 
Patient-doctor communication P. 0 D. 0 0 
P~tient p~va~y : D D d {] . 0 
Practice cost efficiencies p 0. D D D ..... : ... : 
leveratl patient sataty 
. reduction in medication errors 
Section 4· Access to medical information 
:4.1 Please indicate how influential the followlna sources of medical information are In vour oractice. 
Not Somewhat Very 
i!l!luenti~l influential influential 
Ol;ls~rv~ti~m Cilnd d,iSCI,I$:?iQI1 with Gf:l coll~a.gues D · ·· . : t~f . o· 
Correspondence with spec!ali~ts D D D 
Pparrnac~utical company r~p~~ntativ® D .0 D 
Drug product information within clinical ~o~are (e!;J MIMS) 0 0 0 
C~ntinl!ing ¥¢~ ~d\,lea~on (CME} eye~ D 0 D 
Conferences D 0 D 
Austra~l811 M¢1cines H~ D 8 .0 Medical newspapers (eg. Medical Observer/ Australian Doctor} 0 0 
Austr~~ F;mtily Physicifll'! 0 .·o 0 
Peer-reviewed journals 0 D D 
., D 8 D Evidence ~~e~ M~9icin~ guid~§. (eg. l,Jp to Pate) Personal Internet searches (Google, Pub~e~ etc.) 0 D 
Clinical ouidelines from orofessio·na! oraanisations D ·D ·o 
4 
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-
--~-
..t a. 
.......... 
--21101 
-
!National Heart Foundation "HvnArtAn~inn Management Guide for 
Heart Foundation and Cardiac I Society of Australia and New Zealand 
Statement on Upid 
IIVIC111C11;1'" n enr 
I a. I- .t.! - - - I I I __ _.o. - _ - ....I- .a.t- -
RACGP "Red Book"-
Health Australia-
"Chronic Kidney Disease Management 
General Practice" 
neraoeutJc Guidelines- Cardiovascular 
for lipid lowering th .. .,.n;,.., 
I am not aware Not Somewhat Very 
this guideline influential influential influential 
D D D D 
D D D D 
I 
D D D D 
D D D D 
D D D D 
D D D D 
D D D D 
D D D D 
5 
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Section 5: Use of cardiovascular risk assessments 
For patients over 45 years (or over 35 years for indigenous patients), on average how often would you 
calculate cardiovascular risk? 
More than Less than 
Always 50% of the time 50% of time Never 
0 0 0 0 
Paper ~i~mr charts 
0 If you do calculate your patients' (eg. NPS, Heart Fo1,1ndati()n, !'l~w ?eal~d) 
cardiovascular risk which of the following 
resources do you use? Risk calculate~ within your medical software 0 
On-line or downloaded risk caleulators 0 
Pther risk calculation methods: (please specify) 
/ 
Thank you for your participation! 
I 
6 
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Attachment 3: GP interview guide 
Electronic Decision Support 
Feasibility Study ~ v 
Department of 
General 
Practice, 
Westmead 
Hospital 
End of study Evaluation 
Interview guide 
THE GEORGI! 
INS'IITUTl! 
fW--..11/oM 
Part 1 : General overview of the EDS tool 
The aim of the EDS tool Is to assist GPs through the provision of decision support for the management of 
cardiovascular risk. I'd like to start by talking about your personal experience of the EDS tool, and then go on to 
ask your views about its applicability in general practice more generally . 
a. OVerall, what do you think was the impact of the EDS tool on the quality of care you were able to 
provide for your patients? 
b. How useful was the EDS tool in supporting communication with your patients? 
c. How effective was the EDS tool in assisting you to practise according to national guidelines for 
cardiovascular risk management? 
'Part 2: The EDS output 
I'd now liked to show you some sample printouts from patients enrolled in the study at your practice. 
a. What did you find useful about the EDS printout? 
b. What information was not helpful in the EDS printout? 
c. Was there anything confusing about the printout? 
d. How could we improve the printout? 
Part 3: Implementation of the EDS in General Practice 
Our future plans are to integrate the EDS into the commonly used medical software in General Practice. 
a. If we do this, what do you see as its potential benefits? 
b. Would you anticipate any disadvantages? 
c. What barriers do you think we would face? [Probe: practlca!/ technical/ other} 
d. How do you think we could improve it? 
e. Would you personally consider using it in your practice? [Probe: why/ why not?] 
Part 4: Wrap up 
a. Are there any other issues not covered that you would like to talk about? 
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PART 8: EXPLORING THE CONTEXTUAL FACTORS 
THAT INFLUENCE HEALTH CARE ACCESS AND 
QUALITY FOR INDIGENOUS PEOPLES 
/ 
Chapter 6: What influences access to health services for 
Indigenous peoples in Australia, New 
Zealand, Canada and USA? A qualitative 
systematic review utilising candidacy theory 
and focusing on chronic illness care 
Planned publication details: Peiris D, Weeramanthri T, Ingram S, Bleasel J, Devitt J, 
Cass A, What influences the accessibility of health services to Indigenous peoples in 
Australia, New Zealand, Canada and USA? - A qualitative systematic review utilising 
candidacy theory and focussing on chronic illness care. An abbreviated version is currently 
being prepared for submission to BMC Health Services Research 
Author contribution: I designed ~e study, conducted the literature searches, was the 
primary reviewer of the documents retrieved, coded half of the documents retrieved and 
supervised Jonathan Bleasel to code the remainder. In consultation with the co-authors I 
conducted the thematic analyses, wrote the first and subsequent drafts of the chapter and 
am the primary author responsible for progressing this to journal submission. Co-authors 
Weeramanthri, Ingram, Bleasel and Devitt assisted with the critical appraisal of the 
qualitative studies. All co-authors reviewed and commented on chapter drafts. 
6.1 Abstract 
Background: Despite extensive literature documenting inequities in access to health care 
for Indigenous peoples in Australia, New Zealand, Canada and USA, there have been 
limited reviews of the literature to understand why this occurs. The recent construct of 
'candidacy' was developed to analyse health care access for vulnerable populations. It 
describes the ways in which eligibility for health care is jointly negotiated between 
individuals and health services. It recognises that both parties have explicit and implicit 
criteria for whether health care is sought or provided. In this study we assess the utility of 
'candidacy' theory, building a theoretical framework for identifying the factors integral to 
improving Indigenous peoples' access to health care. 
102 
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Methods: A qualitative systematic review was conducted drawing principally on three 
synthesis methods, meta-ethnography, critical interpretive synthesis an4 thematic 
synthesis. We analysed 394 empirical and grey literature documents from Australia, New 
Zealand, Canada and the USA, written between 1990 and 2007, which were retrieved via a 
combination of database searches and purposive sampling. 
Results: Four interrelated thematic domains were identified that affect Indigenous peoples' 
candidacy to health care: (1) authoritarian discourses characterised by oppressive practices 
of the State and disease-dominated, biomedicalised care; (2) Indigenous discourses 
characterised by the right to self-govern health services and to promote alternate models of 
care; (3) health service organisational structures that are easy to navigate especially 
through the availability oflndigenous staff, adequate resources and a focus on quality 
improvement; and ( 4) health care e~counters built on the trustworthiness of care providers, 
awareness of broader contextual factors which affect the acceptance and refusal of care, 
and adequate attention to communication dynamics (both the medium and message). A 
fifth theme, prevalent across all domains, was related to constructions of cultural difference 
and cultural safety as barriers/enablers to candidacy. 
Conclusions: Candidacy is a useful construct for understanding access issues at the 
organisational and health care encounter levels. There are, however, broader systemic 
issues at play in which care is negotiated between (1) a predominantly non-Indigenous 
State that adjudicates through its institutions how care is offered and (2) a predominantly 
Indigenous counter-movement that seeks to maximise participation in shaping those 
institutions. Complex interventions that synergistically enhance candidacy at multiple 
levels (health care encounters, organisations and macro systems) are therefore needed to 
improve service accessibility for Indigenous peoples. 
6.2 Background 
There is extensive literature documenting inequitable access to health care for Indigenous 
peoples in Australia, New Zealand, Canada and USA. Despite this ample evidence there 
have been few attempts to systematically review the literature for the underlying reasons. 
In this review we synthesise the literature to better understand how Indigenous peoples' 
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accessibility to health services is conceived and talked about. There are contested 
definitions of 'access'. For this review we take a broad view drawing on Pechansky and 
Thomas' concept of access as 'the degree of fit between clients and the health care 
system' .1 Guilford et al. suggests that access is a multi-dimensional concept that is not 
merely about service availability but also incorporates broader factors related to utilisation, 
acceptability and affordability, relevance, effectiveness (with a focus on beneficial health 
outcomes) and equity.2 This broader notion of 'access', therefore aligns it closely to 
'quality' of care, particularly Donabedian's original notion of "maximalist' quality which 
is the level and type of care that provides the greatest improvement in health regardless of 
cost.3 Indeed amongst the many dimensions of quality, access is usually one major 
component alongside others (effectiveness, efficiency, safety, equity, appropriateness, 
timeliness, acceptability, patient responsiveness, satisfaction, health improvement and 
continuity).4 Rather than attempting to disentangle access from these other dimensions, we 
have embraced this ambiguity in otl.r appraisal of the literature. 
Our theoretical approach is based on Dixon-Woods and colleagues' 'critical interpretive 
synthesis' of literature related to health care access for vulnerable groups in the United 
Kingdom. 5 Authors of this review, similarly, took a much broader view of access than 
merely service utilisation. The emphasis was on an inductive synthesis of the literature 
rather than a more traditional aggregative review. It included a diverse body of literature 
rather than exclusive reliance on empirical research. From this review a core synthetic 
construct termed candidacy was developed. Candidacy describes the ways in which 
eligibility for medical attention and intervention is jointly negotiated between individuals 
and health services.5 It examines the dynamic interplay between users and providers of a 
service to understand barriers and recognises that both parties may have explicit or implicit 
criteria for whether health care is sought or provided. Three sub-themes within the theory 
are particularly pertinent to this review: (1) Navigation and permeability of services. This 
refers to the routes taken by people to gain a point of entry to health services. It requires an 
awareness of where to go and the mobilisation of personal, social and practical resources in 
order to gain access. Permeable services require little negotiation for entry and a minimal 
level of understanding of how the system works; (2) Presentations, adjudications and 
offers. This describes the circumstances under which people appear, are invited or coerced 
into health care. It also refers to health professional judgements about eligibility for care, 
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the processes by which care is offered and patient decisions to accept, refuse or resist care; 
and (3) Tractability. This refers to the policies, structural developments, resource 
allocations and interventions undertaken by services to address inequity in access to health 
care.
5 
Dixon-Woods and colleagues' review found that health service users in vulnerable groups 
must work hard to promote their candidacy to health care and that the depth and 
complexity of this effort can evolve into insurmountable obstacles. Health services are 
frequently poorly equipped to identify and overcome these obstacles. The candidacy 
construct provides a useful Lens to identify the weaknesses, obstacles and fractures in 
health care systems and their effects on accessibility for disadvantaged groups. In this 
review we apply this lens to determine its utility in the Indigenous health care context for 
the four countries in question and ~e seek to identify factors that might be integral to 
improving Indigenous peoples' access to health care. 
6.3 Methods 
The overall conduct of the review was guided by recommendations from the Evidence for 
Policy and Practice Information and Co-ordinating Centre.6 A review team was assembled 
comprising Indigenous and non-Indigenous people from diverse research disciplines 
(anthropology, health policy, primary health care, health services research, and health 
communication). The following review question was proposed: what influences the 
accessibility of health services for Indigenous peoples in Australia, New Zealand, Canada 
and USA? To narrow the scope somewhat we examined accessibility to chronic illness 
care and prevention with a particular focus on three inte~-related chronic conditions: 
cardiovascular diseases (CVD), chronic kidney disease (CKD) and diabetes. The concepts 
underlying the candidacy constructs were then reviewed and critiqued before commencing 
document searches. 
Literature search strategy 
We took a broad and inclusive search strategy in the initial stages using the three core 
elements of the review question as our search terms: (1) Indigenous peoples from 
Australia, New Zealand, Canada, USA (2) health care services; and (3) chronic illness care 
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and prevention. The search period was 1990-2007 inclusive. The international databases 
examined included: Medline, EMBASE, the Cochrane library, PsyciNFO, ERIC, Science 
Citation and Social Science Citation Indexes via the Web of Science, CINAHL, BiblioMap 
and HealthPromise. The electronic database search was then augmented by purposive 
sampling with a specific focus on capturing grey literatw'e sources. The grey literatw'e was 
considered key in determining perspectives that are not traditionally represented in 
academic journals- especially Indigenous perspectives. The views of health care 
consumers, community groups, clinicians, health service managers, Indigenous 
representative bodies, government and non-government organisations were sought. To 
access this grey literattrre we conducted searches within government and non-government 
websites, general searches using 'Google' and 'Google scholar', a number of Australasian 
databases (AMI, APAIS-Health, ATSihealth, Health and Society, RURAL, Meditext) via 
Informit and the Australian Indigenous Health Infonet and recommendations from personal 
contacts with experts in the field. As we gained more familiarity with the content, forward 
and backward citation tracking from key articles and hand searching of themed issues in 
specific journals was also conducted. 
Exclusion criteria 
Although the themes from the candidacy constructs were helpful in reviewing which 
documents to include, these were not exclusively relied upon when making decisions on 
which documents were included for review. We performed an initial scoping exercise 
based on a cursory review of the types ofliterature that had arisen from the various 
searches. This allowed us to iteratively refme our exclusion criteria. Four main areas of 
exclusion were identified: (1) empirical studies that quantified disparities in health status, 
risk factors and health service utilisation between Indigenous and non-Indigenous peoples 
were excluded as we were exploring the reasons for these disparities rather than their 
magnitude; (2) documents with a health focus beyond the domain of health services, 
particularly community-based health promotion, workforce education issues and research 
methods were considered outside the review scope; (3) documents focussed on clinical 
management and treatment guidelines were considered not relevant; and ( 4) disease 
specific documents not pertaining to the inter-related cluster of CVD, CKD and diabetes 
were excluded unless reviewers considered they addressed health service issues applicable 
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to any health conditions. Documents included for analysis were categorised into primary 
descriptive studies (sub-classified by study design), interventions and program 
descriptions/evaluations, and other sources not based on primary data (sub-classified into 
reviews, reports, opinion pieces, editorials/letters and other grey literature sources). The 
full search and exclusion process is shown in Figure 6-1. 
Data management 
Citations, including abstracts or complete references where available, were exported to 
Endnote X (Thompson Reuters Carlsbad, CA) from each database search and then merged 
to produce a single dataset. Duplicates and irrelevant sources were then removed. 
Additional references found from purposive sampling were then added. This dataset was 
then exported and tabulated in Microsoft Excel. Sources that met the exclusion criteria 
were classified by the reason for exclusion and removed. Full text documents were mainly 
obtained via electronic downloads and where this was not possible, print versions were 
prOcured from a professional librarian service and electronically scanned. The fmal dataset 
of included documents was then imported into NVivo (QSR International Melbourne, Vic) 
and managed for analysis. 
Synthesis methods 
We explored and were influenced by a variety of synthesis techniques, particularly those of 
meta-ethnography,7 critical interpretive synthesis 8 and thematic synthesis.9 Our approach 
was pragmatic and intuitively driven rather than strictly adhering to any one method. The 
analysis process was conducted in three stages. 
First, commencing with the qualitative studies, we sought to gain an initial impression of 
the types of themes talked about in the literature. A quality appraisal process was 
conducted for these studies using the National Health Service Critical Appraisal Skills 
Program (CASP) tool. 10 We were aware of the controversies surrounding quality appraisal 
checklists and took an exploratory approach to this activity.11 This initially involved four 
team members in the appraisal of a small sample of qualitative studies. Each reviewer rated 
his/her level of agreement with the ten CASP statements on a 3 point scale (O=disagree, 
1 =neutral, 2=agree ). The form we used is shown in Attachment 1. At a subsequent meeting 
107 
each reviewer discussed his/her rationale for the scores assigned to each of these studies. 
Following this, two reviewers then conducted a quality appraisal for all qualitative studies 
in the dataset using the CASP tool. 
Second, full text documents within each classification group were read and coded line by 
line in NVivo using the methods outlined by Thomas and Harden.9 This allowed us to 
obtain a descriptive map of the emergent themes. This process was done iteratively, 
initially by the whole review team, to develop preliminary themes and then continued by 
two reviewers for the remainder of the data. These two reviewers remained in constant 
discussion about themes emerging from their respective readings. Modifications to the 
themes and their definitions were carried out. In this process we were influenced by Noblitt 
and Hare's notion of reciprocal translation in which key concepts in each source were 
identified and an attempt was mad~ to translate these concepts into subsequent readings of 
other sources. 7 This was initially a ·highly dynamic process where ways of explaining the 
data were postulated, contested and subsequently revised or discarded. It was facilitated by 
regular informal discussion with the broader review team. The descriptive mapping 
allowed us to appreciate dialectical relationships between particular themes. Drawing on 
Noblitt and Hare's concept of refutational synthesis 7 and Dixon-Woods and colleagues 
emphasis on the critical analysis of contrary evidence, 8 this allowed us to explore 
ambiguities and tensions in the evidence. This process of identifying thematic consistency 
and tension was conducted both within and across the various document types. As the 
analysis progressed this interactive development and mapping of themes became less 
vigorous and a certain level of stasis was attained somewhat akin to the notion of 
saturation in qualitative empirical work. 
Third, following the quality appraisal and descriptive mapping stage, we developed more 
conceptually complex analyses of the key themes within the principal domains identified in 
the descriptive map. A feature common to all qualitative synthesis techniques is the 
development of 'third order' interpretations that maintain a clear connection to the primary 
data but go beyond a mere summative analysis of major themes.12 Noblitt and Hare refer to 
this as lines-of-argument synthesis. 7 Although we were open to generating new synthetic 
constructs, we were particularly interested in examining consistency with and divergence 
from the synthetic constructs already developed within candidacy theory. Consequently, 
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there was a further critical analysis process that involved going back and forth from the 
candidacy constructs to the thematic domains developed in the descriptive mapping phase. 
At frequent moments in this process we returned to the coded data and conducted repeat 
readings of particular documents to ensure our overall synthesising arguments remained 
salient. As much as possible, we heavily referenced the source data so as to provide some 
degree of transparency in how these synthesising arguments were developed. 
6.4 Findings 
Data extraction and classification of the sources 
Figure 6-1 below illustrates the data extraction process using the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses format. 13 
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Figure 6-1 : Data extraction, exclusion process and classification of documents 
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Qualitative studies - critical appraisal 
Four members of the review team conducted a detailed appraisal and analysis of five 
qualitative studies. The appraisal scores using the CASP tool are shown in Table 6-1 and 
demonstrate considerable variation in the scores assigned by each reviewer. 
Table6-1: Quality appraisal scores for five qualitative studies using the Critical Appraisal 
Skills Program (CASP) Tool 
Reviewer 1 Reviewer2 Reviewer3 Reviewer4 
Study Specialist Health Primary care physician & senior 
communications Medical physician & health government 
researcher anthropologist services researcher bureaucrat 
Bartz 199914 10 19 16 15 
Browne 200 liS 17 19 14 18 
Cram2003 16 8 18 16 16 
Ritchie 200 117 14 6 11 15 
Towle 2006 18 12 19 18 19 
• For each of the 10 CASP tool questions reviewers were asked to rate their agreement with the statement (0= disagree, 1 = 
neutral, 2= agree) up to a maximum total score of 20. See Appendix 1 for details 
The key explanation for the disparity appeared to be each reviewer's gestalt opinion on the 
inherent appeal of the study. This related to factors beyond the tool questions and was 
especially influenced by the reviewer's background and experience. For example, the 
ethical conduct of the research was of prime importance to one reviewer, for another the 
use of inappropriate jargon in the methods affected his reading of one study and for two 
reviewers with extensive qualitative research experience the ability to shed new light on a 
topic was key. There was, however, much greater agreement amongst the team on the key 
themes arising from each paper. With this caveat in mind two reviewers then appraised all 
80 qualitative studies using the CASP tool. A marked variation in the quality of the studies 
was noted. Fourteen studies scored below ten; nineteen studies scored between ten and 
fourteen; twenty-three studies scored between fifteen and seventeen; and twenty-four 
studies scored greater than seventeen. Appraisal scores for the 80 studies are available in 
Attachment 2. 
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Thematic syntheses 
Seventeen substantive themes were identified from the 394 full text sources reviewed. 
Table 6-2 highlights the density of themes by document type. We grouped these themes 
into five inter-related domains (represented diagrammatically in Figure 6-2) and these are 
discussed in detail below . 
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Table 6-2: Frequency of coded themes by document type* 
Theme Audits Surveys Qualitative Evaluated Program Reviews and Opinion Editorials 
Studies Programs/ Descriptions reports pieces Letters/ 
Interventions Conferences 
(n=l2) (n=42) (n=80) (n=30) (n=25) (n=78) (n=79) (n=48) 
Authoritarian discourses 
The role ofthe State 0 4 26 4 0 34 30 16 
Biomedicalisation 0 2 33 3 1 18 14 3 
Biomedical health information 2 2 26 3 11 11 7 
Indigenous discourses and de-c:olonising influences 
Self-determination I 3 15 6 9 23 24 5 
-· 
Sociocentric care 0 5 32 4 2 8 7 4 
Indigenous knowledges 1 7 41 1 5 21 10 2 
Health service structure, function and organisation 
Navigation & permeability ofhealth services 0 4 16 13 10 9 15 4 
Health professional relationships & roles 1 2 11 7 6 10 18 
Indigenous staff in health services 3 6 15 13 7 18 20 6 
Resource constraints 0 2 13 11 1 19 19 3 
Quality improvement in health services 9 2 5 13 5 5 10 
Health care interactions 
Patient--centred care & the provider-patient 0 11 52 5 7 23 26 5 
relationship 
Communication, language and literacy 0 6 30 3 3 17 13 
Gender & the body 0 0 l3 0 0 2 3 2 
Role of'culture' 0 7 30 6 4 29 31 12 
*The numbers in each cell represent the number of documents in which the coded theme was considered to be a substantive feature. 
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Figure 6-2: Descriptive map of seventeen key themes identified from the review of 394 full text documents* 
Authoritarian 
discourses 
Role of the State (114) 
Biomedicalisation (74) 
& 
Biomedical health 
information (63) 
--- -Health Service Structure, 
Function & Organisation 
Health professional relationships/ roles (56) 
Importance of Indigenous health staff (88) 
Navigation & permeability of health services (71) 
Resource constraints (68) 
Quality improvement strategies (SO) 
Health care interations 
Patient centred care ( 48)/ 
provider-patient relationship (82) 
Communication (73), Language & literacy (22) 
Role of 'culture' in healthcare (119) 
Indigenous discourses & 
de-colonising influences 
Self-determination (86) 
Sociocentrism (62) 
Indigenous knowledges (88) 
• The number of documents in which a particular theme was identified as a substantive feature is shown in parenthesis next to that theme. 
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Domain 1: Authoritarian discourses 
The role of the State 
The perception that the State perpetuates co Ionising practices was a substantive theme in 
around one quarter of documents and was prevalent across all four countries. The effects of 
inter-personal and institutional oppression, historical trauma and dispossession of land, 
identity and community were strongly voiced in qualitative studies, 18-23 surveys,24-25 
reviewi641 and a large number of opinion pieces/editorials- the majority from Indigenous 
commentators. 42-57 Of particular note, the enduring and often inter-generational effects of 
oppressive practices, such as forced separation of children from their families, were 
remarked on in many interview accounts.15 18 19 21 58-63 These broader societal practices are 
not merely colonial remnants. Some documents suggest that the construction of Indigenous 
people as 'dissolute, neglectful and irresponsible'64 and their communities as riddled by 
violence, sexual abuse and alcohol ~~cess65 has permitted the State to create a discursive 
frar:ne for Indigenous people as discredited medical subjects in need of rectification. 32 36 66 
A coerced candidacy, unilaterally devised by the State under the guise of science and 
public health, then becomes justified.67 It allows for levered social change in the name of 
health improvement. Mutual obligation agreements are an example where the State 
determines eligibility for services and resources on condition that certain social and health 
commitments are made. 50 68 In this way such agreements are framed as inclusive and 
participatory rather than punitive. 
Whilst it is clear that the State is not merely an authoritarian actor, the density of responses 
encountered in this review highlights the challenges faced by the State in its attempts to 
foster a post-colonial society in which Indigenous/non-Indigenous relations can develop 
differently. The State has at times responded to these challenges in ways that might 
perpetuate oppositional stances. This was reflected in a critical discourse analysis of 
Australian ministerial and prime ministerial speeches on Aboriginal affairs over the last 
three decades.26 In these leaders' speeches a number of continuous discourses emerged 
around the competence and capacity of Indigenous people, issues of control and 
responsibility and Indigenous people and circumstances as a ' problem'. This was also 
affirmed in an opinion piece where contemporary parliamentarians were noted to view 
Indigenous people as hopeless and helpless, lacking desire to improve their situation. 69 
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Such discourses firmly position the non-Indigenous State against the Indigenous Other and 
reflect the State's struggles to imagine any alternative. It creates a confused policy 
environment founded on governmental instability about what to do and how to do it. 50 
Several conunentators noted the role of treaties and the obligations of governments to 
honour these agreements as an important mechanism for addressing this propensity for 
confused policy. These treaties, present to varying degrees in all countries except 
Australia, are heavily influential in the way health systems have developed, are supported 
and the breadth and type of care they provide.70-74 Despite a certain amount of structural 
protection afforded by such treaties, a number of conunentators noted that they remain 
contested and vulnerable to being undermined.75-77 There was little discussion about the 
role of international agreements. However, in one Australian document analysis, authors 
concluded that international agreements pertaining to the rights of Indigenous peoples, as 
long as they remain unratified, are highly constrained in their ability to affect 'rights-
based' health system changes.70 
Biomedicalisation and biomedical health information 
Illich' s classic work on medicalisation discussed how the medical institution appropriated 
aspects of the social and cultural world to the medical dominion.78 The expansionism of 
medical jurisdiction, authority and practices into new realms is a global phenomenon that 
escalated post World War II. Clarke and colleagues argue that in more recent times there 
has arisen a new expansionist movement of 'biomedicalisation' in which the biological 
aspects of medicine come to dominate. Biomedicalisation is characterised by techno-
scientific advances, the use of epidemiology to elaborate on risk and surveillance and 
transformations in how biomedical knowledges are produced and consumed. 79 A large 
proportion of excluded articles in this review was related to epidemiological descriptions 
of Indigenous peoples' (ill)-health. These studies frequently have obligatory opening 
sentences that serve to identify Indigenous peoples as first and foremost people of poor 
health status and disadvantage. The adverse consequences of implicitly constructing 
Indigenous peoples as diseased was emphasised in several documents. 42 44 67 80-85 
Interviews with Indigenous participants highlighted how health professionals use 
epidemiology to fuel negative stereotypes.86 Furthermore, by invoking public health 
practices around infectious disease containment the same process is taken through the 
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deployment of expert outsiders to manage chronic diseases. 87 1bis domination of disease 
management, a body parts approach, and poor recognition of and attention to other 
dimensions of health was voiced in several documents.21•22 39 44 58 62 66 88•96 1bis can lead to 
unbridgeable gaps in the clinical encounter and may re-ignite colonial tensions. In one 
opinion piece, rigid enactments of the biomedical role were viewed as a mechanism of 
control and ' white efficiency' .97 In one qualitative study, rather than becoming defined by 
diabetes, this disease was re-framed as a colonising force (the 'Coca-colonisation' of the 
food supply) requiring adaptive responses to ensure survival.98 
Health professional attitudes to the disease-dominated approach were diverse. In some 
.- qualitative studies participants had a tendency to frame cultural identity on the basis of 
disease epidemiology profiles 14 86 99 whilst in others doctors were aware of the potential 
harms in biomedicalising the health ~are encounter.14 100•101 In two studies health 
professionals expressed frustration when biomedical causation was usurped by Indigenous 
causation, with some viewing this as a tactic to avoid taking responsibility.102"103 In one 
revealing case study, a doctor actively avoided validating stress as a factor in her patients 
with diabetes because this was seen as non-medical 'stuff and a distraction from the 
'important' issues of diet, weight, physical activity and taking medicines.14 The nursing 
literature revealed interesting tensions with nurses viewing themselves as disempowered or 
ill-equipped agents of a biomedicalist discourse that traditionally appointed doctors as its 
principal advocates. 17104•106 
Indigenous peoples • apparent lack of awareness of biomedical information including 
specific diseases, risk factors, clinical effects, and optimal management were voiced in 
qualitative studies, 107"109 one survey, 110 reviews, 111"113 opinion pieces, 114"115 and a program 
evaluation.116 A few studies acknowledged that narrow conceptions of knowledge about 
diseases were problematic 117"119 highlighting that issues such as discordant views of 
causation 21120"122 may be an important reason for an apparent poor knowledge uptake. 
Two opinion pieces examined non-Indigenous views on how to make biomedical 
education more accessible through the use of Indigenous language concepts and learning 
styles.123-124 There may, however, be unintended consequences to such approaches with 
one anthropologist arguing that the use of such resources has the potential to 
decontextualise the body and affirm a pedagogic power over the seemingly unknowing 
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subject.67 Thus, in general, documents relating to biomedical knowledges tended to be 
superficial and assume that greater education and heightened awareness would lead to 
increased action on personal health issues. One Indigenous commentator strongly refutes 
this assumption, asserting that didactic biomedical education has, on balance, served to 
disempower, framing people as vacant in understanding their bodies and what is good for 
them.44 
Biomedicalisation is therefore an important discursive lens for understanding Indigenous 
peoples' candidacy for health care. Although there were exceptions in the literature 
proposing alternate frames, 22 it remains the primary mode in which health professionals 
' identify candidacy and make adjudications on the kind of care that should be offered. This 
offer of candidacy is conditional. Indigenous peoples are eligible for care if willing to take 
responsibility for their diseases and ~sk factors. Whilst this may be a feature of any 
Western health care encounter, unique to this context is the way in which biomedicalism is 
enacted on a stage with a colonial backdrop. Health care providers may be cast as agents of 
an oppressive State that perpetrates harm in the name ofbiomedicine.36125 There is limited 
scope in the candidacy construct to incorporate these broader societal level discourses 
despite their apparent profound impact on Indigenous peoples' candidacy for health care. 
Domain 2: Indigenous discourses and de-colon/sing influences 
Three inter-related and predominantly Indigenous driven discourses were identified that 
contrast with the authoritarian discourses described above. The dialectical relationships 
between Indigenous and non-Indigenous discourses have a substantial impact on candidacy 
for health care. 
Self-determination 
One of the most important, commonly voiced themes in this review is the right to full 
participation in how societal institutions such as health are shaped. This participation is 
intimately cotulected with broader self-determination discourses around nationhood. 
Indigenous governed organisations are a key example of how the principles of self-
determination (characterised by self-empowerment, resistance to State control and 
expression oflndigenous ideologies) are incorporated into the structure and function of 
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health services. There were many examples in the literature of how these principles are 
enacted in practical terms?8-30 52 59 72-73 126-138 By aligning health services according to these 
principles they become vehicles for procedural justice.139 Not merely providers of services, 
they serve as symbolic markers of achievement 83 and appear to greatly enhance candidacy 
for health care. 
In all four countries there has been growing recognition of the role of Indigenous governed 
health services. In the USA, self-governance is becoming an increasingly prominent 
feature within the Indian Health Service. In Canada the majority of health services in First 
Nations areas are now self-governed. In New Zealand there are now over 200 Maori health 
providers. In Australia the Aboriginal Community Controlled Health Services (ACCHSs) 
began as small-scale, grassroots movements to now comprise around 150 facilities 
delivering comprehensive primary care services across the country. Despite the size of this 
I 
movement there are ongoing debates about the adequacy of support for such 
initiatives.71140-141 One international review of funding arrangements to self-governed 
organisations in Canada, New Zealand and Australia has been conducted.71 1t concluded 
that when these organisations are recognised by the State as the sole legitimate provider 
rather than having to compete with multiple providers, administrative and financial barriers 
are lessened and services appear to be more comprehensive. 
Despite strong endorsement for community self-governance within descriptive research 
and the grey literature, few quantitative studies examined their role in improving service 
delivery and quality of care. One exception was a New Zealand study, which found that 
community-governed not-for-profit organizations were more likely to charge lower fees, 
employ a higher number of Indigenous staff, have written policies on quality management, 
and a greater degree of community based services ( eg health promotion services ).142 
Self-governed services tend to challenge the conventional power dynamics in the health 
system.28 As much as they are providers of health care, they are also community 
organisations providing services in a variety of areas that may have only indirect links to 
health.97 Tsey describes a pyramidal organisational structure to ACCHSs with Indigenous 
managers at the top, mainly non-Indigenous clinicians occupying the middle layer and 
Indigenous community health workers at the base.143 Whilst there were some accounts of 
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how non-Indigenous health care practitioners may embrace Indigenous self-governance,61 
one qualitative study suggested this position became more ambivalent if it threatened their 
scientific hegemony through competition for resources. 12° Kowal highlights substantial 
tension on the part of non-Indigenous health professionals between a 'universalist' position 
in which there is a moral obligation to intervene in the face of poor health outcomes and 
the 'particularity' of honouring Indigenous self-determination which may be undermined 
by such interventions.144 1bis dilemma of when to intervene was revealed in a poignant 
exchange between a non-Indigenous and an Indigenous primary care physician.145 The 
former publicly wrote about concerns of violence and neglect toward children in the 
community she had worked in for over ten years and the latter discussed the implications 
of such uni-lateral exchanges where discussions between Aboriginal people, communities 
and their care providers are not mutually developed and understood. By contrast, such 
tensions were taken to the opposite ((xtreme by non-Indigenous interviewees in one 
qualitative study who advocated complete withdrawal of non-Indigenous involvement in 
health services even if this meant a worsening of health outcomes in the short term. 17 In 
other studies, however, a more balanced view prevailed where community control did not 
signify an undermining of the technical and political roles played by non-Indigenous staff 
and organizations and these roles were seen as critical to create enabling environments to 
address complex issues. 146 
Sociocentric care 
Whilst cognisant of the debates around individualism-sociocentrism dichotomies, we 
encountered many qualitative studies,35 58 83 147' 148 one survey, 149 one review150 and several 
opinion pieces43 54 56151' 153 in which health and health care was mediated by social context. 
Family-based social structures were a source of practical and emotional support for health 
care needs and motivation to change health behaviours.22 60 147 154"156 Looking after one's 
health was also seen as important in order to maintain responsibilities to family.62 82 107"108 
Caring for family members could also be a reciprocal phenomenon and bring about 
changes in health choices for the carer as well.154 Worry for family well-being and the 
experience of chronic illness in other family members was a notable concern in two 
qualitative studies.62155 Dislocation from family and country was a poignant factor 
amongst the considerable challenges of accessing health care away from home.107 127 157•158 
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Whilst family generally constituted a substantial support mechanism, in some documents 
family was also noted as a barrier to implementing healthy lifestyle choices?2154159 
Candidacy appears to be greatly enhanced when health services embrace sociocentric 
principles. Such services are vibrant social spaces, often marked by a blurred distinction 
between staff and patients. Several studies remarked on how such services convey a sense 
of belonging to their users?9 97 99 108 158 160"161 Health care interventions and programs that 
incorporated sociocentric perspectives were generally considered highly acceptable forms 
of health care.30 98 152160 162"163 There were several examples highlighting how conventional 
health services, especially hospitals, are poorly equipped to embrace such perspectives. 
Issues such as allowing access to visitors, involving family in making treatment decisions, 
obtaining informed consent and knowing who to communicate key messages to about an 
individual's health care were cited ~ instances where health system practices were 
discordant with the expectations of its users.23 164-166 This is made more challenging when 
health practitioners have little awareness of complex kinship structures167 and other 
contextual factors that may easily be misinterpreted as obstruction or disinterest in care 
recommendations.19 By contrast Indigenous-governed health services are more likely to 
face the opposite situation where challenges are posed due to a high degree of intimacy 
between those working in the service and those using it. These intimate relationships may 
challenge conventional management structures. They are continually negotiated and 
factored into a broader dynamic of reciprocal obligations and relationships (e.g. kinship, 
gender, ceremonial status, age). In one qualitative study involving Indigenous managers 
these issues were prominent when considering the different layers of accountability both to 
the community and government funding bodies. These accountabilities were perceived to 
extend far beyond those required for non-Indigenous managers and were viewed as a core 
feature of their job role. 59 
Indigenous knowledges 
Closely related to self-determination discourses was the importance of Indigenous 
knowledge generation as a counter-point to biomedicalisation. Durie asserts that 
Indigenous knowledges are epistemol~gically distinct from those derived from 
biomedicine - the former derives understanding from a synthesis of components based on 
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a wider context whilst the latter constructs knowledge from observation of smaller and 
smaller components of particular phenomena.31 Smylie notes further that this synthesis 
involves combining everyday pragmatism with metaphysical and symbolic realities.41 
These dynamic and differently expressed knowledges are inextricably intertwined with 
ethics and values systems that constitute the fabric of societies.23 They are an integral part 
of the physical and social environment and a collective good. 31 
Knowledges that stemmed from connection to land and natural environments; 31 147168-169 
ceremony, stories and spiritual practice; 20 ss 60 63 82 88 98 119 147 154 156 164 170-176 access to 
traditional foods; 97177"178 and the role of elders in knowledge fonnation 91147"148 164176179 
were strongly voiced. The importance of traditional healing and healers was particularly 
apparent in many qualitative studies, 107 147162 164 172 180 one survey, 181 reviews, 35 150 182 and 
opinion pieces. 76124153 Four survey~ found that use of traditional healers was prominent in 
many US jurisdictions 183"185 and in one First Nations community in Canada.186 Contrasts 
with Western biomedical healing systems were explored in one New Zealand qualitative 
study that examined the different approach to diagnosis taken by Maori traditional 
healers.172 It highlighted a less linear approach in which healing and diagnosis may happen 
contemporaneously and where context and spiritual/supernatural elements were integrated 
into the ontology of identifying, naming and treating illness. A detailed project exploring 
the role of diagnosis amongst Navajo healers and patients, similarly highlighted complex 
processes involved in diagnosis. 182 Although there were ample accounts of these different 
systems of healing, some authors cautioned against artificial reifi.cation of these 
knowledges given the great diversity within and across Indigenous groups and the degree 
of connectedness to non-Indigenous knowledge paradigms. 44 125 179 Several qualitative 
studies highlighted that healing frameworks were not simply polarised into Indigenous and 
non-Indigenous frames and the ability to move freely between these differently constructed 
frames of healing was important when seeking health care?1147 158 162 164 180 
There were several accounts of how State-sanctioned biomedicine resists these 
knowledges. We encountered few interventions and programs that focussed on the 
incorporation of Indigenous knowledge systems and principles into health service 
structures (see the Kaupapa Service- Whanaungatanga Model of Care 160 and the Native 
American Patient Advocate program 161 for exceptions). Several documents commented on 
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how Indigenous concepts of health and healing systems are frequently 
subjugated.3135 39 90 123 146 151187 In one qualitative study authors concluded that health 
professionals considered traditional healing practices to not be of intrinsic interest but were 
tolerated as long as they did no harm. 120 In another, respect for traditional practices was 
apparent at a surface level only and primarily judged against an a priori validity of the 
Western scientific paradigm.103 This subjugation of Indigenous knowledges can result in 
feelings of degradation and secrecy on the part of its proponents. 175 188"189 Even when 
Indigenous knowledge systems are acknowledged they tend to be incorporated in a 
reductionist manner with many elements de-contextualised and ' scientifically' 
appropriated.3139 90119 This further emphasises the importance of a societalleyel candidacy 
in which broader discourses influence the provision and receipt of care. 
Domain 3: Health service stru~ture, function and organisation 
Navigation and permeability of health services 
Many features that promote the navigability and permeability of health services described 
in the Dixon-Woods et al. review were similarly encountered here. 5 They included 
proximity of health services and availability oftransport,2124 99 154 158 165 190-196 minimal or 
no out-of-pocket costs for attendance and treatments 15 32 62 190 197"199 after-hours access 200 
' ' 
and outreach services/mobile clinics.15 128 190"191201-205 Welcoming physical spaces and 
Ind~genous staff as the point of first .contact were also frequently 
highlighted.49 108 128 157 1n 195 199 206-209 The ability of a health service to go beyond its health 
care functions and to serve as a social space was viewed favourably.Z2127 This included the 
promotion of community activities, child care facilities, and social networking 
opportunities.207 Making health services more permeable also had adverse consequences. 
The availability of social facilities, the establishment of open door-policies, walk-in clinics 
and flexibility to see anyone no matter what their circwnstances could lead to 
overcrowding, increased waiting times and concerns about privacy. 127 133 210 Although there 
were a number of interventions and programs with elements that addressed navigation and 
permeability barriers, very few were rigorously evaluated with some exceptions (see Gruen 
et al. for an extensively evaluated program on specialist outreach services165). 
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Tractability of health services (1): the roles of non-Indigenous and Indigenous health 
staff 
Tractable health services have detailed policies and service developments that are oriented 
toward improving access.5 One of the most influential factors on the tractability of services 
in this review was health staff roles, responsibilities and interactions. Health professionals 
frequently commented on their broader population health and managerial roles. 34 97 211-213 
They involve balancing acute care demands with managing broader programs,97127214-216 
negotiating tensions between robust recall and reminder systems and respect for patient 
autonomy, 158 understanding and working within Indigenous governance structures 136 217-218 
and collaborating with other agencies to implement sustainable programs.138 219 Whilst 
these roles were clearly a major source of job satisfaction, they are often roles for which 
staff may not be well equipped. The construction of these challenges as formidable, 
frontier medicine can impart a senseofheroic zeal in staff that choose to work under such 
demanding circumstances.36 Severai such accounts were observed in contemporary opinion 
pieces in this review.220-225 Alongside resource constraints (discussed below), the inability 
to accommodate these challenges results in high staff turnover, loss of corporate memory 
and gaps in basic service provision.138 216 
A second important workforce element that affects the tractability of services is the roles 
taken by Indigenous staff. In several qualitative studies both patients and care providers 
acknowledged Indigenous participation in the health professional workforce as being of 
fimdamental importance. 86 99 127 177 226 Similar sentiments were voiced in 
reviews, 35 38 77 94 227 228 opinion pieces/editorials 76 130 229"231 and one comprehensive review 
of community health worker training?32 Indigenous staff influence candidacy through their 
multifarious roles. These include working as clinicians and health promoters,97 133 205 233-238 
brokering better delivery of health information, 61 111 157 165 198 20s 219 239-241 fulfilling 
responsibilities to patients as friends and family whilst maintaining professionalism and 
avoiding nepotism,29 59127 160"161242"243 and representation in managerial positions.35 59 72 
Balancing community expectations and workplace responsibilities was a source of both 
stress and satisfaction, particularly for managers. 59 The level of training opportunities and 
professional support was perceived in several documents to be incommensurate with the 
considerable demands exacted from these roles. 19 34 244-246 
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Although there was substantial endorsement of the roles played by Indigenous community 
health workers, non-Indigenous health staff did not always appreciate what these roles 
were, the degree of overlap with their own roles and how to best develop congruence 
across the respective roles.17 19 133 206 242-243 247 Although there were few empirical studies 
focussing on Indigenous doctor and nurse perspectives, their presence as leaders in health 
service organisation, delivery and policy was readily apparent in more recent opinion 
pieces.2749 53 75 128"129 187 213 218 248"251 In general, evaluations of the role oflndigenous staff 
in interventions/projects were superficial and yielded little additional insights to those 
gained from other literature sources . 
Tractability of health services (2): Resource constraints 
A second dominating influence on the tractability of services was the issue of resource 
constraints. Problems with insufficient personnel, high staff turnover and inadequate 
infrastructure or funding were freqti~ntly voiced.14 11 104-105 n1-112 126 134 158 201 215 243 252-254 
One review and one program description noted that Australian governments were not 
fulfilling their obligations to provide essential services in remote areas.26 216 Conversely in 
the USA, people residing in urban areas receive minimal funding through the Indian Health 
Service compared to those residing on rural reservations.215 255 Siloed funding streams and 
multiple accountability processes,97136"137 256 ill-defmed resource allocation processes and 
unrealistic expectations from funding bodies, 146 prioritising medical care over preventive 
activities,140 dependency on alternate funding sources to cover shortfalls,77 inadequate 
resources to write funding submissions 136 and lack of flexibility in funding structures138 253 
all contribute to health service vulnerabilities in meeting health care demand. The different 
patterns of service provision in Indigenous health settings where more time may be 
required and more complex health issues are managed were perceived to not be well 
recognised by funding bodies.151 Two program evaluations found a deterioration in clinical 
outcomes following hand over of specialist chronic disease programs to the primary care 
service. Both concluded that competition with other primary care programs for the limited 
resources available were key contributors to the worsening of outcomes. 257-258 
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Tractability of health services (3): Quality improvement in health services 
A number of audits and interventions were focussed on reviews of clinical data to assess 
effectiveness of care. 259-261 Most interventions involved the development of indicators, 
measuring and feedback of performance, and health service actions to improve quality. 
These interventions utilised well-established quality improvement methods such as 
increased access to clinical guidelines, improved computerisation and recall systems, and 
feedback cycles of care.Z02 245 259 262"265 A program based on the use of Chronic Care Model 
has had wide uptake in Australia and shown modest improvement in processes of care,266 
links between Aboriginal Health Workers and improved diabetes care 266 and associations 
between improved system development and quality of diabetes care.Z67 The competing 
demand of acute care services, resource constraints and a lack of clear delineation of staff 
roles were noted in two opinion pieces 87 268 and one program evaluation 257 as major 
barriers to sustainable quality improvement initiatives. There was also substantial tension 
in the literature between the use of health service information for local quality 
improvement purposes and its use for performance management by external funding 
bodies. Experiences where unrealistic expectations of improvements in health status 
measures are placed on health services as a condition of funding highlighted the problems 
with 'top down' approaches to performance management.72126269 In three detailed reviews 
of Canadian, Australian and New Zealand Indigenous health performance measurement 
systems authors argue that the development of macro-system measures, usually based on 
physical and disease variables, often take precedence over the development and use of 
locally specific health indicators.Z70-272 These locally developed measures of service 
delivery may be difficult to quantify, not specifically focussed on health status and 
outcomes, and reflect alternate philosophies and values that are not amenable for use as 
performance measures in the classical sense.190 Despite this, such measures may be very 
meaningful gauges of quality.126 Involvement of Indigenous advisory groups in the 
development of health system indicators; 75 clear, focussed goals that are committed to by 
local health service boards and administrative bodies; 146 and the use of Indigenous health 
worker managed programs237 273 were highlighted as important ingredients for quality 
improvement initiatives. Also highlighted was the need for indicators that monitor 
governments' performance rather than just that of the health service.274 The candidacy 
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framework has limited scope to incorporate these issues of macro-system monitoring for 
quality of care. 
There was little discussion on the role of complaints mechanisms and this does not appear 
in the candidacy framework as a feature of tractable organisations. This was surprising 
given the substantial role played by patient complaints in improving quality and safety of 
care. We found few accounts of patient experiences of making complaints and only cursory 
discussions on the presence or absence of complaints policies. One New Zealand survey 
found that community-governed non-profit health services (which included, but was not 
restricted to Maori health providers) were more likely to have written policies on 
complaints processes than for-profit services.142 At the macro-system level, despite 
recommendations that hospital complaint frequency and availability of complaints 
mechanisms be incorporated into national Indigenous indicator frameworks, 275 this does 
; 
not appear to be nationally monitored in any of the four countries. 
Domain 4: Health care Interactions 
The health care encounter is the crucible in which the above domains exert their influence. 
Within the candidacy construct the sub-theme of ' presentations, adjudications and offers' 
is particularly salient here. This theme describes the circumstances by which people 
present for care; adjudications or judgements on the part of care providers on whether care 
ought to be offered (e.g. moral deservingness or perceived benefit); and decisions by 
patients to accept or refuse these offers. Of particular relevance is the idea that health 
services rely on an 'ideal user' who is equipped with exactly the right set of competencies 
and demands that health services are designed to meet.5 We identified three substantive 
areas which impact on these presentations, adjudications and offers: (1) the care provider-
patient relationship and patient centred care; (2) communication, language and literacy; 
and (3) the role of gender and the body in care. 
Care provider-patient relationship and patient centred care 
The core components of patient-centred care feature strongly as enablers of effective 
patient-provider interactions. Acknowledgement of the patient' s worldview, validation of 
his or her agenda, affirmation of individuality and autonomy, and empowerment in the 
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inter-related issues of (in)-sufficient time 14 18 21 86 99 157 206 276 and 
( dis)-trust.15 18 62 147 154 164 166 173 in care encounters were important components affecting the 
quality of the care provider-patient relationship. In one qualitative analysis of why patients 
take their own leave from hospital, distrust of the care provider was found to have enduring 
effects on individuals, and their families' decisions to present for care for years to come.157 
Towle and colleagues found that insufficient time and distrust were also closely connected 
to historical oppression. 18 These factors contrast with health services' ideal users who do 
not take up too much time and have implicit trust in the system and its workers. 
A number of other documents highlighted that the decisions people make about their health 
and presentations to care are contextually mediated. The (in)-ability of care providers to be 
perceptive of this was noted to be a key element in bow the care provider-patient 
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relationship manifests.15 127 227 276-277:For care providers this poses tensions between the 
utilitarian agenda of 'knowing' a person to adjudicate on the management of illness and 
recognition of alternate and potentially unknowable processes that may manifest as 
refusals to accept care (e.g. alternate knowledge and healing systems, consensus based 
decision-making processes that exceed personal autonomy, and apparent 'unhealthy' 
choices driven by difficult social circumstances and minimal institutional support). Once 
again the ideal user should present to the health care encounter with no contextual baggage 
and health services would not need to validate such baggage as being important. Only a 
few qualitative studies explored care provider perspectives on refusals to accept care. 
These tended to be restricted to a superficial examination of issues related to personal 
responsibility.154 196 208 228 One in depth qualitative study, however, did explore in detail 
care provider attitudes about patient 'compliance, to management recommendations.278 
Rather than considering it a 'problem' related to 'patient behaviours,, authors conclude 
that it ought to be considered as the 'material consequences of particular models and 
practices of health service provision, undertaken within particular institutional, political, 
social and cultural contexts'. When viewed in this way 'compliance' fits well with the 
underlying premise of candidacy, namely that eligibility for care is jointly negotiated 
between individuals and health service. However, it goes further to suggest that this 
negotiation process is mediated by broader societal parameters. 
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Gender and the body 
Although less frequent than other themes, some studies identified sensitivities around the 
way bodies are treated in health care interactions that may contribute significantly to 
acceptance or refusal of care. There were accounts of a patient's body being viewed as 
dirty and handled disrespectfully by a care provider in one study,276 adjudications by care 
providers of perceived dirty or unhygienic lifestyles due to a lack of washing 223 and 
circumstances in which traumatic experiences in residential schools rendered some women 
feeling very vulnerable in physical examinations.15 In this latter example the body becomes 
a locus for oppressive medical practices whose antecedents were laid in the colonial era. 
Feelings of vulnerability for women undergoing invasive procedures were also voiced in a 
qualitative study involving American Indian women.147 One participant in this study, 
however, considered that having invasive physical procedures was an important and 
acceptable part of taking care of oneself. There were few documents examining health 
I 
provider and organisational responses to these issues. In one New Zealand qualitative 
study of non-Maori care providers, there was a brief mention by some participants of the 
need to obey protocols in asking permission to touch or examine a person.120 Similarly, 
there were only cursory explorations of specific gendered responses to health care 
provision which focussed mainly on issues of gender discordance between provider and 
patient, 102 209 279"280 different patterns of presentation by males to care providers, 227 different 
responses to health information 22 and conflicts between health advice and notions of ideal 
body types.154 
Communication, language and literacy 
The role of communication dynamics, language and literacy in patient-provider 
inter~tions was a frequently occurring theme that appears to profoundly influence 
presentations, adjudications and offers of care. The most commonly discussed problems 
were: a lack of understanding of written or spoken health professional advice; 41 107 112154 
too much, too little or too rapidly delivered information; 154 162173 dissonance in the 
primary languages spoken by care providers and patients; 20 41 167 177 212 225 228 and the lack 
of interpreter services and ineffective use of these services when they were available.148 166 
177 281 Pervasive miscommunication (often unrecognised by both care providers and 
patients) and failure to achieve a shared understanding of key, usually biomedical concepts 
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was encountered in one Australian study of health care interactions in the renal dialysis 
setting. 282 These issues highlight again the orientation of health services around the ideal 
user who is able to attain a satisfactory level of comprehension from the information the 
system provides. 
Patient sensitivity to care providers' non-verbal communication, (particularly subtle 
nuances in tone, gestures, body positioning) were also noted as influential factors in the 
acceptability of care.20 208 276"277 By contrast, however, Towle and colleagues' qualitative 
study of doctor-patient communication found participants talked very little about the 
importance of non-verbal communication despite being vigilant for these issues.18 
Nevertheless, the use of communication devices such as indirect story telling, prioritising 
the nurturing of the relationship over management of the health problem, the use of silence, 
metaphor and seemingly circular ~anguage featured prominently.23 95 148 154163 166 177 Health 
professionals' inattention to the use of these devices may lead to false adjudications of 
passivity or unwillingness to engage. This may be an especially pertinent issue in health 
care encounters with elders. This is not to say that patients do not actively refuse to provide 
information. For one participant in a qualitative study, the withholding of information 
represented a resilience strategy in response to perceived past injustices where one's stories 
were frequently manipulated. 19 Consequently. there are a range of complex communication 
dynamics and devices at play that may impact on offers, acceptances and refusals of care. 
In parallel with issues related to the communication medium, was discussion around the 
message, especially biomedically oriented messages. It was common to find in the 
concluding recommendations to many studies that more 'appropriate' resources are needed 
to address information gaps. In particular, it was frequently recommended that care 
providers need to deliver messages consistent with the worldview of the 
patient101 102 171 225 283 or that information needs to be simplified in order to make it more 
accessible.113 Lea questions the value of simplifying information when such information 
may be underpinned by complex epistemologies ofwesternised good health.67 By contrast, 
Durie argues that perceived knowledge divides and disparate world views are bridged 
frequently and comfortably by Indigenous peoples.31 Interestingly, in two qualitative 
studies, despite perceived lack of information and discordant knowledge being common, 
this did not necessarily diminish the acceptability of health care.21158 This suggests that 
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acceptable communication encounters are not just about bridging different ontological 
perspectives. They are intimately connected to the processes by whlch messages are 
constructed and delivered. Smylie's review oflndigenous health literacy asserts that proper 
attention to these processes can become part of a broader act of self-determination. 41 
There were few examples from programs and interventions specifically related to 
enhancing communication encounters. Some strategies considered to be effective (but 
generally not evaluated) include information delivered by peers who had experience of 
diabetes, 109 introducing information through mechanisms such as talking circles98 and the 
generation of knowledge products that paid attention to the source, presentation and 
dissemination of such products. 148 Strategies such as language revitalisation programs were 
commented on in one qualitative study to be an especially useful way to engage with 
young Maori on health issues.61 Two studies broadened communication with individuals to 
I 
that of the network. Energising these networks ensures messages are more coherent and 
thls plays a key role in the sustainability of health programs.21 138 Consistent with a socio-
centric approach, two studies concluded that important health messages needed to be 
communicated to social/family networks to allow for effective decision-making 
processes. 165 167 Thus attention to broader communication processes can uncover creative 
opportunities in communication dynamics rather than it being viewed merely as a contest 
of competing agencies.284 
Domain 5: The role of 'culture' 
An intersecting theme across all the above domains was the role played by culture and 
cultural difference in candidacy for health care. Different attitudes to food, the role of 
shame, different clothes, different gender and avoidance protocols, different social 
obligations, different spiritual and healing beliefs, different use of time, differences in 
'traditional' compared to 'non-traditional' peoples, different levels of passivity and 
shyness were frequently mentioned as potential barriers to accessing care. There are many 
references to such differences.1s-2129 48 92 111 119 124 167209 212 214 211284-289 This leads to the 
assertion that cultural difference is a root cause for diminished candidacy. If cultural 
differences are constructed as potential barriers it is assumed, therefore, that better health 
professional awareness of and sensitivity to these issues may improve candidacy. Several 
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references endorsed this assumption.17 60 92 94 98 113 156 164 208 281290 A common health system 
response is to package an understanding of cultural differences into staff cross-cultural 
awareness courses. One opinion piece provides an especially poignant example where a 
series of tables are presented in a staff education handbook to contrast the difference 
between 'American Indians' and 'Euro-Americans' .286 The key issue here is not to debate 
whether these differences ex,ist but to recognise the potential consequences that may result 
from essentialising Indigenous cultural identities. Such culturalist approaches construct 
highly stylised, imaginary conceptions of cultural difference where particular essences are 
reified and either upheld as noble or denigrated as problem behaviours. Moreover they 
assume a homogenous mono-cultural identity to care providers, placing the cross-cultural 
gaze on the Indigenous Other from a supposed neutral (White) platform. This is ironic 
given the multiple cultural identities of health professionals in the four countries 
studied.29I-292 
By contrast, there is an alternative voice in the literature that critiques culturalism. Cultural 
safety, a term originally proposed by Maori nurses, shifts the role of culture away from a 
check -list approach based on a person's ethnic background and toward a critical 
examination of the power imbalances in health care encounters.293 Drawing on the 
mainstream movement of quality and safety in health care it is built on principles of 
minimising risk and reducing error. Reflecting its origins, the use of this term is most 
commonly encountered in the nursing literature and there are several references to cultural 
safety and security in the documents we reviewed. 37 40 47 57 ss 92 153 171 231 293-301 It builds on a 
realisation that sensitivity and awareness have done little to serve the interests of 
Indigenous peoples' access to better health care. 54 293 Cultural safety, therefore, is a 
reflexive process that shifts the lens back to the self.293 It is a method of decolonisation, 
allowing health services to re-orient themselves to better meet the needs of vulnerable 
groups, irrespective of their cultural identity. Examples include, shifts from awareness 
training to anti-racism training; 247 developing tools that critically examine notions of 
culture, race and oppression and avoid essentialising and stereotyping; 58 294 300 
organisational audits for compliance with treaty principles; 75 and making explicit the 
differences between cultural phenomena and those related to socio-economic inequity.3064 
301 Such interventions are intended to increase the tractability of whole institutions and 
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strengthen candidacy for care through enhanced navigation (by making services more 
permeable), increased presentations (by making people more comfortable to claim 
eligibility for care) and fairer adjudications (by making staff more cognisant ofhow they 
make judgements). 
6.5 Discussion 
This review of documents from Australia, Canada, New Zealand and the USA, over the 
period 1990-2007, has sought to elaborate on the factors that influence Indigenous peoples' 
accessibility to health care with a focus on chronic illnesses. We applied the candidacy 
construct as a theoretical framework upon which to understand access. Although developed 
with reference to a number of vulnerable populations in the United Kingdom, we found the 
synthetic constructs derived from candidacy theory to be highly useful in this context. As a 
general organising theory, its gre~test contribution is the ability for it to be intricately 
woven into several inter-related aspects of the health system, especially at the levels of 
organisational structures, workforce, and health care encounters. 
There are important implications for Indigenous health services research and approaches to 
system change. A key fmding was the scant evaluation of programs and a dearth of 
research interventions that address candidacy. Aside from quality improvement studies, 
which are mainly focussed on effectiveness of care, there is an insufficiently developed 
body of knowledge with which to be able to test whether interventions in our principal 
thematic areas enhance candidacy. Based on our findings, it is likely that interventions to 
improve access need to be complex and multifaceted, simultaneously enhancing candidacy 
at a number of levels. Quantitative studies must overcome the challenges of developing 
validated measures of candidacy. Although empirical qualitative studies have potential to 
provide valuable insights, as seen in this review, it is important that they be rigorously 
conducted in order to provide sufficient depth to understand what works and how. We 
therefore would recommend that research interventions and programs incorporate a mixed 
methods approach to their design and evaluation and that the very conduct of such research 
be cognisant of the candidacy issues raised in this paper. 
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The most important limitation to candidacy theory that we encountered was a restricted 
scope in incorporating macro-system issues. Within all five interpretative domains in this 
review, we found that access to health services is influenced by broader societal discourses 
of power. Many participants in qualitative studies and commentators in reviews and 
opinion pieces perceived the State to be a perpetrator of past and contemporary oppressive 
practices. In the health care arena this manifests most strongly through the 
biomedicalisation of care and endorsement of culturalist agendas. Indigenous peoples' 
resistance to these agendas was palpable and underscores a movement to re-shape health 
institutions that are predicated on an inappropriate ideal user. Political struggles for self-
determination and validation of alternate knowledge systems and approaches to care were 
amply expressed. Whilst these factors may not be unique to the Indigenous health context, 
their enactment in the context of non-Indigenous/Indigenous post-colonial power relations 
affords them specific meanings. Thus these broader discourses of power have a profound 
impact on candidacy and its sub-themes. We consider, therefore, the need to incorporate a 
'societal candidacy' in which eligibility for care is negotiated in arenas beyond the health 
care space. Societal candidacy is characterised by a dialectical relationship between a non-
Indigenous State that adjudicates through its institutions how care is offered and a 
predominantly Indigenous counter-movement that seeks to maximise participation in 
shaping those institutions. Greater appreciation of this dynamic and contested space, in 
which neo-colonial and decolonising discourses are enacted, not only helps explain why 
systems of care break down but it can foster different approaches to enhancing candidacy. 
There are potential limitations to how we conducted this review. Our attempt to include a 
diversity of voices resulted in a labyrinthine mix of qualitative studies, audits and surveys, 
programs with at best cursory evaluations, quality improvement interventions, mainly non-
systematic topic reviews and a plethora of opinion pieces. Whilst we considered the 
incorporation of non-traditional document sources essential for ensuring a balanced 
representation, we could be criticised for putting undue emphasis on untested views. 
Table 2, however, highlights a similar breadth of themes encountered in opinion pieces to 
the qualitative empirical studies and thus we believe it constitutes a rich data source with 
which to triangulate fmdings. Despite this, there are important limitations in how we 
sampled these opinion piece documents. By mainly focussing on database searches our 
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grey literature may not adequately capture Indigenous perspectives from non-scientific 
sources. A more expansive search of non-health and non-print media would have been a 
useful adjunct. 'This would, however, have made the scale of the project prohibitively 
large. 
Another limitation is that by drawing on a variety of synthesis methods (meta-ethnography, 
critical interpretive synthesis and thematic synthesis) we may be criticised for not 
sufficiently adhering to any one method. We contend, however, that these synthesis 
methods remain emergent and as such pragmatism is an appropriate strategy to explore 
their utility. At the earlier stages, thematic synthesis was especially useful in developing a 
~ descriptive map of what was most talked about in the literature. The critical aspect of the 
I critical interpretive synthesis approach was most helpful at the later stages of the analysis 
I 
in which the principal thematic dqmains and tensions highlighted within and across them 
were brought together. The meta-ethnographic technique of reciprocal translation worked 
reasonably well across qualitative studies, reviews and opinion pieces. We were less 
successful, however in translating themes to the quantitative empirical studies and 
programs and interventions. Consequently themes such as 'quality improvement' derived 
mainly from audit studies and interventions tended not to translate well into other areas. 
Although the principal of refotational synthesis was appealing we did not discretely apply 
this method. Rather it was in the critical analysis stage of our overall synthesising 
arguments that certain refutations like the cultural awareness-cultural safety divide became 
apparent. 
Our quality appraisal process for the qualitative studies emphasises the inherently 
subjective nature of qualitative research. The high degree of inter-rater variability in the 
use of the CASP tool raised concerns about its validity. Our findings support those of 
others that quality appraisal checklists tend to be overridden by overall judgement.11 To 
this end, however, a strength of our review process was the differing epistemological 
influences of our team. This allowed us to interpret the data in different ways and develop 
syntheses that reflected this diversity. Involvement of researchers with disparate 
backgrounds who each have a key stake in the relevance of the fmdings was a useful way 
to gauge the quality of documents and the subsequent synthesis of the fmdings. Further, for 
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all aspects of our synthesis, we have sought to make explicit our reflexivity in the analysis 
by exhaustively referencing our interpretations. 
In our attempt to synthesise fmdings across countries we run the risk of being reductionist. 
Much of the literature we analysed is locally specific, small in scale, variable in quality and 
there were few existing international reviews to guide our analyses. This makes national 
and international extrapolation difficult. Inattention to context, oversimplification of 
themes and artificially constructing dichotomies, when these are expressed differently at 
the local level, are all potential pitfalls in such an exercise. All of the themes reported in 
this review were widely prevalent across all four countries and whilst they were certainly 
expressed differently there appeared to be sufficient points of similarity to enable an 
adequate synthesising argument. Also, by examining constructs and counter-constructs, 
such as the State authoritarian- I~digenous decolonising discourses, we were able to 
identify patterns of dissent across.'particular themes. These conflicts and points of tension 
tended not to be restricted to any one country. Although we could never do justice to the 
importance of locally specific analyses, we hope that the provision of detailed references 
makes our interpretations transparent and can allow others to use these analyses to explore 
local issues in more depth. 
Addressing inequitable access to health care is a major focus of all four countries' health 
systems and features prominently in current health reform agendas. Candidacy frameworks 
help explain why the 'many barriers' approach to conceptualising access is not helpful. 
Barriers are mediated by complex institutional environments and thus their removal is 
rarely a straightforward process. Candidacy theory highlights the need to apply multiple, 
synergistic approaches at different levels. For this reason, it is unlikely that implementing 
'candidacy checklists' would be an effective way of improving care. Organisational audits 
framed around candidacy, however, could be an appealing way of identifying strategies to 
improve access. Such audits would need to be collaboratively developed by system 
planners, service managers, care providers and community users. They could be equally 
pertinent to macro systems as they are to local health care organisations. By focussing on 
organisational culture there is an increased prospect of embedding integrated interventions 
into health care systems, rather than focussing on specific barriers in isolation. Culturally 
'aware' personnel cannot meaningfully enhance Indigenous peoples' candidacy in the 
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absence of whole of organisation initiatives to make services safer and more tractable. 
Indigenous staff that are poorly remunerated· and given access to limited training 
opportunities are unlikely to support the sociocentric function of health services. 
Improving health care provider communication styles and making more effective resources 
available will not necessarily enhance candidacy if there is inadequate health service 
governance and poor infrastructural supports. 
Candidacy theory, especially if broadened to incorporate societal and macro-level issues, 
can assist in embracing systemic and inter-personal aspects of health care. Although the 
development of successful strategies to enhance Indigenous peoples' candidacy for care 
remains a challenge, this review outlines for care providers, policy makers and health 
service researchers a range of factors at multiple levels that warrant consideration. 
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6. 7 Attachments 
Attachment 1: Screening questions for appraising qualitative literature using 
the Critical Skills Appraisal Toolkit 
General 
1. Was there a dear statement of the aims of the research? 0Agree 
Consider: 
0Neutral 
• what the goal of the research was 
• why it is important Onisagree 
• its relevance 
2. Was a qualitative methodology appropriate? 0Agree 
Consider: 
0Neutral 
• if the research seeks to interpret or illuminate the actions and/or subjective experiences 
of research participants Onisagree 
. 
Study Design 
3. Was the research design appropriate to address the aims of the research? 0Agree 
Consider: 
0Neutral 
• if the researcher has justified the research design (e.g. have they discussed how they 
decided which methods to use?) Onisagree 
4. Was the recruitment strategy appropriate to the aims of the research? 0Agree 
Consider: 
0Neutral 
• if the researcher has explained how the participants were selected 
• if they explained why the participants they selected were the most appropriate to Onisagree 
provide access to the type of knowledge sought by the study 
• if there are any discussions around recruitment (e.g. why some people chose not to take 
part) 
Data Collection 
5. Were the data collected in a way that addressed the research issue? 0Agree 
Consider: 
0Neutral 
• if the setting for data collection was justified 
• ifit is clear how data were collected (e.g. focus group, semi-structured interview etc) Dnisagree 
• if the researcher has justified the methods chosen 
• if the researcher has made the methods explicit (e.g. for interview method, is there an 
indication of how interviews were conducted, did they used a topic guide?) 
• if methods were modified during the study. If so, has the researcher explained how and 
why? 
• if the form of data is clear (e.g. tape recordings, video material, notes etc) 
• if the researcher has discussed saturation of data 
--- -- -- --
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Reflexivity and Ethics 
6. Has the relationship between researcher and participants been adequately 
considered? 
Consider whether it is clear: 
• if the researcher critically examined their own role, potential bias and influence during 
formulation of research questions 
• how data were collected, including sample recruitment and choice of location 
• how the researcher responded to events during the study and whether they considered 
the implications of any changes in the research design 
7. Have ethical issues been taken into consideration? 
Consider: 
• if there are sufficient details of how the research was explained to participants for the 
reader to assess whether ethical standards were maintained 
• if the researcher has discussed issues raised by the study (e. g. issues around informed 
consent or confidentiality or how they have handled the effects of the study on the 
participants during and after the study) 
• if approval has been sought from the ethics committee 
Data Analysis 
8. Was the data analysis sufficiently rigorous? 
Consider: 
• if there is an in-depth description of the analysis process 
• if thematic analysis is used. If so, is it clear how the categories/themes were derived? 
• whether the researcher explains how the data presented were selected from the original 
sample to demonstrate the analysis process 
• if sufficient data are presented to support the findings 
• to what extent contradictory data are taken into account 
• whether the researcher critically examined their own role, potential bias and influence 
during analysis and selection of data for presentation 
9. Is there a clear statement of findings? 
Consider: 
• if the findings are explicit 
• if there is adequate discussion of the evidence both for and against the researcher's 
argwnents 
• if the researcher has discussed the credibility of their findings (e.g. triangulation. 
respondent validation. more than one analyst.) 
• if the findings are discussed in relation to the original research questions 
Value of the Research 
10. How valuable is the research? 
Consider: 
• if the researcher discusses the contribution the study makes to existing knowledge or 
Wlderstanding (e.g. do they consider the findings in relation to current practice or 
policy, or relevant research-based literature?) 
• if they identify new areas where research is necessary 
• if the researchers have discussed whether or how the findings can be transferred to 
other populations or considered other ways the research may be used 
0Agree 
0Neutral 
Ooisagree 
0Agree 
0 Neutral 
0Disagree 
0Agree 
0Neutral 
Ooisagree 
0Agree 
0Neutral 
Ooisagree 
0Agree 
0Neutral 
0Disagree 
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Attachment 2: Table of quality appraisal scores for 80 qualitative studies 
FintAuthor Year Reference Country Tittel CASP Tool Question Number (See attachment 1) ToW 
2 3 4 5 6 7 8 9 10 
Andrews, B. 2002 Aust J Rural Health 10(4): 196-201 Australia IdentifYing and overcoming the barriers to 2 2 1 1 1 2 2 0 0 2 13 
Aboriginal access to general practitioner services 
in rural New South Wales 
Amaert,A 2006 Accid Emerg Nurs 14(2): 97-103 Canada Cultural awareness ofinuit patients' experiences 2 2 2 2 2 2 2 2 2 2 20 
with emergency nursing care 
Ban, P. 2004 Aust J Prim Health 10(2): 29-35 Australia Access and attitudes to health care ofTorrcs 2 2 2 2 1 2 2 1 1 I 16 
Strait islanders living in mainland Australia 
Barr, D. A. 2005 Fam Med 37(3): 199-204 USA Listening to patients: cultural and lin_gu~tic 2 2 2 2 2 2 2 1 1 2 18 
barriers to health care access 
Bartlett, J. G. 2005 Can J Public Health 96( S I): S22-7 Canada Health and well-being for Metis women in 2 2 2 2 2 2 2 1 2 2 19 
Manitoba 
Barton, S. S. 2005 Aust J Rural Health 13(4): 242-6 Canada The diabetes experiences of Aboriginal people 2 2 2 1 2 2 2 1 2 I 17 
living in a rural Canadian community 
Bartz. R. 1999 J Fam Pract48{8): 601-7 USA Beyond the biopsychosocial model: new 2 2 2 2 2 2 2 2 I 2 19 
approaches to doctor-patient interactions. 
Bennett, E. 1995 Aust J Public Health 19(6): 610-5 Australia Cultural factors in dialysis and renal 2 2 2 2 2 1 1 1 2 2 17 
transplantation among aborigines and Torres 
Strait Islanders in north Queensland 
Benoit, C. 2003 Soc Sci Med 56(4): 821-33 Canada In search of a healing place: Aboriginal women 2 2 2 2 2 2 2 2 2 2 20 
in Vancouvet's Downtown Eastside 
Browne, AI 2005 Can J Nursing Research 37(4): 62-87 Canada Discourses influencing nurses' perceptions of 2 2 2 1 2 2 2 2 2 2 19 
First Nations patients 
Browne. A. J. 2001 West 1 Nurs Res 23(2): 126-147 Canada First Nations women's encounters with 2 2 2 2 2 2 2 2 2 2 20 
mainstream health care services 
Browne, A. 1. 1995 Can 1 Nursing Research 27(4): 95-109 Canada The meaning of respect: a First Nations 2 2 2 2 2 2 2 2 2 2 20 
perspective 
Buehler. 1. A. 1992 1 Holist Nurs 10(1): 18-33 USA Traditional Crow Indian health beliefs and 2 2 2 2 2 2 2 I 1 I 17 
practices. Toward a grounded theory 
Canales,M. 2004 Health Care Women Int 25(5): 411-35 USA Taking care of self: Health care decision making 2 2 2 I 2 I 2 1 1 I IS 
of American Indian women 
160 
' 
First Author Year Reference Country Title 1 CASP Tool Question Number (See attachment l) Total 
1 2 3 4 5 6 7 8 9 10 
Carrese, 1. A. 1995 1AMA 274(10): 826-9 USA Western bioethics on the Navajo reservation. 2 2 2 2 2 2 2 I 2 I 18 
Benefit or harm?[see comment] 
Chang, H. K. 2001 Pac Health Dialog 8(2): 260-73 USA Hawaiian health practitioners in contemporary 2 2 I 1 1 l 1 1 I 1 12 
society 
Cmm,F. 2003 N Z Med J 116: 1170 NZ Mapping the themes of Maori talk about health 2 2 2 2 2 2 1 1 2 2 18 
Cramer, J. H. 2006 Contemp Nurs 22(2): 191·202 Australia Amorphous practice: nursing in a remote 2 I 1 0 1 0 0 0 2 1 8 
Indigenous community of Australia 
de Crespigny, c. 1998 Aust 1 Prim Health Interchange 4(4): 6- Australia Older Aboriginal women's experiences of 2 2 2 2 2 2 2 0 2 1 17 
17 medications in urban South Australia 
Dodgson, J. E. 2005 J Transcult Nurs 16(4): 339-46 USA Indigenous women's voices: marginalization and 2 2 2 0 1 I 2 2 2 1 15 
health 
-
Franks, C. 2002 Aboriginal lsi Health Work 1 26(4): 3-8 Australia A Qualitative Analysis of Patients Taking Their 2 2 2 2 1 I 2 1 2 1 16 
Own Leave from Alice Springs Hospital in 1998 
Fredericks, B. 2006 Contemp Nurs 23(1): 87-99 Australia Which way? Educating for nursing Aboriginal 2 I I 1 I 2 2 1 2 13 
and Torres Stmit Islander peoples 
Garvey, G. 2004 1 Med Ethics 30(6): 570-575 Australia Is there an Aboriginal bioethic? 1 0 0 0 0 2 0 0 I I 5 
Gregory, D. 1999 Can 1 Nursing Research 31(1): 101-15 Canada Exploring the experience of type 2 diabetes in 2 2 1 0 1 2 2 I 1 J 13 
urban aboriginal people 
Hamrosi, K. 2006 Rural Remote Health 6(2): 557 Australia Issues with prescribed medications in Aboriginal 2 2 2 I 2 2 2 l 2 1 17 
communities: Aboriginal health workers' 
perspectives 
Hanrahan, M. C. 2002 Can J Public Health 93(2): 149-52 Canada Identifying the needs oflnnu and Inuit patients 2 2 2 1 2 2 2 1 1 l 16 
in urban health settings in Newfoundland and 
Labrador 
Harrington, Z. 2006 Med J Aust 184(10): 5I4·7 Australia Challenging perceptions of non-compliance with 2 2 2 I 2 2 2 2 2 2 19 
rheumatic fever prophylaxis in a remote 
Aboriginal community.[see comment] 
Hatton, D. C. 1994 West 1 Nurs Res 16(4): 392-403 USA Health perceptions among older urban American 2 1 I 0 I 0 0 0 I 0 6 
Indians 
Hernandez, C. A. 1999 J Transcult Nurs 10(3): 220-8 Canada A grounded theory study of the experience of 2 2 2 2 2 2 2 2 2 2 20 
type 2 diabetes mellitus in First Nations adults in 
Canada 
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FintAutbor Year Reference Country Title I CASP Tool Question Number (See attachment 1) Total 
2 3 4 5 6 7 8 9 10 
Hiii,P. S. 2001 Soc Sci Med 52(3): 467-80 Australia Tactics at the interface: Australian Aboriginal 2 2 2 1 1 1 2 2 I 2 16 
and Torres Strait Islander health managers 
Hooper,K. 2007 Aust J Rural Health 15(1): 46-51 Australia Health professional partnerships and their impact 1 2 0 0 0 0 1 0 1 0 s 
on Aboriginal health: an occupational therapist's 
and Aboriginal health worker's perspective 
Hopkins, S. E. 2007 IntJ Circumpolar Health 66(1): 42-50 Canada Keeping busy: a Yup'ikiCup'ik perspective on 2 2 2 0 2 2 2 1 2 0 15 
health and aging 
Hunter, L. M. 2006 1 Transcult Nurs 17(1 ): 13-22 Canada Aboriginal healing: regaining balance and 2 2 2 2 2 2 2 2 2 2 20 
culture 
Hurst,S. 2006 Int J Qual Health Care 18(4): 294-8 1ntematio Building community involvement in cross- 2 2 1 2 2 2 2 1 2 1 17 
nal cultural Indigenous health programs 
Iwasaki, Y. 2004 Ethn Health 9(2):189-212 Canada An examination of stress among Abpriginal 
women and men with diabetes in ManitOba, 
2 2 2 2 2 2 2 2 2 2 l O 
Canada 
Jones, R. 2000 Pac Health Dialog 7(1): 17-24 NZ Diagnosis in traditional Maori healing: a 2 2 1 0 I 1 1 2 2 1 13 
contemporary urban clinic 
Kelly, L. 2002 Can Farn Physician 48:1645-52 USA Listening to native patients. Changes in 2 2 2 2 2 2 2 2 1 I 18 
physicians' understanding and behaviour 
Kendall, E. 2004 Rehabil Psychol49(1): 5-13 Australia Factors that prevent equitable access to I 2 0 0 1 1 0 0 1 0 6 
rehabilitation for Aboriginal Australians with 
disabilities: the need for culturally safe 
rehabilitation 
King,KM. 2007 Qual Health Res 17(8): 1074-87 Canada First Nations People's Challenge in Managing 2 2 2 2 2 2 2 1 1 1 17 
Coronary Artery Disease rusk 
King,M. 2001 Contemp Nurs 10(3-4): 147-62 Australia The diabetes health care of Aboriginal people in 2 2 2 2 1 0 1 1 1 I 13 
South Australia (Pan 1) 
Kirkwood, M. 1997 N Z Med J 110(1055): 415-7 NZ Perceptions of diabetes among rural Maori elders 2 2 2 2 2 2 2 1 2 1 18 
and spokespersons 
Kowal, E. 2005 Soc Sci Med 60(6): 1347-57 Australia Ambivalent helpers and unhealthy choices: 2 1 2 2 1 2 2 2 2 2 18 
public health practitioners' narratives of 
Indigeoom ill-health 
Landon, B. 2004 J Rural Health 20(3): 221-30 USA Factors influencing the retention and attrition of I 2 2 2 1 I I 1 I 1 13 
community health aides/practitioners in Alaska 
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First Autbor Year Reference Country Title 1 CASP Tool Question Number (See attachment 1) Total 
1 2 3 4 5 6 7 8 9 10 
Lautenschlager, L. 2006 J Nutr Educ Behav 38(5): 307-15 USA Low-income American Indians' perceptions of I 1 1 I 0 0 0 1 1 0 6 
diabetes 
Levin, R 2005 Soc Work Health Care 39(1-2): 165-79 Canada The experience of urban aboriginals with health 0 2 1 0 I 0 0 1 1 I 7 
care services in Canada: implications for social 
work practice 
London, J. A. 1998 Aust N Z J Public Health 22(6): 726-8 Australia Aboriginal perspectives of diabetes in a remote 2 2 2 1 1 0 0 l 2 2 13 
community in the Northern Territory 
Lowe,J. 2005 1 Cult Divers 12(2): 37-49 USA Being influenced: a Cherokee way of mentoring 2 2 1 l 2 2 2 2 2 2 18 
Lowe,J. 2002 1 TranscultNurs 13(4): 287-95 USA Cherokee self-reliance 2 2 2 2 2 2 2 I 1 1 17 
Mak, D. B. 2006 Med Teach 28(6): e149-<:ISS Australia I have learnt a different way oflooldng at I 2 1 0 1 1 0 I I 0 8 
people's health: An evaluation of a prevocational 
medical training program in public.l)eal!!_l 
medicine and primary health care in remote 
Australia 
McCarthy, A. 2007 Sociol Health Illn 29( 1 ): 82-99 Australia 'A politics of what': the enactment of peritoneal 2 2 1 1 I 1 2 1 2 1 14 
dialysis in indigenous Australians 
McCreanor, T. 2002 J Health Psychol7: 509-18 NZ Tauiwi general practitioners explanations of 2 2 2 1 1 2 I 0 I 1 13 
Maori health:cotonial relations in primary 
healthcare in Aotearo&'New Zealand 
McCreanor, T. 2002 N Z Med J II S( 1167): U272 NZ Tauiwi general practitioners talk about Maori 2 2 1 0 1 0 0 0 I l 8 
health: interpretative repertoires 
McGrath,P. 2005 Aust Health Rev 29(3): 306-17 Australia The 'right story' to the 'right person': 2 2 2 2 2 l 2 1 l l 16 
communication issues in end-of-life care for 
Indigenous people 
McGrath,P. 2006 AustJ Prim Health 12(1): 56-64 Australia The importance of the 'family meeting' in health 2 2 I 2 2 1 2 1 1 1 IS 
care communication with indigenous people: 
Findings from an Australian study 
McShane, K. E. 2006 Can J Public Health 97(4): 296-9 Canada Guiding health promotion efforts with urban 2 2 2 2 2 2 2 0 I I 16 
Inuit: a community-specific perspective on 
health information sources and dissemination 
strategies 
Mincham, C. M. 2003 Aust J Rural Health 11(6): 260-5 Australia Patient views on the management of rheumatic 2 2 1 0 0 2 2 l I 1 ll 
fever and rheumatic heart disease in the 
Kimberley: a qualitative study 
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First Author Year Reference Country Title 1 CASP Tool Question Number (See attachment 1) Total 
2 3 4 s 6 7 8 9 10 
Minore, B. 2005 Can J Nursing Research 37(1): 86-100 Canada The effects of nursing turnover on continuity of 1 2 1 2 1 1 2 I 0 1 12 
care in isolated First Nation 
communities.[erraturn appears in Can J Nurs 
Res. 2005 Jun;37(2):2] 
Mitchell, D. 1996 Aust J Anthropol 7(3): 258-274 Australia Sickening bodies : how racism and essentialism 2 2 1 0 l 0 0 2 2 2 12 
feature in Aboriginal women's discourse about 
health 
Parker, J. G. 1994 J Transcult Nurs 6(1): 4-5 USA The lived experience of Native Americans with 2 1 1 2 2 2 2 1 0 0 13 
diabetes within a transcultural nursing 
perspective 
Ritchie, L. 2001 Qual Health Res 11(2): 190-205 Australia Empowennent and Australian comro!Ulity health 2 2 2 l 2 2 2 2 2 2 19 
nurses' work with aboriginal clients: the 
sociopolitical context 
Schoenberg, N. E. 2005 Med Anthropol Q 19(2): 17l-93 USA Situating stress: lessons from lay discourses on 2 2 2 1 2 2 2 2 2 0 17 
diabetes 
Simon, V. 2006 COntemp Nurs 22(2): 203-13 NZ Characterising Maori nursing practice 2 2 0 1 0 l 2 0 0 0 8 
Struthers, R. 2005 Comp Ther Clin Practice 11(2): 78-86 USA Being healed by an indigenous traditional healer: 1 1 0 I 1 1 0 0 0 0 s 
sacred healing stories ofNative Americans. Part 
II 
Struthers, R. 2003 J Rural Health 19(2): 174-80 USA 1be experience of native peer faci litators in the 2 2 I 0 1 I I 1 1 1 11 
campaign against type 2 diabetes 
Struthers, R. 2003 Qual Health Res 13(8): 1094-115 USA Participant experiences of Talking Circles on 1 2 2 2 2 2 2 2 2 I 18 
type 2 diabetes in two Northern Plains American 
Indian Tribes 
Struthers, R. 2000 J Holist Nurs 18(3): 261·79 USA The lived experience of Ojibwa and Cree women 2 2 1 1 2 1 2 2 2 1 16 
healers 
Sunday, J. 2001 Soc Sci Med 52(4): 635-50 Canada Managing and treating risk and IUlCCrtainty for 2 2 2 0 2 2 2 2 2 2 18 
health: a case study of diabetes among First 
Nation's people in Ontario, Canada 
Tamwoy,E. 2004 Health Promot J Aust 15(3): 231-6 Australia Living and coping with diabetes in the Torres 0 l 2 2 1 2 2 l 0 0 11 
Strait and Northern Peninsula Area 
Taylor, C. 2004 Prev Chronic Dis 1(2): A06 USA Social and cultural barriers to diabetes 2 I 1 I 0 2 2 1 1 1 ll 
prevention in Oklahoma American Indian 
women 
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FlntAuthor Year Reference Country Title 1 CASP Tool Question Number (See attachment 1) Total 
1 2 3 4 s 6 7 8 9 10 
Thompson, S. J. 2000 Soc Sci Med 51(10): 1457-72 Australia Trying to keep a balance: the meaning of health 2 2 2 2 2 2 2 1 2 2 19 
and diabetes in an urban aboriginal community 
Towle, A. 2006 Patient Educ Couns 62(3): 340-6 Canada Doctor-patient communications in the 2 2 2 2 2 2 2 2 2 2 20 
Aboriginal community: towards the development 
of educational programs 
Van Uchelen, C. P. 1997 Can J Commun Ment Health 16(2): 37- Canada What makes us strong: urban aboriginal 2 2 2 1 2 1 1 2 2 I 16 
so perspectives on wellness and strength 
Watego, A. 1997 Aboriginal lsi Health Wolk: J 21(3) Australia A community based study: people with diabetes 1 1 1 0 0 1 2 0 1 0 7 
Watson, J. 2001 Aust J Rural Health 9(3): 121-6 Australia Diabetic foot care: developing culturally 2 1 1 1 I 0 2 0 0 0 8 
appropriate educational tools for Aboriginal and 
Torres Strait Islander peoples in the Northern 
Territory, Australia · - --
Wecramanthri, T. 1997 Soc Sci Med 45(7): I 005-15 Australia Painting a Leonardo with finger paint: medical 2 2 2 I I 2 I 2 2 2 17 
practitioners communicating about death with 
aboriginal people 
Willms, D. G. 1992 CanJ Public Health 83{5): 331-4 Canada A lament by women for "the people, the land" 1 I 1 2 2 2 2 2 2 1 16 
[Nishnawbi-Asld Nation}: an experience of loss 
Wilson, D. 2003 Contemp Nurs 15(3): 232-40 NZ The nurse's role in improving indigenous health I 2 2 2 0 1 2 0 0 0 10 
Wolslco,C. 2006 Etlm Health 11(4): 345-63 USA Conceptions ofwellness among the Yup'ik of the 2 2 2 2 2 2 I 2 2 I 18 
Yukon-Kuslcokw~ Delta: the vitality of social 
and natural cormection 
Wong,M. 2005 Aust J Rural Health 13(3): 172-7 Australia Perspectives on clinic attendance, medication 2 2 2 2 1 2 1 0 1 0 13 
and foot-care among people with diabetes in the 
Torres Strait Islands and Northern Peninsula 
Area 
Woolfson, P. 1995 Med Anthropol Q 9(4): 503-9 USA Mohawk English in the medical interview I I 0 0 1 0 0 1 1 0 s 
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Chapter 7: Building better systems of care for Aboriginal 
and Torres Strait Islander peoples: The 
Kanyini Qualitative Study 
Planned publication details: Peiris D, Rickards BA, Mentha R, Brady JP, Devries J, 
Fewquandie B, Liu H, Ingram S, Brown ADH, Devitt J, Weeramanthri T, Cass A, Building 
better systems of care for Aboriginal and Torres Strait Islander peoples: The Kanyini 
Qualitative Study. An abbreviated version of this paper is currently being prepared for 
submission to BMC Health Services Research 
Author contribution: I co-designed the study with co-authors Brown, Cass, Rickards and 
Devitt. I wrote the study protocol, coordinated ethics submissions, and co-designed the 
attachments to this paper with Mi~hael Howard and Bernadette Rickards. I supported and 
trained co-authors Brady, Devries~ Fewquandie in conducting interviews and data analysis. 
I coordinated all aspects of data management. I coded and performed the primary analyses 
of the health systems assessments interview data, wrote the first and subsequent drafts of 
this chapter and will be the primary author responsible for progressing this chapter to 
journal submission. 
7.1 Abstract 
Background: Aboriginal and Torres Strait Islander peoples experience inequitable access 
to health care. The Kanyini Vascular Collaboration (KVC) is a health services research 
program involving Aboriginal Medical Services (AMSs) with its principal aims being to 
understand and overcome gaps in health care access and quality. This paper has two 
components: (1) A detailed account of the methods used in one KVC study, the Kanyini 
Qualitative Study (KQS); and (2) presentation of the findings from the first part of the 
KQS, the 'health systems assessment'. 
Objeetives: (1) To understand community and health professional views on barriers and 
enablers to optimal primary, specialist and hospital care; (2) to determine which 
organisational components affect accessibility and quality of care; (3) to situate findings 
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within the context of the recent Cotu1cil of Australian Goverrunents (COAG) 'Close the 
Gap' Indigenous health policy initiatives. 
Methods: The study was iteratively designed by a multi-disciplinary team, including six 
Indigenous researchers with extensive AMS experience. Two theoretical frameworks were 
used: the candidacy construct, described in Chapter 6, and the Central Australian concept 
of kanyini, or 'holding' which describes the principle and obligations of nurturing and 
protecting others. There were two study components: (1) Health systems assessments 
involving staff focus groups at seven AMS sites participating in the Kanyini audit (see 
j Chapter 3); and (2) semi-structured interviews involving community (n=l 08) and staff 
r (n=96). For both study components, a purposive, maximum diversity sample was sought. 
r We interviewed regular AMS users (with and without vascular diseases), non-users of the 
AMS, health professionals, mana&ers and external service providers. Site-specific and 
central thematic analyses were conducted involving the whole research team. Data 
management was supported by NVivo 8. 
Results from the health systems assessment: 3 7 staff participated in seven health 
systems assessments. Staff emphasised that AMS health care was distinct to mainstream 
services. Community governance and leadership, community representation on staff 
(especially Aboriginal Health Workers), and commitment to community development were 
important organisational features to 'hold' people. In accordance with candidacy theory, 
these features allow an organisation to be more 'tractable' to vulnerable populations. The 
responsibility to 'hold' people, however, was undermined by considerable insecurity in 
whether government supports the AMS sector. Grossly inadequate staff capacity and poor 
information systems were the most cited barriers to quality improvement. By contrast on-
site specialist services, managed by AMS staff, were a strong enabler of comprehensive 
and coordinated support. Staff described several patient experiences of discrimination in 
hospitals that required considerable effort on their part to reinstate care. This suggests that 
hospitals still construct Indigenous peoples as 'non-ideal users' whom they are unwilling to 
properly 'hold'. 
Discussion: Kanyini and candidacy are promising theories for conceptualising issues 
affecting health care access and quality. Some COAG initiatives (workforce capacity 
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strengthening, improving chronic care delivery systems and increasing access to specialist 
services) are well placed to address barriers cited here. However, there are few initiatives 
that capitalise on the unique mechanisms by which AMSs 'hold' their users and enhance 
their candidacy to health care. Further, the COAG emphasis on improving access to 
mainstream services may contribute to AMS sector insecurity and resistance to collaborate. 
Forthcoming analyses ofKQS data will further develop the insights gained here. 
7.2 Background 
In the previous chapter we explored candidacy as a theoretical construct to understand how 
the contemporary literature frames issues of access to health care for Indigenous peoples in 
Australia, New Zealand, Canada and USA. Our synthesis of both empirical and grey 
literature sources identified a number of thematic domains that influence access to health 
care. At the broadest level we iden#fied a dialectical relationship in which non-Indigenous 
· State sponsored health institutions are juxtaposed alongside an Indigenous counter-
movement that seeks greater participation in the governance of those institutions. 1bis 
relationship is historically informed by the colonial encounter and permeates many aspects 
of the delivery and receipt of health care. 
Although candidacy theory was somewhat limited in incorporating these societal level 
issues, we found it apposite for understanding access barriers and enablers at the level of 
health care organisations. Three sub-themes to the theory were particularly relevant. (1) 
Tractability refers to the policies, structural developments, resource allocations and 
interventions undertaken by services to address inequity in access to health care. Our 
review found that Indigenous staff employment, adequate resources and a commitment to 
quality improvement were key features of a ' tractable' health service. (2) Navigation and 
permeability of services refers to the routes taken by people to gain a point of entry to 
health services with penneable services requiring little negotiation for entry and a minimal 
level of understanding of how the system works. Here also, Indigenous staff played a key 
role in making services more permeable. Transport services, flexible appointment 
structures, minimal out-of-pocket expenses, and welcoming physical spaces that conveyed 
a sense of belonging to the service were also important features of a permeable service. (3) 
Presentations, adjudications and offirs which describes the circumstances under which 
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people appear, are invited or are coerced into health care. The notion that health services 
are frequently designed to only meet the needs of an 'ideal user' who has a particular set of 
competencies and demands is particularly pertinent here. We identified the care provider-
patient relationship; communication, language and literacy; and the importance of gender 
and the body to be three key areas that influence presentations, adjudications and offers of 
care. 
In this paper we develop these insights further through an empirical qualitative study, the 
Kanyini Qualitative Study (KQS). Study aims are to: (1) understand community, clinician, 
health service manager and external service provider perspectives on the barriers and 
enablers to good health care; (2) determine organisational factors that affect health care 
access and quality; (3) explore whether barriers and enablers to care manifest differently in 
primary care, specialist and hospit~ settings; (4) situate findings within a policy relevant 
framework, identifying strategies for potential improvement of care. 
We locate our analysis in the context of recent shifts in Australian government policy for 
Aboriginal and Torres Strait Islander health. In November 2008 the Council of Australian 
Governments established a National Partnership Agreement on ' Closing the Gap' in 
Indigenous health outcomes (henceforth the COAG NP A). In addition to other agreements 
on housing and employment, the COAG NP A, budgeted at $1.6 billion over four years, has 
created unprecedented levels of ftmding for health service initiatives. The $800 million 
Commonwealth component is focussed on improving outcomes for chronic diseases.1 The 
package is divided into three areas: (1) 'tackling chronic disease risk factors' focuses on 
reducing smoking prevalence, the creation of an Indigenous tobacco and lifestyle 
workforce, and use of social marketing campaigns to promote better health; (2) 'improving 
chronic disease management and follow-up care ' focuses on improved access to 
medicines, incentives to care providers to improve chronic care management, improved 
care coordination and access to specialist services, and monitoring and evaluation of all 
these initiatives; and (3) 'workforce expansion' focuses on increasing primary care 
workforce capacity, the use of Indigenous outreach workers to broker health services, 
additional nursing and general practitioner (GP) training placements and promotion of 
guideline-based care. The COAG NP A is directly relevant to enhancing candidacy to 
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health care. We therefore seek to use our study findings to help inform this emerging 
policy environment and to identify factors that might be key to successful implementation. 
The Kanyinl Vascular Collaboration 
The Kanyini Vascular Collaboration (KVC) is a five year health services research program 
established in late 2006 and funded by the Australian National Health and Medical 
Research Council. The primary aim of the collaboration has been to work with Aboriginal 
Medical Services (AMSs) to increase access to high quality care for Aboriginal and Torres 
Strait Islander peoples. Participating AMSs are based in New South Wales (NSW), 
Queensland and Central Australia covering urban, rural and remote locations. KVC is 
multi-disciplinary in nature bringing together researchers, health service managers, clinical 
and non-clinical health staff and policy-makers. Its objectives are to better understand gaps 
in health care access and quality for Aboriginal and Torres Strait Islander people with a 
focus on management and prevention of vascular diseases; to collaborate with AMSs to 
develop and test strategies to overcome system barriers; to improve research and service 
delivery capacity within AMSs; and to use study findings to better inform policy 
directions. 
A series of discrete but inter-related studies are incorporated into the program. Studies 
include (1) the Kanyini Audit of prevention and management practices relating to chronic 
diseases in the community-controlled primary care sector (described in Chapter 3); (2) the 
KQS- the subject of this paper; (3) the Kanyini-GAP randomised controlled trial of a 
polypill based strategy to maximise access to evidence-based, long-term treatments among 
individuals at high vascular risk; and ( 4) a series of innovative quality improvement 
projects to improve the prevention and management of vascular diseases within primary 
health care services. 
Theoretical framework 
Starting with candidacy theory and its sub-themes, the research team held a series of 
workshops, teleconferences and face-to-face meetings over a six month period in 2007 to 
critique these themes and assess their applicability and relevance to the participating 
AMSs. This process occurred concurrently with the systematic review of the literature 
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described in Chapter 6. Given the pressing need to promote Indigenous-specific models of 
care we also explored Central Australian philosophical concepts relevant to health care 
access. In particular we focussed on the concept of kanyini. This term is used by a number 
oflanguage groups in Central Australia, including Pitjantjatjara, Pintubi and Luritja. 
Kanyini represents one of the four foundations of Aboriginal life in Central Australia: 
Tjukurpa (Law, Dreaming); Walytja (Family); Ngurra (Land, Country) and Kanyini. In 
essence, kanyini describes the principle and primacy of caring for others - an obligation to 
nurture, protect and care for other people, family, country and the law.2 Myers' 
ethnography 3 describes Pintubi concepts of kanyini: 
The metaphor of 'holding' (kanyininpa) is rooted in a powerful experience: it derives 
from a linguistic expression describing how a small child is held in one's arm against 
the breast (kanyimu yampungka). The image of security, protection and nourishment 
is immediate. Extension of this usage characterises a wide range of relationships as 
variants of this mixture of authority and succour. An older woman who oversees and 
looks after the younger girls and women in the single women's camp is said to 'hold" 
them. Most fully, the concept designates a central core of senior persons around whom 
juniors aggregate and by whom they are 'held'. (p.212) 
Similarly McCoy highlights how kanyirninpa is expressed in relationships that involve 
teaching and learning, and how it is viewed as an essential ingredient for social and 
emotional wellbeing.4 Randall defined kanyini as an unconditional love and responsibility 
to all things.5 Although rooted in Central Australian life there are related concepts 
described in health services research from other regions such as Y olngu concepts of djiika 
(caring) and gungayun (assisting).6 The use of the term kanyini for the name of our 
collaboration (K.VC) was discussed with health service partners. Despite being specific to 
Central Australia it had inherent appeal across all sites and there was interest in exploring 
its relevance to health services research. In this way we inductively merged theories from 
the broader literature with Aboriginal philosophies, resulting in a conceptual framework 
centred around candidacy and kanyini. 
7.3 Methods 
Design and planning 
There are two components to the KQS study design: (I) Health Systems Assessments 
involving structured AMS staff focus groups; and (2) semi-structured interviews with 
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community and health professionals. Figure 7-1 below outlines the study schema and its 
relationship to the Kanyini Audit. The rest of this paper describes in detail the methods 
used to develop both components and presents an analysis of data from the first 
component, the Health Systems Assessment. 
Figure 7-1: Kanyini Qualitative Study- Study Schema 
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Thematic analysis using a common 
coding framework 
The KQS was strongly informed by the Improving Access to Kidney Transplants 
(IMPAKT) project.8 This inter-disciplinary health services research program examined, 
using a patient journey approach, the obstacles encountered in accessing dialysis and 
transplant services for Aboriginal and Torres Strait Islander peoples. The IMPAKT project 
was large. The team spoke with 241 Indigenous and non-Indigenous patients, 95 renal 
related staff and 28 other key informants across 26 urban, regional and remote dialysis and 
transplant centres in every Australian state and territory. There were clear synergies with 
KQS. Involving health services in the design and conduct of the project, the use of in-depth 
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qualitative research methods on a large multi-site scale, and the shared objective of 
identifying system level barriers/enablers which could inform future policy are similar 
features to the two projects. Three researchers from I.MPAKT played a core role in the 
KQS which allowed us to adapt a range of scientific and operational methods from this 
program. 
Research team 
Two research institutes, based in Sydney and Alice Springs, coordinated the project. 
Kanyini chief investigators provided research guidance to the project and played an active 
role in all aspects of the study. Project staff consisted of two program managers at each 
institute, a research officer with several years experience as a remote area nurse and a 
senior research fellow who was a practising AMS GP with detailed knowledge of quality 
improvement programs in AMS settings. Although the study was implemented at several 
' 
sites in two Australian states and one territory, a strong local focus was also maintained. 
This acknowledges that personal contacts with key stakeholders, recognition of local 
differences and forming local relationships are critical. Central to this local focus was a 
commitment to build local research capacity within AMSs through the employment of 
Indigenous Research Fellows (IRFs). Five positions were created - one in Central 
Australia, three in Queensland and one in New South Wales. These staff had considerable 
experience in AMSs having worked as Aboriginal Health Workers (AHWs), program 
coordinators, researchers and project officers. All were employees of the participating 
AMSs with the exception of the Central Australian IRF who was employed directly by the 
coordinating research institute. The IRFs drew on their past professional experience, 
community networks and relationships within the health service to guide the conduct of the 
study. In the initial phases of the project they coordinated the formation of community site 
reference groups comprising key local Aboriginal and Torres Strait Islander stakeholders 
(agencies or individuals). These groups reviewed the study procedures and provided 
guidance on how best to implement the study at each site (see Attachment 1 for the terms 
of reference). 
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Health Systems Assessment 
Design 
The transition point between the Kanyini Audit and Qualitative Study was a qualitative 
assessment of the health systems in place at each AMS (see Figure 7-1). In this study 
component we were influenced by the Audit and Best Practice for Chronic Disease 
(ABCD) research program which has taken a systems level approach to quality 
improvement in several AMSs. In ABCD a series of cross sectional clinical audits are 
coupled with a structured systems assessment in which staff are guided by a facilitator to 
assess the quality of their systems. The methodology and resources are adapted from the 
Assessment of Chronic Illness Care survey instruments12 and are based on the Chronic 
Care Model (CCM) developed by the US Improving Chronic Illness Care program.13 This 
. survey was in turn modelled on an instrument developed by the US Indian Health Service 
for evaluating diabetes care. 14 TP.e ABCD systems assessment is intended for use by health 
services to: (1) identify areas for improvement in care for chronic illness before beginning 
quality improvement work; and (2) evaluate the level and nature of improvements made in 
response to quality improvement interventions. Assessments are made along six CCM 
components- community resources, health organisation, self-management support, 
delivery system design, decision support and clinical information systems. The ABCD 
team has integrated this tool into an assessment, planning and action cycle. This approach 
has demonstrated modest improvements in process outcomes (improved delivery of 
scheduled services) and clinical endpoints (diabetes control and cholesterol 
reductions). 15"16 
Based on the experience of the ABCD and IMP AKT projects, when health service staff 
met to collectively discuss and determine responses to a structured health systems 
assessment (ABCD) or a review of processes of care (IMP AKT), important discussions 
were generated. Drawing on these two studies, we used the Kanyini Audit fmdings to 
explore staff perspectives on health systems issues that impact on access to quality health 
care. The purpose of this exercise was descriptive and exploratory rather than as part of a 
quality improvement methodology. A structured assessment form was developed to guide 
discussions with staff. Four principal domains of inquiry were developed. These were 
informed by our review of candidacy theory; concepts of kanyini; the fmdings from 
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IMP AK.T and ABCD projects; and infonnal observations of health service systems that 
were made during the conduct of the Kanyini Audit. These domains covered the following: 
(1) Health service governance and cultural safety; (2) workforce issues and professional 
standards; (3) experiences of quality improvement activities and supports; and (4) 
navigation of care including access to hospital and specialist services. A series of 
structured questions were developed around these domains. A sample of the Health 
Systems Assessment fonn and the accompanying facilitator guide is shown in Attachments 
2.1 and 2.2. 
Sampling 
We invited the eight participating AMSs in the Kanyini Audit to participate. These sites 
were selected on the basis of interest in participating and reflected diverse governance, 
funding arrangements, service activity and staffing mix. 9 According to the Australian 
Standard Geographical Classification, 10 two AMSs are urban, one is inner regional, two are 
outer regional, one is remote and two are very remote. According to National Aboriginal 
Community Controlled Health Service Organisation (NACCHO) defmitions seven services 
are Aboriginal Community Controlled Health Services (ACCHSs) and one is a state 
government run AMS.tt Each assessment involved one staff focus group per site with three 
to seven participants and two research facilitators per group. We purposively sampled to 
ensure a diverse range of clinical, administrative and managerial staff participated. 
Focus group conduct 
Each session lasted approximately two hours. The first hour involved a brief presentation 
by the research facilitator and review of a site-specific feedback report on the key fmdings 
from the Kanyini Audit (see Figure 7-1). A sample feedback report is shown in Attachment 
3. Discussion of audit fmdings was unstructured and served as an ' ice-breaker' for 
focusing on the systems assessment In the second hour the structured focus group was 
conducted covering the questions in the systems assessment fonn. Each group was 
facilitated by one researcher and the program manager from one of the two coordinating 
research institutes. All facilitators had detailed experience of working in AMSs and 
specific appreciation oflocal context having been involved in data collection for the 
Kanyini Audit. Staff were encouraged to give expansive explanations of their views and 
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these sessions were digitally recorded and professionally transcribed. Specific survey 
responses will be correlated with the fmdings from the Kanyini audit as part of a 
quantitative systems modelling exercise. For the KQS, however, our focus was oriented 
toward the conversations generated around these domains rather than answers to specific 
questions. Analysis of these health systems focus group data was conducted concurrently 
with analysis of the semi-structured interview data (see 7.3.7 below). 
Semi-structured interviews 
Design 
I r Following the Health Systems Assessment we progressed to semi-structured interviews 
[ with health professionals and the community. From the conceptual frameworks of kanyini 
and candidacy we developed five inter-related domains of inquiry which guided the 
. 
conduct of the individual intervie'o/s: (I) how people engage with care; (2) staff and 
community experiences of care; (3) what people (staff and community) consider to be the 
features of proper care; (4) specific barriers and enablers to receiving and providing proper 
care; and (5) approaches needed to build better systems of care. From these broad domains 
of inquiry interview questions and accompanying probes were iteratively developed by the 
research team. The exhaustive list of suggested primary questions and potential probing 
questions is shown in Attachment 4.1 (community interviews) and Attachment 5.1 (health 
professional interviews). These sample questions were then further refined over the next 3 
months following pilot testing at each health service site. In this phase interviewers were 
encouraged to adapt the questions to make them applicable to local context and suitable to 
their interview style. This led to refinements in the type, phrasing and order of questions 
asked. IRFs were given direct supervision and training to assist with conducting 
interviews. Two-weekly teleconferences and four-monthly face-to-face site specific 
training workshops were provided to support each research team member to gain 
confidence in conducting semi-structured interviews. 
Sampling 
The eight AMSs partner sites from the Kanyini Audit, as well as one additional, outer 
regional ACCHS that had newly joined the collaboration were the organising hubs for the 
semi-structured interviews. In addition to working with these AMSs, interviews were 
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conducted with staff from a range of specialist, allied health and hospital services based on 
recommendations at each site. We used a purposive, maximum variation sampling strategy 
to guide the selection of interview participants.19 Three groups of community participants 
were sought: people with chronic diseases who regularly used the AMS for their routine 
health care; people without chronic conditions that regularly used the AMS; and where 
possible we drew on local networks to invite people who never use or irregularly use their 
local AMS to participate. Across these categories a balance between male and female 
participants and an even distribution of ages was sought. For staff interviews we sought 
views from Indigenous and non-Indigenous health staff. This includes clinical staff 
(doctors, nurses, Aboriginal Health Workers and allied health staff), non-clinical 
administrative staff (receptionists, transport workers, other administrative officers), visiting 
health professionals, health service managers and directors on local boards of management. 
Where possible we also sought vie;ws from key informant hospital and government 
community service health professionals. A sampling matrix spreadsheet was developed at 
each site for both community and health professional staff with these broad characteristics. 
Interviewers regularly updated this sheet and this was used to guide future people to 
sample. This was useful to prevent over- and under-sampling of particular groups. These 
sampling matrices were locally maintained by IRFs and aggregated centrally at the two 
coordinating research institutes at frequent intervals to oversee sampling progress across 
all sites. 
Interview conduct 
We drew on the rich, multidisciplinary nature of our research team to conduct the semi-
structured interviews. IRFs provided guidance on who to talk to, the appropriate setting 
and who might be the best person to conduct the interview. We adopted three different 
strategies to interviewing: (1) For many interviews we used a peer to peer interviewing 
strategy8 17 (e.g. a GP researcher spoke with a GP, an IRF spoke with Aboriginal Health 
Workers and community members). This allowed health professional participants to have a 
collegial level discussion and was particularly helpful for senior staff and medical staff 
where there were limited opportunities for interviewing. For community participants this 
was also helpful in establishing rapport, communicating the purpose of the study and 
giving participants a known person to whom post-interview issues could be referred. (2) 
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Whilst peer-to~ peer interviewing has obvious strengths there were a number of times where 
we departed from this in favour of an 'outsider' approach where an external researcher 
conducted the interview. This was particularly helpful for health professional interviews 
where sensitive workplace issues might arise and for community interviews where 
participants had a close relationship to the IRF. (3) For several interviews we also took an 
'insider~outsider' approach where two people (one internal and one external to the 
organisation) interviewed together.18 This combination allowed the outsider to ask 'naive' 
questions and clarify assumed contextual factors whilst the insider was able to draw on 
deeper understandings of community and workplace issues to enrich discussions further. 
Individual interviews wen~ conducted using a narrative ( open~ended question) approach. 
The approach was informal, flexible and respectful, with the primary motivation being to 
encourage participants to articula~e their experiences and views in the five domains of 
inquiry. Interviews were conducted in a variety of settings including the AMS and other 
non-government Indigenous organisations such as elders' associations, participants' 
homes, hospitals and community health centres. Unless the participant had any objections, 
interviews were digitally recorded and professional transcribed (see data management 
process below). 
We also conducted interviews in languages other than English. Rather than interpreter-
guided interviews we employed a similar strategy to IMP AK.T in which researchers who 
were fluent speakers of the participants' primary languages conducted the interviews. We 
were fortunate that one IRF team member was a fluent Kriol speaker. For Central 
Australian interviews a non-Aboriginal anthropologist, fluent in a number of regional 
languages, was sub-contracted to conduct a small number of interviews. Following 
completion of the interview in the person's primary language, another research team 
member conducted a 'second order' interview with this anthropologist in English. This 
interview would generate a conversation around the key issues raised by the participant 
and this was digitally recorded and professionally transcribed as usual. This transcript and 
any relevant field notes were then reviewed at the analysis stage. 
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Data management 
Basic demographic details for participants in both the Health Systems Assessment and the 
semi-structured interviews were collected on a record of interview form (see Attachment 
4.2 for community and Attachment 5.2 for staff versions). This form was also used by the 
interviewer to record any relevant field notes and observations made during the interview. 
Alternatively, interviewers used the digital voice recorder to make any additional 
comments about the interview and these were transcribed and appended as field notes to 
the interview transcript. 
Because of the multi-site nature of this study, there needed to be clear processes in how we 
managed the data. This process is outlined in Attachment 8. Each site maintained a study 
log which ensured that essential interview data were managed appropriately and various 
tasks were completed post-interview. This included recording the interview participant 
I 
details from the record of interview form into the study log; emailing the interview audio 
recording to the relevant coordinating research institute for professional transcription; 
recording details in the sampling matrix; and returning the transcribed interview to the 
participant if requested and responding to any recommended changes. Upon completion of 
these steps the interview transcript was ready for importing into NVivo 8 (QSR 
International, Vic) for coding and analysis. Periodically all site specific study logs were 
merged to produce an overall study log. This allowed us to assess progress on interviews 
conducted across all sites. Summary tables of interview data were reviewed at study 
meetings and this guided decisions on when to stop conducting further interviews. The 
local NVivo files were also periodically merged to produce a single file with all coded 
interview data. 
Ethical considerations 
This study seeks to provide an in-depth analysis of the journeys made by patients and their 
care providers when seeking and providing health care. It was important to our team that 
the principles of kanyini be applied not only to understanding the delivery of health care 
but to the conduct of our research. In so doing we were strongly aware of our 
responsibilities and obligations to participants and our partner health services. Consent 
material comprised of a written information sheet about the study and an informed consent 
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form to participate. Separate versions were developed for community and health 
professional participants. Samples are provided in Attachments 6.1-6.4. Whilst for many 
the opportunity to voice their stories was welcomed, there was the potential for this to 
cause distress. A locally developed distress protocol was used at each site in order to guide 
interview staff on the appropriate actions to be taken in these situations. These protocols 
were reviewed by ethics committees and community reference groups. A sample distress 
protocol is provided in Attachment 7. 
Privacy of data was also an important consideration, particularly where staff were 
providing details about their workplace. Participants were asked where they would like 
their interview information stored and who was allowed access to this information. In some 
instances this meant that information was held off site and research staff who were 
employees of the health service di~ not have access to the data. At other times staff and 
community participants welcomed full participation from local research staff in analysis 
and interpretation of the data and in these cases password protected interview data were 
stored locally and only accessible by designated research staff. Five site specific ethics 
committees, including one Aboriginal committee, reviewed and approved the study 
protocol. Memoranda of understanding and/or partnership agreements were established 
between the coordination research institutes and the respective governing bodies at each 
health service. These covered all components of the KVC program. Job descriptions, 
professional development plans. formal and informal support to Kanyini IRFs were 
included as attachments to these documents. 
Analysis process 
Thematic analyses were conducted contemporaneously with data collection, following the 
methods outlined by Patton.19 We developed a single coding and analysis framework for 
both the health systems assessment interview data and the semi-structured interviews. 
There were four discrete stages to its development. 
Stage 1: October 2008 to March 2009 
Responses to the Health Systems Assessment form were tabulated and reviewed by the 
research team. Two researchers at each of the coordinating institutes conducted repeat 
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readings of the focus group transcripts. At this stage these interviews were used to get a 
broad sense of the systems issues raised by staff. Using this as background context, we 
then focussed our attention on analysis of the semi-structured interviews. Team members 
involved in interviews at each site selected two interview transcripts (usually one staff and 
one community participant) and these were circulated and read by eight team members. A 
half-day video conference was then convened in which these interviews were discussed in 
depth. One of the interviewers would inform us of any relevant contextual factors and 
provide a brief summary of the key issues arising from the interview. A pre-assigned 
discussant, usually based at another site, then provided detailed comments based on his/her 
reading of the transcript. All team members then participated in an open discussion to 
clarify the themes. The process was repeated for six interviews in total and a summary of 
the emerging themes was produced. This summary was refmed in subsequent 
teleconferences and interviewers were able to use the outcomes from this early stage 
analysis to inform subsequent interviews. 
Stage 2: April to August 2009 
A similar process was conducted with a further four interviews analysed in a face to face 
meeting. The summary of themes developed in Stage 1 was further refmed and the major 
findings thus far were presented at the annual Kanyini investigator meeting. This meeting 
had around 30 attendees from health service partners, study chief investigators, research 
staff and other key government and non-government stakeholders. The discussions arising 
from this meeting further refined our analysis process. Following this meeting, one or two 
new interview transcripts were similarly discussed at our fortnightly teleconferences. 
Stage 3: August 2009 
By the end of this preliminary analysis process we commenced the coding of interviews. 
The team met for a two-day face to face workshop with the aim of further developing our 
skills in coding interview transcripts. This was facilitated by an experienced qualitative 
researcher who had played a mentorship role throughout the development of the study. 
Various exercises were conducted to critique study objectives and conduct line by line 
coding of selected transcripts. Training in the use ofNVivo was also provided. Several 
important issues arose from this workshop that shaped our approach to analysis. There was 
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a strong need to maintain the integrity of interview participant accounts and to recognise 
that thematic analyses had the potential to be· overly reductive in aggregating selected 
transcript excerpts from multiple participants. Each of us had unique approaches to 
interpreting and perceiving the data particularly in relation to our health professional and 
cultural background. This required the analysis process to be handled sensitively and 
democratically. Another important aspect that aided this process was the personal insights 
from research team members who were employees of partner health services. Awareness 
of organisational history, governance, operational management, program development and 
staff workforce issues provided important context to interpretation of the data. Similarly 
the experienced researchers on our team played a key role in situating findings within the 
broader historical and contemporary health systems context. Their insights from other 
related qualitative work also contributed greatly to this. 
Stage 4: October 2009 to March 2010 
With some guiding principles to coding established we then created the coding framework 
with which to analyse the interviews. Four new interview transcripts (two health 
professional and two community) from four sites and the seven health systems assessments 
interview transcripts were then coded line by line in NVivo. Despite having already 
reviewed several interviews, we sought to open code these interviews without referring to 
the provisional themes that had been developed. Where possible, all research staff coded 
their own interview data, usually in teams of two or three people. This resulted in four 
NVivo files (one for Central Australia, two for Queensland and one for New South Wales) 
which were then merged to a single central file. The locally generated codes were grouped 
into clusters and these were critically reviewed in a fourth workshop conducted over two 
days. Overlapping codes from each site were collapsed together, whilst in other instances 
site specific codes were maintained. A complete draft coding framework with 
accompanying definitions was then agreed upon and this was then used to code the 
remainder of the data collected. Periodic revisions were needed to this coding framework 
as new codes emerged from subsequent interviews. These were discussed in the fortnightly 
teleconferences and the recommended changes were incorporated into the coding 
framework. The use of multiple NVivo files with the identical coding framework allowed 
up to nine researchers at different sites to code data. This made it possible to conduct site 
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specific analyses whilst at the same time ensuring some harmony to interview coding 
across all sites. 
Communication of study progress and findings 
Using study findings to inform policy agenda is a central KVC objective and therefore an 
effective communication strategy is important. Health service partners and other interested 
stakeholders are informed of the study's progress via a quarterly newsletter, website 
updates and annual investigators' meetings. Those services in which an IRF is based 
receive additional updates via internal staff meetings. Project staff at the two co-ordinating 
institutes also have a regular presence at each AMS site, conducting two monthly face-to-
face visits and regular telephone meetings. For most sites this has occurred for over three 
years. 
A structured dissemination strategy will be implemented over 201 0 and has been budgeted 
accordingly. Feedback will consist of three components. (1) A preliminary site specific 
analysis will be presented at each AMS to allow sites to reflect on the interpretation of 
their local data. This feedback will be used as a type of 'member checking' process to 
determine the salience of the findings and to guide us on the need for additional analyses. 
We will draw on our feedback experience with the Kanyini Audit in which a series of 
meetings were held with AMS boards of directors, management staff and clinical staff. 
Open community forums are also planned. (2) As our analyses develop further a second 
feedback activity centred on the study's overall findings will then be conducted at each 
site. (3) Study findings will then be communicated to a wider audience via conference 
presentations, publications and a series of policy stakeholder forums in which key 
government and non-government agencies will be invited to discuss study findings. 
7.4 Results 
Seven Health Systems Assessments involving 37 staff were conducted between May and 
July 2008, soon after completion of the Kanyini Audit. Table 7-1 provides a profile of the 
services and professional categories of the participating staff. Due to a range of competing 
priorities one of the remote services that participated in the Kanyini Audit was unable to 
participate. 
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Table 7-1: Health service characteristics for the health systems assessment• 
Service Urban 1 Urban2 Regional I Regional2 Regional3 Remote I Remote2 
Service population (%regular clients) 3444 (63%) 2882 (76%) 504 (63%) 748 (76%) 11740 (70%) 780 (72%) 1100 (91%) 
Indigenous governed No Yes Yes Yes Yes Yes Yes 
Indigenous manager Yes Yes Yes Yes Yes Yes No 
Workforce total (Indigenous) 26 (9) 42 (23) 6 (5) 9 (4) 133 (103) 7(2) 12 (6) 
General Practitioners (Indigenous) 4 (1) 6 1b 2 (1) 8 1 I* 
Registered Nurses (Indigenous) 9 (1) 1 2 (1) L 14 (2) 4 3 
Aboriginal Health Workers 2 3 0 2 17 2 2 
Allied health staff 3 0 0 0 2 0 0 
Chronic disease specific staff Yes No No No Yes Yes No 
Systems 
Electronic record system Practix MDc Ferret/MOe MDc MDc Communi care Communicare 
Automated pathology Yes Yes Yes No Yes Yes Yes 
Disease register system Yes Yes Yes No Yes Yes Yes 
Home medicines review No No No Yes No No No 
Transport services No Yes Yes No Yes Yes Yes 
On-site specialist services 
General physician 2 weekly 2weekly - monthly weekly 2 monthly yearly 
Cardiologist - - - - - 6 monthly yearly 
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Service 
Nephrologist 
Ophthalmologist 
Podiatry 
Dietician 
Dentist 
Local hospital servius 
Cardiology 
Cardiac rehabilitation 
Nephrologist 
Dialysis 
Table Notes 
a. Focus group participants 
Urban 1 
daily 
daily 
Yes 
Yes 
Yes 
Yes 
Urban2 Regional 1 
weekly -
daily -
Yes No 
Yes No 
Yes No 
Yes Yes 
Urban 1: 
Urban 2: 
Clinical director, GPs (x2), Chronic disease RN, AHW project officers (x2), Aboriginal liaison manager 
Board member, GP, AHWs (x2), RN, Finance manager 
Regional1: Chief Executive Officer, GP, RN, Driver, Receptionist 
Regional 2: GP (x2), RN, AHW (x2), Receptionist 
Regional3: GP, Chronic disease AHW, Cardiac Rehabilitation AHW, Programs Coordinator 
Remote 1: GP, RN (x2) 
Remote 2: RN (x3) 
b. Part-time locum only 
c. Medical Director 
\ 
Regionall Regional3 Remote 1 Remote2 
yearly yearly 
- -
6monthly 
monthly daily - 3 monthly 
- daily 2monthly 6 monthly 
Yes Yes Yes Yes 
Yes Yes No No 
No Yes No Yes 
Yes Yes No Yes 
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For the semi-structured interviews we spoke with 108 community members and 96 staff 
over a 14 month period from October 2008 to December 2009. Analyses of these semi-
structured interview data will be reported in subsequent papers not contained in this thesis. 
Qualitative themes from the Health Systems Assessment 
Five core themes from the staff focus group discussions on their health systems are 
discussed here. They are: (1) AMSs are different to the mainstream; (2) AMSs are under 
threat; (3) Workforce roles and capacity; (4) Commitment to quality improvement; and (5) 
Challenges in access to hospital and specialist care. 
Theme 1: AMSs are different to the mainstream 
At all sites staff emphasised the unique aspects of AMS service delivezy when compared 
with the mainstream. In particular, engagement with local Aboriginal and Torres Strait 
Islander communities was repeatedly affirmed as the main difference. Staff viewed the 
type of care they provided to be comprehensive, responsive to community expectations and 
patient, rather than business-oriented. 
They (clients) get such a marvellous wide ranging preventive health service. 
Aboriginal people only come when they' re sick, so you've got to seize that moment 
and address all the other issues, like diabetes, or hypertension, or kidney disease. And 
so, with this sort of organization, you can't solve all those problems, but you can 
attempt to address them. In a normal general practice, or in a mainstream setting, that 
would never happen. So I think they' re wonderful organizations for preventive health. 
(CEO Regional AMS) 
By contrast, private general practice was viewed as focussing on maximising business 
revenue and providing reactive rather than preventive health care. It was also felt to 
inadequately acknowledge the particular needs of Aboriginal and Torres Strait Islander 
peoples. 
I suppose, as an Indigenous doctor, you often get (patients saying) 'I'm happy to talk 
to you about this, but I wouldn't really want to talk to the GP down the road about it 
... If it's something to do with emotional, cultural, spiritual stuff, then that really does 
need to be addressed. But, you know, mainstream practices might not see it as 'true' 
medicine. (GP regional AMS) 
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Although community linkages are known to be an important component to chronic care, 
the depth of community connection in AMSs goes beyond this. Even for the only non-
community governed health service, staff stressed the importance of ensuring community 
input and that this is usually not appreciated in mainstream services. 
Even though we're a mainstream health service we do work really strongly with the 
community and I think that's probably a big plus for us. There's nothing more 
important than having local people (on staft) . .. that liaise between the community 
and us ... We still have that strong contact, especially with the elders ... Normally 
mainstream health services never venture out in Indigenous health to actually work 
with the community and not many (patients) come to them. (Clinical director urban 
AMS) 
Consistent with our theoretical understandings of kanyini, staff frequently commented on 
the obligations they felt to reach people and act in their best interests. This need to hold 
and nurture people was most profoundly felt by Aboriginal Health Workers. 
Not only do we work here but we live in the community. So a lot of the clients that 
come are our relatives or a relative of our relatives ... So our work doesn' tjust stop 
when we finish work, it continues after work as well. (AHW /Programs coordinator 
regional AMS) 
These obligations constitute a powerful mechanism for enhancing the candidacy of 
Indigenous communities for health care. For AHWs there was an unconditional quality to 
the care provided, subtly blending the well-demarcated work responsibilities with diffuse 
personal obligations in the community. Whilst these obligations may manifest quite 
differently for non-Indigenous staff a similar dedication beyond the ordinary was apparent. 
.. . we go in on the weekend to see people in hospital, on our weekends off . .. It is an 
absolute necessity that it's done but nurses are having to pick up the burden of the 
social aspects ofthe clinic and (they are) doing them in their own time. (Registered 
nurse remote AMS) 
This duty to reach people also helps explain why health promotion constitutes a key part of 
service activity. Bridging clinical services with activities that develop community capacity 
are central to health service function. 
Daniel (pseudonym for an Indigenous project officer) works on a shared responsibility 
agreement with the football club. It's brought in an investment of a few hundred 
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thousand dollars to the community and has been used here to engage health promotion 
initiatives ... I think that is a really good example of delivering health in a very 
different way and engaging the community's strengths. Rugby league is a huge factor 
for a man and it shows in figures that men attending the clinic are still under 
represented ... So the work that's been undertaken has seen an investment of 
infrastructure in the community sector as well as furthering this clinic. (Aboriginal 
health promotion officer urban AMS) 
In order for an AMS to 'hold' and nurture its community, this engagement is needed at all 
levels of the organisation, not just with the governing board. Only when local staff are 
employed across a variety of positions can this hold be consolidated. This workforce 
affirms community linkages and the consequent legitimacy of the organisation. 
Being a community controlled service you not only have it (community control) at the 
board level but it should be reflected in the organisational structure right through to 
even the groundsmen ... it gives the staff themselves a sense of belonging and 
knowing that it is owned by the community. We all live in this community so we're a 
part of the organisation and we're working for it, showing to the wider community 
that we are able to work at all these different levels. (AHW regional AMS) 
One health system feature that strongly reflects kanyini is the availability of transport 
services. This was universally acknowledged as a critical component to good health care 
rather than merely an ancillary support. Staff from all professional backgrounds 
commented that the level of care provided is heavily influenced by the availability of 
transport and that its absence 'defeats the purpose of us being here'. For one urban service 
that is not funded to provide transport, clinical managers frequently bent rules to ensure 
patients attended appointments. Similarly for the two remote services, transport was 
critically important. One service provided daily visits to homelands, transporting people 
either back to the clinic or to the major referral centre if acute or specialist care was 
needed. Substantial monetary and human resources were allocated to maintain this service. 
For the other remote site airplane transport services were especially dire with long wait 
times and patients having to travel alone to attend appointments. 1bis left many feeling 
vulnerable when 'stuck' without family in the referral centre. For some people this 
impacted greatly on future decisions to seek specialist care. Thus transport is a key 
mechanism by which people are 'held' by their health service and supported to navigate 
the system. 
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Theme 2: AMSs under threat 
Despite the primary importance of firm connections to community, several AMSs felt that 
their community governance structures were under threat. These perceived threats manifest 
at a number oflevels. For several of the ACCHSs, relationships with their principal 
funding body, the Office of Aboriginal and Torres Strait Islander Health, were a frequent 
source of tension. Many staff commented on the challenges ofhaving to compromise 
community needs and expectations in order to satisfy external expectations, particularly 
complex reporting to funding bodies. A robust governing board was considered critical to 
balancing these tensions. 
The Board are better equipped and better able to run the health service because they're 
from the community, they know what the community need. To me it's a best practice 
approach, it's an evidence based approach because we are the community. We know 
what we want. We don't alway~ have to be told 'you need this, you need that', or 'you 
should be doing this'. (AHW r~gional AMS) 
For the two services under the auspices of ACCHSs from other regions, staff felt the 
fundamental principle of community governance was being undermined. Relationships 
with the auspicing body were volatile and for one service, the continual lack of progress 
toward becoming an independent health service left many staff feeling despondent. 
There's probably to some extent a fundamental flaw in that we aren't as community 
controlled as we'd like to be. We're controlled by a different community, which just 
doesn't make sense. (The local Board is) a bit of a toothless tiger unfortunately ... 
About five years ago, it was really strong ... and (names people) were working really 
hard towards us becoming independent. But there's only so many times you can get 
kicked in the teeth before you stop going back there to get another one. (GP regional 
AMS) 
This volatile relationship often resulted in confusion amongst staff about who are the 
decision makers and what are the appropriate lines of management. At one service it left 
staff feeling that directives were made in a top heavy manner with little consideration of 
their opinions. 
Well, the biggest problem at the minute is that there's too many chefs in the kitchen 
... And the big picture seems to get lost ... and this has to be put back on track ... And 
when you've got fifty thousand different opinions it gets very muddled. (Nurse 
regional AMS) 
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By contrast, one large and experienced AMS considered it had a duty to support new 
AMSs in the region and its experience in auspicing several fledgling health services were 
recounted positively. These arrangements were always intended to be temporary with the 
view to supporting the health service to become independent. 
There are five or six of them (auspiced services) around here and the AMS has played 
an important part in setting them up and then handing them over to people in those 
communities that run those affairs. And that speaks volumes about their approach to 
doing business. (AHW regional AMS) 
Another frequently perceived threat is that mainstream health service providers do not 
,. consider that AMSs provide adequate services, thereby legitimising increased external 
involvement. In this poignant interaction between an AMS board member (PI) and AHW 
(P2) both felt there was a hidden agenda to eliminate AMSs altogether, replacing them 
with poor quality 'mainstream' heal~ care. 
Pl: They (government community health services) shouldn't think that they are far 
superior to the AMS team. That sort of an attitude, they should cut it out. 
P2: Oh that attitude will stay aroundfor a long time until somebody, until the boss 
of this organisation says something to them ... I've seen it happen ever since 
this partnership agreement first started. 
PI: But they say that we need their services too but that doesn't mean they should 
come and tell you to do this, do this, do this. Low grade services ... they try to 
bung it onto us. 
P2: They have been for quite some time though. 
PI: Still trying ... Ifwe look a little bit further down the track, say five, ten years 
time there won't be any more AMSs in New South Wales. They will become all 
mainstream. 
P2: That's a plan of the minister ... low grade services. 
PI: That's where we're heading, towards mainstream. 
Despite these fears of being consumed by the mainstream, there were examples of 
successful partnerships between AMSs, government and other non~government agencies. 
One Aboriginal Health Worker argued for a 'co-operative self-detennination' where 
government agencies practise non-interference whilst still maintaining support to AMSs to 
self-direct the delivery of health care. At one health service site the establishment of an 
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inter-agency forum over 14 years ago has allowed government and non-government 
organisations (NGOs) to have equal representation and complete several collaborative 
projects. Indigenous project officers from the health centre have played a central 
coordinating role for this forum and have supported a number of small Indigenous NGOs 
to expand their comnumity development capacity. This appears to have been successful in 
implementing a 'co-operative self-determination' model. 
Theme 3: Workforce roles and capacity 
Lack of staff 
Several people interviewed felt chronic staff shortages curtailed the quality of care they 
provided. This was the major contributor to staff burn out. In particular, insufficient staff to 
meet acute care needs was considered a critical barrier to developing sustainable chronic 
disease services. 
In the past. patients would have a preventive health check but this has stopped because 
there's been an influx in acute care ... That leaves the doctors no time to manage 
chronic needs and help patients to self-manage ... So I think we need to look at how 
are we as an organisation going to tackle acute care. And then by reducing that, I think 
it would then have an impact on the chronic disease because a lot of the acute care is 
manifesting as chronic disease later. (GP regional AMS) 
These comments are supported by the Kanyini Audit findings in which over 40% of 
routinely attending adults aged 30 and over were at high risk of vascular diseases or 
already had these diseases.7 It highlights that patient care cannot be easily dichotomised 
into acute and chronic care. Chronic care is likely to be everyone's business, whether in the 
specialised or general clinic setting. The sequelae of this are that adequate resources are 
essential in order to provide comprehensive chronic care services to routinely attending 
patients, regardless of the reason for the encounter. 
Role of Aboriginal health workers 
In candidacy theory, 'tractability' refers to organisational policies that are specifically 
geared toward increasing access for vulnerable populations. AHWs appear to be one of the 
key mechanisms to making AMSs more tractable. Many staff commented on their ability 
to expand the type of care provided and that their unique skills to engage with community 
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members is a critical adjunct to conventional medical services. This was not merely an 
issue of their identification as an Aboriginal and/or Torres Strait Islander person. One 
Aboriginal GP commented that AHWs added value in ways that he could not. 
An Aboriginal health worker is a key person that community members will feel more 
comfortable talking to about stuff than even with me ... When Tanya (pseudonym) 
was working as a health worker, it was just a different place to work altogether. If I 
was struggling to chase someone up for weeks. I might just mention it to her and she'd 
say, 'Oh look, today they're probably down here', and go and get them. One of the 
things that helps me out as the GP is having that true feedback from the community as 
to what's really going on. Because sometimes people tell me stuff, and it's not quite 
what everyone else is talking about ... So, it puts you on the right foot to initiate what 
you believe to be appropriate treatments. (GP regional AMS) 
The diverse roles fulfilled by AHWs were evident in this study. In several sites a more 
traditional AMS model was in operation where the AHW works at the 'frontline' of 
clinical care providing the first poiP,_t of contact for triage and health screening. Brokerage 
roles such as making health information more accessible are a key part of this role. 
I like working with my own people ... It's great that I'm the clinical health worker 
because I break down the barriers ... Doctors tend to talk big words and a lot of the 
community don't understand that. So I'll break it down into our jargon and I put it 
straight to them. (AHW urban AMS) 
Juxtaposed with these traditional clinical and brokerage roles is an increasing emphasis on 
health promotion and community development roles. For one project officer the delivery of 
'strengths based health promotion' was closely aligned with asserting Indigenous concepts 
of health. 
I've always struggled with the role of the Indigenous health worker and where we sit 
in the structure ... I think there's a lot of uncertainty and health workers work in very 
different environments ... And I guess where I feel most comfortable is around 
community-based health promotion and delivering health from an Indigenous 
perspective of health. So not just thinking about food and exercising but thinking 
about community wellbeing. That's my agenda and what I see as important as an 
Indigenous person in the health profession. (Indigenous project officer urban AMS) 
In one remote service, registered nurses felt AHW staff had a nominal presence in the 
health service only, suggesting they served no useful function at all, acting rather as ' pin-
ups'. Competing priorities with family responsibilities branded them as unreliable and 
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because they were not of sufficient standing in the community they lacked the respect of 
the people they served. 
They (AHWs) are terrific to use as go-getters and liaisons and communicators and 
things like that, but they don't want to do health work ... There's a lot of issues 
because for both of our health workers ther~'s family groups that they won't go near 
... And I just think that being a health worker here is a position that doesn't have any 
credence or respect in the community ... Ideally the health worker here would be 
someone who's indigenous and knowledgeable with the people, but who's not from 
here, who is impartial to all the different groups of people here. (Nurse remote AMS) 
Such comments stand in stark contrast to the preceding ones in which AHW s play an 
expansive role as the nexus between service and community, broker of services, 
coordinator of health promotion activities and embodiment of a community governance 
model. They emphasise a more narrow view of AHWs as medical assistants. These 
apparent weaknesses of over-familiarity with the community can constitute a substantial 
I 
asset to the health service if supported appropriately. The level of organisational support 
for these roles is therefore a critical factor in maximising the contribution of the AHW 
workforce to improved care. 
Workplace orientation and professional development support 
Although access to professional development opportunities seemed well supported, few 
sites had any formal orientation to prepare staff for working in AMSs. Only the state-run 
service has obligatory cultural awareness training workshops for new staff and many 
commented that this course· was tokenistic, poorly preparing staff for the realities of their 
work on the ground. Similarly staff who attended state goverrunent run clinical orientation 
training workshops considered them to be 'just a piece of paper' bearing little relevance to 
what was actually needed. Despite this limited orientation, staff commented on a wide 
variety of informal measures through which they gained experience and support to carry 
out their job roles. In particular, guidance from senior Indigenous people was highly 
valued. In some services consultation with elders (either as patients or at community 
education events) was used to get advice on appropriate professional conduct. Senior 
Aboriginal clinical staff also played a critical role. One GP commented on how he would 
seek advice from an Aboriginal nurse manager for difficult management issues. This 
support allowed him to feel his work practices were safe. In another service doctors 
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received ad hoc 'corridor' training from the senior doctor. This doctor's multiple 
perspectives as an Aboriginal person, respected clinical manager and medically qualified 
health professional enabled him to support a variety of staff on a breadth of issues. 
Fulfilling these roles, however, placed great demands on him. 
It's very refreshing and very exciting having one of the other doctors who is 
Indigenous because it just helps keep everything in a better balance . .. I think Jason 
(pseudonym) was an incredible person ... Everybody wanted him because he's 
confident, affable and smart. The difficulty was that although it was fantastic having 
him in that role, it was also very difficult for him to ac~ally perform the role 
adequately because he had so many other responsibilities ... I think that must always 
be a tension for people in that position. (GP regional AMS) 
Theme 4: Commitment to Quality improvement (QI) 
Three components of the CCM were most talked about in relation to effective quality 
' 
improvement strategies. These 'Yere related to organisational influence (especially 
_leadership), information systems, and delivery system design (especially care planning and 
follow-up). 
Organisational influence and leadership 
Interest and capacity at the highest levels of management appear key to establishing 
satisfactory QI systems in AMSs. At one service, three senior positions (executive officer, 
medical director and a dedicated systems manager) take responsibility for QI activities. Of 
particular importance is the link between the medical director and the executive. For many 
years this relationship had been extremely productive and QI activities thrived. In recent 
times with the medical director position becoming vacant and high turnover in the systems 
manager position, this leadership structure has become more tenuous and QI activities are 
noticeably less robust. At another site, staff felt that managers were out of touch with their 
needs and made decisions that were ill-informed or cost-driven rather that patient care 
driven. 
To provide good chronic disease management you need great systems and at the 
moment we've had problems with that ... From experience, systems are always forced 
upon us by higher management .. . systems we don't want. (Clinical director AMS) 
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Delivery systems and care planning 
The issues of sufficient numbers of adequately trained staff for quality improvement 
activities was extensively discussed. There was a variety of approaches as to how staff 
should take responsibility for recall systems and chronic care planning. In two services 
nurses had the primary responsibility to manage recall systems whilst at another service, 
AHW program coordinators managed disease specific programs such as diabetes and 
cardiac rehabilitation. These approaches contrast with another service's experience where 
chronic care coordination was provided as a part of a joint state and federal funded 
initiative conducted in partnership with three AMSs and other regional health providers. 
Under this program externally funded 'care units', based at the AMS, initiated health 
assessments and care plans. Additional funding was also available to assist patients to 
access specialist services under this scheme. Whilst care coordination is inherently 
appealing and has been trialled successfully elsewhere, the AMS staff we interviewed felt 
' 
that the program was overly driven by the external stakeholders and that this actually 
hindered effective care coordination. These external managers of the program were 
considered to be overly focused on data collection for statistical reports and less committed 
to actual coordination of care. 
There were mixed views about the role of Medicare health assessments and care plans as a 
component to chronic care delivery systems. For one service an upfront investment in 
nursing staff to manage these Medicare items proved to be a successful business strategy as 
the income generated was able to ostensibly fund these positions. At another service, 
however, the chief executive officer cautioned that when this became the end rather than a 
means to quality patient care it could compromise the integrity of the service. 
You can spend all your time chasing Medicare dollars ... you can do health 
assessments just for the sake of doing health assessments and not actually help the 
patients .. . It's not necessarily the great pot of gold ... it's not going to solve all your 
problems ... And chasing a handful of dollars, sometimes you don't pursue the right 
directions, and your directions should be primarily improving the health of the 
community that you're working with. (CEO regional AMS) 
Information Computer Technology/Information Management (ICTIIM) 
Many staff felt their ICTIIM infrastructure was sub-standard. This constitutes a major 
barrier to supporting a culture of quality improvement in chronic care. Whilst there were 
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simple problems such as not enough computers, the most common and serious concern was 
that systems had frequent outages and that support services were inadequate to 
troubleshoot problems when they arose. Staff were concerned about inadequate data back-
ups, unsystematic processing and potential loss of important information, and fears that 
outages of paperless systems could substantially compromise patient safety. We witnessed 
several outages at a number of services during data collection for the Kanyini Audit. On 
one occasion this was so severe that managers closed the clinic and many patients who had 
already completed screening procedures were turned away. 
Dissatisfaction with Patient Information Recall Systems (PIRS) was equally important. Of 
the various systems used there appeared to be strengths and weaknesses with each of them 
with no one system being an ideal fit. 
I 
I would really love to marry Ferret, Communicare and Medical Director all into one. 
That would be the best program because I think they all have something within them 
that's so good and then there's a part of them that is so crap ... We all need different 
bits out of it so the doctors need the clinical side, health workers need the management 
side and the Board and management need all the data for their reports, for funding 
purposes. So we all need something out of it, but one program never gives all of it ... I 
think the person who comes up with this program is going to be a national icon! 
(AHW regional AMS) 
This again emphasises the unique needs of AMSs where different PIRS components are 
needed for a wide range of purposes. Equally important was the lack of staff training to 
fully reap the benefits of whichever system was being used. Staff felt that even after 
several years of use they were still discovering new things. 
I think we're done a disservice because we're not oriented properly to Medical 
Director when we start here. So it takes you a year or two to actually learn how to use 
it properly ... And my argument with this organisation which was saying, 'Let's bring 
in Ferret', was 'Let's use Medical Director properly and make the recall system work 
properly.' Sure, you don't have exactly the population data that you do with Ferret but 
if we did the best job we could with Medical Director, we would actually be doing a 
pretty good job. (GP regional AMS) 
Thus despite the varied QI strategies in place, a common theme was the need for high level 
leadership with a strong investment in nursing and/or AHW staff. Adequate information 
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systems are desperately needed with barriers operating at the level of users (poor training 
and support), the environment (poor infrastructure) and unsuitable software systems. 
Theme 5: Challenges in access to hospital and specialised care 
Another key CCM component of good delivery systems design is the degree of 
coordination between primary care and specialist services. There were again mixed views 
on satisfaction with hospital and specialist services. Staff identified several barriers related 
to poor hospital communication, experiences of discrimination and difficulty in navigating 
specialist services. 
Hospital communication 
There were mixed accounts regarding satisfaction with the care provided by hospitals. 
Generally in the urban and larger:regional centres staff were satisfied with service provided 
. 
and the level of communication. At the smaller rural and remote sites, however, AMS staff 
felt that communication processes were often poor, particularly at the time of hospital 
discharge. At one regional site successful communication appeared to be 'hit and miss' 
depending on whether there were conscientious staff working there at the time. At one 
remote site, staff commented that it was common to be completely unaware of an episode 
of hospital care with it only coming to their attention when the patient subsequently 
attended the AMS requesting medication. At the other extreme, information would be 
faxed for people that the AMS did not provide care to and this would create burdensome 
work ensuring that other health services were notified. As one remote GP commented, 
'The fax just seems to spit stuff out at us all day long'. 
Discrimination 
Experiences of discrimination in the hospital and specialist care systems were pervasive in 
all settings. There were abundant stories of hospital staff displaying hostile attitudes to 
patients. These were often fuelled by stereotypical assumptions about Aboriginal people. 
We had a young Aboriginal fella, he went to the hospital, presented at A&E, and the 
nurse asked him 'when was the last time you had a bath?' (fhe person then walked 
out). And I heard about this young fella over the weekend and Monday morning, we 
went looking for him. We brought him in to see the doctor. It turned out he had an 
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abscess on his lung which was really serious and he had to be hospitalised straight 
away. (AHW regional AMS) 
Such discriminatory attitudes emphasise that Aboriginal and Torres Strait Islander people 
may be viewed a priori as non-ideal users and treated hostilely by the hospital system. 
Patients may have little recourse to address this hostility other than to leave. The hospital 
system's preference for the ideal user makes it highly intractable. Although patient 
complaints may be responded to appropriately, at one site staff commented that this did not 
seem to change the way the system functioned. 
I have asked patients to write letters of complaint ... And then we've got really nice 
letters back saying there are taxi vouchers for them and everything. And then it 
happens again. (GP regional AMS) 
The volume of accounts of discrimination experienced by patients means that AMS staff 
I 
are frequently intervening on the patient's behalf to restore access rights. Doctors in 
particular use their power to soften hardline stances taken by hospital and specialist staff. 
Interviewer: Have you heard of discriminatory practices in the hospital sector and how 
do you deal with that? 
Participant: A lot of advocating from me ... ringing and cutting through the crap, the 
resistance and the verbal ' rolling ofthe eyes' and just keeping on pushing until the 
appointment happens. And apologising on the patient's behalf and explaining why 
certain appointments haven't been attended and 'could we please now have it 
happen?' (GP urban AMS) 
Specialised care 
Access to specialist services in remote areas was a substantial problem in the two services 
we interviewed. Consistent with the ideal user concept, remote area specialist services 
appear to struggle with the need to adapt systems to circumstances that are quite different 
from those in the city. 
One of the issues is that people at the end of the line are so busy that they don't 
actually think, 'Gee this person comes from a 1000 km away, so we actually have to 
think differently about this person'. Yes, we need to do what we would do for 
everybody else but hey, we can't send them back and get them back next week. (GP 
remote AMS) · 
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In one service this led to devastating consequences where a patient with suspected 
coronary heart disease was asked to travel back to her community to await coronary 
angiography at a major referral centre. During this waiting period she had a fatal heart 
attack. 
In regional and urban areas specialist availability was also a challenge. AMSs in those 
areas are continually cultivating networks of specialists whom they know are favourably 
disposed toward providing care to Aboriginal and Torres Strait Islander people. Personal 
connections and feedback from patients are the most important mechanisms for gauging if 
these services are suitable. Eliminating financial barriers through the availability of bulk-
billing specialists is a key consideration for determining suitable specialists to which to 
refer. Although these specialist networks tend to develop in an ad hoc manner, there were 
·several examples of highly succe~sful partnerships that are improving access to specialised 
services. The primary ingredient in these partnerships was the enhancement of on-site 
service provision. At one AMS a cardiac rehabilitation service was established through 
formal agreements with the hospital. Local AMS staff managed the program and external 
hospital staff would provide on-site services. There has been a dramatic increase in 
attendance since commencing this program. Central to the program's early success has 
been management by an AHW who has himself experienced a heart attack. In this way a 
specialist service can be delivered by trusted local staff on site, thus facilitating access to 
the full range of other AMS services such as transport, dental care, social and emotional 
well-being services and general primary care. 
Other innovative strategies to improve access to on-site specialist services included 
partnerships with endocrine and ophthalmology services to up skill local GPs in diabetic 
retinal screening and intensive insulin management; research partnerships with universities 
and institutes that had dedicated service provision components; and establishment of 
interagency agreements with other service delivery organisations to ensure harmonisation 
of care and more efficient distribution of resources. 
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7.5 Discussion 
This analysis of AMS health systems forms the ftrst component of the KQS. It provides a 
useful snapshot into staff perceptions of barriers and enablers to health care access and 
quality for Aboriginal and Torres Strait Islander peoples. Two theoretical constructs, 
kanyini and candidacy, developed from very different epistemological positions, guided 
our analyses. Consistent with the systematic review fmdings in Chapter 6, candidacy 
prevails as a useful way of describing and understanding access issues. The sub-constructs 
of tractability and navigation of health services are particularly helpful. Tractable and 
navigable health services have good governance structures, sound leadership, systems that 
welcome the 'non-ideal user', and a well-supported workforce with a strong Indigenous 
staff component. The relevance of kanyini was different from but complementary to 
candidacy. It provides an important frame with which to understand the distinct features of 
the way care is provided in AMS 'settings. Kanyini is rooted in power:ful emotional, 
' 
spiritual and culturally specific dimensions. This does not mean, however, that its 
underlying epistemologies are irrelevant to health care systems and the individuals 
working within them. McCoy uses kanyini concepts to explain the excellent educational 
outcomes that were achieved in one Central Australian school.4 The way in which this 
institution 'held' people, honouring its obligations to nurture and ' grow' its students could 
be viewed as a systems approach. Similarly, the multiple strategies that AMSs take to 
ensure community governance, community representation on staff, and strengths based 
health promotion activities are all features of this obligation to hold people from childhood 
to old age. The degree to which a person, family or community feel held may be a 
fundamental driver of whether care is viewed as 'proper'4 and this will be a key part of 
forthcoming analyses of the semi-structured interview component of this study. 
This duty felt by AMSs to properly 'hold' people is undermined by a substantial fear about 
the viability of the AMS sector. Despite the ACCHS sector having a stronger national 
presence than ever before, staff remain suspicious of government intentions. The COAG 
NPA has had mixed responses from the ACCHS sector. Many ACCHS advocates are 
concerned that these initiatives are primarily targeted toward improving Aboriginal 
people's access to mainstream general practice services, and that they are neglecting the 
substantial role played by this sector.20 Although the focus groups in this study pre-date the 
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COAG NPA, it is quite likely that these new initiatives would further compound rather 
than allay the feeling of being under threat. For organisations that are under auspicing 
arrangements with OATSIH there are particular policy challenges. Where there is a clear 
commitment to hand over governance to the local AMS, then the auspicing arrangements 
appear satisfactory. Where relationships with the auspicing body are such that there is little 
scope for local governance or where the auspicing body itself is experiencing difficulties 
then good governance and sound operations management appear untenable. From a 
funding body perspective it is clear that fledgling organisations with limited capacity to 
function independently pose a high risk of not remaining viable. Further, there are 
substantial gains to be made from shared infrastructure, especially IT and human resource 
support, and financial management. OATSIH conducts regular risk assessment reviews as 
a part of their funding agreements with health services.21 Whilst auspicing arrangements 
· are clearly a useful strategy for mitigating risk, this study highlights that a better balance 
may be needed between upholdirig community engagement principles and provision of 
external support to ensure viability of the AMS. 
Consistent again with the systematic review findings in the previous chapter, the 
employment and support of Indigenous staff is a critical component to enhancing 
tractability of AMSs. AHWs make a vital contribution to ensuring that people are properly 
held. These findings are pertinent to the workforce expansion component of the COAG 
NP A in which several hundred new Indigenous workforce positions will be created 
including tobacco workers, lifestyle workers, outreach workers and self-management 
workers.1 Whilst such a large workforce commitment may be a sound investment there are 
cautionary aspects to this policy. The ability of an AMS to 'hold' its community is equally 
applicable to its staff, especially its Indigenous staff. Given a large proportion of these new 
workforce positions will be based in Divisions of General Practice there is potential to shift 
existing AHW s away from the AMS sector into organisational environments that are 
isolating for Indigenous staff. Further, there are important supports needed for the 
professional development of the AHW workforce. Despite a national workforce strategic 
framework being developed in 2002, 22 progress on implementation has been slow and 
barriers to improving workforce standards remain.23-24 There are, however, promising 
initiatives currently being implemented. The recently launched National Aboriginal and 
Torres Strait Islander Health Worker Association may help to address this with the creation 
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of national registration and accreditation standards. It is hoped that this agency will provide 
professional development opportunities that are flexibly delivered and that recognise the 
diverse roles played by AHWs. Institutional supports such as these are vital mechanisms to 
better 'holding' this workforce. 
A recent systematic review found that interventions in a number of CCM components 
(delivery system design, self-management and clinical information systems/decision 
support) led to small to moderate improvements in diabetes care. 16 Staff in this study 
identified a number of barriers and enablers to successful delivery system models. Of 
particular relevance to the COAG NP A is the use of Medicare incentives to promote better 
systems of chronic care. Financial incentives will be provided to AMSs and private general 
practices for registering and providing a minimum number of Medicare services to 
Aboriginal and Torres Strait Islander peoples with or at risk of a chronic disease.1 Low 
' 
uptake of these Indigenous specific Medicare items has been well documented in both the 
Kanyini Audit' and elsewhere. 25 We identified several system issues that might contribute 
to this, especially poor information management and inadequate staff resources. Perhaps 
more important, however, were the mixed views of the value of these Medicare items for 
patient care. Whilst the larger sites felt incentives could assist in providing comprehensive 
care and additional business revenue, at the smaller sites the additional bureaucratic 
hurdles they created were viewed as distractions from good health care. ACCHS advocates 
have voiced similar concerns that the use of Medicare incentives in the COAG NPA will 
create an 'inverse care' situation where those that need the least care will be more likely to 
receive these Medicare services and ACCHSs with the least capacity and those patients 
with more complex care needs will miss out.2° Close monitoring will be needed to identify 
if such uptake patterns do indeed emerge. 
The information barriers we encountered are highly consistent with a recent OATSIH 
review of health service views on reporting requirements?' The Aboriginal Health and 
Medical Research Council has also recently conducted a series of organisational audits on 
ICT/IM capacity in NSW ACCHSs?6 This review found a considerable shortfall in budget 
allocation toward information systems, low levels ofiCT/IM governance within ACCHSs, 
and poor computer literacy amongst staff members. These issues are again consistent with 
our study findings and warrant urgent attention. The COAG NPA includes a component for 
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the monitoring and evaluation of package initiatives at 32 sentinel sites, 1 however there are 
no specific initiatives to address infrastructure barriers and staff support. NACCHO and its 
ACCHS state affiliate organisations are, however, developing ICT/IM strategies and two 
state affiliates have successfully implemented performance indicator programs. Whilst this 
progress is encouraging, the scale of these barriers is so large that substantial commitment 
will be needed to improve ICTIIM capacity nationally. 
Whilst there were relatively minor frustrations about hospital systems (especially 
communication processes), the most concerning issue was the repeated accounts of 
perceived discrimination experienced by patients. In one NSW and Qld survey, 
discrimination in everyday life was experienced by 43% of Indigenous respondents 
compared with approximately 25% of those who were not from an Indigenous 
background. 27 Dealing with thesf1 negative experiences appears to be a regular component 
of AMS health professionals' work. Discussion of institutional and interpersonal 
discrimination in hospitals is beyond the scope of this paper, but it seems likely that 
conventional cultural awareness training workshops do little to address such a complex and 
highly pervasive issue. Some potentially instructive alternative strategies include anti-
racism training28 and the development of tools that critically examine notions of culture, 
race and oppression.Z9-31 At an institutional level, New Zealand Maori advocates have 
called for organisational audits for compliance with Treaty ofWaitangi principles.32 In 
addition, several New Zealand district health boards have policies outlining tikanga best 
practice guidelines for respecting Maori principles in relation to hospital care. 33 In 
Australia, the Victorian Health Promotion Foundation has conducted extensive reviews of 
the literature and surveys of community attitudes to discrimination. This organisation is 
currently developing a range of workforce and organisational development strategies, 
although hospital based interventions are not currently a major focus.34 
On-site specialist outreach clinics appear to be a beneficial strategy to enhance the proper 
holding of people. Our fmdings complement those found in the evaluation of the Northern 
Territory Specialist Outreach Program.35 Although such services are likely to meet the 
chronic care needs of a minority of clients, there are delivery systems benefits beyond 
making services more permeable and navigable. On-site services foster sound 
collaborating relationships between AMSs, government and private agencies. They support 
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AMSs to more comprehensively 'hold' clients by better coordinating primary and 
specialist service delivery. The use of adequately supported and trained AHW coordinators 
can impart a strong nurturing component to these services. At a systems level, on-site 
services can enhance professional development opportunities for local staff (e.g. via case 
conferences, journal clubs, and training in technical procedures) and there are clear 
advantages with using local PIRS systems for information management. The federally 
funded Medical Specialist Outreach Assistance Program complements state and territory 
outreach specialist programs in rural and remote communities. Within the COAG NP A, 
increased funding will be provided to expand this program. 36 Our study fmdings support 
this policy decision and, if adequately financed, it has the potential to make an important 
contribution to improving the navigation of specialist care in the bush. 
An important fmding from this study is that whilst the barriers may manifest differently, 
I 
improved access to specialist services is not exclusively an issue of geographical isolation. 
In 2006-7 non-recurrent funding was provided for five brokerage services to make 
specialist access more navigable, particularly in urban settings. 37 One of the Kanyini sites 
is participating in this initiative, but unfortunately has encountered major difficulties with 
poor governance arrangements between the key stakeholders. Some COAG NP A funding 
has been allocated to enhancing specialist access in urban areas, however, there is little 
detail on how this will be implemented. Recommendations from the National Hospitals 
and Health Reform Commission to develop a single funding authority for all Aboriginal 
and Torres Strait Islander health services is another promising initiative to address 
navigational barriers between the primary and specialist care settings.38 Similar to the 
Australian Department of Veteran Affairs model, eligible patients would receive universal 
entitlements to particular services. This would allow the patient to be the arbiter of which 
services to access and care providers would be able to claim benefits from this funding 
authority. Given the substantial restriction in choice of specialist provider and the 
accompanying financial and transport barriers discussed in this study, innovative models 
should be explored. This is needed not only in regional and remote areas, where chronic 
under-supply predominates, but also in urban settings, where access challenges prevail 
despite specialist supply being less of an issue. 
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Although analysis of the KQS data is ongoing, we are making steady progress to 
developing a detailed understanding of the issues affecting health care access and quality 
for Aboriginal and Torres Strait Islander peoples. The critical next step is to assess whether 
these fmdings are pertinent in our interviews with community participants. Analyses of 
individual staff interviews will also provide important corroborating data to determine 
whether our fmdings are consistent. Based on the health systems assessment fmdings, the 
frameworks of kanyini and candidacy are useful theoretical foundations. They hold 
promise in providing important policy relevant insights for enhancing AMS sector capacity 
and may be of value in other health service contexts that provide care for underserved 
populations. With federal and state governments embarking on major health reforms for all 
Australians, large scale qualitative work of this nature can play a key role in determining 
strategies that will lead to better systems of care. 
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Attachment 1: Local Reference Group Terms of Reference 
Mission Statement: 
Kan_yini Va5CUlar Collaboration -
Local Reference Group 
T enn5 of Reference 
The Local Reference Group will guide the research and ensure transparency and accountability in dealing with 
critical issues relevant to their local Aboriginal and Torres Strait Islander community and organisations. 
Ove.rview of the Kanyini Vascular Collaboration: 
The Kanyini Vascular Collaboration is the coming together of a committed group of Indigenous and non-
Indigenous researchers, Aboriginal Medical Services (AMSs), a government primary health care service, 
community members and policy-makers. The research will be conducted Australia-wide across several sites in 
NSW, Qld and Central Australia. 
The two main co-ordinating bodies are The George Institute for International Health in Sydney and the Baker 
Heart Research Institute in Alice Springs. 
This program will help us know why Aboriginal people are missing out on best practice care and help us to work 
out how to keep people healthy. Our goal is to improve health outcomes for Aboriginal people at risk of vascular 
disease (especially heart and kidney disease and diabetes). We want to: 
• Understand health system and health service barriers; 
• Develop, implement and evaluate appropriate models of care; and 
• Engage Aboriginal and Torres Strait Islander communities and policy makers. 
The research program is comprised of four separate yet inter-related projects; 
i. the Kanyini Audit Study, 
ii. the Kanyini Interview Study, 
iii. the Kanyini Documentary project, 
iv. the Kanyini Polypill Study. 
A representative from the George Institute will provide further information about each of the component studies. 
Time frame: 
• The Kanyini Vascular Collaboration commenced in August 2006 and is approximately 5 years duration 
• Once established the Local Reference Group will guide the research program to completion of the 
program. 
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Role of the Local Reference Group: 
The role of the Local Reference Group is as follows: 
i To eosure that Indigenous community p~ves are asserted in the overall govemaoce of the program. 
ii To cn$arc that local and external. reseaich staff are condw:ting the Kanyini studies in a professional and 
competent manner that·scrves the interests of the community 
iii. To determine the best ways to conduct communitr consultatiC)ll and fccdbaclc processes 
iv. To provide advice as needed on the Kanyini component studies 
Examples of this include: 
1. Reviewing processes for conducting interviews 
2. Speci.fic advice on the appropriateness of illlervicw questions 
3. ldentifying apprppriatc members of the community for particil'iltion in the Kanyini studies 
4. Strategies for involving the local community U1 the ~yini clinical intcrv=ion studies. 
Fl1rthcr dctaib will be-given in advance relating to specific • required 
Members of the Local RefeRuce Group: 
These will be comprised ot Aboriginal and torres Strait Islander members across the following: 
• Indigenous Research Fellow (IRF) -Chair 
• Aboriginal and Toctes Strait Islander representatives from goV'emmc:nt and DOil·govemme:nt sector~ 
• RepresentativeS frOm ACCHS. and/or IndigenQus spccifi.c primacy care services 
• Hcalths~att~ 
There w.ill be c:Oosistent rcprcscotati6n by the established memb~ listed in Attachment 1 (a proxy ~ 
may be nominated by the eStablished member to attend a meeting if required). 
Meetmes: 
The LR.G will meet 4 tinlts a year. The key aspects of these meetings are the following: 
• Cllair: The DJ.CCtin8' will be chaired by the Indigenous Research Fellow. Meetings ahould not proceed 
withoot the Chair. 
• Atteaduc:e: Meetings will only proceed if there IU'C. •••• membc:n present (half+ 1). A representative 
from The George I~e is expected to attend these .meeting.c; qnless otherwise requested by the Chair. 
• Location: Meeting$ will be at a location and date agreed upon by tho group. The Chair will nptify 
members of this and cltculatc an agenda in advance. 
• Danttioo: Approx 1- 1 ¥..· bottrs 
• Mimltcs will be taken by ail ~tal>lished member of the LRG 
lteimbunement 1br time: 
Sitting: fees will be negotiated with members and the Georg(: lnst,itUtc represc:ll1ativc at the fust meeting of the. 
Local Reference Group. This will 't!e documented in the Terms of Reference for each l-ocal RefcrcDCC Group. 
Members: 
Name Organisation Position Title 
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Attachment 2.1: Kanyini Health Systems Assessment Form 
Lliifii_iliiJililltlii 
population: Total Number Indigenous: 
Estimated number regular dients: GPs: Number Indigenous: 
RNs: Number Indigenous: 
Estimated number visitors/ irregular dients: Allied Health staff: Number Indigenous: 
MaleAHNs: 
Total budget: FemaleAHN: 
% budget aUocated for chronic disease: 
Indigenous governing board: 
Indigenous manager: 
Orientation to community provided to new staff: 
Client transport services available: 
[:s;!J~,.~ ~!-~~_~::.~:;:·;_ .-:-_::--!-1··:~--:I:'"~~ .. :~:-'::· - i 
Cultural awareness programs available y N 
Cultural leave provided y N 
Use /support of Ngangkari/ traditional healing y N 
Funded Ngangkari/ traditional healing services y N 
Availability cl separate male and female spaces y N 
ic~ .. F ;.;;. '· ~~.:~};;:.:,:. .. ·, ."'.:·;,~-~<.~,. . •. : ~ -<· _ .... .-. • ..... - ,,} 
Routine Quality Improvement activities conducted Y N 
Dedicated Quality Improvement staff y N 
Chronic disease coordinator y N 
Clinical service orientation y N 
Prclessional development support y N 
Guidelines for chronic disease management y N 
Guideline training provided to staff y N 
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Outreach clinics conducted y N Computerised record system y N 
Chronic disease prevention programs y N Automated pathology available y N 
Chronic disease case management y N Routine population data y N 
Onsite pharmacist y N Recall system in place y N 
Access to Section 100 y N Chronic disease register available y N 
Home medicines review available y N 
Adherence monitoring available y N 
!11·-:-·:--·:':" '-":.-::."""···~··. - .·";"1"~ '"": • .. ~.'IUili:if&i--~ ;l"~":;;·J:Stz.'~"i·:Zi1 JtJ..:..._--~~-~~~--'--:0... I . - . . - - - . .--?:" - .... ~..;~) 
Hospital liaison staff available Y N 
Care planning includes hospital staff Y N 
Quality of communication: Admission notification 
Outpatient departmenV Specialist 
Discharge notification 
Consistency in management between hospital and health service: 
0 (score 1-10) 
0 (score 1-10) 
D (score 1-10) 
D (score 1-10) 
::;;:~=::::=-~~,;;~~~~,;,;~=:!:'""""e'!· ·!!!!:·~~· ·Jr....f~~~~::~_ .. i · ;~:;r~r::_7~..-:-~~ 
~!r:sfiQloav ~~~~ 
Cardiologist available y N 
AMS clinics y N How often? 
Hospital outpatient clinics y N How often? 
Cardiac rehabilitation services available y N locaiO regional 0 distant 0 
Echocardiography service available y N locaiO regional D distant 0 
Stress tests available y N locaiO regional 0 distant 0 
Angiography services available y N locaiO regional 0 distant 0 
~engl Services 
Nephrologist available y N 
AMS clinics y N How often? 
Hospital outpatient clinics y N How often? 
Dialysis services available y N 1oca1 D regional 0 distant 0 
Transplant services available y N locaiO regional D distant 0 
Qlabe!H ~rvlcg based !! the AM~ 
Physician y N How often? 
Ophthalmology y N How often? 
Podiatry y N How often? 
Dietician y N How often? 
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Attachment 2.2: Kanyini Systems Assessment Tool- Facilitators Guide 
ACCBS code 
Aboriginal Community Controlled Health Service (ACCHS) identifier, unique number allocated to each ACCHS 
involved in the research project. Numerical4 digit identifier 
Date of Interview 
Record date Systems Assessment interview conducted. [DDIMMIYY] 
Interviewer 
Record the initials of the individual conducting the Systems Assessment interview. 
Focus group members 
Record the initials of each individual participating in the Systems Assessment interview . 
..sen~ce _._ --"' ..... _ ............... ......-
Estimated service population 
Record the total number of clients registered as attendees to the health service. 
Estimated number of regular clients 
Record the number of regular clients attending the health service (who routinely receive PHC at the health 
service). 
Estimated number of visitors/ irregular clients 
Record the number of visiting clients that attend the health service (A visitor is someone who does not live within 
the catchment area, but that has previously attended the health service). 
Total operating budget 
Record the total operating budget of the health service. NB: Answering this question is optional 
Proportion for CD 
Record the proportion of the budget that is specifically identified for the delivery of chronic disease care or 
programs. NB: Answering this question is optional 
Total staff 
Record the total number of staff employed by the health service (including clinical, administration, and ancillary 
stafi) 
General Practitioners 
Record the number of GPs currently employed within the health service. Record the number of GPs who are 
indigenous. 
Registered N urse.s 
Record the number ofRNs currently employed within the health service. Record the number ofRNs who are 
indigenous. 
Male Aborigin.al Health Workers 
Record the number of male AHWs currently employed within the health service. 
Female Aboriginal Health Workers 
Record the number offemale AHWs currently employed within the health service. 
Allied Health staff 
Record the number of Allied Health persons currently employed. List each Allied Health position(s). 
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Indigenous governing board 
Is the ACCHS governed by a completely or majority indigenous governing board? 
Indigenous manager 
Is the Manager (or 'CEO', 'Administrator', ' Director' etc) of the health service indigenous? 
Community orientation 
Does the health service provide an orientation to the community for staff on commencement? What form does this 
orientation take? 
Client transport service 
Does the health service provide a transport service to its clients to anend the health service and/or other 
services/regional hospital? [Can you descnbe what transport is provided for?] 
·caltaral..eo 
Cultural Awareness Promm 
Do health service staff undertake cultural awareness training programs when commencing work at the service? 
Cultural leave provision 
Does the health service have provision for indigenous staff to take cultural leave for funerals etc.? 
Use/support ofNgangkari/ tnnditonal healing 
Does the health service use and support the use ofNgangkarifTraditional Healers? 
Funded Ngangkari/ traditional healing services 
Are Ngangkari!Traditional Healers paid by the health service for consultations? 
Separate Men's and Women's space 
Does the health service have designated women's! men' s areas within the service? 
Qpalltx.ofcare- -- --
Routine quality improvement activities conducted 
Does the health service have a systematic Quality Improvement (QO process in place? Can you describe the Ql 
initiatives that are in place? 
Dedic:.ated quality improvement staff 
Does the health service have an identified position responsible for developing, maintaining and coordinating 
Quality Improvement processes within the health service? 
Chronic: disease coordinator 
Does the health service have an identified position responsible for coordinating chronic disease care? What are the 
responsibilities of this position? 
Clinical service orientation 
Does the health service have a formal clinical orientation programme for new clinical staff on commencement of 
employment? Can you descnbe what this programme consists of! 
Professional development support 
Does the health service encourage and provide support for staff to attend PD activities? 
Does the health service have a formal Professional Development programme for staff? Can you descnbe what this 
programme consists of! 
Guidelines for chronic: disease management 
Does the health service have accessible, user friendly guidelines available and encouraged/mandated for use by aU 
practitioners with respect to the identification and management of chronic disease? (E.g. CARP A, NHF A, CARl, 
NHMRC]. 
2 15 
GuideUne training provided to staff 
Does the health service provide training to staff, in the use of these guidelines? Can you describe what the training 
consists or? 
Mo4111 C!f.site 
Outreach cUnics 
Does the health service provide outreach primary care services? Can you descnbe these services? 
Chronic disease case management 
Does the health service use a case management model for clients with an identified CD? Can you descnbe the 
model used? 
Case management refers to planning, coordinating. managing and reviewing the care of an individual patient. This 
may involve, assigning each person a 'case manager' who is responsible for assessing patients' needs; developing 
a care plan, arranging suitable care; monitoring the quality of care; and maintaining contact with the patient and 
their family. 
Chronic disease prevention programmes 
Does the health service have any chronic disease prevention initiatives in place? Can you descnbe the initiatives 
that are in place? 
Oosite Pharmacist 
Is there an onsite pharmacist? 
Access to Section 100 
Does the health service have access to Section 100 arrangements for the supply of pharmaceutical goods? 
Home medicines review process 
Is there a process in place for conducting Home Medication Reviews and claiming the available Medicare rebate? 
Monitoring adherence 
Is there a process for monitoring adherence? Descnbe 
Computerised record system 
Is there a computerised Patient Information and Recall System (PIRS) in use? 
Automated pathology 
Is there an automated system for receiving pathology results? 
Routine population data 
Is there a formalised mechanism for providing regular population health data to the community and health service 
staff? 
Recall system 
Is there a client recall system in place that supports the delivery of or 'recalls' individuals to receive scheduled 
services? 
Chronic disease register 
Is there a register of all clients with chronic disease? 
Hospital Liaison 
Record if the health service employs a hospital liaison officer. 
Care planning includes hospital staff 
Record if hospital staff are included in the development of Team Care Arrangements [EPC 723 or equivalent). 
Communication. Accessibility and Consistency of Hospital Based Services. 
The following questions seek to build consensus among focus group participants, by considering the usual process 
and barriers to care and ease of communication between primary care staff and hospital staff when arranging [or 
216 
attempting to ammge] admission, refctra1, assessmt!lt an.d management by specialists withiu hospitals. ~md tm 
occurs.following a patients' discharge from hospital. 
AdmiSsion; 1 2 3. 4 s· 
Describe the Extremely Signiflcant Acccs~to Ad,missiOn and Well 
ease of 
'communicating difficult to barriers to admission iS conununication developed 
communicate admission~ Ofu:b., butnot isgood,but systam and/or 
with and 
andan'ange always, occasiottal relationships 
·acccssfuiley of 
admission difficult difiicull;ies exist that ease hospital semces 
adtnUision 
when attempting 
to arrange the 
a.dmis$iOn of a 
patient to 
hospital for 
assessment or 
I managcm.cnt? I 
" I OPD/Spedallst; 1 2 3 4 s 
How would you Extremely Significant A<:cess to OPD Arranging OPD wen descrihe the difficult to baniers to eppointtnents appointments is de\rcloped ease of 
arrangeOPD OPD is fair with eaSy with good s~that communicating appo~ents aPpo'ii$n~ts reasonable; ~~on,.. ensure 
wi'th.and 
accessibility of with little or no & copununictatiqn ~ QCCaSi~ appofnttnents/ 
communication communicating difficulties exis.t con:un.upicatlon hospital 
afterwards outcOllles ¢Xist of results outpaticht Qr 
specialist 
services?' 
~e: 1 2 3 4 s. 
How wotJ,ld you ThePHC Significant Discharge Comntu.niecition Well describe the 
tlowof service is bmic:rs to Slltiil'Jl3.ries. at the time of developed 
infonnatiat\ rarely or never ~g eareplansand discharge is system$ and/or 
contacted by between results are gQOd. but relationships patient results ho ita1 staff hospital staff often, but not occasional that ensure the and care ~ 
requiremellt$ prior to and PHCexist always difficulties exist flow of discharge and con:uuunieated information following a discharge toPHC staff following hospital 
summaries patient 
admission? (al'ely are discharge. 
forwarded. 
· Consiste.nq in 1 2 3 4 ·S 
IIUutagement Minimal or no Carep~and Consistency is Consistew::y is The care of between 
consistency discbaige fair With go~ but patients with hospital mt4 
medications modifications occasional CD is PHC:Towhat 
are frequently ma4e S<Jil1,e of modifi.cati~ns consistent degree are 
changed to fit the time. must be made between mana~ with local EB Hospital and practices, guidelines PHC 
medications and 
follow-up 
similar{Je.tween 
hospital at,Jd 
PHC services 
with relation to 
CD care? 
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II.ISecYtca J 
Cardiologist services 
Does a cardiologist visit the heaLth service to provide clinical care? If so, how often? 
Is there a cardiologist at the hospital accessed by health service clients or referred to by the health service? 
Cardiac Rehabilitation services 
Do heaLth services clients have access to cardiac rehabilitation services or programmes? If so, are they run by the 
health service or external agencies/providers? 
Ecbocardiograpby service 
Are echocardiography services available for health service clients? [Local, Regional, Distant Tertiary Referral]. 
If so, are there any difficulties for clients accessing them? 
Stress tests available 
Are Exercise Stress Testing services available for health service cLients? [Local, Regional, Distant Tertiary 
Referral). 
If so, are there any di.fliculties for cLients accessing them? 
Angiography services 
Are angiography services available for health service clients? [Local, Regional, Distant Tertiary Referral]. 
If so, are there any difficulties for clients accessing them? 
Renal services 
Does a Nephrologist visit the health service to provide clinical care? If so, how often? 
Is there a nephrologist at the hospital accessed by health service clients or referred to by the health service? 
Dialysis 
Are renal dialysis services available for health service cLients? [Local, Regiona~ Distant Tertiary Referral). 
If so, are there any difficulties for clients accessing them? 
Transplant 
Are kidney transplant services available for health service clients? [Local, Regional, Distant Tertiary Referral] . 
If so, are there any difficulties for clients accessing them? 
Diabetes services at the AMS 
Does a physician visit the health service to provide clinical care? If so, bow often? 
Ophthalmologist 
Does an ophthalmologist visit the health service to provide clinical care? If so, bow often? 
Podiatry 
Does a podiatrist visit the health service? If so, bow often? 
Dietician 
Does a dietician visit the health service? If so, bow often? 
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Attachment 3: Sample Kanyini Audit Study Feedback Report 
-~------~-- --·--- --
Kan!:fini Audit Stud!:'- XYZ Health Service feedback Report 
XYZ t:IS:IIlb kods;~ National 
Records audited 200 Records audited 
Mean age 42.9 Mean age 
%Male 43.5% %Male 
%Female 56.5% %Female 
·~ r---------------------------------------------, 
' 
- 1 • I 
-·--
·~ 1---------------~' :,-::..,~ I -
.... 
... 
... 
.. -1- .1 ~ ./ r 
Jo.r e>~· ~r " •"' ~ /.:s .... .I' 
•• ...-~' 
/ er.r .,/ 
/ I' 
1165 
41.1 
40.5% 
59.5% 
Comment: 
These spedfic 
recorded 
conditions were 
looked for in this 
audit. The 
results do not 
reflect all 
recorded 
conditions found 
in the case 
record 
Smokina status Bodv Mass Index 
~r----------------------------------, ~ r----------------------------------, 
- 1 • I 
- 1--------, 
-
·-
1:::- · 
... 
•,!."::-' I I I u. 
-
... -:.\' ... c tl ._..M ,_., ,.._,.. ,.., e _ _... ~"-
-· 
Albuminuria Chronic Kidney Disease 
QreMc ,..,_., DIM• .. 
(O•ta A• ... W.: ............... XYZ Meeta .. ,... II•Ut) 
-
(Oolo ___ liYZ __ _ 
I;.."':.:. .. -. II ~------!:;;... I 
... 
-· 
~~":.a~r' 
-~-.:, ... 
-
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XYZ Health National 
(n=39) 
~-
(n=1165} 
Risk factor recorded Ofo Ofo 
--BIQ9d Pressure 98.5% 90.2 
91.5% 78.9 
Smok!n9 status 80..,_0% • 71,_i_ 
Uplds 67.0% 58.9 
eGFR 65.5% 57.4 
--
Body Mass Index (BMI) 59% 55.7 
Albumin Creatine Ratio (ACR) ~.0% 2 9.0 
ACR and eGFR for at lisk CKD* 32.5% 31.8 
* n=151 for XYZ, n=851 for National 
-
-
-
- 1:::-s.-.1 ' 
-
-
-
... 
.......,.. .. *X>ft ....... ~ l)lo ......... f ............ ow ..... ., •• 
SOI!Io 
·~ 
401!1o 
J~ 
JOI!Io 
f 2~ 
201!1o 
1~ 
10'!1o 
5~ 
0'11. 
........ .... 
urder 10'11. 10.14'11. 1~ or ~r•c.r P~"'o..,. CVO )Uuflldtntdota Ill 
·- ('llo diDtal AM!'e >30.,n Otl) 
I::::-s--. 1 
*Suffident data were only available for 82 of 154 people in the sample aged over 30 
years old and therefore results should be interpreted with caution 
I 
Comment: 
People at risk of 
Chronic Kidney 
Disease (CKD)' 
is based on 
Kidney Health 
Australia 
guidelines and 
indudes any one 
of the following: 
. 
. 
Age>SO 
years 
BP >140/90 
mmHg 
Diabetes 
Current 
smoker 
BMI?!::.30 
kg!ml 
Comment: 
Only 36 of 55 
people with 
diabetes had 
suffident data 
to record 
albuminuria 
Comment: 
cardiovascular 
risk is calculated 
using the 
Framingham 
based New 
Zealand 
Cardiovascular 
Guidelines. This 
lndudesa 5% 
addition to the 
risk calculation 
for Indigenous 
populations. 
The risk 
assessment 
algorithm Is not 
validated for 
under 30 year 
olds 
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~ r--------------------------------, 
1-
.. -i: 
-
~------------~'P-7--- 1 
·-
1::;-- = I 
== 
..... ...... ............. 
. __. ....... ._......_ .... 
-
Comment: 
Ufestyle assessment was recorded as present If there 
was any evidence in the clinical record of discussion 
with the client about smoking, nutrition, physical 
activity or alcohol in the past 2 years 
EPC Me die•• le meXYZ Health Service 
(For Item 710n=156, 704n=«. 72ffl5 n=66} Comment: 
·~ ~-r--~--~~~----~--r---~--~----~~~---r--~- EPC Items were 
recorded as 
complete If there 
was evidence In 
the record of a 
complete 
assessment 
and/or evidence of 
billing for that 
item. If there was 
evidence of an 
unclaimed or 
partially filled 
assessment it was 
recorded as 
Incomplete. 
-
-
10'11. 
-
-
-
lOOio 
-la.o. 
3 
ActA HMti'l OldJirC*'ION' ~(I) I;P'fNI'Iii9IIIT'.. A.,.., ol•Gt Tum(We 
O.Ck710 chocl<104 ._....., p~onru p~onm A-125 
EPC Medlc:•eltems· National 
(For rtem 710 n-940. 704 n<US, 721·725 n•322) 
100, ~~--~-----r---r-----r---r-----r--~----~--~----~--,--, 
~ 
·~ 
7~ 
6~ 
5~ 
4011. 
J~ 
2~ 
l O'llo 
0' 
Aclllt Haith Odor - s' Oo<umortod CD GP m11nagement Revltw d a GP T•m Care 
Chedt 710 check 704 care pion pion 721 pion 723 Mangement 
725 
221 
Total Sample Clients with 
Diabetes* 
XYZ National >rfZ National 
""'200 n=1165 n=SS n=249 
Medications % % % % 
Blo&i ~ressure lowering - - -30% 28 
-
66% 76 
-
Cholesterol lowering 27% 22 69% 64 
- -Antiplatelet medication 18% 21 
-
44% 62 
-
BP + Statln + Antiplatelet 11% 14 29% 42 
Blood pressure management- prescribing patterns 
Clients with CVD* 
>rfZ 
i n=27 
% 
82% 
74% 
63% 
44% 
National 
n=101 
% 
~1 
77 
-74 
58 
Comment: 
Treatment 
thresholds were 
based on the 
average of the 
two most recent 
systolic blood 
pressure 
recorded values 
Treatment 
Indications and 
target values 
were measured 
against the 
National Heart 
Foundation 
guidelines 
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lipid management- prescribing patterns 
.,. ..... _ .. "__ 
• a...oaGVD•.,yllvot 
• ToiiiiCh>ll.,_.&m-d 
• ToiiiiCh>llllo-5.5814 .0.<1.0 
"froallllont llrgot.l,.,..,.~ 
or_,_.._ 
Comment: 
Treatment 
thresholds were 
based on the 
most recent 
cholesterol 
results. 
Treatment 
Indications and 
target values 
were measured 
against the 2007 
Pharmaceutical 
Benefits Scheme 
Indications for 
Aboriginal and 
Torres Strait 
Islander people . 
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Attachment 4.1: Community interview guide and suggested probes sample 
KanylnfQualltallv8 study Interview Guide- Community Partlc:IPints 
IOM: 
1. What does 'being well' or 'being healthy' mean to you? 
2. Do you think of yourself as a well/healthy person? 
3. What do you do to stay well/healthy? 
Possible Prompts: 
Are there any things you do that you think help you stay healthy? 
What help do you get to stay well? 
Where do you get help from? 
4. Can you tell me about the last time that you felt unwell? 
Possible Prompts: 
• What happened? 
Were you unwell enough that you needed to get help from family, community, clinic, hospital? 
5. When you have been unwell, have people looked after you properly? 
Possible prompts around Family-community based 'proper care' context: 
What does it mean to you, to be looked after 'properly' when you are unwell? 
Have family ever cared for you when you were unwell? What kinds of things did they do to look 
after you? 
How do you want to be looked after, when you are unwell? What do you need? 
Possible prompts around Clinical 'proper care' context: 
• What sorts of things make a nurse a 'good' nurse? 
• What do you think makes a 'good' doctor? 
When you are unwell and at the clinic, what should happen for you to feel properly looked after? 
If you're unwell in the hospital, what should staff do to look after you properly? 
Are there some places where you've felt properly cared for/looked after each time you go there? 
Why did you feel properly looked after In those places? 
Are there some places where you've gone to get help/ care when you've been unwell, but people 
have not looked after you properly? What happened there? 
6. What makes It easier for you to get care when you are unwell? 
Possible prompts: 
When you have been unwell, what things have made It easier for you to get the care that you need to 
get better? 
• What makes getting the care you need at (AMS, community clinic) easier for people? 
What things make It easier for you and your family to get looked after properly In hospital? 
7. Can you tell me about any problems you've had trying to get care when you've been unwell? 
Possible prompts: 
What things can make It hard for you to get care/get looked after properly when you are unwell? 
• What things make getting the care you need at (AMS, community clinic) hard sometimes? 
What things make gettlng care at the hospital hard for you and your family? 
8. Do you know someone In your community or family who has an Illness like diabetes, heart 
disease or kidney disease? 
Possible Prompts: 
Can you tell me their story about having an illness like (diabetes, heart disease or kidney disease)? 
What things happened to them when they started to get unwell? 
Where did they go for help? Why go there? [talk to someone in family, go to community dinlc/AMS, go 
to hospital ... ] 
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• Cid they get looked aft:er properly at these places? 
• How has having this Illness affected them or-changed their life? How has It changed their family'$ Uves? 
• Even thoUgh this person has (OM, OiD, CK[)), do··tt\ey seem healthy to you ? Why/why no.t? 
• Do peo~le In your COfT)munJty· 9r ~rriliY .talk abou~ geJ;tjng unwel! fwlth OM, CHO, CKD )? Do, they share 
the!~ (gOod and bad) ~ries about. pettfog..c;are wt'ien tHey are unw~ll? . 
• OQ .they talk about how to adapt to or manage having an Illness like (OM, CHO, Cl.<0)1 What things do 
they say help them.stay healthy? · 
• Does thinking about other people$' $tnries of getting unwell like tbls make you want to change 
anything In your II~? 
9. Do you have an Ulness l.ike diabetes, heart disease, or kidney disease? 
lu 'NO' to this question try these probes/prompts and then GO TO QUESTION 12 
• How do you know you don't have theSe. klnds·of Illness? 
• Do you think that Y9U might get d~betes, heart disease, or kidney disease one day? Why/Why not? 
• Co you think there are some things that people do 'ln their everyday lives that can affect their 
health? What are some <Jf these things do you think? 
• What kinds of things might hefp someone to avoid/Stop them from getting Illnesses like these? 
( If 'YES' to this question GO TO QUESTION 10 •11 
10. What happened when'you found out you w~re unwell with {diabetes, heart or kidney 
disease)? 
Possible prompts: 
• Wbat did you do whEm you when you found out you were unwell with (diabetes, heart or kidney 
disease)? r 
• How were- you feeling when you fir.st got unwell with (diabetes, orCfiD, or 0<0)7 
• Were there some slgns/feellngs ·that made you reallze that you were unwell? What were·they? [Insert 
a/sea~pedfic symptoms as promp.ts If requfred] 
• What happened next? Old. you tal~ to someone? Wh~t did they say? 
• Did you go some place to get help for this Ulrless? Where did YO\J go? [~IJ!ily, Ngangkari, CQmmunity 
AMS/dink,. h(}Splt:al.,.] 
• Why go ta this person/this place for help? 
• What dld they do to help you? Old you get tM help/care that you needed from there? 
• Did people l;leiP. you unde~tan~. ab.out.thls Illness? How did they do thjs? 
• Old pep'ple help you to manage this Ulness cmd tea'c:tl. you how to ,look' after yourself? 
11. How has having this JUoess chanved your life1 
Possible Protnp.ts: 
• How has it affected you? 
• Do you feel unwell having thts disease? Why/Why not? 
• How ha9 lt affected your family? 
• Did you have a JQb before you got unwell? Were you able to keep working after ge~ng u~~ll? 
• Have tflere,fleel'\ cMrtge5 to, your life' no.w because you are unvielllike [more dink visits, need more 
medicines/treatments, ne«J'new/moie tests to be done, iJeed to travel to ap{ioln~nts In town, see· 
otherdoctr>rs, Soinetlmes feel so unwell you need to go:to·bospltai ... J · 
• Are tfiesetl\iri9sh.ard t9 se' or'hard tO do fo'r you and 'Your·famJiy? 
• Do ~~ !'I~ famUy to help you manage .your illqess? [getting the mediCines that you need,. ge_tt~ng 
the foUow~p ca~ getting to appo1nt:ments. •• ] 
12. How an things be made better for V<MJ at1d your family to get the care you need when you 
are unwell 
Possible prompts! 
• How carfthlngs be made better at yoor (AMS, community dlnlc)? 
• How can ti)lngs be maae !letter In hospitals for you and'your family when they get unwell? 
• If you could change ~nyt,hlng l.n the h~lth service what would I~ be? 
• [E.g. better follow•up care for ~pi~ when they. first get sick, more help with management 8nd SI.I.P'PI)I 
of medicines, access to practical "and feaflstfc ·tJfetary advice~. Ask specific qu~ons If they have 
diabetes, heart disease, kidney disease?] 
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Attachment 4.2: Record of interview form for community participants 
What is your age? 
What is your postcode? 
Gender Male U 
Female 0 
Ethnicity 
(tick as many as apply to you) 
Aboriginal bJ 
Torres Strait Islander 0 
Both Aboriginal and Torres Strait Islander 0 
Other (please specify): 
What languagc(s) do you speak at home? 
Where are you currently living? Own home/ flat D 
A home/flat owned by family 0 
A rented home/flat 0 
A friend' s house/flat 0 
A hosteV other temporary accommodation 0 
Other (please specify): 0 
What is your current relationship status? Married t:::J 
I 
Divorced/ Separated 0 I 
Widowed 0 
De facto/long term partner 0 
Single 0 
Other relationship (please specify): 0 
What is your highest level of school education? 
(Year 1 to Year 12) 
What is your employment status? Full-time work U 
(tick as many as apply) Part-time/ Casual work 0 
Full or part-time study 0 
Unpaid/ Volunteer work 0 
Unemployed 0 
Other (please specify): 
Do you have regular access to the following: Yes No 
Phone 0 0 
Car 0 0 
Computer 0 0 
Internet 0 0 
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Attachment 5.1: Health professional interview guide and suggested probes 
sample 
Kanylnl QualltalfVe·Study Interview Guide- Health· Pr8ctillot18t 
Introductions •••••• 
1. What is your role/job In this Health Service? 
2. What do you think influences Aboriginal peoples' decisions to seek care from your 
Health Service? 
Probe 
• What issues do you think infiuence how Aboriginal people engage with care from your HS? 
• What things about your Health Service encourage engagement? 
3. What challenges do Aboriginal people have to overcome to get care from your HS? 
4. What does 'caring well' for your patients involve? 
Probes 
• What do you need to do in your job to feel that you've cared for someone well/properly? 
• can you tell me about a 'good' experience you 've had of caring for an Aboriginal patient 
with chronic disease? 
• can you tell me about an experience that was 'bad' or unsuccessful in your view? 
• What makes a 'good' doctor/a 'good' nurse/ a good team? 
• Do your Aboriginal patients sometimes have needs that you can't provide? 
• Do you see any difference between these kinds of issues and those that affect non-
Aboriginal patients? 
5. What is your experience of the role of family in caring for Aboriginal people? 
Probes 
• What is the role of family In caring for an Aboriginal person who becomes Ill with a chronic 
disease (diabetes, heart or kidney disease)? 
• Does the health service you're working in include the families of Aboriginal patients? How do 
they do this? 
6. Are you aware of any other types of care that your Aboriginal patients may have 
sought before they come to this HS for care? 
Probes 
• Have your patients accessed care such as: Ngangkari, Jay person, AHW living in their 
community, family? 
• What kind of care is provided In these settings? 
7. During your time working in Aboriginal health have you changed your practice in 
anyway? 
Probes 
• Have you changed anything about the way you approach your job, to better meet the needs 
of your Aboriginal patients? If so, what sorts of things 
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8. What is needed to provide better care for ~rigfnal people with chronic disease? 
Probes 
• It we were able to redesign this Health Servtce to make it able to care well for people with 
chronic disease - what would it look like? 
• Wll,at would you change about your Health service lf you- ·could? 
• Are there f~ctors outside yo1,1r contrQI/your health service that impact upon care for your 
patients? 
• What do you need from 'the system' in order to look after Aboriginal people with chronic 
disease properly? ·- - - -
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Attachment 5.2: Record of interview form for health professional participants 
-~~,t;;:;<o~j~~if~iiii:'s ~;· ·• ·-r~~:·;;~~.:~r·.,o,:: :•·•~•·  • ~-·,~-·;~ 
• : . > .. • ·<"' · · ~~~~~"::} c·'r->11 ··0·r,-.•,.,:.::.'ii.)'.HA.<~4'.f,!:j~q rc""·'~+.''~- .• ,··:,:x·~....,.}~ 
• - ' _ .. ~~·!"6~~~--~~.;.'·t.~~~~~~~if~~:~i--~~-:c:;..::i::_;:·~::::ti~ 
PI the foU 
-----··- ------ · --e· 
What is your age? 
Gender Female B Male 
Ethnicity Aboriginal LJ 
(tick as many as apply to you) Torres Strait Islander [J 
Both Aboriginal & Torres Strait Islander lJ 
Other (please 1q>ttify): 
What language(s) do you speak at home? 
Were you born in Australia? Yes !d 
No 0 
If you were born overseas please specify your Country of birth: 
counlry of birth and the year you arrived in 
Australia. Year first arrived: 
What is your job title? 
(If you have more than one job please include 
the one where you are most involved in working 
with Aboriginal/ Torres Strait Islander people) 
How long have you been working in this 
position? 
How long have you been involved in working 
with Indigenous communities? (either in 
Australia or overseas) 
What is your highest level of school education? 
(Year 1 to Year 12) 
Do you have any post-school qualillcations? Yes ~ No 
lfyou ticked ·yes' please list your qualifications. Qualifications Year 
(Tick as many as apply. Please also write the year TAFEl VET or equivalent certificates u 
you obtained the most recent qualification in 
each category) Diplomas D 
Bachelor degrees u 
Post~te Certificates/ Diplomas u 
Masters Degree/PhD p 
Other qualillcations ( eg Nurses boards, RACGP) 
Do you have membership with any professional Yes u 
organisations or elected committees? (eg. No 0 CAT SIN, CRANA, Nursing Union/ RCNA. 
AIDA. GP/Spccialist colleges, Public Health If yes please list the organisations you belong to: 
Association, AMA) 
-------
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Attachment 6.1: Sample study information sheet for community participants 
What Is the Kanyfni Interview study? 
The study is about talking with Aboriginal patients living with heart disease, 
kidney disease and diabetes. We would like to understand your stories of using 
health services, both in the community and hospital and to hear what you have to 
say about the difficulties in getting the care you need. We will also talk separately 
to health centre staff and other people working in Aboriginal health. 
The Kanyini Interview study is part of a larger program which is looking at why 
Aboriginal people are missing out on the best care and to help us to work out 
how to keep people healthy. There are four studies in the program which will help 
us to develop information to overcome these barriers so that you can get the 
better care. 
Why are we doing this stu~ 
Aboriginal people have too much heart disease, diabetes and kidney disease. 
These sicknesses are causing too many deaths across the country. We know 
that there are treatments that work to keep people well, but Aboriginal people are 
less likely to get them. This study will help us to know why this happens and help 
us to work out better ways to keep people healthy. 
How will we do the studt? 
We will be talking to patients, health workers, staff and doctors in several health 
centres across NSW, Qld and the NT. We will come and meet with you at a time 
and place that is best for you. We would like you to feel comfortable so you can 
choose how you would Uke to be interviewed; whether in a small group or one-
orK>ne. We can arrange an interpreter if you like. 
Who are the people doin9_ this research? 
The research will be conducted Australia-wide across several sites in NSW, Qld 
and the NT. Some key people in the research team include: 
What will it mean If you take part In the Kanylnl Qualitative studt? 
A study team member would talk to you about your health and what you think 
about using health services. You may wish to share both positive and negative 
experiences in using health services. If there are any difficult or upsetting 
experiences that you prefer not to talk about we will always respect that. You can 
stop the interview at anytime. If you wish we will also try to get help for you to 
deal with any specific problems you may be having. 
Page I of2 QUAL_PIF _PAH_ V1 .1_5Juty07 
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Heart Research Institute 
Queensland 
Government 
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There are no medical tests or treatments as part of this study. No money will be 
paid to you if you decide to participate in the study. 
What will happen to the information collected? 
We would like to tape your interviews and will provide you with either a paper copy 
or audio copy after the interview. We would like you to listen/read the interview 
transcript and give us feedback on its contents by; 
• Giving your consent that the transcript is a satisfactory representation of 
your views, 
• Making changes to the existing transcript, 
• Asking us for a repeat interview to expand on or change things that you 
said, or 
• Withdrawing your data and consent to participate in the study. 
All information will be kept private. All study information will be securely stored in a 
locked file at the George Institute for International Health in Sydney and only 
accessed by study team members. Nothing written in reports will link you 
personally to the study. 
What benefits can come from this study? 
The study will benefit Aboriginal people with heart disease, kidney disease and 
diabetes or people at risk of getting any of these diseases. The information from 
this study will give a better understanding of the barriers to finding these diseases 
early and help to work out how to keep people healthy. 
We know that patients are often not listened to when it comes to telling their 
stories about trying to get the right health care. This study gives you the chance to 
speak out and let us know what you think. The information you give will help the 
people who plan and organise health services to improve them and give Aboriginal 
people better care. 
Does the study have ethical approval? 
This study has been reviewed and approved by the Princess Alexandra Hospital 
Human Research Ethics Committee. Should you wish to discuss the study with 
someone not directly involved, in particular in relation to matters concerning 
policies, information about the conduct of the study or your rights as a participant. 
or should you wish to make an independent complaint, you can contact the Ethics 
Manager, Princess Alexandra Hospital Human Research Ethics Committee on 
telephone (07) 3240 5856 or email PAH Ethics Research@health.gld.gov.au. 
KANYINI_QUAL PIF _PAH_V1 .1 
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Attachment 6.2: Sample study information sheet for health professional 
participants 
What Is the Kanylni Qualitative study? 
The Kanyini Quafrtative study is a qualitative evaluation of knowledge, 
attitudes, practices and perceived needs of patients, communities, health care 
providers and policy makers with respect to the prevention and management of 
chronic disease. We would like to hear your stories as a health professional 
about systemic barriers to health care for Aboriginal people with cardiovascular 
and chronic kidney diseases (CVO and CKO) and diabetes. 
The Qualitative study is part of a larger program which aims to look at why 
Aboriginal people are missing out on best practice care and to help us to work 
out how to keep people healthy. There are four component studies within the 
collaboration. The first two studies are aimed at identifying barriers to optimal 
chronic disease care and based on the information found in these studies two 
further studies wiU look at trialling interventions to overcome these barriers. 
How will we do the Kanxlnl Qualitative study? 
The Kanyini Qualitative study will be conducted Australia-wide across several 
sites in NSW, Old and the NT. We aim to Interview around 180 patients and 
120 health related staff; health care providers (such as Aboriginal health 
workers, doctors, nurses} and senior health organisation leaders, bureaucrats, 
managers and policy makers from the Aboriginal Community Controlled Health 
Services (ACCHS's), hospital and government sector. 
The interview process is informal and flexible as our main aim is to encourage 
study participants to articulate their experiences and views. The interviews can 
take place in small groups or one-on-one. Please let us know if you have a 
preference. 
Who Is Involved in this research? 
~ V~ TliE CWR(,£ I~' I Il l" rt ,, ,....,_,_.,~.a;. 
2 er 
He3rt Rftsearch lnstrtute 
Queensland 
Government 
The Kanyini Vascular Collaboration is made up of an experienced team of ln<f~genous and 
non-Indigenous health service and clinical researchers, policy-makers, health economists, 
clinicians, and communities. Some key people involved in this study include: 
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What will it mean If you partlcip_ate In this study? 
If you participate in this study you will be interviewed by a study team member who is skilled in 
this type of research. The focus of the interview will depend on your area of expertise. Our aim is 
to hear your experiences and views about the barriers to health services for Aboriginal people. 
What will happen once we've collected your information? 
We would like to tape your interviews and will provide you with either a paper copy or audio copy 
after the interview. We would like you to listen/read the interview transcript and give us feedback 
on its contents by either; 
• Giving your consent that the transcript is a satisfactory representation of your views, 
• Asking for minor changes to be made to the existing transcript, 
• Asking us for a repeat interview to expand on or change things that you said, or 
• Withdrawing your data and consent to participate in the study. 
All information will remain confidential. Study information will be stored in a securely locked file at 
the George Institute for International Health and will be accessed only by study team members. 
Nothing written in reports will link you personally to the study. 
What benefits can come from this study? 
This study seeks to understand the personal perspective of staff working within the Aboriginal 
health sector at a variety of levels. Through this process we hope to provide a better 
understanding of what are the systemic barriers to providing best practice chronic disease care 
for Aboriginal people. We will use this knowledge to develop, implement and evaluate innovative 
best-practice models, developed in partnership with, and specifically for, Aboriginal people. The 
information gained from this study will be regularly fed back and formally integrated into a series 
of policy forums with the view to stimulating productive dialogue on ways forward in chronic 
disease care. 
Does the stu~ have ethical approval? 
This study has been reviewed and approved by the Princess Alexandra Hospital Human 
Research Ethics Committee. Should you wish to discuss the study with someone not 
directly involved, in particular in relation to matters concerning policies, information about 
the conduct of the study or your rights as a participant, or should you wish to make an 
independent complaint, you can contact the Ethics Manager, Princess Alexandra Hospital 
Human Research Ethics Committee on telephone (07) 3240 5856 or email 
PAH Ethics Research@health.qld.qov.au 
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Attachment 6.3: Sample consent form for community participants 
Before you sign this form please be Sti"e that you understand what it means to be part 
of the study. Please read (or have read to you) the Information Sheet Please ask the 
study team member to answer any questions you have. 
It is important to understand: 
• You do not have to take part in this study if you do not wish to. 
• You can stop taking part at any time. 
• You may decide not to take part in the study. This will not affect your 
treatment or health care. 
• Information you give wid be used only for this study. h will be stored in a 
secure place. Only study team members will have access. 
• Your name and details !i!1.nQt be made public. Nothing written in 
reports wil link you personany to the study. 
1. I have a copy of the study information sheet and have had an 
opportunity to ask questions about the study. 
2. I agree to take part in an interview for the study. 
3. Do you agree that the interview be taped? 
4. Do you wish to have an interpreter present at the interview? 
5. Would you fike a (written) copy of your interview? 
6. Do you wish to check the interview as described in the 
information sheet? 
7. Do you agree that some of your words (not your name) be 
used in the study reports? 
8. At the end of the study do you wish our interview record to be 
destroyed? 
9. Do you understand that you have the right to withdraw your 
consent and cease involvement in the study at any time 
without penalty, either financial or personal? 
Participant to complete: 
yes o 
yes o 
yeso 
yes o 
yes o 
yes o 
yes o 
yes o 
yes o 
noo 
no o 
no o 
no o 
no o 
no o 
no o 
no o 
no o 
~ '\.~T rw <:to~t< .i: l'''"lll 
y i 1·-· "-/II.,, 
0 
Biker 
Heart Resenrr:h Insti tute 
Queensland 
Government 
hereby consent to take part in this study. 
§!g_nature: Date: 
Witness to complete: 
hereby consent to take part in this study. 
Signature: Date: 
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Investigator to complete: 
Name: Role in Proiect 
I have explained the nature and purpose of the study to the above participant and have answered 
their questions. 
Signature: Date: 
Ethical Approval: 
This study has been reviewed and approved by the Princess Alexandra Hospital Human 
Research Ethics Committee. Should you wish to discuss the study with someone not directly 
involved, in particular in relation to matters concerning policies. information about the conduct of 
the study or your rights as a participan~ or should you wish to make an independent complaint, 
you can contact the Ethics Manager, Princess Alexandra Hospital Human Research Ethics 
Committee on telephone (07) 3240 5856 or email PAH Ethics Research@health.qld.gov.au. 
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Attachment 6.4: Sample consent form for health professional participants 
Before you sign this form please be sure that you understand what it means to be part 
of the study. Please read (or have read to you) the Information Sheet Please ask the 
study team member to answer any questions you have. 
It Is important to understand: 
• You do not have to take part in this study if you do not wish to. 
• You can stop taking part at any time. 
• You may decide not to take part in the study. 
• Information you give will be used only for this study. It wiD be stored in a secure place. 
Only study team members will have access. 
• Your name and details will not be made public. Nothing written in reports will fink you 
personally to the study. 
1. I have a copy of the study information sheet and have had 
an opportunity to ask questions about the study. 
2. I agree to take part in an interview for the study 
3. Do you agree that the interview be taped? 
4. Would you fike a (written) copy of your interview? 
5. Do you wish to check the interview as descn'bed in the 
information sheet? 
6. Do you agree that some of your words (not your name) be 
used in the study reports? 
7. Do you have any objections to the Interview record being 
kept at the end of the study? 
8. Do you understand that you have the right to withdraw your 
consent and cease involvement in the study at any time 
without penalty. either financial or personal. 
Participant to complete: 
yes o 
yes o 
yes o 
yes o 
yes o 
yes o 
yes o 
yes o 
no o 
no o 
no o 
no o 
no o 
no o 
no o 
no o 
~ V~ THt: GEORGI:: IN~ n ll' l t I'• I.- otk'IM IJ,.!JI, 
2 er 
Heart Research Institut e 
Queensland 
Government 
------- ------Name) hereby consent to take part in this study. 
S)gnature: Date: 
Witness to complete: 
- ------------Name) hereby consent to take part in this study. 
S!9,nature: Date: 
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Investigator to complete: 
Name: Role in Project 
I have explained the nature and purpose of the study to the above 
participant and have answered their questions 
Signature: Date: 
Ethical Approval: 
This study has been reviewed and approved by the Princess Alexandra Hospital Human 
Research Ethics Committee. Should you wish to discuss the study with someone not 
directly involved, in particular in relation to matters concerning policies, information about 
the conduct of the study or your rights as a participant, or should you wish to make an 
independent complaint, you can contact the Ethics Manager, Princess Alexandra 
Hospital Human Research Ethics Committee on telephone {07) 3240 5856 or email 
PAH Ethics Research@health.qld.qov.au 
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Attachment 7: Participant distress protocol sample 
Kan9ini Vascular Collaboration- Qualitative Stud9 
r rO<:e$5 for management of participant distress 
The Kanyini Qualitative study aims to provide an in depth analysis of the journeys that 
patients and their care providers make when dealing with chronic diseases. This study is 
primarily oriented to respectfully and authentically documenting participant reflections 
on these journeys. The welfare of participants is of prime importance in this study and at 
all times takes precedence over data collection. This includes both the welfare of 
individual patients and their health services as organisations. It is vital that this be 
respected in all phases of the study conduct. Whilst for many participants the opportunity 
to voice these stories may be welcomed, interviewers need to be sensitive to any 
potential distress that may arise from such a process. It is recommended that the 
following points are addressed at each interview site to provide an effective and sensitive 
process for interviewers to follow in the event of participants becoming distressed 
~ v n:r.G~<,...( I'NTTllt 
~· ~~ Baker 
Heart R•~"""'" lnUitule 
The Kanyioi Vascular Collaboration (KVq must ensure that these site-specific: 
processes to manage distress are established before any local interviews oc:c:ur. 
Prior to interviews: 
1. At each health service the KVC will work with a Local Reference Group (LRG) comprising key local 
stakeholders, the Indigenous Research Fellow and a designated community advocate (agency or individual). 
2. The KVC and the LRG will work together to develop a site specific procedure for reporting and managing 
participant distress. Together they will: 
Create a ootification of distress form (sec sample attached) 
Identify suitable counselling/ other support services that can be referred to if needed. 
Ensure that these services are willing and have the capacity to provide support. 
Ensure all interview staff are familiar with the local distress management procedure and that due care is 
taken in the conduct of any interviews. 
Review any significant issues of concern that are occurring as a result of this study. 
At the time of the interview: 
As a part of the informed consent process participants will be made aware of their right to withdraw from the 
study at any time. Interviewers will be trained appropriately to be sensitive to any signs of distress that may arise 
during an interview. Prior to commencing the interview each participant will be informed of the nominated 
support person whom they can contact if need be a.fter the interview process. 
In collaboration with the participant they may be required to take any of the following actions: 
1. Breaking off the interview prematurely; 
2. Agreeing to leave the distressing topic; 
3. Referral for additional support to the participant. This may involve: 
a. Arranging a clinical visit with the participant's usual care provider to address the problem or; 
b. Arranging for counselling support. 
c. Other appropriate support mechanisms as determined by the LRG 
Post Interview: 
If referral for additional support is needed then the interviewer will complete a notification form and submit to the 
referral service for review. The referral service will then be responsible for reviewing the case and arranging to 
tallc with the participant. The referral service will provide brief documentation of the actions taken and the referral 
form will be retained in the confidential client record 
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Kan~ini V aacular Collaboration -Qualitative Stud~ 
Reporting of participant distress 
(fo be completed by the interviewer) 
Participant is seeking funber support: 
Name of participant: 
YES NO 
Date of reporting: --------------------
Study site: 
Interviewer: 
Dateofmterview: ----------------------------------------
Name of support person/ service referred to: 
Actions the interviewer bas taken in responding to the distress. 
Name of interviewer: 
Signature: 
Date: 
(fo be completed by the nominated support person/ services) 
Details of follow up action taken by the support person/services: 
~ 
V\ nn C:r<>ltc.F l~tTn.:rt ~>--"-"' 
~ B.aker 
Heal1 Researc-h lnstttute 
Nameofreferralperson: -----------------------------------------------------
Signature: 
Date: 
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Chapter 8: New tools for an old trade -A sociotechnical 
appraisal of how electronic decision support 
is used by primary care practitioners 
Publication details: Peiris D, Usherwood T, Weeramanthri T, Cass A, Patel A, New tools 
for an old trade: a sociotechnical appraisal of how electronic decision support is used by 
primary care practitioners. Sociology of Health and lllness in press, accepted 17/112011 
Author contribution: I designed the study, coordinated ethics submissions, conducted the 
interviews, performed the primary analyses of the fmdings, worked with co-authors 
U sherwood, Weeramanthri and Cass in interpreting the findings and wrote the first and 
subsequent drafts for journal submission. I was the primary author for responding to 
reviewer comments. All co-authors reviewed and commented on journal manuscript drafts. 
8.1 Abstract 
This article explores Austra)-ian general practitioners' (GPs) views on a novel electronic 
decision support (EDS) tool being developed for cardiovascular disease management. We 
use Timmerman and Berg's technology-in-practice approach to examine how technologies 
influence and are influenced by the social networks in which they are placed. In all 21 
general practitioners who piloted the tool were interviewed. The tool occupied an ill-
defmed middle ground in a dialectical relationship between GPs' routine care and factors 
promoting best practice. Drawing on Lipsky's concept of 'street-level bureaucrats', the 
tool's ability to process workloads expeditiously was of greatest appeal to GPs. In doing 
so, the tool has potential to alter the structure, process and content of health-care 
encounters. The credibility ofEDS tools appears to be mediated by fluid notions of best 
practice, based on an expert scrutiny of the evidence, synthesis via authoritative guidelines 
and dissemination through trusted and often informal networks. Balanced against this is the 
importance of 'soft' forms of knowledge such as intuition and timing in everyday decision-
making. This resonates with Aristotle's theory ofphronesis (practical wisdom) and may 
render EDS tools inconsequential if they merely process biomedical data. While EDS tools 
show promise in improving health practitioner performance, the socio-technical 
dimensions of their implementation warrant careful consideration. 
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8.2 Background 
Systematic reviews have shown that electronic decision support (EDS) systems may 
improve practitioner performance in health care (Garg et al. 2005, Kawamoto eta/. 2005, 
Shojania et al. 2009). Despite the rapid proliferation of such systems and their appeal to 
health-systems planners there has been limited sociological inquiry into their impact. This 
is needed because a narrow focus on effectiveness, as gauged by practitioner performance, 
will not assess their influence on other dimensions of health-care quality. Further, the 
demonstration of their efficacy in trial settings is likely to understate many of the real 
world contingencies that will impact on uptake of these technologies. 
Timmermans and Berg (2003) have outlined three contrasting theoretical approaches to 
understanding how medical technologies influence health-care practices: (i) technological 
determinism, in which innovation acts as an instrument of power imposed as part of 'a 
medico-industrial complex' onto doctors and patients who have limited agency in the 
process; (ii) social essentialism, in which social and political realities preferentially select 
particular technologies to suit their purposes and the technologies themselves are blank 
slates absorbing and reflecting these prevailing paradigms; and (iii) technology-in-practice, 
which assumes a dialectical relationship between the technologies and their users. This last 
approach draws on actor-network theory (Latour 2005) and views technologies as one of 
many actors neither devoid of ability to influence nor assuming a 'super agency ' with 
extraordinary power over other actors. 
Marc Berg has written extensively about the ways in which technologies such as decision 
support systems (Berg, 1997b ), patient care information systems (Berg 2001 ), clinical 
protocols (Berg 1997a), guidelines (Berget al. 2000) and even the medical record itself 
(Berg and Harterink, 2004) function as non-human actors in the health-care context. 
Drawing mainly from ethnomethodological studies, this work allows us to appreciate how 
these teclmologies influence the ways in which organisations deliver healthcare and how 
human actors (doctors, nurses, patients and others) respond. By following the interactions 
created by these human and non-human actors we can begin to appreciate their 
sociological effects. Latour (2005: 12) states: 
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you have 'to follow the actors themselves', that is try to catch up with their often wild 
innovations in order to learn from them what the collective existence has become in their 
hands, which methods they have elaborated to make it fit together, which accounts could 
best defme the new associations that they have been forced to establish. 
Health professionals' core business of delivering quality patient care is characterised by 
complex knowledge processes that are not amenable to a simple process of behaviour 
change. While guidelines and protocols have appeal in providing professional transparency 
about decision-making processes, they tend to presuppose medical action as a logical 
sequence of steps toward a perceived, single optimum code of practice (Berg 1997a) . 
Greatbatch et al. 's (2005) ethnographic work shows that rule-based expert systems capture 
only part of what experts do. Health professionals are constantly sidelining rules based on 
their expertise, practicallimitations,andjudgements about their patients' expectations and 
capabilities (Summerskill and Pope, 2002). Berg found that decision support systems were 
frequently modified once implemented, often compromising substantially the original 
'scientific' thought processes that went into their algorithms (Berg 1997b). Appreciation of 
these factors is important in explaining the known limited effectiveness of protocols and 
guidelines (Grimshaw eta/. 2004). 
The role of technologies as non-human actors in the health-care encounter can pose 
epistemological challenges. Alongside traditional doctor-centred and emerging patient-
centred agencies such as shared decision-making, culturally competent care and self-
management, are third party actors with regulatory authority (May eta/. 2006). One such 
actor is the evidence-based medicine (EBM) movement in which predominantly clinical 
trial and population-based evidence has come to define appropriate care. EBM is asserted 
to be the guiding principle by which the profession defines and regulates appropriate 
conduct (Armstrong 2002). The core dilemma faced by EBM is overcoming the challenge 
of applying population-based findings to individual health-care encounters in which doctor 
and patient agencies prevail (May et al. 2006). Hence, new technologies such as point-of-
care decision support are viewed optimistically by health system planners because of their 
potential to narrow 'evidence-practice gaps', bringing epidemiological and clinical trial 
evidence into everyday practice. 
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This convergence of human and non-human actors in the health-care encounter produces a 
symbolic drama (May et al. 2006) whose effects are not well elaborated. In this article we 
draw on the technology-in-practice approach (Timmermans and Berg 2003) to develop an 
understanding of the ways in which EDS tools function as actors in the social context of 
primary care. This forms part of a broader research programme to develop an EDS tool in 
Australian primary care settings, described below. A previously published pilot evaluation 
(Peiris et a/. 2009a), focused on tool design and the modifications needed to allow for its 
routine use by general practitioners. The motivation for this sub-study arose from a 
dedicated part of the interview evaluation in which general practitioners (GPs) were 
encouraged to give a more expansive account of the implications of the future 
implementation of the tool in practice. It was in this part of the interview that important 
data emerged relating to the dialectical relationship between routine care provided by GPs 
and the promotion of best practice,, in particular the role of evidence, guidelines and 
I 
technological tools. In this article we more thoroughly explore this relationship by 
examining the actors and social settings in which EDS tools are placed. 
Development of an Australian EDS tool for cardiovascular disease risk 
management 
EDS systems are relatively underdeveloped in Australian primary care settings. In 2005 
researchers at The George Institute, in partnership with several collaborators, established a 
research programme to develop and implement a suite of EDS tools for use in primary 
health care. A specific objective of this programme is ensuring these tools are suitable for 
use in private general practices and community-governed Aboriginal medical services 
(AMS). The first major project in this programme focuses on CVD. CVD is a collective 
term to include diseases such as coronary heart disease, stroke and peripheral vascular 
diseases. Despite major advances over the last two decades in CVD epidemiology and a 
plethora of clinical trials establishing the efficacy and safety of various therapeutic 
interventions there has been variable translation of this knowledge into practice. Multiple, 
complex guidelines and inadequate resources to implement them at the point of care are 
contributing factors to the low uptake of best practice recommendations in Australia (Peiris 
eta/. 2009b' Webster et al. 2009). To help address this, an EDS tool was developed that 
synthesises recommendations from several Australian guidelines into a single CVD 
management algorithm to provide point-of-care recommendations. 
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8.3 Methods 
In the pilot implementation a stand-alone version of the tool was field tested with 21 GPs 
working in eight private, teaching general practices and three AMSs. Sampling was 
purposive. We sought GPs interested in research, medical education and the provision of 
services to Aboriginal people. It was considered that GPs with these interests might subject 
the tool to vigorous scrutiny and provide recommendations for its future development. 
Prior to study commencement, research staff provided GPs with an orientation to the tool 
and interpretation of the output. In all200 routinely attending adult patients (33% 
Aboriginal, 67% non-Aboriginal) within the age ranges recommended for CVD risk 
..- assessment were invited from the waiting room to participate in the study. A research 
assistant accessed the patient's electronic health record and entered data into the EDS tool, 
thus simulating the automated data entry that would occur if the tool was fully integrated in 
the GP's software system. The re~Ultant output was printed and given directly to GPs to 
review during their consultation with the patient. A sample annotated output is shown in 
Figure 8-1. The manner in which GPs used the tool in the consultation was at their 
discretion, including whether or not to show the tool output to the patient. Each GP had 
outputs generated for up to I 0 patients, a big enough number with which to gain an 
appreciation of the tool's application in a typical working day. 
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Figure 8-1: Sample output from the Electronic Decision Support Tool 
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At the study completion, the GPs participated in an in-depth interview evaluation and 
completed a survey about their professional background and attitudes to electronic 
information. The interviews were conducted by the lead author, a practising GP who had a 
working knowledge of the tool but was not involved in its development. Two interviews 
were conducted by phone with the remainder in the GPs' consulting rooms. This not only 
created a comfortable setting but it provided contextual information about the setting in 
which routine health-care encounters occur. It also allowed for easy access to computer 
records for patients seen in the study. The interviews were generally conducted on the day 
or within a few days of use of the tool and ranged from 30 to 60 minutes' duration. The 
interview was semi -structured and was conducted in three parts. The interview guide is 
provided in Chapter 5, Attachment 3. The first part involved an initial discussion about 
attitudes to the tool and its impact on the health-care consultation. In the second part, 
sample tool outputs were selected in order to stimulate a collegial discussion about actual 
clinical scenarios and the rationale for particular management decisions. This allowed GPs 
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to recount the 'story' of the health-care encounter (Greenhalgh and Hurwitz 1999) in much 
the same way as cases are discussed for management purposes with colleagues and for 
medical education. During these discussions GPs frequently reviewed the patients' 
electronic health records to elucidate the decisions made. The third and final component of 
the interview involved discussing recommendations for the future implementation of the 
tool in routine general practice. 
Interview recordings were professionally transcribed and thematic content analysis was 
conducted following the methods outlined by Patton (2002). Analyses were conducted 
contemporaneously with data collection and used to inform subsequent interviews. As we 
began to identify the socio-technical aspects of tools to be a substantive issue, more weight 
was given to this in subsequent interviews. Upon completion of all interviews repeat 
readings of interview transcripts were conducted and the findings were then provisionally 
categorised by theme. These themes were jointly discussed by the research team over a 
series of meetings and the major thematic groupings were refmed. The team comprised the 
lead author; a senior GP academic who has provided strategic advice on tool development 
from an early stage of the project; two health service researchers not involved in the 
project, who offered an outsider perspective to the analyses; and the project leader, who 
has been responsible for the broader EDS research and development programme since its 
inception. This insider-outsider team composition was especially useful for challenging 
and justifying particular thematic interpretations, and mitigating any bias arising from a 
single interviewer being used. 
NVivo 8 (QSR International, Melbourne, Victoria) was used to assist with organising the 
data. Principal study findings were fed back to the participating GPs and AMS managers as 
a written report and oral presentations. The study was approved by both the Sydney South 
West Area Health Service and Aboriginal Health and Medical Research Council ethics 
committees. Patients and GPs gave their written consent to participate and signed 
agreements were obtained from the governing bodies for the three participating AMSs. 
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8.4 Findings and interpretation 
A total of 12 male GPs and nine female GPs participated. Nine GPs worked in AMSs and 
the remainder in urban, teaching, private general practices. The practice size varied greatly, 
ranging from solo operators to a large multidisciplinary service with 20 GPs. Four GPs 
were under 40-years old, 11 were 40-49-years old and six were over 50-years old. All 
spoke English as their primary language. Eighteen were Australian university graduates . 
High levels of professional training were attained. Fifteen held fellowship status with the 
Royal Australian College of General Practitioners, 11 held postgraduate diplomas and four 
held Master's degrees. All but two participants regularly conducted or participated in 
research projects. Overall 19 participants reported use of the Internet at least once daily. 
Table 8-1 provides the survey results. Although there are limitations to self-reported data, 
the participants recorded a high uptake of electronic practice software features and positive 
attitudes to the role of computers 'in general practice. 
I 
Table 8-1: Survey responses on attitudes to computers and sources of medical 
information for the 21 participating GPs 
Electronic practice software features used Always used Sometimes used Not used or not 
available 
Medication prescribing 20 
Automated pathology results 19 1 1 
On-line billing 14 - 7 
Electronic patient recalls 13 6 2 
Scanning of paper documents 12 - 9 
Electronic care plans 12 7 2 
Chronic disease patient registers 7 10 4 
Positive/ Negative/ Effect of computers on the following No effect 
very positive very negative 
Patient safety 18 3 
Practice of evidenced based medicine 17 3 1 
Practice cost efficiencies 14 7 
Patient privacy 11 9 
Patient/doctor communication 10 8 3 
248 
' 
lv 
~ 
Soun~e of medical information Very influential Somewhat Not influential influential 
Specialists* 14 6 
Clinical guidelines from professional 13 8 
organisations 
Continuing medical education events 1l 8 2 
Pharmaceutical product information in medical 10 9 2 
software 
GP colleagues 9 12 
Electronic textbooks 9 10 2 
Personal internet searches 8 12 1 
Peer-reviewed journals 8 9 4 
Conferences** 7 9 3 
Medical newspapers 2 15 4 
Pharmaceutical representatives j - 7 14 
* 1 missing response 
- 2 missing responses 
Five principal themes and their resonances with particular studies are discussed here. Two 
themes relate to how and why the tool might influence the routine care provided by GPs. 
They include 'GPs as street-level bureaucrats' and 'communication influences' . Tbree 
further themes relate to the role of the tool in notions of best practice care. They include 
'techno governance', 'mindlines' and 'phronesis'. 
GPs as street·level bureaucrats 
Checkland (2004) used Lipsky's concept of ' street-level bureaucrats' (Lipsky 1980) to 
better understand the impact of normative codes of practice such as clinical guidelines on 
the work ofGPs. Framing GPs as street-level bureaucrats recognises their role as powerful, 
semi-autonomous workers directly engaging with a demanding public and having to 
process voluminous data to make rapid, safe and effective decisions (Lipsky 1980). The 
pressures of processing information efficiently were noted in this study. Despite guideline 
recommendations to perform regular CVD risk assessments, nearly all 19 participants 
reported performing these infrequently or not at all in their routine practice. A major 
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barrier was that the most commonly used paper chart version was not practical to 
implement: 
Interviewer: Are you a prior user of the New Zealand [paper] risk chart calculator? 
Participant: Look I've seen it and I haven't used it simply because where do I put it? I 
mean there's enough junk on my desk and around this room already. So unless it's in 
the software it's not useful. (Interview 7: Private practice male GP 60+ years) 
In this way GPs indicated that the most supportive function of an EDS tool was if it 
enabled access to resources and guidelines during the health-care encounter. On reflecting 
why she didn't use guidelines more often at the point of care, one GP said: 
I think that's really been the reason why I haven't used them more routinely because 
yeah I know the guidelines but I have them in another place. So it's been an issue in 
terms of first of all getting [access to them] and then applying it ... and all that time 
that's involved with that. So hhink it can only be a bonus the fact that it's 
immediately there. (Interview 5: AMS female GP 30-39 years) 
Similarly, rather than actively not implementing evidence, GPs are more likely to be 
-
simply distracted from certain management actions by the routine pressures of the health-
care encounter: 
I think that there is the scenario that [for] the people you know well you often 
overlook things. And it is very useful to have a tool that actually brings you back to 
basics again. You know, sometimes you are just so focused on things and you forget. 
(Interview 3: AMS female GP 40-49 years) 
Juxtaposed against this appreciation for being brought back to the basics, one GP 
expressed irritation when the tool failed to acknowledge previously performed work and 
made blanket or seemingly obvious recommendations: 
She's [already] had her cholesterol done and then it says 'cholesterol evaluation is 
recommended ... ' They're telling us to suck eggs repeatedly, and I don't like it. 
(Interview 15: Private practice female GP 40-49 years) 
GPs also frequently commented on the failure of on-screen prompts to effectively integrate 
with the natural workflow of the clinical consultation. They cautioned against EDS tools 
adding to the already burdensome prompts to perform various clinical tasks. 
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I mean there are already a lot of pop-up windows ... and adding another one isn't going 
to get anyone very excited . .. Imagine how much better the software would be if it 
tracks the way you use a consultation. (Interview 4: AMS male GP 30-39 years) 
Communication influences 
The tool exerted additional important influences beyond expeditious processing. In these 
instances the tool punctuated conversations about CVD risk in new ways. For one GP the 
tool created quarantined discussions around cardiovascular risk management: 
I think it was quite a good thing because you would finish the consultation about 
whatever that was about and then you'd almost have a separate time set for looking at 
cardiovascular risk ... So having that piece of paper [the tool output] there gave you 
that conversation: 'well now we've fmished everything, let's look at this.' (Interview 
13: Private practice male GP 40-49 years) 
Another GP forewarned of dang~rs if the tool distorted priorities in the health-care 
encounter. By eliciting particular types of information related to cardiovascular risk this 
may come at the expense of other, potentially more patient-focused information: 
One of the dangers I would see with this is the encouragement of game playing .. . So 
an electronic decision support module that is only related to cardiovascular disease ... 
could lead you to focus on getting cholesterol and things done and perhaps forget 
immunisations or pap smears or the housing forms because that's what the computer is 
flashing up at you. (Interview 4: AMS male GP 30-39 years) 
While some of the above observations are informed conjecture based on how GPs may 
implement the tool in routine care, they demonstrate how innovative technologies have the 
potential to synchronise the solicitation and delivery of particular types of information 
(Greatbatch et al. 2001). Such technologies have the capacity to focus GPs' attention and 
produce particular kinds of conversations with patients, potentially displacing others. A 
number of GPs described how the tool not only created space for these conversations but 
shaped the content of their talk, broadening the existing communication devices that are 
deployed to discuss CVD risk management. One GP found this changed her overall 
communication package: 
I think the biggest impact is that it changed the way I talked about what I was doing 
with them. in that it made it a much more slick, neat package to describe the normal 
251 
I 
screening that you do for risk management. And so I felt it was easier to deliver some 
description of where they're at now. (Interview 2: AMS female GP 40-49 years) 
Several GPs commented on how they used the classification of the person's risk on the 
colour spectrum bar to influence discussions (see Figure 8-1). For one GP the graphic 
representation of risk coupled with the unquestionable authority of the computer became a 
device for the delivery of routine messages about adopting healthy lifestyles: 
Yeah and even a coloured diagram is really helpful in being able to say, ' look, the 
computer says it's true. This isn'tjust me making up words around diabetes. Look, 
this is going into orange- this says 'high' in red'. And there's almost an emotional 
response to the colours that come back that is actually really useful compared to me 
saying, 'look people with diabetes have heart attacks and strokes'. (Interview 4: AMS 
male GP 30-39 years) 
In this way the tool output, and in particular the use of colour, can be viewed as a boundary 
object (Star and Griesemer 1989); an entity that establishes coherency between the 
disparate world-views of researchers, clinicians and patients but may be used differently by 
each of these actors. It is not merely a means of representing categories of risk on the basis 
of inputs to the tool algoritlim. Rather, it can become an influential entry point for how 
health professionals frame risk and advise on actions to mitigate risk, and how patients 
interpret risk. 
Technogovernance 
May et al. (2006) describe a process of 'technogovemance' in which technological 
innovation is used to create a differently distributed accountability from that seen in the 
traditional doctor-patient dyad. Non-human actors, such as EDS tools, can change the 
structure and direction of decision-making processes. By actively bringing guidelines into 
the consultation, these tools become a third epistemological authority (alongside the 
doctor's and patient's) bringing about new practices of governance. 
We encountered diverse views from GPs about these technogovemance issues. A number 
of GPs expressed being at ease with this third presence. Although we cannot know how 
this may have manifested in actual practice, some of the more experienced GPs welcomed 
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being made aware of an ideal and potentially unachievable management scenario for their 
patients: 
I'm comfortable in that ifl don't meet a target and I've made a conscious decision 
about that I'm comfortable to live with that, I've been making those decisions for 20 
odd years. But I'm comfortable that the guidelines are there now, I feel much safer. 
(Interview 17: AMS male GP 50-59 years) 
I don't have a problem with seeing that that's where this person ought to be ... Ifs a 
goal and you can explain that to the patient by saying 'Look this will move, if we do 
this, but the choice is really yours'. There's lifestyle, there's enjoyment of life, there's 
the ideal situation and we'll come to some consensus. (Interview 7: Private practice 
male GP 60+ years) 
Two GPs, however, were challenged by the tool's perceived external authority and its 
agency was palpable in their accounts. For one GP the tool took on a threatening and 
vexatious quality 'embarrassing' him into better practice. 
They [patients] come for condition X and the machine is tapping me on the shoulder 
and saying, 'by the way, look at this'. Well I suppose one thing that crosses my mind 
is embarrassment If it was so bad that you'd missed it and it said, 'hey you need to 
prescribe this like now', I would be thinking 'who's running the show, the machine or 
me?' ... Somewhere in my past I've always wanted to make sure that the doctor is the 
one who is making the decisions. (Interview 11: Private practice male GP 50-59 years) 
Another GP perceived that the tool changed the direction of engagement when her patient 
reviewed the recommendations and suggested to her that a medication be prescribed: 
Interviewer: What about the prompts around meeting targets? I think you did in fact 
make changes to his blood pressure and cholesterol medicines. 
GP: You made me do that! You see ... [laughing], the older my patients get the less I 
like to interfere ... So your tool has made me do an intervention which I'm not sure if 
it's okay or not actually ... John [pseudonym] himself wanted to see this ... so that's 
partly what made me change his stuff ... Once a patient sees this ... like you and I, we 
can intellectualise about it and recognise it's just a tool, but for a patient it's very real 
and they would often in fact want treatment. (Interview 14: Private practice female GP 
40-49 years) 
This GP also raised concerns about the tool's potential for use by health system 
bureaucracies as a mechanism to assess performance and outcome payments: 
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This too I ... what I'd hate to see is if we ever get to outcome payments . . . because this 
hasn't been performed within six months- maybe for some very valid reasons and 
because of other issues with the patient. So I'd hate that. (Interview 14: Private 
practice female GP 40-49 years) 
Mindlines 
Related to the technogovemance issues were broader discussions about how GPs relate to 
evidence in practice. Gabbay and LeMay's ethnographic study found that participating 
GPs rarely 'accessed, appraised and used explicit evidence directly from research or other 
formal sources' (2004: 3). Rather, they relied on mindlines -tacit guidelines informed by 
brief readings of guidelines but, more importantly, collectively mediated through various 
informal networks (colleagues, opinion leaders and even their patients). Despite the 
limitations of self-reported data, Table 1 indicates that the most influential sources of 
medical information for participating GPs were specialists, professional guidelines and 
continuing medical education activities. More direct sources of evidence, such as peer-
reviewed journals, were less influential. Although these GPs had high levels of 
postgraduate training and a predisposition to research, they seemed to indicate that 
evidence needs to be validated through trusted networks, especially colleagues and 
professional organisations. This was particularly important when GPs considered 
incorporating new evidence into practice: 
There's an element of consensus around what peers are doing. So an example would 
be, say, using ACE inhibitors and A2 antagonists [two blood pressure medicines]. ... 
The recommendations were to use both [in combination] and then the evidence came 
out that it doesn't seem to be any more effective. My feeling is that I don't really want 
to be using both of them. But I haven' t got a feel for what my peers are doing yet .. . 
and what the specialists are doing. So I'm in that discomfort zone where I'm actually 
fairly comfortable with what the evidence shows, but I'm not sure what' s being 
recommended by everyone else yet. (Interview 4: AMS male GP, 30-39-years old) 
Thus, new and emerging evidence was often greeted cautiously. Until this evidence 
becomes embedded in particular mindlines its utility is of questionable relevance. 
Guidelines from trusted organisations constitute an important component to these 
rnindlines even if they are out of date or conflict with emerging evidence: 
From a GP's point of view, you just want the guidelines. You don' t want to know 
about what's coming up because what's coming up may or may not change. You can 
get one trial that's says this is a great thing and then a few years later you might get 
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another trial that's effectively the opposite .... As a GP you can't know about all the 
little bits and pieces of everything that's not_ going to lead to a change in management. 
(Interview 12: private practice male GP, 40-49-years old) 
There was also concern that premature adoption of research-based recommendations had 
the potential to damage the credibility of the profession. The example of delayed findings 
of increased risks associated with hormone replacement therapy (HRT) was cited: 
I think if it's not proven to be a guideline we're going to look like we did with HRT. 
You've gotto be pretty sure before you put it in a guideline. I imagine it's got to be as 
solid as it can be. (Interview 16: private practice female GP, 40-49-years old) 
If decision support tools challenge established and trusted networks they may create 
inconsistencies with these mindlines. The existence of multiple, sometimes conflicting and 
out-of-date guidelines for CVD in {\ustralia could exacerbate these inconsistencies. One 
GP commented on the confusion that could occur if the authors ofEDS tools became 
alternative expert actors who proposed recommendations that were different from those of 
existing experts: 
It could get confusing, because I think you'd end up having the programmers or the 
decision-makers around the computer system becoming experts ... and then there 
would be all sorts of quotes from professors or medical newspapers saying, 'Well, 
that's not the recommendation and we shouldn't be doing that'. It leads to confusing 
messages because there isn't actually the consensus around something until it hits the 
guidelines. (Interview 4: AMS male GP, 30-39-years old) 
Phronesis 
While evidence, guidelines and protocol implementations were important factors in how 
decisions are made, the participating GPs made a number of references to the role of 
wisdom, intuition and timing as being of prime importance. Their comments resonate with 
Aristotle's theory ofphronesis, often translated as 'prudence' or 'practical wisdom' 
(Flyvbjerg 2001). One GP questioned the value ofCVD-related tools and felt that 
assessing a patient's risk was an intuitive process that came with experience: 
In general practice [tools are] not that important. ... I think most of us, we really treat 
on empirical grounds. We have a feeling that this person is at higher risk, and we just 
treat them .... I don't seem to have many slip through my fmgers, because I see them 
255 
I 
I 
I 
I 
a couple of times a year for coughs and colds etcetera. (Interview l 0: private practice 
male GP, 50-59-years old) 
In particular, the fact that management is implemented over a series of consultations can 
take precedence over point-of-care decision support: 
I think that's where continuity of care and the art of general practice really comes to 
the fore ... that you actually try to meet the patient's and the doctor's agenda. But you 
know, ' the longitudinal consultation', I think that's the important thing .. .. What I 
would love is a tool to show the effectiveness of continuity of care. Like, John, for 
instance, I've seen him for 25 years. There is no tool like that. Continuity of care is 
probably . .. his biggest [contributor to] improvement in health. (Interview 14: private 
practice female GP, 40-49-years old) 
Even for the few, mainly younger, GPs who performed CVD risk assessments regularly, 
the skill of applying the process ~ a meaningful way took on more prominence than the 
results of the assessment itself: . 
It takes a long time to do it [CVD risk assessments] properly . .. and to make people 
understand them. The more I did it actually, the less that I used it after . .. the more I 
realised it was an art. I think it's great having the numbers but it's how you apply that 
number to that person sitting there, is my real feeling. (Interview 19: AMS female GP, 
20-29-years old) 
Phronesis is characterised by an openness to change through reflection both in action 
during the health-care encounter and ' on-action' after the encounter (Schon 1983). This 
reflective process was described by one AMS GP for whom awareness of population data 
on risk factors and inequitable health outcomes for Aboriginal peoples was influencing his 
previously conservative approach to treatment decisions: 
My practice is changing .... I've come from a practice where I was saying 'let's see 
how it goes' because patients are unwilling to take a new medication or increase the 
dose .... Whereas out here, I think you've just got to do it. They [Aboriginal people] 
are a really at-risk group .... And if you say, 'Wait, that's okay' you're sending a 
message that you're not that comfortable starting them on something. (Interview 17: 
AMS male GP, 50-59-years old) 
Thus much of the decision-making process for GPs is not merely scientifically based. It is 
equally bounded by the social and moral values that influence the interaction between 
doctors and patients. As Dew et a/. (20 1 0) state, 'the delivery of a diagnosis and a 
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treatment plan is an interactionally complex matter that does not lend itself to the rigid 
following of a protocol'. Technologies that privilege 'hard', coded data may therefore be 
ineffective in influencing 'soft', value-laden decision-making processes. 
8.5 Discussion and Conclusion 
This exploratory study of Australian GP attitudes to a novel EDS tool for CVD risk 
management provides some insights into how EDS tools might function in the primary 
care workplace. Our findings suggest that EDS occupies an ill-defmed middle ground in a 
dialectical relationship between the routine care provided by GPs and a range of 
interrelated actors promoting best practice. 
EDS tools have the potential to offer practical support to GPs for the more efficient 
conduct of routine care. The concept of street-level bureaucrats is helpful in understanding 
why care may be perceived to be enhanced. Lipsky (1980: xii) wrote: 'The decisions of 
street-level bureaucrats, the routines they establish, and the devices they invent to cope 
with uncertainty and work pressures, effectively become the public policies they carry out' . 
Factors that influence the adoption of particular policies include consistency with personal 
vision and professional values, harmony with local practices, adequate resources and lack 
of competing priorities. There were several accounts in this study where GPs saw the 
potential for the EDS tool to support their public policies, especially through the 
expeditious processing of workloads. Tills helps explain the fmdings from meta-analyses 
of trial data in which issues such as incorporation of tools in routine work flow and 
availability at the time and the location of decision-making are associated with improved 
practitioner performance (Kawamoto eta/. 2005). 
Although we did not analyse the real-time use of the tool the interview accounts also 
indicated that GPs fashioned the tool in particular ways to make it relevant in the clinical 
encounter. Heath eta/. (2003) suggest that technological tools are artefacts 'made at home' 
in the workplace and necessarily undergo a process of transformation according to a tacit 
body of practice and reasoning. Participating GPs talked of using the tool as a device to 
punctuate particular discussions, particularly focusing on risks of developing CVD. In this 
pilot the tool output came pre-prepared for use in the health-care encounter. The future, 
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practice-ready version of the tool will allow for real-time changing of input data during the 
consultation. lhis may alter how GPs and patients use the tool to direct the timing and 
flow of the clinical encounter when compared with the pilot version. Great batch et al. 
(200 1) found that the computer creates structured conversational boundaries by focusing 
patients' and doctors' gaze on the screen and directing conversations via the populating of 
particular screen fields. We found GPs alluded to such conversational boundaries, 
particularly when using the tool's risk score and colour category to explain the patient's 
current and projected state of health. Consistent with the notion of the tool as a boundary 
object (Star and Griesemer, 1989), it may be deployed and interpreted differently by the 
various actors that are engaging with it. Importantly, it does not necessarily privilege GP 
agency over that of the patient. In this study there was a striking account where a patient 
initiated treatment decisions based on the tool outputs, thus altering the GP' s preferred 
management recommendations. 
Alongside the tool's ability to support and influence routine care, we identified competing 
elements that can render EDS tools inconsequential. The theory of phronesis helps to 
appreciate the role of soft knowledge construction when GPs make decisions in practice. 
The notion of time as an important factor in decision-making was emphasised in this study, 
particularly the way in which decisions are distributed over a series of encounters between 
GPs and their patients (Rapley 2008). These encounters constitute a narrative that is 
intuitively 'read' by doctors (Greenhalgh and Hurwitz 1999). lhis narrative is not linear. 
The journey made between doctor and patient is marked by 'advances and reversals, 
· vectored progress and cyclic repetitio~ bursts of change and lulls of sameness' (Charon 
1000: 64). Greenhalgh and Hurwitz (1999) highlight four distinct texts that are o-perating in 
this journey: the experiential text of the patient's life outside the health-care encounter, the 
narrative· text constructed by the doctor about the p:;ttient' s illness, the physical or 
perceptual text derived from physical examination and the instrumental text derived from 
tests and machines. Decision support, when derived primarily from the latter two texts, can 
be of secondary interest. The development of patient-specific interfaces and access to data 
outside of the health-care encounter may, therefore, be effective strategies to better 
incorporate these broader narrative and experiential texts. 
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In addition to the tool's potential to support routine care was a range of views on how it 
might represent a vehicle for best practice. We found that decision support tools interact 
with a variety of other agents of best practice, particularly EBM, guidelines and 
professional organisations. The participating GPs viewed best practice as a fluid process 
where evidence is scrutinised by trusted experts, distilled into guidelines and disseminated 
through trusted networks. Gabbay and le May's (2004) conception of a non-linear 
incorporation of EBM along tacit mindline networks appears germane. EDS tools that are 
inconsistent with these mindlines may be viewed as irrelevant and potentially even 
untrustworthy. 
Rather than a form of technological determinism (Tinunermans and Berg 2003), we found 
that GPs actively engaged with this tool, being neither subsumed under its force nor inert 
to its potential influences. Most G:Ps did not perceive the tool as challenging their 
epistemological position in any meaningful way. Of note, however, the tool's authoritarian 
agency was salient for two participants, one of whom expressed fear of the potential use of 
such tools to rate performance. It is conceivable that as these tools become organisationally 
embedded and promoted through national programmes their potential to influence the 
agency of the GP could grow. Ethnographic studies examining the implementation of the 
UK's Quality and Outcomes Framework pay-for-performance programme have found that 
the collection of biomedical data is being prioritised over other dimensions of health-care 
quality in order to meet indicator targets (Checkland eta!. 2007; Grant eta!. 2009). While 
pay-for-performance programmes may be viewed suspiciously, peak professional bodies, 
by contrast, appear to be perceived as trusted technogovemors. Endorsement and 
dissemination of tools by these organisations might be expected to enhance their credibility 
and diminish any sense of authoritarian agency. However, from Gab bay's work, we see 
that the energising of informal networks, particularly personal accounts from other 
professional colleagues, is likely to be an influential factor in uptake. 
Limitations 
Our study sample clearly has bearing on the findings presented here and their implications. 
The participating GPs were highly trained and generally demonstrated favourable attitudes 
to the role of information technology in general practice. Resistance to uptake of decision 
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support tools may be greater among GPs who are less research- and education-oriented and 
less embracing of technological innovation. Alternatively, GPs with less interest in this 
area may be less likely to question the veracity of recommendations and be more reliant on 
such tools. Post hoc interviews, using a peer-to-peer method of data collection, afforded us 
some advantages by engaging GPs in collegial conversations but this may have 
predisposed GPs to reflect their ideals rather than their practice. Further, our interpretation 
of the tool's influence on communication might have been different if we were able to 
witness actual health-care encounters. Moreover, had we explored patients' views different 
interpretations of the key themes may well have arisen. For example, while we found little 
difference in opinions for GPs working in Aboriginal health settings compared with those 
in mainstream general practice, a patient-focused enquiry might have produced quite 
different fmdings in these two settings. 
Implementation in a broader range ·of primary care settings, involvement of the patient 
perspective and the use of ethnomethodology are key areas to focus on for future work in 
this area. In the next phase of this project the tool will be integrated into primary care 
software systems and there will be a specific patient interface for use both within and 
outside the health-care encounter. It will be trialled over a 12-month period in a larger 
number of settings to those studied here. This will allow us to enlist a combination of 
methods, including ethnography, to understand in more detail whether and how these tools 
become embedded both in the workplace and the community. 
The context of general practice has shifted from the surgery, in which discrete illnesses 
episodes are treated, to a complex environment where health, illness and risks are more 
diffusely located between the consultation room and the community (Armstrong 2004). 
The application ofEDS tools is becoming equally complex. Other human actors (such as 
specialists, non-GP health professionals, lay peer supporters and families), non-human 
technological actors (for example, personal e-health records, mobile phones, cloud 
computing, personal and shared e-health records) and technogovernors (for example, e-
health regulators, professional standards bodies and pay-for-performance programmes) are 
all shaping health care in new and potentially profound ways. It will be important to follow 
these actors carefully as our current appreciation of their roles and influence is limited. 
While it is apparent that EDS tools and related technologies have the potential to improve 
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health system performance, our gaze should not be limited to only this aspect of health~ 
care quality. It is only through appreciation of the socio-technical dimensions of these tools 
that we will be able to understand their broader implications. 
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Chapter 9: Discussion and Conclusions 
In this thesis I have adopted a multimethods research design to address two inter-related 
questions. How effective is the care provided in Indigenous primary health care services 
and what is needed to build better primary care systems for Indigenous peoples? At the 
commencement of this body of work, I expected to identify barriers and enablers in the 
health system that impacted on Indigenous peoples' health care. Based on my inductive 
stream of work, mainly derived from Part B of the thesis, I have learnt that a 'many 
barriers/enablers' approach is not helpful in bringing about health system improvements. 
Their mere identification fails to recognise the interactive and multiplicative manner in 
which they operate. Overcoming barriers and enhancing enablers is thus, rarely, a 
straightforward process. If interventions are too narrowly focussed at the individual level 
or on organisational diffusion they are unlikely to make much of an impact. This has 
i 
important implications for my deductive stream of work (Part A) in which I identify 
widespread system under-performance and explore electronic tools as a strategy to address 
this. Such strategies, however promising, can be undermined by complex socio-political 
factors when translated into practice. The central challenge, therefore, is to develop and 
implement complementary interventions in such a manner that they are responsive to 
complex environments. I have sought to elaborate a nuanced understanding of some of the 
contextual factors that contribute to this complexity in the field of Indigenous health. These 
factors are operating at the levels of the macro health system, health services and health 
care encounters. 
9.1 Macro health systems 
Gauging effectiveness of care and system performance requires robust monitoring. In 
Chapter Two, I address the first question in my deductive stream of the thesis: How 
adequately do health systems monitor the effectiveness of primary health care for 
Indigenous peoples? I used a case study of vascular and maternal/newborn health 
monitoring by Aboriginal status in the New South Wales (NSW) health system to illustrate 
deficiencies in both the breadth and depth of indicators that are currently reported. A 
particular limitation was the lack of reporting on primary care performance for vascular 
health indicators. Whilst my analysis focussed on only two aspects of health systems 
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monitoring in one Australian state jurisdiction, other literature (discussed in Chapter 2) 
suggests that these issues are pertinent to other health systems both in Australia and 
elsewhere. Whilst these issues remain, macro level monitoring of health system 
performance, at least in the area of vascular health care, is limited in informing progress on 
effectiveness of care for Indigenous peoples. I made a nwnber of recommendations on 
• ( strategies to improve system monitoring. These include the need for population-
representative data from the primary health care sector; greater coordination between 
hospitals and primary care; improved health survey sampling with the incorporation of 
physical and laboratory measures; and sustained efforts to address under-enumeration of 
Indigenous status. 
~ 
In Chapter 6, I build on this analysis of health systems in a different way by qualitatively 
reviewing the issues that influen~e access to health care for Indigenous peoples in 
Australia, New Zealand, Canada and the USA. For this review I took a broad definition of 
·health care 'access' which incorporates many dimensions beyond service utilisation 
including acceptability and affordability, relevance, effectiveness and equity. I drew my 
analysis from a diverse body of empirical and grey literature sources over the last twenty 
years to assess this. At the core of my enquiry was a critical examination of the construct 
of candidacy to health care. Whilst candidacy theory was able to be applied well at the 
level of health care services and encounters between providers and patients, there were 
limitations to its utility at the macro systems level. Through the synthesis of these literature 
sources I identified that systems of care for Indigenous peoples evolve from a dialectical 
relationship between a non-Indigenous State that adjudicates through its institutions how 
care is offered and a predominantly Indigenous counter-movement that seeks to maximise 
participation in shaping those institutions. I termed this a 'societal candidacy' in which 
eligibility for care is negotiated in socio-political arenas beyond the health care space. 
These negotiations are historically informed and have currency in broader political 
movements, particularly assimilation and self-determination. These societal level factors 
fundamentally shape the way in which health systems have evolved in the four countries. 
Further, they are not merely remnants of the colonial encounter. The Kanyini Qualitative 
Study analysis in Chapter 7 identified that both Aboriginal and non-Aboriginal staff, 
working in community governed Aboriginal Medical Services (AMSs), feel the very 
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existence of these sexvices to be under threat because of changing policy directions of the 
State. 
I concluded, therefore that strategies designed to enhance candidacy at this societal level 
can heavily influence how health institutions are shaped and the type of care that is 
negotiated between them and the community. These strategies are necessarily complex. 
Establishing legally binding treaties and implementing rights-based frameworks require 
paradigmatic shifts in government policy and therefore can remain elusive. However, 
where such frameworks already exist, their principles could be more firmly embedded into 
health systems structures. Although the challenges are clearly greater if there is resistance 
to addressing these societal factors, the health system can still be proactive in enhancing 
candidacy. In Chapter 6, I raise the possibility of candidacy organisational audits in which 
institutions are reviewed against multi-level criteria which are drivers for enhanced 
candidacy. Similar to Maori advocacy for Treaty ofWaitangi audits (see discussion 
Chapter 6), candidacy audits could provide service wide recognition of particular 
principles that need to be adhered to in order to enhance accessibility and quality of health 
care. The methodological approach to developing such audits would need itself to be 
cognisant of the issues of candidacy and maximise involvement from a range of 
Indigenous and non-Indigenous stakeholders. 
9.2 Health services 
In Chapter 3 and Appendices A and 8, I address the second question in my deductive 
stream of research: what is the extent and nature of the gaps between best practice 
recommendations and actual care provided in both Aboriginal and mainstream primary 
care services in Australia? In combination, the case record audit in AMSs (Kanyini Audit), 
and two cross-sectional studies of mainstream primary care for almost exclusively non-
Aboriginal patients (the Bettering the Evaluation and Care of Health (BEACH) program 
and the Australian Hypertension and Absolute Risk Study (AusHEART)) provide one of 
the most comprehensive pictures to date of primary care performance for the prevention 
and management of vascular diseases in Australia. In all three studies substantial gaps on a 
range of clinical indicators related to effectiveness of care were foimd. In the Kanyinf 
Audit (Chapter 3) and BEACH studies (Appendix A), around one half of routinely 
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attending adults (aged 30+ years) lacked sufficient information with which to make a 
comprehensive vascular risk assessment. In all three studies, for those who were identified 
at high risk of vascular diseases, a large proportion was not receiving guideline 
recommended treatments. Figure 9-1 shows the prescribing rates of guideline indicated 
medicines for people with established vascular diseases (aspirin, statins and blood pressure 
medicines) and those at high risk of those diseases (blood pressure and statins) for all three 
studies. It highlights that many people are missing out on appropriate prescription of these 
medicines. 
Figure 9-1 : Prescribing rates of guideline indicated medicines for people at high risk of 
cardiovascular diseases - A comparison of three studies 
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Although the methods for each study were different, this figure demonstrates some 
encouraging signs that performance in the Kanyini AMS sites is at least comparable and 
possibly even better than in the mainstream general practices involved in the other two 
studies. Despite this, there are system wide issues across all settings that need to be 
addressed to close these and related performance gaps. 
I used the inductive stream of work to elaborate on these systems issues for Indigenous 
peoples' health care. In Chapter 6, the qualitative literature synthesis identified the utility 
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of a number of candidacy sub-constructs to better understand health care access and 
quality. In particular, the constructs of navigation/permeability (e.g. transport, friendly 
reception staff, welcoming spaces, flexible appointments) and tractability (especially the 
role oflndigenous staff, resource limitations and commitment to quality improvement 
activities) were useful ways in which to frame the contextual factors that might affect 
access and quality at the health service level. In Chapter 7, I used fmdings from the 
Kanyini Qualitative Study to explore local systems at AMSs. I continued to apply 
candidacy theory but also introduced the central Australian concept of kanyini as a 
companion theoretical framework to understanding how care is delivered in AMS settings. 
From this study I conclude that the type of care provided in AMSs is different from that in 
mainstream services. Consistent with the underlying philosophy of kanyini, this different 
care is characterised by a deep emotional connection to local communities. AMS care 
providers feel a strong obligation to nurture and protect the communities they service. The 
Health Systems Assessment findings from Chapter 7 suggest that the principles to 
maximise this holding are based on good governance, a good workforce and good systems 
design. Although these principles may be equally pertinent to non-AMS organisations, 
they manifest uniquely within this broader context of kanyini. Concordant with the 
findings in the literature review, the presence of Indigenous staff represented at all levels 
of the organisation was critical to enable the 'holding' responsibility of services to be 
properly fulfilled. Such sociocentric models of care need substantial support and generally 
staff felt that despite persistent advocacy for such a model, Australian government 
authorities frequently failed to acknowledge its importance. Many health service 
organisational features identified in this study were aligned with the Chronic Care Model 
and in particular were related to leadership, information systems and delivery system 
design. Noteworthy features include the role of care planning, navigable specialist services 
and receptive hospital enviromnents. There were ample accounts of where systems became 
vulnerable if these factors were not simultaneously operating well. Multifaceted and well-
resourced interventions that address factors at the levels of health service governance, 
workforce and delivery design features are therefore needed to enable AMSs to provide 
better systems of care. 
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9.3 Health care encounters 
Having identified limitations to the effectiveness of vascular health care in both AMSs and 
mainstream general practices, Chapters 4 and 5 examined the role of point of care 
electronic tools in improving clinical practice. Although both of these projects were early 
in their inception, the findings demonstrate that these tools were both acceptable and 
feasible to use for primary care practitioners in both Indigenous health services and 
mainstream general practice in Australia and New Zealand. There were also preliminary 
signs that widespread implementation of such tools could play an important role in 
enhancing effectiveness of care, but clearly further work is needed to substantiate this 
claim. A further important application is the capacity for electronic clinical tools to provide 
good quality primary care data for monitoring performance both within and across health 
services. As highlighted in Chapter 2, this is essential for monitoring health system 
responsiveness to reducing inequi~'es in health care and outcomes for Indigenous peoples. 
The New Zealand CVD risk assessment program at Tamaki Health care provided reliable 
and easy to obtain data on a large number of patients. These data showed that despite large 
variations in risk factor prevalence by etlmicity, there was little variation in prescribing of 
guideline-indicated medicines for different ethnic sub-populations. Information of this 
nature can be of immense value to health systems planners, regional providers of primary 
care services and care providers themselves. 
In Chapter 5 I explored the role of electronic decision support (EDS) for CVD risk 
management in Australian primary care. This pilot study demonstrated that general 
practitioners (GPs) considered the EDS tool acceptable for use in both mainstream general 
practice and AMS settings. There are, however, key design feature elements that require 
attention if such tools are to be used as a part of routine care. These fmdings are now being 
used to inform subsequent development of a system that is fully integrated with two of the 
most commonly used primary care software platforms in Australia. A large scale cluster 
randomised controlled trial with a qualitative process evaluation involving both AMSs and 
mainstream general practices is planned for mid-2011. 
Although systematic review evidence suggests that EDS tools are effective in improving 
performance, the effect size is highly variable. In addition to specific design features, this 
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suggests there are contextual factors that influence their uptake and effectiveness. The 
inductive stream of this thesis has been instructive in appreciating some of these factors. 
Health care encounter level factors such as communication, patient centred care, adherence 
to cultural safety principles, and the roles played by Indigenous community workers were 
identified in both Chapters 6 and 7 as being important influences on the type of care 
provided. 
Specific to electronic tool interventions, Chapter 8 explores the role of factors related to 
organisational culture and attitudes of health practitioners. I took a sociological perspective 
to explore these factors by conducting further analyses of interview data from the pilot 
study described in Chapter 5. In this study I sought to better understand the relationship 
between electronic tools, their users and the organisational environments in which they are 
placed. Although less familiar to clhricians and health service researchers, the sociological 
literature provided useful theoretical insights to interpret the findings. GPs' personal values 
and professional standards play a critical role in attitudes to technological tools. Further, 
there are both internal (e.g. the ability to process patient care efficiently) and external 
organisational factors (e.g. the· role played by professional bodies) that affect the way in 
which health care decisions are made. Of note, there were few substantive differences in 
the findings for GPs working in AMSs compared with those working in non-AMSs. I 
conclude from this work that technological innovation using decision support has potential 
to make a major impact on how primary health care is delivered. Given the pilot nature of 
the project and limited exposure that GPs had to the EDS tool, it is too early to determine 
the extent of this impact. For the proposed cluster trial in 2011, intervention sites (AMS 
and mainstream general practice) will receive the EDS system for 12 months. A mixed 
methods evaluation is again planned and the qualitative component will explore the 
implications for health services and the degree to which the EDS system becomes 
embedded into organisational culture. By involving AMS and non-AMS sites there will be 
further opportunities to review the effect of the EDS system in different organisational 
environments. 
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9.4 Limitations 
There are a number oflimitations to each component study in this thesis and these are 
discussed in each chapter. There are also broader issues to the way this thesis was 
conducted that are of relevance to the findings. With the exception of Chapters 4 and 6 the 
bulk of this thesis has focussed on issues of access and effectiveness of care for Australian 
Aboriginal and Torres Strait Islander peoples. Although Chapters 4 and 6 suggest the 
findings are of relevance to Indigenous health care in other regions, there is a danger of 
over-extrapolating findings and ignoring the role played by the specific context of 
Australian health care systems . 
For my deductive stream (Part A) I focussed mainly on measures of effective clinical care 
for vascular health care. Although many of these measures are strongly associated with 
improved health outcomes they remain process oriented. Cohort study designs that 
assessed the associations between clinical process of care and patient outcomes would be 
needed to address this. Further, by focussing mainly on effectiveness of care the thesis has 
not quantitatively examined other patient focussed indicators of health care quality, in 
particular satisfaction, acceptability, timeliness, efficiency, and safety. Although the 
inductive stream (Part B) offers a number of important insights into these areas, empirical 
studies specifically targeting the patient experience are needed to explore these other 
domains of quality in health care. A related limitation in relation to the evaluation of 
electronic tools was scant understanding of patient perspectives. The degree to which these 
tools are acceptable, easy to interpret and able to empower patients to make health care 
decisions was not explored and is a vital area for further enquiry. This is of particular 
relevance as there is now emerging interest in developing EDS tools to assist with self-
management of chronic diseases. 
Similarly, from the inductive stream of work, my analysis of how to build better systems of 
care often came from the perspective of health professionals. The semi-structured 
interview component of the K.anyini Qualitative Study in which over one hundred 
community participants were involved will provide critical insights into patient 
perspectives. It will allow us to triangulate the findings from the Health Systems 
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Assessment and open up new areas of inquiry. Analysis of these data has commenced and 
the reporting offmdings is expected to commence in late 2010. 
9.5 Concluding remarks 
Three years ago I commenced this work to make more sense of my own workplace and 
habits and to explore ways of improving the quality of my work and that provided in 
Aboriginal Medical Services. Through this thesis I have sought to progress a series of 
qualitative, quantitative and mixed methods studies to sequentially build a greater 
understanding of what is needed to build better primary care systems. Whilst the focus of 
this work was specific to Indigenous health, the fmdings could be of relevance to other 
populations that experience difficulties in health care access and quality. Being a 
multimethods research program, an important requirement is that it produces a body of 
work that is more than the sum of its parts. By combining an inductive, exploratory 
component with a deductive, hypothesis-driven component I offer both pragmatic and 
complex insights to this field of inquiry. As a clinician it has been important for me to 
incorporate medically oriented ~lements that may assist with the everyday demands of 
providing health care. Equally important, however, has been the need to expand my 
clinical gaze further to include a sociological dimension. By progressively building on 
these clinical and sociological perspectives I have come to appreciate their complementary 
roles in contributing to improved primary health care for Indigenous peoples. 
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HEALTH CARE 
Gaps in cardiovascular disease risk management in 
Australian general practice 
Ruth J Webster, Emma L Heeley, David P Peitis, Oare Bayram, Alan Cass and Anushka A Patel 
I n 2005, cardiovascular disease (CVD} was responsible for 35'l6 of deaths in Australia, and In the financial year 
2005~6. for more than 450 000 hosp!tal 
admissions. 1 Prevention is a natiooal health 
prlor!ly. With 88% of Ausual!ans estimated 
to have visited a general practitionet at least 
once in 200~6.1 the primary health care 
setting provides a clear oppottunity for 
addrusiog CVD risk. 
It is Increasingly being recognised that 
managanent of an indivlduaUi risk factors 
should be based on the person!; overall or 
absolute risk of expertenctng a cardiovascu-
lar event, rather than on the levels of each 
risk factor. 3 Many tools are now available to 
estimate an individual!; 5- oc 10-roear risk of 
coronary heart disease or CVD. ln Aus-
tralia, many evidence-based guidelines are 
available to guide GPs In assessing and 
managing CVD risk. Although there is still a 
£ocus on publishing sq>arate guidelines for 
single risk factors (eg, hypertens!on,7 
dysl!pldaemia8 and diabetes9), these guide-
~ !ncteasingly Incorporate an absolute 
risk approach. Such a strategy, by targeting 
Individuals with the greatest poten1ial. for 
benefit, maximises the cost-effectiveness of 
pharmacological intetvcnlions. 10 ln pantcu-
lar, an absolute tisk strategy identifies people 
with mild or moderate abnormalities of a 
number of factors that, in combination, 
substantially Increase their risk. 
However, few data are available on the 
management of overall CVD rlsk in general 
practice. We sought to evaluate, In contem-
porary Australian general practice scllint;s: 
• the extent to which GPs have data avail-
able, at the·time of consultation, to allow 
management of CVD tisk factors, with a 
focus on absolute risk; 
• where data are available, the lev!:! of 
adheren<:e to current guidelines for manag-
Ing individual risk fac:tolll; and 
• patterns In current prescribing for patients 
with different levels o£ absolute risk. 
METHODS 
The Bettering the Evaluation and Care of 
Health (BEACH) program is a continuing 
national cross-sectional survey of general 
ABSTRACT 
Objective: To evaluate the management of cardiovascular disease [CVD) risk in 
Australian general practice. 
Design, setting and partidpants: National cross-sectional survey of99 Australian 
general practitioners participating in the Bettering the Evaluation and Care of Health 
(BEACH) program. Data on 2618 conserutive adult patients presenting to the 
participating GPs over a 5-week period from September to October 2006 were analysed. 
Main outcome measures: Proportions of patients screened, treated and reaching 
targets according to (1) rurrent Australian CVD risk guidelines and al overall or absolute 
CVD risk. 
Results: Blood pressure (BP) had not been recorded for 13% of the sample. Of 1400 
patients not prescribed antihypertensive medication, treatment was indicated for 8%. 
Of 821 patients already presc:nbed antihypertensive medication, 59% were adlieving 
target BPs. Data on low-density lipoprotein (LOU cholesterol levels were not available 
for 53% of the 2175 patients who should have had ltpid screening according to the 
guidelines, Of 624 patients not prescribed a stalin, treatment was indicated for 41%. 
Of 368 a I ~'~lady prescribed a statin, 62% were achieving target LDL cholesterol levels. 
Sufficient data for calculation of absolute risk had been recorded for 74% of the 1736 
patients for whom such calrulation was recommended by the guidelines. The remaining 
26% either had at least one required variable wvneasured (20%) or missing from the data 
collection (6%). For those at high absolute CVD risk (without established disease) and 
those with established CVD, 23% and 53%, respectively, had been prescribed both 
antihypertensive medication and a statin. 
Conclusions: Gaps between guideline recommendations and practice in recording 
and managing BP were relatively low compared with gaps for lipids. 'Mien stratified by 
absolute risk, patients at high risk of a cardiovascular event were found to be 
substantially undertreated. 
practice activity in Australia. A random 
sample of GPs who have claimed at least 
375 general practice items of setvice in the 
preceding 3 months is regularly drawn 
from Health Insurance Commission (Medi-
care) data by the Primary and Ambulatory 
Care Division of the Department of Health 
and Ageing. These GPs are approached by 
letter and followed up by telephone. Par-
ticipating GPs complete details for 100 
consecutive patient encounters on struc-
tured paper forms and provide informa-
tion about themselves and their practice. 
In the 200~7 colkct!on year. contact 
was attempted with 4576 GPs, of whom 
4057 were contactable and 930 (23'l6) 
collected the data. 11 The reliability and 
validity of data collected via the BEACH 
methodology have been tested and 
desc:r!bed elsewhere.12 
MJA2009; 191: 324-329 
Data for our study were collected as a 
Supplemenlary Analysis of Nominated Data 
(SAND) substudy of the BEACH program 
from a random sample of 99 GPs over a 
5-week period from September to Octobet 
2006. ln each substudy. the GP, In discus-
sion with the palimt and using information 
from the patient!; record, records informa-
tion about aspects of the patient!; health 
additional to BEACH encounter data. The 
full methodology of ~e substudies is 
reported elsewhere.13 
In our study. GPs recorded, for a sub-
sample of 30 of the 100 consecutive encoun-
ters (if the patient was aged 18 years or 
over), the preseru:c, measurement and levels 
of CVD rlsk factors and relevant medication 
use (Box 1). All parameters used for calcula-
tion of CVD risk, estimation of indications 
lOr treatment and target levels £or risk factors 
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1 Questions asked of general 
practitioners 
Whlcto best describes the patient's smoking 
statu a? 
Current smoker 
Quit < 12 months ago 
Quit > 12 months ago 
Naver smoked 
Does the patient have ... 7 
(yaslno/don't know) 
Coronary heart <f•aase 
Cerebrovascular disease 
Peripheral vascular <fosease 
Ove.--ight/obesity 
Family histoty of heart disease 
Proteinuria 
Diabetes 
Is the patient currently taking ••. 7 (yes/no) 
Statio 
Antiplatelet therapy 
ACE inhibiiPr 
Angiotensin recaptor blocker 
li-B locker 
Other antihypertensive agent 
What was the patient's most recent BP 
reading? 
Systolic BP/diastollc BP/don't knew 
What was the most recent serum creatinine 
level? 
._p.movt/don't know 
What were th most r.c:ent r-ts of total 
cholesteroi/HDL ctoolestarolltrlglyeerldaa? 
..•. mrnoWdon't know 
The patient's most recent tests for eacto of 
total ctoolest<JI'OI/HOL dlolestMoV 
tr1glycerides wwe 
< 12 months ago 
> 12 months ago 
ACE - ongiOMnoliK'Onwrtlng enzyme. 
BP • blood pross .. e. HOL • high-density 
~ . 
were taken from Austnlian guidelines cur-
~ at the time of data collection.7Aa.u 
Estimation of cardiovascular dlseE!se risk 
l!e<:ause CVD rule assessment tools are val-
idated only fot people aged 30 years and 
over, patients under 30 years were excluded 
from the calculation of risk. For eligible 
patienls fot whom thue were sufficient data, 
the estimated 5-ycar risk o£ a cardioV'ISCUiar 
event was calculated using the Framingham 
cquation.1 As data on left w:ntricular hyper-
trophy were not collected, this was assumed 
to be absent in aU patients. 
HEALTH CARE 
National Heart Foundation of Austnlia 
(NHF) guidelines were followed in appl~ 
adjustments to the Framingham equation. 
For patients with diabetes and for patients 
aged 75 years and over, tlu: estimated 5-year 
risk was adjusted to a minimum of 15%. 
Estimated risk was increased by~% in the 
presence of a famUy history of coronary 
heart disease, identification as Aboriginal or 
Torres Strait Islander, systolic blood pres-
sure (BP) > 170 mmHg, diastolic BP 
> lOOmmHg, or total cholesterol level 
> 8 mmoi!L This 5% incmnent was applied 
only once for any indivtdual patient. 
Patients with established coronaty heart dis-
case, cerebrovascular disease or periphenl 
vascular disease were categorised in a sep-
arate high-risk group - those with "estab-
lished CVD". 
Patients for whom the GP had indicated 
"don't know" for at least one risk factor 
required for calculation of absolute rlslc 
were put in the category of "data not meas-
uredlunknovm•. A funher category. "data 
mlsslng"; encompassed patients about 
whom at. least one risk factor required for 
calculating absolute risk had not been pro-
vided by the GP and "don't know- had not 
been selected. 
Patients whose data were "missing" or for 
whom the GP had indicated "don't know" 
for varlables indicating clin1cal conditions 
(cg, proteinuria, diabetes) were assumed not 
to have the clinical condition. 
Determination of indications for 
measuring blood pressure, lipid levels 
and absolute risk 
NHF guidelines recommend BP measure-
ment for all people aged 18 yean and over. 
Thus, all patients in our study should have 
had their BP measured. 7 
For lipid screening, NHF guidelin£S rec-
ommend measurement for people who have 
esabUshed CVD, BP >110/90mmHg. dia-
betes, chronic renal failure, proteinuria or a 
family blstory of coronary heart disease; or 
who are current smoms, obese, or Abori-
ginal or Tom:s Strait Islander descent, or 
aged aver 45 ycars.11•16 
For absolute risk screening, various 
guidelines reconunend measurement for 
people who arc of Aboriginal or Torres Strait 
'!$lander descmt or aged over SO years, or 
who have established CVD, BP > 140/ 
90 mmHg, low-dcnslly lipoprotein O..Dl.) 
cholesterol level > 2.5mmol!L, triglyt:eride 
level > 2 mmoi!L, diabetes or estimated 
glomerular filtration rat~:. < 60 mUrnin/ 
1.73m1_7.S.L4.l' Because o£ space limitations 
on the BEAOI form, we could not ask GPs 
to indicate whether they had actually calcu-
lated absolute risk. 
Oetenninatlon of indications for 
pharmacological treatment 
For patients currently not prescribed statins 
or antihypertensive medication, indications 
for treatment were determined for those for 
whom data were available? .8,1-t,l!l,lf In addi-
tion, Cor these patients, we determined 
whether the 2006 Pharmaceutical Benefits 
Scheme (PBS) criteria (which were cum:nt 
for the period o£ data coiiec:tion) for subsi-
dised p=rlption of stalin therapy were 
met · 
Ascertainment of target levels for 
patients already prescribed medication 
For pattents already taking a stalin or anti-
hypertensive medication, we assessed the 
attaimncnt o£ NHF-recommended BP and 
lipid (LDL cholesterol <2.5 mmoi!I.) tar-
gcts.a 
Statistical analyses 
Data are presented as means (SDs) or pro-
portions, as appropriate. The difference In 
mean age between participating GPs and all 
Austtaliau GPs was ~ed using a paired I 
test. ·t tests were used to compare the age 
and sex distribution of GPs In our study 
with the 17 628 Australian GPs (defined as 
vocationally registered GPs and GP regis-
trars) who claimed at least 375 general 
practice items of service in the comparable 
3-month Medicare data period. Swl.stlcal 
analyses Wt:Ie carried out using SAS soft-
ware, version 9.1 (SAS lnstitutc, Cary, NC, 
USA). 
Ethics approval 
Ethics approval was obtained from the Eth-
ics Comm.IUee of the Australian Institute of 
Heahh and Wdfare. 
RESULTS 
Ninety-nine GPs provided data for 2618 
palicnrs aged 18 years and over. GPs agree-
ing to participate in the BEAOI prognm 
have previously been shown to be generally 
repn:scnt2tive of the current GP "WOrkforce, 
apart from having a higher mean agc.18 Our 
sample had fewer GPs aged under 45 years 
than the: broader GP workforce (13% v J'f%; 
r -20.5; P<0.001),18 but was tcpresenta-
tive with regard to the proportion of male 
GPs (68% v 6.5%, respectivdy; P•0.61). 
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2 Patient characteristics* 
Variable Men(n-1034) Women (n•1571) Total(ns2618)t 
Mean age in years (SD) 54.7 (18.7) 52.5 (20.2) 53.3 (19.6) 
location of practiceU 
Metropolitan 720 (70%) 1094(70%) 1820(70%) 
Rural or remote 295 (29%) 448 (29%) 743 (211%) 
Unknown 19(2%) 29 (2%) 55(2%) 
Reported diabetes 125(12%) 127 (8%) 253(10%) 
Current smoker1 254(25%) 280(18%) 537 (21%) 
Riskofcvos 
Established CVD 225(22%) 203(13%) 428(16%) 
High risk (> 15%) (excluding patients 150(15%) 229(15%) 380(15%) 
with established CVD) 
Moderate risk (10%-15%) 49(5%) 25 (2%) 74(3%) 
Low risk(< 10%) 138(13%) 327 (21%) 465(18%) 
Unable to estimate risk: 472(46%) 787 (50%} 1271 (49%} 
At. least one variable not 304 (29%) 448 (29%) 755(29%) 
measured by/unknown to GP 
At. least one variable missing in 45(4%) 74(5%} 128(5%) 
data collection 
Age < 30 years 123(12%) 265(19%) 388(15%) 
Medication use 
Statin 247 (24%) 266(17%) 513(20%) 
Antiplatelet therapy 225 (22%) 222(14%) 449 (17%) 
Antihypertensive therapy 385 (37%) 460(29%) 849(32%) 
CVO • cardovaSOJiar disease. GP • general prflctitioner. *Figures are number(%) of patients, axcept where 
othe!Wite specified. t Data on sex were missing for 13 patients. t Data on sex were missing for six patients In 
metropolitan areas and seven patients in •unknown• areas. § Percentages may not add up to 100% due to 
rounding. 1Currentsmokaror quit within past 12months. + 
Missing data 
Proportions of missing data for each variable 
were small (1 %-6%). 
Patient characteristics 
Patient characteristics are shown in Box 2. 
The sex distribution and location (ruraV 
metropolitan) of respondents were similar to 
the distributions for aU BEACH encounters. 
Blood pressure management 
Gaps relating to antihypertensive treatment 
are shown in Box 3. Of patients not being 
treated, 112 (8%) qualified for treatment 
according to the 2004 NHF hypertension 
management guidelines.7 When the data 
were re-analysed using the recommenda-
tions of the updated 2008 NHF hyperten-
sion guidelines,19 this figure rose to 482 
(34%). 
Lipid management 
Of the 2618 patients, 2175 (83%) should, 
according to NHF guidelines, have had their 
lipid levels measured. Gaps in lipid manage-
ment are summarised in Box 4. A total 
cholesterol value had been recorded for 
1444 patients (66%). Sufficient information 
to determine aU lipid fractions (high-density 
lipoprotein cholesterol, LDL cholesterol and 
triglycerides) was available for 1029 patients 
(47%). The numbe7 of participants with 
LDL information was used as the basis for 
3 Distribution of patients with data on antihypertensive therapy (AHT), and management gap* 
BP lnfo<matlon 
not measured 
n= 282 (11%); 
missing 
n• 54(2%) 
BP 
Information 
recorded 
ns2282 (87%) 
Treatment not 
Indicated 
n=1288 (92%) 
Treatment 
Indicated 
n= 112 (8%) 
Not attalnino 
target BP' 
n= 339(41%) 
Achieving 
target BP' 
n=482 (59%) 
BP-blood pressure. •Treatment Indication was determined according to National Heart Foundation of Australia guidelines for the management of hypertenolon. Target 
BP levels are defined as 40125/75 mmHg for patients with diabetes and proteinuria; 4i 130(80 mmHg for patients with clabetes without p1oteinuria; and 4i 140190 mmHg 
for all other patients.' • 
326 MJA • Volume 191 Number 6 • 21 September 2009 
Appendix A - 4 
HEALTH CARE 
4 Distribution of patients with data on statin treatment, and management gap* 
LDL cholesterol 
In forma don 
not measured 
n=968 (45%); 
missing 
n=178 (8%) 
LDL cholesterol 
Information 
recorded 
n=1029 (47%) 
ll'eatment not 
Indicated 
nz370(59%) 
ll'eatmenl 
Indicated 
nz254 (41%) 
Not attalnlng 
target level' 
n=139 (38%) 
Achieving 
target level' 
n=229(62%) 
LDL- I<>I'Hlensity lipoprotein. • Treabnentindicationwas determined according to National Heart Foundetion of Australia/Cardiac Society of Australia and New Zealand 
guidelines on lipid management. Target LDL d1olesterollevel is defined as < 2.5 mmoVL 1 + 
the flowchart in Box 4, as this is the key 
variable in determining NHF treatment 
recommendations. Of the 624 patients not 
prescribed a statin, 254 ( 41 %) qualified for 
treatment under NHF criteria. Applying the 
then-current PBS criteria, 64 (25%) of these 
254 would have been eligible for cost-
subsidised stalin treatment Applying the 
current PBS criteria would increase those 
eligible to 139 (55%). 
Absolute risk 
According to the guidelines, absolute risk 
should have been calculated for 1736 
patients (66% of the sample), all of whom 
were aged 30 years or over. Sufficient infor-
mation was available to calculate this risk in 
1282 patients (74%); the necessary data 
were not measured/unknown for 348 
patients (20%); and data were missing for 
the remainili.g 99 patients (6%). The distri-
bution of risk for the 1736 patients for 
whom absolute risk should have been calcu-
lated is shown in Box 5. More than a fifth of 
these patients (22%) were at high risk for 
CVD. 
Treatment stratified by risk category 
The proportions of patients in each risk 
category who were prescribed various 
cardiovascular medications are summarised 
in Box 6. Sixty-five per cent of high-risk 
participants were prescribed at least one 
medication (a stalin, antihypertensive agent 
or antiplatelet drug). Fifty-three per cent of 
patients with established CVD and 23% of 
those at high risk of CVD (without estab-
lished CVD) were prescribed a combination 
of an antihypertensive medication and a 
sratin. 
Gap between guideline 
recommendations and actual 
treatment for high-risk patients 
Of the 264 patients at high risk who did not 
have established CVD and who were not 
prescribed statins, 10% would have been 
eligible for treatment according to the 2005 
NHF lipid guidelines (52% bad insufficient 
Information to make the assessment). Simi-
larly; of the 166 patients at high risk who 
did not have established CVD and who were 
not prescribed antihypertensive medication, 
51% would have been eligible for treatment 
according to the 2004 NHF hypertension 
guidelines (28% had insufficient informa-
tion to make the assessment). 
DISCUSSION 
Our survey reveals significant gaps in CVD 
risk screening and management in Austra-
lian general practice. This has been docu-
mented pr eviously for people with 
established disease.20 We assessed manage-
ment gaps in the context of the relatively 
new clinical paradigm of prevention of CVD 
according to absolute risk. It was not our 
5 Distribution of risk and missing 
data in patients who should have 
had absolute risk of CVD 
measured* (n •1736) 
Risk category Number(%) 
Established CVD 426 (25%) 
High risk (exduding patients 373 (22%) 
with established CVD) 
Medium risk 74(4%) 
Low risk 416(24%) 
Unable to estimate risk 348(20%) 
(at least one variable not 
measured by/unknown to GP): 
HDL cholesterol 325 (93%)1 
Total cholesterol 194(56%)1 
Diabetes status 31 (9%)t 
Sex 0 
Smoking status 5(1%)t 
Blood pressure 4(1%)t 
Unable to estimate risk 99(6%) 
(at least one variable missing): 
HDL cholesterol 64 (65%)* 
Total cholesterol 25 (25%)* 
Diabetes status 7J (27%)* 
Sex 7 (7%)* 
Smoking status 11 (11%)* 
Blood pressure 20 (20%)* 
CVD- cardiovascular disease. HDL• high-density 
lipoprotein. • According to the guidelines} .I.M.os 
t Denominator- 348. :!:Denominator- 99. • 
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6 Among patients for whom absolute risk of CVD should have bean estimated,* 
proportions of patients reeeMng antihypertensive t herapy (AHn, a stat ln or 
antlp latalat therapy (APn, by CVD risk catagoryt 
100% 
80% 
.~ 80% 
170% 
f 
t 
'l5 
i 
eo% 
50% 
40% 
30'!!. 
20% 
10% 
0 AHT 
" ...• 
Stalin APT 
D Hal rtek 
0 Medumrlak 
~ LDwrtek 
AHT+ 
llalln 
Medicallon 
...... ""' Any 
tnoelrnems trea......,tt 
CVD • c:ardoYHcular.._. • According to the g.~ido1Jnes.7A''" t Nuni>er ofp~~tienta in eoch risk catego<y: 
Mtablished CVD (4261, !-0gh rille (373), ..-ium rtslc U4), low risk (416). *Any lrAtment refen to ot least one of 
1 mtin or ontihypetteruNe or ""tiplallllet medication. • 
aim to assess the appropriateness of guide-
line recommendations for the calculation or 
adjustment of absolute risk. These issues 
require debate in other forums. Instead, we 
sought to quantify guideline adherence and 
the extent of absolute-risk-based prescrib-
ing. 
In terms of Individual risk factor guide-
lines, BP was managed reasonably well 
according to the guidelines current at the 
time. However, 71% of patients eligible for 
lipid screening were ti~r not recognised as 
needing to be screened, were not prescribed 
appropriate medicines or, once prescribed, 
were not attaining recommended targets. 
When patients were stratified by absolute 
risk, ~ management gaps were more strik-
ing. Fewer· than half of those with estab-
lished CVD - arguably those at highest risk 
- were being prescribed the universally 
recommended combination of antihyperten-
sive, statln and antlplatelet medica-
tions.'.ll.ll For those at high risk who had 
not }'l:t experienced a cardiovascular event, 
about a third were taking no medications to 
modify their risk, and fewer than a quaner 
were prescribed the combination of antihy-
penen5lve and statin medications. 
We uncovered several factors that may 
explain these low prescribing rates. First, 
relevant data were available for fewer than 
half (-+7%) of the patients for whom lipid 
screening was indicated. Having appropriate 
data is an essential first step in assessing and 
managing risk. For 20% of patients for 
whom absolute risk should have been calcu-
lated, GPs lacked the data to do so, prim-
arily because lipid levels had not been 
measured. 
Second, treatment generally appears to be 
based on levels of Individual risk factors 
rather than on absolute risk. This is sup-
paned by the guidelines' focus on risk factor 
levels as targets rather than on treatment to 
lower absolute risk. Although in our study 
we were unable to directly assess how fre-
quently GPs performed absolute risk assess-
ment, other studies have shown that most 
GPs do not routinely calculate absolute 
risk.23)+ 
Third, under the guidelines current at the 
time of our s tudy. statins and antihyperten-
sive medications would not have been 
recommended for some high-risk individu-
als. lt has been shown that guideline recom-
mendations do not always accurately target 
those at highest risk of CVD.l'.l6 Our data 
support this contention. The move in the 
2008 NHF hypeTtenslon management 
guidelines19 towards risk-based prescribing 
recommendations (with antihypertensive 
treatment recommended for all high-risk 
patients) is a promising initiative. However, 
the differing approaches between the NHF 
hypertension and lipid guidelines (includ-
Ing slighdy different deftn!Uons of patients 
at high risk, and recommendations for pre-
scribing lipid-modifying therapy in certain 
high-risk groups being based primarily on 
LDL cholesterol levels rather than level of 
CVD risk) could lead to confusion or failure 
to follow the recommendations. 
Fourth, GPs are restricted by PBS pre-
scribing criteria. We found marked differ-
ences In recommendations between the 
NHF lipid guidelines and ~ 2006 PBS 
criteria for prescribing statins, although the 
latest PBS criteria are an improvement. 
Our study did not assess non-pharmaco-
logical measures of control. Funhennore, 
we only collected single measurements of 
BP and lipid levels. ln general practice, 
before prescribing medications, a trial of 
lifestyle modification and monitoring of risk 
factors over time is commonly undenaken. 
ln this context, these aspects of study design 
might have led to an overestimation of 
management gaps. However, in relaUon to 
patients at highest risk, who require phar-
macological therapy, this is unlikely to sig-
nificantly affect our~· 
In addition to non-pharmacological 
approaches, the use of statins and antihyper-
tensive and antiplatelet medications is the 
established evidence-based strategy for 
reducing CVD risk. Clinical practice guide-
lines help clinicians discern "best-practice 
medicine". Having multiple, sometimes con-
llicting, single-risk-factor guidelines con -
fuses time-poor GPs, who are expected to 
apply different guideLines concurrently. The 
separate updating of each guideline makes 
additional demands on GPs' time. Funher-
more, CVD risk management, although 
important, is only one aspect of a GP!; 
worldoad and can often be provided only 
opportunistically during consultations, usu-
ally about other problems. 
The substantial undertreatment of high-
risk patients demonstrated In our study 
suggests that synthesis of current multiple 
risk Jaaor management guidelines into a 
single CVD risk management guideline is 
urgently required. Essential components of 
such a guideline would be the endorsement 
of absolute-risk-based screening and the 
integration of risk assessment with multifac-
torial recommendations on management. 
Such a guideline should comply with 
National Health and Medical Research 
Council (NHMRQ recommendationsl7 and 
be endorsed nationally by all relevant peak 
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professional bodies. Availability of a single 
consolidated guideline could be an impor-
tant and necessary initial step towards 
achieving substantial improvement in CVD 
risk management in general practice. 
A comprehensive sttategy for guideline 
dissemination, to both GPs and specialists, 
Is also essentiaL Simply providing guidellnes 
will not be sufficiem to change clinical 
practice and alleviate treatment gaps. Devel-
opment of novel, effective strategies to 
enhance adherence by both care providers 
and patients must also be a priority. 
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Cardiovascular risk perception and evidence-practice gaps in 
Australian general practice (the AusH EART study) 
Emma L Heeley, David P Peiris, Anushka A Patel, Alan Cass, Andrew Weekes, Claire Morgan, Craig SAnderson and John P Chalmers 
C ardiovascular ~ (CVD) is the leading cause of death and disability worldwide.1 In 2005, CVD was 
responsible for 35% of deaths In Australia 
and an estimated l.i million Australians 
(6.9% of the population) were living with a 
CVD-related disability.2 Ninety percent of 
Australian adults have at least one modi-
fiable CVD risk factor and 25% have three or 
more modifiable risk factors.3 Because 
around 85% of Australians visit a general 
practitioner every year,1 primary care is the 
ideal setting for CVD prevention. The fed-
eral government has targeted CVD as a 
priority area In its proposed National Pri-
mary Health Care Strategy' and has set 
specific performance benchmarks for the 
management of CVD risk and for the pre-
vention of CVD.6 As vascular health checks 
in primary health care have been shown to 
be highly cost-effective, improving the per-
formance of these checks could reduce the 
rising costs of acute hospital care. 7.8 
Despite evidence that CVD management 
and prevention should be based on an indi-
vidual's overall or absolute risk. theR: has 
been little analysis on how extensively this 
evidence is being implemented in primary 
health care. One qualitlltive study demon-
strated that GPs do not routinely perform 
absolute CVD risk assessments. 9 Barriers 
identified include lack of understanding of 
the difference between absolute and relative 
risk, poor understanding of how to use CVD 
risk tools in clinical management, and lack 
of incorporation of risk tools into practice 
software. Several recently published studies 
have revealed substantial gaps in CVD risk 
management.1o.IJ Potential barriers that 
have been iilentified include guidelines for 
single diseases and conflicts with the criteria 
for prescribing subsidised medications 
within the Pharmaceutical Benefits Scheme 
(PBS). 
New guidelines for the assessment of 
absolute CVD risk were published by the 
National Vascular Disease Prevention Alli-
ance (NVDPA) in March 2009.11 In this 
study, we sought to describe the distribution 
of CVD risk according to various guidelines, 
to ascertain GPs' perceptions of their 
patients' CVD risks and to determine the 
proportion of patients whose CVD risk is 
254 
ABSTRACT 
Objective: To examine the perception and management of cardiovascular disease 
(CVD) risk in Australian primary care. 
Design, setting and participants: The Australian Hypertension and Absolute Risk 
Study (AusHEARl) was a nationally representative, cluster-stratified, cross-sectional 
survey of 322 general practitioners. Each GP was asked to collect data on CVD risk 
factors and their management in 1 ~20 consecutive patients aged ;;. 55 years who 
presented between April and June 2008, and to estimate each patient's absolute risk 
of a cardiovascular event in the next 5 years. 
Main outcome measures: Estimatec15-year risk of a cardiovascular event, proportion 
of patients receiving appropriate treatment. 
Results: Among 5293 patients, 29% (1548) had established CVD. A further 22% (1145), 
when categorised according to the 2009 National Vascular Disease Prevention Alliance 
guideline, to 42% (2211 ), when categorised according to National Heart Foundation 
(NHF) 2004 guideline, had a high (;;.15%) 5-year risk of a cardiovascular event Of the 
1548 patients with established CVD, 50% were prescribed a combination of a blood 
pressure (BP)-iowering medication, a statin and an antiplatelet agent, and 9% were 
prescribed a BP-Iowering medication and a statin but not an antiplatelet agent. Among 
high-risk patients without established CVD, categorised using NHF 2004 adjustments, 
34% were prescribed a combination of a BP-lowering medication and a statin. GPs 
estimated 60% of patients with established CVD as having a risk of less than 15%. The 
GPs' estimates of risk among patients without established CVD agreed with the centrally 
calculated estimate (according to the NHF 2004 guideline) in 48% of instances(.: • 0.21 ). 
Conclusions: These data confirm substantial undertreatment of patients who are at high 
risk of a cardiovascular event. We recommend that GPs assess absolute risk for older 
patients and ensure that high-risk patients receive evidence-based pharmacotherapy. 
being managed according to current Aus-
tralian evidence-based guidelines. 
METHODS 
The Australian Hypertension and Absolute 
Risk Study (AusHEART) was a nationally 
representative, cluster-stratified, cross-sec-
tional survey of CVD risk management prac-
tice in primary health care for patients aged 
55 years or older. The study des!~ is based 
on previously used methodology. 5 
Sampling and investigator selection 
GPs were recruited on the basis of interest in 
participating in the study. Two mail-outs to all 
21 OH registered GPs in Australia were con-
ducted during January and February 2008. 
GPs who expressed an Interest in participat-
ing in the study were stratified according to 
location within each state and territory and 
whether their practice was in a rural or urban 
MJA • Volume192 Number 5 • 1 March 2010 
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area, using a classification derived from 
national rural, remote and metropolitan area 
categortes.16 We randomly selected interested 
GP Investigators in a stratified manner to 
ensure that state and rural-urban splits 
reflected the distribution of the adult popula-
tion according to 200i census data. Charac-
teristics of the selected GPs were compaR:d 
with those who weR: not selected and with 
the Australian GP workforce for the 2007-08 
fmancial year. 17 
Data collection 
GP investigators were requested to recruit 
15-20 consecutively-presenting consenting 
adults aged 55 yars or older, irR:spective of 
their reason for the consultation. All patients 
were given the option to consent to partici-
pate In a second component of the study, in 
which each patielm health care expenditure 
would be tracked across the next 5 years 
through linkage with their Medicare number. 
Appendix B - 2 
RESEARCH 
1 Guidellne-biiMd adjustments to the Framingham risk estimates 
NHF 2004 guldeilne19 
Patients in whom the Framingham method is likely to underestimate risk (Aboriginal, TOOTes 
Strait Islander, Maori and Pacific Islander patients; patients aged ;ao 75 years; patients wi1h 
diabetes, c:lvonic kidney d isease, aortic disease, left ventricular hypertrophy, vascular disease, 
ultrasonic or rediological evidence of atherosclerotic plaque, or hypertensive retinopathy 
[Grade 11 or moreD -e assigned a risk of 15% if the calallated risk was lower. In addition, risk 
was inaeased by 5% (once only) in patients where it is likely that the Framingham equations 
underestimate risk (patients with BMI ;ao 30 kglm2, total cholesterol > 8.5 mmofll.. systolic BP 
> 170mmHg and diastolic BP > 100mmHg or first degree relative with CVD before 60 years 
of age). 
NHF 2008 guidellne20 
Very similar to the NHF 2004 guideline except that patients with a family history of premature 
CVD and patients with hypercholesterolaemia (total cholesterol > 7.5 mmoi/L) were also 
categorised as high risk foe, assigned a risk of 15% if the calculated risk was lower). 
NVDPA 2009 guidellne14 
Adults were classified into the high-risk category if they -• considered to be at increased risk 
(high risic) and estimation of risk was not required due to: diabetes and age > 60 years; diabetes 
and microalbumlnuria; moderate or severe CKD with eGFR < 45 mllmin/1.73m2; systolic BP 
;ao 180mmHg; diastolic BP ;ao 110mmHg; or serum cholesterol> 7.5 mmolll. 
NHF•Notic>MI HNrtFound.tlon. BMI-body mass index. BP•blood f'"IIIU,.. CVO•cardlovucular 
dlaa-. Cl<D - chronic kidney diMasa. eGFR- estimated glomenjor filtnotion rote. + 
For each patient who was recruited, GPs 
completed a one-page questionnaire on 
CVD risk factors and cunmtly prescribed 
medications. Included in this was a n:quest 
to repeat tests for fasting blood lipids, fast-
ing blood glucose and estimated glomerular 
filtration rate, if these had not been per-
formed within the guideline-recommended 
time fmne. Urinary dipsticks were supplied 
to assess albumin to creatinine ratio (ACR). 
Ninety percent of participating GPs wen: 
already using electronic blood pn:ssure (BP) 
monitors or were provided with one, for use 
in this study, through the High Blood Pres-
sure Research Council of Austmlia Better 
Blood P~ure Measurement lnitiative. GPs 
also provided their estimate of each patient's 
absolut.e risk of having a cardiovascular 
event within the next 5 years. This was 
requested without specifying how the GP 
should come to this determination. Data 
were collected prospectively between April 
and june 2008. GPs wen: contacted to 
resolve illegible or missing information on 
the questionnaires. In cases where missing 
or unknown values were not resolved, we 
assumed, when calculating CVD risk, that 
the patient did not have the risk factor. 
Estimation of absolute CVD risk 
Following data collection, estimation of 
absolute 5-year risk of a cardiovascular 
event was calculated centrally (by one of us 
[E L H), using available data) for each 
patient without established CVD, using the 
1991 Framingham risk equations. 18 This is 
based on age, sex, smoking status, BP, total 
and high-density lipoprotein cholesterol lev-
els, diabetes and left ventricular hypertro-
phy to predict a first 0/D event. 
Adjustments to the Framingham risk cal-
culation were made according to three 
guidelines - the National Heart Founda-
tion (NHF) Hy/:rtens!on rnanagtml!nt guJdt 
for doctors 2004 9 (the prevailing guideline at 
the time of data collection), the NHF Gu!tl£ 
to managtmmt of hypemnslon 2008,20 and 
the NVDPA Guidellnts for tm assessment of 
absolllk canliovasculat disease risk (published 
in 2009). 1t The adjustment criteria are sum-
marised in BolC 1. The NVDPA 2009 guide-
line also states that the Framingham method 
is likd.y to underestimate absolute risk in 
certain patients (Aboriginal and Torres Strait 
lslander patients, patients with diabetes who 
are younger than 60 years and do not have 
microalbuminuria, overweight or obese 
patients, md patients aged 75 years or 
older), for whom clinical judgement is 
required. However, we did not make any 
further automatic adjustments to the Fram-
ingham method of calculating risk in 
response to the NVDPA suggestion of groups 
in whom risk might be underestimated. 
Unadjusted and adjusted 5-year risks of a 
cardiovascular event were then classified 
into low (< 10%), moderate (10% to< 15%) 
and high (;;o. 15%) categories, as specl.fled in 
the NHF 200-+ ,19 NHF 200820 and NVDPA 
20091t guidelines. Patients with established 
CVD (defined as pn:vious myocardiallnfarc-
tion, stroke, peripheral arterial disease, 
revascularisation, tranSient ischaem!c attack 
or angina) were classified into a separate 
category. 
Statistical analyses 
Differences between data on particirting 
GPs and data on the GP workforce1 were 
tested using the t test. Sex differences were 
tested using the t test for categorical varia-
bles and the independent t test for differ-
ences between means. Agreement between 
GP estimates of risk and centrally calculated 
estimates of risk was evaluated using x: 
statistics. Data entry and manipulations 
were carried out using SAS version 9 .1 (SAS 
Institute, Cary, NC, USA). Statistical analy-
ses wen: conducted using STAT A version 9.2 
(Stata Corpomtion, College Station, Tex, 
USA). 
Ethics approval 
The study was approved by the Royal Aus-
tralian College of General Practitioners 
(RACGP) National Research and Evaluation 
Ethics Committu. All patients gave written 
informed consent to participate in the study. 
RESULTS 
GP characteristics and completion 
of questionnaires 
A total of 14-16 GPs expressed interest In 
participating in the AusHEART study, of 
whom 53-+ were selected to participate. or 
those selected, 322 GPs (60%), provided 
data for an average of 16 patients each; the 
remaining 212 did not contribute data or 
Connally withdrew befon: contributing data. 
Characteristics of the actively participating 
GPs, compared with non-participating GPs 
and the Australian GP workforce, are shown 
in Box 2. When compared with the Austral-
ian GP workforce, the actively participating 
GPs were mon: likely to be older and located 
in a rural area. 
A1 the time of data lock on 28 November 
2008, less than 5% of data were missing for 
most variables on questionnaires completed 
by GPs. 'Wriables with greater than 5% 
missing data (ic, data field not completed or 
indicated as "unknown") wen:: Rrst degree 
relative with 0ID at < 60 years (9%), left 
ventricular hypertrophy (8%), hypertensive 
retinopathy (7%), ultrasound or radiological 
evidence of atherosclerotic plaque (13%) 
and estimate of cardiovascular risk In the 
next 5 years (11 %). 
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RESEARCH 
2 Characteristics of general pn~ctitlonars In the AusHEART study c:omparwd with the Austl"llllan GP woricforce 
GPs who expressed an interest In partldpatlng 
Australian 
GP workforce Total Noni)artldpating GPs Partidpatlng GPs 
(n•24903)• (n•1416) (n•212) (n•322) pt 
Women 9636(39%) 504(36%) 70(33%) 129(40%) 0.59 
Age (yean)* <0.001 
<35 2370(10%) 57(4%) 11 (5%) 9(3%) 
35-44 6080(24%) 252(18%) 39(18%) 57(18%) 
45-54 ~76(32%) 506(36%) 72 (34%) 138(43%) 
;o.SS 8377 (34%) 574(41%) 88(42%) 112(35%) 
State 0.66 
Australian Capital Territory 383(2%) 28 (2%) 2(1%) 7(2%) 
New South Wales 7948(32%) 528(37%) 67 (32%) 113 (35%) 
Northern Territory 345(1%) 8(0.6%) 3(1%) 2(0.6%) 
Queensland 5051 (20%) 271 (19%) 41 (19%) 61 (19%) 
South Australia 2100(8%) 100(7%) 20(9%) 21 (7%) 
Tasmania 660(3%) 31 (2%) 5(2%) 8(2%) 
Victoria 6057 (24%) 311 (22%) 51 (24%) 81 (25%) 
Western Australia 2359 (9%) 139(10%) 23(11%) 29 (9%) 
Practiao in rural areal 7097 (28%) 335(24%) 68(32%) 115(36%) 0.004 
Practiao uses computerised records na 1138(~) 185(87%) 260(81%) 
Cardlovasc:ular risk calculaton used' na 885(63%) 137 (65%) 2ffl (65%) 
Paper risk charts na 554(39%) 135(42%) 83 (39%) 
Online or downloaded calculators na 73(5%) 22(7%) 10(5%) 
Calculators within electronic record system na 420(30%) 96(30%) 68(32%) 
• Number of GPs for "l!:t11-a!. finandol year, ond dab from the Austrollan Gowmment Department of Health and Ageing.11 t P valueo rep.-nt t test comparing 
octively participating GPs with Australian GP worlcforce; P values for age and state dota repnosent 1Mts for dffontnc:eo in distribution in age and state categories, 
.. opectMoly. *Some Gf's cld not deda,.lheir age.§ Includes pl3<:tices in remota oren. 1 Soma GPs uaed more than one calculator. na • not available. • 
Patient characteristics and risk 
distribution 
Data were obtained from 5293 patients 
whose sex was recorded and who were aged 
55 or older, of whom 3-+62 (65%) consented 
to participate in the longitudinal follow-up 
component of the study. Their demographic 
and CVD risk factor details are summarised 
in Box 3. Box 4 shows the distribution of risk 
categories using Framingham-based risk esti-
mates atone,' as well as the distribution using 
adjustments from the three different Austral-
ian guidelines. Using the NHF 2004, NHF 
2008 and NVDPA 2009 guideline adjust-
ments, 2211 (42%), H65 (47%) and 1H5 
(22%) patients, resptttively, were classified 
as high risk. The NVDPA guideline did, 
however, state that risk might be underesti-
mated in 793 of the 2026 low-risk patients 
(39%) and 241 of the 458 moderate-risk 
patients (53%). r£ these patients were all 
categorised as high risk, this would result in 
a similar risk distribution to that resulting 
from NHF 2004 adjustments. 
256 
GP perception of risk 
Of 1548 patients with established CVD, GPs 
provided an estimated 5-year risk of a 
cardiovascular event for 1345 patients 
(87%). For this group, the mean '5-year risk 
was estimated to be 17%. However, GPs 
categorised 805 patients with established 
CVD (60%) as having a 5-year risk of less 
than 15%. 
For the 3745 patients without established 
CVD, GPs estimated the 5-year risk of a 
cardiovascular event for 3364 (90%) of 
patients. Comparison of GP estimates of risk 
category with centrally calculated estimates 
showed 48% agreement with estimates cal-
culated using the NHF 2004 guideline (x-
0.21), 47% agreement with estimates calcu-
lated using the NHF 2008 guideline (x • 
0.20), and 58% agreement with estimates 
calculated using the NVDPA 2009 guideline 
(r.:-0.31). GP risk categorisation had the 
strongest agreement with risk calculated 
using the unadjusted Framingham risk cal-
culation - 60% agreement (x- 0.33). By 
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comparison with NHF and NVDPA guide-
line-based estimation of risk, GPs tended to 
underestimate their patients' risks. 
Prescribing gaps 
Box 5 shows prescribing patterns for major 
cardiovascular medication groups stratified 
by categories of risk estimated using NHF 
2004 guideline adjustments. Of the 1548 
patients with established CVD, 780 ('50%) 
were prescribed a combination of a BP-
Iowering medication, a statin and an 
antiplatdet agent, and 14 3 (9%) were pre-
scribed a BP-lowering medication and a 
stalin without an antiplatelet agent. Using 
unadjusted Framingham risk estimates as 
well as estimates calculated using the NHF 
2004, NHF 2008 and NVDPA 2009 guide-
line adjustments, 39%, 34%, 32% and 42%, 
respec:tivdy. of patients at high risk of a 
cardiovascular event in the next 5 years (but 
without established CVD) were prescribed a 
combination of a BP-lowering medication 
and a statin (with or without an antiplatelet 
Appendix 8 - 4 
RESEARCH 
3 Charac:terlstlc:s of patients In the AusHEART study* 
Total Men Women 
Variable (n•5293) (n•2325) (n•2968) 
Age (years) 68:t9 68:t8 68:t9 
Current smoker 425(8%) 208 (9%) 217 (7%)1 
Body mass index ;.o 30 kg/m2 1705 (33%) 721 (32%) 984 (34%) 
Diabetes 1163 (22%) 616(2.7%) 547 (19%) 
Established cardiovascular disease 1548 (2.9%) 870 (37%) 678(2.3%)• 
Previously documented chronic kidney disease 312 (6%) 151 (6%) 161 (5%) 
Systolic blood pressure (mmHg) 136:t17 136:t17 135:t17 
Diastolic blood pressure (mmHg) 76:t11 76:t11 76:t11 
Cholesterol 
Total cholesterol (mmoVI.J 4.97±1.04 4.70:t1.03 5.18:tl.OO' 
low-density lipoprotein cholesterol (mmoVI.J 2.85:t0.92 2.72.:t0.91 2.96:t0.92' 
High -density lipoprotein cholesterol (mmoVLJ 1.43:t0.44 1.26:t0.37 1 .56 :t0.45t 
Albuminuria 
Miaoalbuminuria* 1121 (22%) 586(26%) 535(19%) 
Macroalbuminuria or proteinurial 2.03 (4%) 110(5%) 93(3%) 
eGFR ""45 mUmin/1.73rf?- 229(4%) 99(4%) ' 1:ll (5%) 
* Data .,. mean ± SO Of m.mber (%), and percentogas ""' baed on non-misoing ... 1.-. t P < 0.001 diff""""'a 
between men and women. ; Miaoalbumi!Uia defined ao: ACR labon!tooy result. 2..5-25 mg/rnmol (men) 0< 
3.5-35 mglmmol (women); 0< ACR urin..y dpotick mult. 3.4-18.2 mglmmol. § Macroolbumlnuna a< proteinuria 
defined os: ACR labomay rwouit. >2Smglmmol (lnen) or >3Smgfmmol (women);.,. ACR umary dpotick 
"""it. > 33 mglmmol. eGFR- •limA tad glomerular f~lmion note. ACR-albumin to cnoalinna ratio. • 
agent). When applying the criteria for PBS 
statin subsidy for high-risk patients without 
established CVD (using NHF 200-4 guide-
line adjustments), treatment would not be 
recommended to 1537 of 2211 patients 
(70%) despite being at high risk. An esti-
mated 6'1% (-429 of 67-4 patients) of high-
risk patients eligible for a statin subsidy 
under the PBS were prescribed a statin. 
or the 1799 patients with and without 
CVD not prescribed at least one BP-lowering 
medication, treatment was indicated for 802 
(iS%), according to the NHF 200-4 guide-
lines. Statin treatment was indicated for 892 
(3-4%) of tht 2597 patients not prescribed a 
statin, according to the 2005 NHF and 
Cardiac Society of Australia and New Zea-
land guidelines.Z1 
Achieving target levels of cholesterol 
and blood pressure 
Of the 236'1 patients with and without 
established CVD who were prescribed a 
statin, 1250 (53%) were not achieving target 
low-density lipoprotein cholesterol levels 
(defined as < 2 mmoi/L for patients with 
CVD or < 2.5 mmoi/L for all others). Among 
the 33-42 patients with and without estab-
lished CVD who were prescribed a BP-
lowering agent, 1956 (59%) were not 
achieving target BP levels (defined as,.;; 1251 
75 mmHg for patients with proteinuria, 
,.;; 130185 mmHg for those with coronary 
heart disease, diabetes, stroke, transient 
ischaemic attack, macroalbuminuria or 
known chronic kidney disease, or "" HOI 
90 mmHg for all others). 
DISCUSSION 
The AusHEART study shows that large evi-
dence-practice gaps exist in primary and 
secondary prevention of CVD for older Aus-
tralians. Our findings are similar to those of 
our previous cross-sectional studies involv-
ing younger adults in mainstream and Indig-
enous health settings,10•13 and are consistent 
with recent findings by other investiga-
tors.11·12 The consistency of outcomes sug-
gests that these gaps are entrenched in 
primary care. 
A clear outcome of this study is that 
uptake of the paradigm for care based on 
absolute risk is limited. The infrequent use 
of absolute risk assessments to guide care 
was shown in three distinct ways. First, 
about 60% of participating GPs reported 
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using CVD risk calculators. Second, there 
was substantial disagreement between 
patients' risks as p=i.ved by GPs and as 
derived from Framingham-based algo-
rithms. This discordance was prevalent 
regardless of which guideline adjustment 
method was used, and GPs tended to sub-
stantially underestimate their patients' abso-
lute risks. Third, when stratified by absolute 
risk category, around two-thirds of patients 
at high risk of a first CVD event were not 
prescribed a combination of a BP-lowering 
medication and a statin. 
These evidence-practice gaps are not only 
related to low uptake of absolute risk-based 
care. Around half of the patients with estab-
lished CVD, for whom the evidence for 
benefits of combination BP-lowering. statin 
and anti-platelet therapy are well estab-
lished, were not prescribed this combina-
tion. Given that the risk of a subsequent 
CVD event is very high in patients with 
established CVD, there are substantial 
health gains to be made by specifically 
targeting improved management in this 
group of patients alone. With around one-
third of the sample having established CVD 
and up to a further -40% assessed as being at 
high risk of a first CVD event, as well as 
evidence of substantial evidence-practice 
gaps, prevention efforts targeted to patients 
at highest risk might prove highly cost-
effective. 
It Is possible that this study is not fully 
representative of the evidence-practice gaps 
in general practice. Some study factors sug-
gest that the actual gaps might be wider. 
First, although the sampling method was 
random, the final group of GPs who panici-
pated might represent those more likely to 
have a specific interest in CVD risk manage-
ment_ Second, the study design prompted 
the measurement of risk factors if these had 
not been assessed recently. Such additional 
measurements might not otherwise have 
occurred in routine clinical care. Other 
study factors suggest ~t the actual gaps 
might be nanower. First, GPs participating 
in this study were older than the broader GP 
workfon:e and more likely to be practising 
in a rural area. Second, prescribing pattern 
assessments were based on a single consul-
tation and therefore did not include new 
prescriptions provided at subsequent con-
sultations. The planned 5-year follow-up of 
a large proportion of the cohen will address 
this limitation and provide data on patients' 
use of prescribed medications throughout 
the follow-up period. 
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4 Distributio n of CVD risk cat egories for pat ients In the AusHEART study 
(n • 5293), calculated using Framingham risk equations 18 and diffe rent 
guldeUne adjustments 14. 19•20 
50% r 0 Lowrisk(<10%) [)Moderate risk (10%to <15'll,) II High risk( .. 15%) 
l' 
45'lr. 
40% 
i 35'lr. lm; 
0 2S'lr. !:, 
:!20% 
~ 15% 
. 
0.. 10% 
S'lr. 
0 
fTamingham 
only 
Framingham + NHF 
2004 adjustments 
Framingham + NHF 
2006 adjustments 
Framingham + NVOPA 
2!»1 adjustments 
Risk calculation method 
CVD-cardiovascular disease. NHF • National Heart Foundation. NVOPA • National Vucular Disease 
Prevention Alliance. • 
5 Prescription of major cardiovascula r medication groups by CVO risk category, 
calculated using NHF 2004 guidelines,19 for patients in t he AusHEART study 
(n • 5293) 
100% 
] 90% f 0 Low risk (<10%) f8 Mode<ate risk (10% to <15'lr.) Ill High riok (;oo15%) • Establi<hed CVD 
I: 
!160% 
·!SO% 
a. (;40% 
~30'lf, 
!20% 
:. 10% 
0 
BP-lowering 
medication 
Stalin Antiplatelet agent BP-Iowering 
medication 
+- statln 
BP~owering 
medication + statin + 
antiplatelet agent 
Medication classes 
CVD • cardiovas<>Jiar disease. NHF • National Heart Foundation, BP• blood pressure. • 
The evidence-practice gaps found in this 
study are not only the domain of individual 
clinicians, they also relate to system failure. 
A stronger effon to rationalise the many 
guidelines for assessment and management 
of CVD risk factors is needed. The NVDPA 
guideline for CVD risk assessment and 
future plans for an accompanying manage-
ment guideline are important advances in 
creating a standardised approach in primary 
health care. ln addition, the NVOPA is aim-
ing to raise awareness about CVD risk 
assessment in the general population by 
providing a simple online risk calculator. 22 
A departure from the many existing guide-
258 
lines for individual diseases might also sim-
plify management options. Harmonisation 
of guidelines with the PBS is a key accompa-
nying step. The development of point-of-
care decision suppon tools might be another 
way to increase the use of guidelinesY 
PraCtice nurses and other non-GP care pro-
viders could also play a role in supponing 
CVD risk management. 2t 
This survey highlighted that most patients 
aged 55 or older who attend GPs are at high 
risk of CVD. It also revealed significant 
evidence-practice gaps and, in light of the 
availability of known and effective therapies 
to reduce risk, we should give priority to 
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strategies for improving CVD risk manage-
ment in primary care. We recommend that 
GPs assess the absolute CVD risk of their 
older patients and ensure that high-risk 
patients receive evidence-based pharmaco-
therapy. 
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HOW TO TREAT 
{ro11t ('MiiOUI ('afe 
factor mfoi'ITI3tion tO the 55· 
64 year-old chart, it is easy to 
dernOIUO"ate that his risk will 
increase up to the 16-19% 
'high' r.~n,;e over the nexr t S 
yean if there are no other 
changes ro his currmt lifestyle. 
If he develops diabetes over 
this period and his blood pres-
sure stans ro rise , his risk 
escalates to the 25-29% range. 
While there arc many com· 
plex issues at play in how risk 
is communic:ued, this 
appro3Ch can be helpful in dis-
cussing the importance of 
lifestyle and pharmacological 
maru~gemcnt of cardiovascu-
lar risk factors. 
c. ......... rille In. 
....................... 
... 
Mrs 8G, a 50-year-old 
accountant, is planning to 
travel 10 Thailand on a holi-
day a.nd is seeking advice on 
any immunisation require-
menu. She mentions that a first 
cousin, a male aged 68, has 
recently undergone cororu~ry 
artery bypass gr.~fting. 1 
She remembers that at her 
last consultation (six months I 
ago) you had noced her blood 
pressure was high and that you 
had counselled her on lifestyle 
modification. On review of her 
previous records, you note that 
her blood pressure six months 
ago was 152176mmHg. You body weight since she bstsaw 
decide this will be a good you, but engages in linle phys-
opponuniry for a cardiovasc:u- ica I exercise. 
Jar risk assessment. 1 On examination you note 
You confirm with Mrs BG I that her BMl is 26kflm1 with a 
that she has never been diag- waist circumference of 95cm. 
nosed with any cororu~ty, cere- Her blood pressure today is 
brovascular or peripheral vas- 162/84mmHg. She does not 
cular disease. She is currently have any vascular bruits. Fast· 
well and has nor experienced ing blood tests performed at 
any new l)'lllptOms suggestive I her la.st consultation showed a 
of underlying vascular disease. blood glucose level of 
Mrs BG is a former smoker, 4.9mmolll.., total cholesterol 
having stopped two years ago of S.8mmoi/L and HDl. cho-
after 25 years of smoking lesrerol of 1.2mmoVL. The 
about one pack a day. serum creatinine and eGFR 
Apan from her cousin, the levels were within the labora-
only orber family history of tory reference range for 
vascular disease you can ascer· 1 noi'ITI31. 
rain is that her f.uher died sud-
denly aged 74. She has one 
older brorher aged 54 and her 
mother is currently 76, neither 
of whom have any known vas· 
cular disease. She is nor taking 
any medications at present. 
She says she has lost 1 kg in 
"" 1. O..lhllllltllnt IIIVe • 
llldory •••rur• ed canllt-
,_.,..._.., 
&sed on Mrs BG's history and 
the absence of clinical signs 
suggesting oven vascular dis-
case, it is reasonable to assume 
the absence of major vascular 
disease. 
St., 2. Whit .... 
~rlllt lined 0111he 
 IIIII dlarts? 
&sed on this information, her 
calculated five-year risk of a 
cardiovascular event is 5-9% 
using the new Ausmlian risk 
charrs. This assumes absence 
of dhtbetes (based on the fast· 
ing blood glucose level) and 
current non-smoking srarus. 
step 1 ..... ., ellllr 
tAIIcallllleiMIIDIIIIIat _.. !lin.-.... _, .... 
~rislc? 
Her family history'would nor 
be considered strongly sugges-
tive of prernarure vascular dis-
ease. She is currently a non· 
smoker but has only recently 
absrained. She is overweight 
and does not exercise. 
There is evidence that the 
cardiovascular risks decline 
gradually after smoking cessa-
tion (until reaching levels simi-
lar to that of a lifetime non-
smoker afrer about 10 yea.rs), 
suggesting she may have some 
residual risk. Based on this 
additional information, you 
might considtr her risk to be at 
the higher end of the 'low risk • 
range. You do nor have assess-
menu of the presence or 
absence of left ventricular 
hypertrophy or albuminuria, 
which might innuence your 
assessment funher. 
step 4. SIMiuld I anllr lilY 
IICidl1lciDII a.1s 10 refltle my 
_..._ ....... 
c:anlovasalllr rlllt1 
Perfonning an ECG (and an 
echocardiogram, if accessible, 
or if the ECG indicates left 
ventricular hypertrophy by 
voltage criteria) would be 
useful, a.s would be testing for 
microalbuminuria. Presence of 
either of these characteristic$ 
would suggest that Mrs BG's 
long·term risk of a cardiovas-
cular event is higher than esti-
mated with the Framingham 
risk tool. 
- 5. .._ lhoiM tills 
Cll'llonsaUr rlllt -· ...._..,. .......... 
~'"'*'' In the absence of a single vas· 
cular risk-management guide-
line, separate suidclines or 
position statements would 
need ro be considered. 
BP lowerins (National Heart 
Poundalion of Australia Guide 
to Mana~mDtt of Hypnten-
sion 2008). If there are no 
orher risk factors uncovered 
that would reclassify Mrs BG's 
five-year cardiovascular risk 
estimate to > 10%, current 
guidelines suggest thar she is at 
the borderline for initiating 
drug therapy if lifestyle meas-
ures fail to persistently reduce 
her systolic blood pressure ro 
helow 150mmHg and her~ 
tolic blood pressure to below 
90mmHg. 
However, it is important ro 
note that her cardiovascular 
risk will progressiVely 1.ncreasc 
as she ages. If she has any a<kli-
rional risks (eg, left ventricular 
hypemophy on F.CG), current 
guidelines recommend imme-
diate initiation of drug treat· 
mmr. 
0\otcsterollowering (National 
Heart Foundation of Aus-
tralia/Cardiac Society of Aus-
tralia and New Zealand Posi-
tion Statement on Lipid 
Manage~nt 2005). Statin 
therapy would noc he currmtly 
recommended for Mrs BG 
unless the five-year cardiovas-
cular risk is estimated to be 
15%, or 10-15% with the 
presence of rhe merabolic syn-
drome or a significant family 
history of premature cardio-
vascular disease. 
Aspirin. &sed on the results 
of rhe Women's Health Snldy, 
caution with use of aspirin is 
recommended in women aged 
under 65 unless the overall 
cardiovascular risk is very 
high. Thus, the use of low-
dose aspirin in Mrs BG would 
not be recom~ded. 
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GP's contribution 
DR SANJYOT VAGHOI.KAR 
"1111ewood, NSW 
C...ttudJ 
DAVID, 58, is an electrician who has 
been visiting the practice for about 10 
years. He ha.s been well, apart from 
treatment of some benign skin lesions 
and osreoanhriris of his right knee, and 
over the years has seen different GPs 
in the practice. 
Periodically he has had his lipids 
checked. liis total cholesterol has 
ranged from S.O to 6.5 mmoVl. on dif-
ferent occ:asions over the 1.1St few years. 
David has no history of cardiovascular 
disease or diabetes, does nor smoke and 
has no significant family history of ill-
ness. 
I saw him recently when he came in ro 
review lipid results from a few days car· 
lier and ro olnin a repear script for rosu-
vasrarin Smg daily, which he had bcc:n 
sr.arted on about a month earlier by 
another GP. The recent results after a 
month of rosuvasradn were rorol choles-
terol S.4mmoi/L, triglycerides 
0.9mmoVL, HDL cholesterol I.SmmoVL 
and LDL cholesterol J.SmmoVL 
On examination blood pressure was 
126/70mmHg, weight 6Skg, height 
1.73m, BMJ 22kglm'. His lipids before 
sraning rosuvastatin were roral choles-
terol 6.-4mmolll triglycerides 1. 7mmolll... 
HDL cholesterol I.JmmoVl. and LDL 
cholesterol -4.2mmoVL. 
On reviewing rhe siruarion ir became 
apparent that David did nor qualify for 
PBS-subsidised ~arin treatment. I discussed 
this with him and explained that he could 
continue on rosuvasratin but would have 
to pay the full COSt of therapy. He was nor 
in a position to afford this at present. 
........................ 
How could cardiovascular risk assess-
ment help in managing this patient? 
Assuming the absence of any modify-
ing factors (eg, chronic kidney disease), 
David's estimated live-year risk of a car· 
diovucular evenr before treatment with 
stnrins, is S-10%. Prolonged statio ther-
apy might be expected to reduce this 
risk by about 20%, so that the probabil-
ity of such event occurring over a five-
year period would be about -4-8%. 
This type of cardiovascular risk 
assessment will allow David to better 
understand rhe extent of the likely ben-
efits of srarin therapy ro him at the pres-
ent rime- it wggests the current poren-
rial bc:nefirs of stann treatment for him 
are real, bur quantitatively modest 
because of his relatively low initial ri,k. 
The risk chatrs would also help show 
how the situation would change if his 
blood pr~ssure levels rise or he is diag-
nosed with diabetes, which might rein-
force any messages about maintaining 
healthy lifestyle hehnviours. Of course, 
simply ageing will have the greatest 
c:ffect on his estimated risk, which will 
increase to the "moderate ri.sk • cate-
gory of 10- IS% in 10 years time with 
no change in oth~r risk factors, and 
current PBS criteria will still not 
permit subsidised starin therapy. 
The reality is that there is a discon-
nect between guideline recommenda-
rions and PBS subsidy criteria, 
although this gap reduced substantially 
with the latest revisions ro the PBS 
COIII'd nul {>ate 
l.)()Ctot: 
....... ,.. ...... 
• National Vascular Disease 
Prnmrion AUiaJK"C. 
Guidclintt for the 
a~~C~~~~~tnt of ab&olute 
cardiovascular diseuc 
fiSk . 2()()9. 
www.hcartfoundarion.lltJI. 
au/ProfesJionaUnformari 
on/Ciinicai_PracricciPaga 
• Narional Heart 
foundation of Australia. 
Guide 10 manqe!Mflt of 
hypencnaioa 2008. 
www.beanfoundarioa.ora 
.auiSireCollecrionDocurm 
nrt/A %20Hypm%20Gui 
delmn2008%20Gu•dellne 
.pdf 
• Huna J, for the Medical 
luun Commmcc of the 
National Uean 
Foundation of Ausrnalia. 
Aspirin for cardiOvascular 
d~~nse prevention: 
www.mja.eom.au/pubhclis 
sun/179_0l_04080Vhun 
10816_hn.html 
• Huna j . Aspirin for 
pr1mary p~ver~uon of 
card•ovuc:ular diseate in 
wnmm: dnea seJC Olaner? 
www.mja.eom.au/publidit 
sun/184_06_lOOJ06/hun 
11121_fm.html 
• National I lean 
foundation of 
AusrraiWCardiac Society 
of Auatral~a and New 
Ulland. Position 
Statement on I..Jp;d 
Manaaemcnt - 200.S: 
www.hcanfoundation.org. 
eu/SirtCollecriooDcxumen 
u/Upods%20HLC%20Pos 
%20Statemmr.pdf 
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Appendix D: Addressing inequities in access to quality 
health care for Indigenous people 
Publication details: Peiris D, Brown A, Cass A, Addressing inequities in access to quality 
health care for indigenous people, Canadian Medical Association Journal, 2008: 179, 985-
6 
Author contribution: This was an invited editorial for an original research article. I 
conceived of the paper, and used the preliminary findings from the literature review in 
Chapter 6 to write the first and subsequent drafts. Co-authors Cass and Brown commented 
on manuscript drafts. 
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Addressing inequities in access to quality health care 
for indigenous people 
David Peiris MBBS MIPH, Alex Brown BMed MPH, Alan Cass MBBS PhD 
ocoo See related n:seaR:h paper by Gao and colleagues. page 1007 
M any issues influence access to quality health care for indigenous people. In th.is issue of CMAJ, Gao and colleagues' describe inequities in acces.~ to 
health care and service utilization among Canadian Aborig-
inal people with chronic kidney disease. Similar findings 
have been reported in Australia.' New Zealand' and the 
United Sr:ues_ • Although well-conducted studies that quan-
tify the extent of the disparity and trends in health care ac-
cess are needed, addressing the underlying causes of this 
disparity is a priority- not merely because such disparities 
are unacceptable but because disparities in access contribute 
to major and avoidable ill health. 
One key contextual barrier to accessing health care that has 
been described in the literature from Australia. Canada, New 
Zealand and the US is the continuing impact of col.onization.' 
The Can:ldian Royal Commission on Aboriginal Peoples and 
the Australian Royal Commission on Aboriginal Deaths in. 
Custody comprehensively documented the contemporary ef-
fects of past discriminatory policies on indigenous people."' 
Although few empirical studies have examined the health 
effects of discriminatory policies, a well-conducted cohort 
study in Australia reported that the forced removal of Aborig-
inal children from their families affected health for genera-
tions_' By engendering distrust in govem.ment agencies, pol-
icies such as these contribute to high levels of stress among 
indigenous people. Psychosocial stress. a phenomenon com-
mon to many vulnerable populations, is an important barrier to 
accessing health care and has been consistently associated 
with adverse health outcomes for indigenous people.' 
Health care systems and health care services are not im-
mune from this historical policy contexL Studies, predomin-
antly with qualitative designs, have shown that indigenous peo-
ple are sensitive to power imbolances in their interactions with 
health care services. This is intimately linked with the domi-
nance of the biomedical paradigm and the view that noncom-
pliant behaviours by indigenous people are the cause of poor 
health outcomes. By contrast, when care providers promote a 
nonbiomedical approach to health care interactions, through 
trust, reciprocity and shared decision-making, they can em-
power recipients and more effectively deliver interventions to 
reduce the gap in health outcomes. Much work focuses on mis-
communication as an access barrier. 10 Relevant factors include 
; conununication dynamics and sharing of health infonn:ltion, §. language and literacy. In heal.th care for indigenous people, the 
! power dynamic directly affects communication. 
~ A related, comp.lex area is the attribution or cultural factors 
- as both barriers to and facilitators of health care. There is a 
~ clear need to abandon stereotypical concepts of indige.nous 
8 cultures and the simplistic embrace of particular culture-based 
Key points 
• lnequitles in acteS5 to necessary health care are unaccept-
able and contribute to gaps in health status between 
indigenous and non-indigenous people. 
• Access b~rrien exist in patient-provider interactions, 
health services .ld hulth SyStems. 
• Indigenous perspectives on access barriers are poorly 
represented and undervalued in the sci~tiflc literature. 
• Consider mcwing tow~rd the concept of •cuJtural safety• 
rather than~ checklist approach. 
ingredients as means of transforming services into becoming 
44appropriat.e.," .. aware," ''sc.nsjtive" or ••competent" - tcnns 
that are often poorly defmed. The more dynamic concept of 
"cultural safety," originally developed by Maori nurses, is 
quite different." Cultural safety shifts the ro.le of culture away 
from a check-list approach based on a person's ethnic back-
ground and toward a critical examination of the power imbal-
ances in health care encounters between indigenous patients 
and non-indigenous health care providers. When viewed in 
this way, culturally safe health care becomes a core principle 
for the reorientation of health services to better meet the needs 
of vulnerable groups, irrespective of their ethnic background. 
We need to move beyond patient-provider interactions in 
developing a policy-informing agenda on access. Known fa-
cilitators of access are the establishment of community-gov-
erned health services, a robust indigenous managerial and 
clinical workforce and the ability to deliver models of care 
that embrace indigenous knowledge systems.11 The inteqxe-
tive synthesis of the literature about the barriers to access for 
vulnerable groups by Dixon-Woods and colleagues has led to 
the development of the useful concepts of "navigationH and 
"penneability."u Navigation requires an awareness of the 
available services and the mobilization of personal and health 
service resources to provide access, such as transport. min-
imal out-of-pocket cost and Oexible hours. Permeable ser-
vices require little negotiation for entry and a minimal level of 
understanding of how the system works. These services may 
include having welcoming physical spaces, open-door pol-
icies and reception staff who are known to the community. 
Measures of health system performance are incre:~Singly 
used to improve access and quality of care. The US Indian 
Health Service has invested substantially in information tceh-
from the George Institute for lnternatlon.t HNith (hirls, ~. sydney; the 
c.ntre for Indigenous VMCUiar .00 Diabetes "esearch (Brown), Iaker 101 
~art and ~tes Institute. Ali« Springs; 1M Poche Centra for Indigenous 
Health(~. University of Sydney, ~.Australia 
All odlta<~ monor In CMA.J rep~nts the oplnlom of tiM outhon ond not nKI>IMily those of tho c.tnadlan ModicoiA,.odation. 
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nology to support macrosysrem monitoring of quality meas-
ures.'' The Austr.llian government is developing quality indi-
cator programs for Aboriginal health scrvK:es. Although these 
approaches are valuable. caution is needed in their applica-
tion. In a review of indigenous health performance measure-
ment systems. Smylie and colleagues argue that the develop-
ment of these macrosystem measures, which are usually 
based on physical and disease variables, often come at the 
expense of developing locally specific he:1lth indicators for 
indigenous populations. OJ The article by Goo and colleagues 
exempHfies the problem discussed by Anderson and col-
leagues> in the classiftcation of ethnicity, particularly for peo-
ple of mixed descenL The classification of non-swus First 
Nations and Metis people as non-Aboriginal is epidemiolog-
ically expedient, but it raises concerns about equity. Support 
foe local measurement systems responsive to indigenous peo-
ple and to their health service priorities can complement con-
ventional performance measures and ensure valid interpreta-
tion of those measurements. 
Our l.ist of bamers and facilitators is not exhaustive. A 
key consideration is the need for greater clarity in how we 
conceptuali7.e baniers, their defming cJuuucteristics and their 
causes. Closely related is the need to move beyond explana-
tory models, which focus on deficiencies in individuals and 
services, and toward a better understanding of existing facili-
tators to improved access and quality. The research on which 
to base policy is a labyrinthine mix of qualit:ltive studies, 
audits and surveys, program evaluations. advocacy. quality 
improvement projects, nonsystematic topic reviews and 
opinion pieces. Opinion pieces are often key sources of in-
digenous perspectives but are poorly represented and under-
valued in the scientific literature. Much of this disparate liter-
ature is locally specific. small in scale and is often not 
amenable to the reductionism of conventional systematic re-
views. This makes national and international extrapolation 
difficult and poses dilemmas for the development of 
evidence-based policy. 
In Canada, Australia. New Zealand and the US, inequities 
in access to health care and outcomes for indigenous people 
have been well-characterized. To dose these gaps, we need 
to document disparities and understand their causes more 
precisely and make collaborative changes. Such changes are 
often resisted by institutional. political, structural, social and 
cultural forces. As indicated by an Aborigi03J man with end-
stage kidney disease interviewed for the Improving Access 
to IGdney Trnnsplants study'• when discussing communi-
cation with his kidney specialists: "You don' t go knocking 
on their door, [that's the] 'danger one.' The door is locked. 
They sit behind closed doors." If we are able to open these 
doors. our health care system.~ may perform beuer for the 
most vulnerable. 
Comswtlaa Interests: None declomt. 
CootrlbulorS: Each of lhe IIUIIlors coneribuced co lhe c:on~enc of lhe anicle. 
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Appendix E: Other outputs during my doctoral studies 
Awards 
2008 Early in Career Public Health Award, Public Health Association of Australia 
2009 Cross Cultural Public Health Research Award, Faculty of Medicine, University of 
Sydney 
Invited presentations 
• NHMRC International Clinical Trials Symposium, Sydney. 'Focus group on 
Indigenous health - 'What can you do?' September, 2007 
• Aboriginal Health Research Conference Plenary Session Sydney - Working 
effectively with communities, April 2008 
• Aboriginal Health & Medical Research Council GP update forum, Sydney. 
'Cardiovascular risk management in Aboriginal Medical Services' June 2008 
• Aboriginal Drug and Alcohol Network Conference, Tamworth. 'Chronic Diseases in 
Aboriginal Health- Closing treatment gaps' July 2008 
• Aboriginal Health & Medical Research Council GP update forum, Sydney. 
'Research in an Aboriginal Community Controlled context ' May 2009 
• Cardiac Society of Australia and New Zealand Inaugural Indigenous Cardiovascular 
Health Conference, Chronic care in the primary health sector- Will COAG help? 
August 2009 
• Aboriginal Health & Medical Research Council Action for Health Conference 
Plenary Session, Sydney 'Monitoring and Clinical Systems in Primary Care' 
September 2009 
• Presentation to Margaret Chan, Director General, World Health Organisation, 'The 
Kanyini Vascular Collaboration', Wuchopperen Health Service, Cairns, November 
2009 
• Wentwest Division of General Practice annual GP Expo - One day workshop on 
CVD risk management and prevention in primary care. Sydney, May 2010 
Media appearances 
The findings from the Kanyini Audit (Chapter 2) and the 'Identifying the Gaps in 
Cardiovascular Risk Management' paper (Appendix A) received widespread media 
attention. I appeared in 25 national TV, radio and newspaper sources during the last week 
of September. I also demonstrated the electronic CVD decision support system, described 
in Chapter 5, to Dr Norman Swan on the ABC Catalyst program on October 1, 2009 
Appendix E - 1 
Committee appointments 
• Royal Australian College of General Practitioners Faculty of Aboriginal and Torres 
Strait Islander Health 
• Aboriginal Health & Medical Research Council Information Computer 
Technology/Information Management Reference Group 
• Technical Reference Group member advising the Department of Health and Ageing 
on Pharmaceutical Benefits Scheme Measures for the Council of Australian 
Governments National Partnership Agreement on Closing the Gap in Indigenous 
Health Outcomes 
• Technical Reference Group member advising the Department of Health and Ageing 
on the development of a Primary Health Care Resource for the Council of Australian 
Governments National Partnership Agreement on Closing the Gap in Indigenous 
Health Outcomes 
• Baker IDI NHMRC diabetes management guidelines implementation working group 
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